data_1n87_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n87 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.192 0.52 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.19 138.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.741 1.258 . . . . 0.0 113.409 -168.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.72 49.13 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.116 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.6 -58.23 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.095 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.3 m -135.95 -5.58 2.15 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.48 7.35 79.36 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-N 119.961 1.255 . . . . 0.0 115.444 172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.4 141.67 58.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.018 2.527 . . . . 0.0 111.783 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.04 114.63 19.1 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 169.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 145.66 37.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 114.038 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -91.89 -31.39 15.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.772 2.029 . . . . 0.0 110.136 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -126.42 83.25 64.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 126.29 1.836 . . . . 0.0 109.482 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.99 127.48 25.19 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.036 3.157 . . . . 0.0 110.637 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.3 t -141.63 143.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 126.413 1.885 . . . . 0.0 110.842 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -125.29 157.4 36.73 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.979 1.712 . . . . 0.0 110.296 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 t -127.51 133.35 24.99 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.699 1.599 . . . . 0.0 108.619 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -55.05 -13.61 6.88 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.931 3.088 . . . . 0.0 117.058 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -95.88 -56.99 2.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.142 0.883 . . . . 0.0 111.619 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.7 p -63.78 -37.95 89.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.252 1.821 . . . . 0.0 114.264 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 58.62 1.14 0.17 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 128.965 2.906 . . . . 0.0 116.923 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -69.52 177.38 2.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.556 1.942 . . . . 0.0 110.04 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.45 115.81 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 169.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.67 169.21 9.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 112.282 172.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -74.25 131.02 40.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.389 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.42 -42.65 64.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.684 1.593 . . . . 0.0 110.622 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -63.55 -40.42 96.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.83 -35.18 60.06 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.443 -0.786 . . . . 0.0 111.336 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.17 -44.79 94.47 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 119.091 -0.481 . . . . 0.0 109.714 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -54.94 -38.93 68.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.646 0.778 . . . . 0.0 111.401 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.69 -53.32 58.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.122 0.487 . . . . 0.0 112.112 171.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.18 -34.78 78.25 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.984 0.897 . . . . 0.0 112.328 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.461 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.1 p -83.07 -17.36 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.739 1.215 . . . . 0.0 112.795 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -92.81 -14.65 27.5 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.854 -1.154 . . . . 0.0 111.405 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -56.96 4.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.995 1.718 . . . . 0.0 111.677 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -133.67 -21.61 1.95 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.938 1.295 . . . . 0.0 112.505 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.85 -11.9 55.11 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.086 0.85 . . . . 0.0 113.658 -172.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -67.17 154.51 41.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.222 1.511 . . . . 0.0 113.317 -170.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.63 133.94 79.45 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.11 -14.08 7.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.157 3.238 . . . . 0.0 118.002 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.97 -48.84 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.712 1.142 . . . . 0.0 111.548 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.3 p -85.84 -11.12 54.18 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.333 0.3 OUTLIER 48.71 24.75 0.85 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.049 2.54 . . . . 0.0 115.295 -169.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.13 118.44 49.65 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.24 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.96 132.52 52.71 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.448 2.765 . . . . 0.0 113.91 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp 72.19 144.59 0.07 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 128.822 2.849 . . . . 0.0 111.864 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.9 t -143.32 -61.5 0.41 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.662 1.585 . . . . 0.0 111.151 -169.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.461 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -62.72 -26.89 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.69 -5.95 33.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.446 1.098 . . . . 0.0 112.301 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -128.67 11.85 6.26 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.47 1.908 . . . . 0.0 112.328 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 7.1 tt -57.8 143.62 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.756 1.622 . . . . 0.0 114.697 -171.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.66 86.22 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.207 2.203 . . . . 0.0 109.15 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -72.02 125.92 28.45 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.014 . . . . 0.0 111.412 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 126.309 1.844 . . . . 0.0 109.196 -175.725 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.479 0.657 . . . . 0.0 112.066 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.2 m -59.7 137.55 58.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -168.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.38 -25.0 63.05 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.088 0.471 . . . . 0.0 112.174 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.41 -51.58 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.037 1.735 . . . . 0.0 111.584 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 p -123.33 -18.7 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.19 11.31 84.5 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.68 167.45 13.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.112 2.565 . . . . 0.0 113.157 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.0 t -83.45 107.91 11.5 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.76 127.61 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.484 2.123 . . . . 0.0 113.624 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -71.1 -39.47 72.07 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.096 1.358 . . . . 0.0 111.065 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -124.7 86.83 55.42 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.792 1.237 . . . . 0.0 109.969 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.18 127.33 25.6 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.009 3.139 . . . . 0.0 110.712 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.5 t -140.01 142.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.415 1.886 . . . . 0.0 109.858 -170.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.56 157.4 46.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.801 1.641 . . . . 0.0 110.923 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -132.03 128.32 21.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.959 1.704 . . . . 0.0 108.221 169.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.68 -12.59 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.502 3.468 . . . . 0.0 116.714 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -83.79 -58.11 2.93 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.106 1.363 . . . . 0.0 110.567 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -27.16 68.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.035 1.734 . . . . 0.0 114.705 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 46.35 45.74 13.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 126.344 1.858 . . . . 0.0 113.959 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -136.71 174.5 10.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.145 2.578 . . . . 0.0 109.401 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.52 116.75 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -111.47 168.18 9.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 111.472 173.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.97 131.11 41.09 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.778 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -46.88 -45.48 20.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.807 1.643 . . . . 0.0 109.739 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -59.29 -37.87 78.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -40.12 33.86 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.008 0.523 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.5 tp -63.11 -45.68 90.9 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -55.6 -42.62 75.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.484 1.514 . . . . 0.0 111.798 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -59.15 -53.07 62.49 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.293 -0.879 . . . . 0.0 111.408 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -67.37 -34.26 76.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.913 1.285 . . . . 0.0 112.427 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.02 -17.35 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.264 1.025 . . . . 0.0 112.845 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.61 -21.03 24.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.963 1.305 . . . . 0.0 111.426 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -57.64 3.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.348 1.859 . . . . 0.0 111.451 175.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.3 p -133.27 -21.53 2.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.143 1.377 . . . . 0.0 112.45 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.84 -12.45 57.18 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.248 0.927 . . . . 0.0 113.387 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.24 156.44 34.23 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.492 1.646 . . . . 0.0 113.267 -170.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.42 134.96 57.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 167.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.87 -5.21 12.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.993 2.462 . . . . 0.0 115.377 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.9 mt -121.55 -48.08 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.904 1.282 . . . . 0.0 111.506 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.9 p -88.75 -12.34 42.44 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.356 0.3 OUTLIER 47.42 25.17 0.57 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.053 2.541 . . . . 0.0 115.149 -169.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.72 129.96 90.77 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.495 -0.764 . . . . 0.0 110.243 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 134.47 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.958 2.438 . . . . 0.0 112.541 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.267 41.0 mt 71.79 133.92 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.695 3.198 . . . . 0.0 113.371 -175.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.12 -45.03 0.71 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.88 2.072 . . . . 0.0 111.424 -169.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.517 ' H ' HG23 ' A' ' 32' ' ' VAL . 11.1 tp -58.33 -35.12 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.476 1.911 . . . . 0.0 114.469 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.18 -8.21 36.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.499 1.519 . . . . 0.0 111.912 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.71 7.21 5.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.442 1.497 . . . . 0.0 113.1 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.3 145.36 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.895 1.331 . . . . 0.0 114.492 -169.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.25 96.53 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.168 2.587 . . . . 0.0 108.548 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.37 117.57 27.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.976 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 125.377 1.471 . . . . 0.0 109.463 172.806 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.652 0.739 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.5 t -64.89 141.3 58.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.98 1.371 . . . . 0.0 113.482 -168.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.64 -18.51 31.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.47 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.68 -52.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.328 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -140.19 -6.62 1.22 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.31 74.81 Favored Glycine 0 N--CA 1.474 1.205 0 O-C-N 120.842 -1.161 . . . . 0.0 115.263 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.07 142.67 41.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.822 2.449 . . . . 0.0 110.969 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.17 108.41 2.47 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.73 109.99 0.5 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.816 2.344 . . . . 0.0 114.367 -169.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -60.5 -48.83 80.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.556 1.142 . . . . 0.0 110.781 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -119.21 88.59 37.75 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 126.231 1.812 . . . . 0.0 109.235 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 127.65 23.74 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.029 3.153 . . . . 0.0 111.588 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.55 144.32 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 126.163 1.785 . . . . 0.0 110.104 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -133.37 149.74 51.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.401 1.88 . . . . 0.0 110.555 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 t -132.67 117.64 15.33 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.91 -12.82 5.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.327 3.351 . . . . 0.0 116.693 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -47.19 60.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.764 1.225 . . . . 0.0 112.086 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -96.77 -19.76 18.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.867 1.267 . . . . 0.0 112.592 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 64.3 -3.94 0.46 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 128.941 2.896 . . . . 0.0 116.031 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 p -72.83 168.13 19.51 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.792 2.037 . . . . 0.0 113.037 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 mm -115.11 115.96 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.32 171.98 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.05 1.74 . . . . 0.0 111.514 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.12 138.27 43.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.88 -46.41 51.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.672 1.589 . . . . 0.0 109.559 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.77 -40.83 69.01 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.487 -0.758 . . . . 0.0 111.483 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.49 -44.1 95.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.428 0.558 . . . . 0.0 109.575 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.77 -39.26 70.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.479 0.712 . . . . 0.0 111.442 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.36 -45.65 83.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.662 -0.649 . . . . 0.0 111.904 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -69.63 -37.83 76.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.312 1.045 . . . . 0.0 112.241 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.437 HG22 ' H ' ' A' ' 47' ' ' ILE . 2.5 p -79.63 -18.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.251 1.02 . . . . 0.0 112.688 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -79.2 -30.25 43.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.9 2.08 . . . . 0.0 110.269 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -55.26 6.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.109 1.764 . . . . 0.0 111.675 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.7 p -134.24 -21.18 1.84 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.162 1.385 . . . . 0.0 112.175 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.71 -10.63 61.7 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.998 0.808 . . . . 0.0 113.193 -170.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.16 155.4 35.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.467 1.634 . . . . 0.0 113.257 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -78.11 136.69 61.38 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -55.79 -17.37 18.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.82 3.013 . . . . 0.0 118.584 -169.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.8 mt -126.71 -46.29 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 120.253 1.388 . . . . 0.0 111.819 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -81.42 -13.35 58.35 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.309 0.5 OUTLIER 44.66 30.29 0.5 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.927 2.491 . . . . 0.0 114.633 -170.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.23 135.64 89.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.769 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.14 135.83 28.05 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.661 2.241 . . . . 0.0 112.246 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp 70.1 147.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 0.0 111.673 -172.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 t -146.38 -48.47 0.2 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.503 1.921 . . . . 0.0 110.621 -169.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.437 ' H ' HG22 ' A' ' 32' ' ' VAL . 9.3 tp -56.89 -31.39 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 127.279 2.231 . . . . 0.0 114.986 174.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.2 -6.89 25.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.93 1.292 . . . . 0.0 112.129 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.29 8.87 4.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.627 1.571 . . . . 0.0 112.813 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 tt -60.31 137.1 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.806 1.289 . . . . 0.0 113.106 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.93 97.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 127.379 2.272 . . . . 0.0 108.575 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -76.24 124.06 26.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.915 -1.116 . . . . 0.0 109.778 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 124.697 1.199 . . . . 0.0 109.908 -174.052 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.036 0.446 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 1.8 m -48.94 125.42 10.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -167.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.21 62.1 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.98 -57.58 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.947 2.099 . . . . 0.0 111.056 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -126.78 -11.3 6.08 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.14 14.27 82.0 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.587 1.085 . . . . 0.0 114.519 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -71.84 163.77 27.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.929 2.892 . . . . 0.0 111.516 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.8 110.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.0 126.68 12.73 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.013 1.809 . . . . 0.0 112.224 -169.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -78.46 -33.61 48.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.263 1.425 . . . . 0.0 111.84 170.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -129.93 83.89 62.4 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.688 1.595 . . . . 0.0 109.72 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.13 132.95 52.27 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.582 2.855 . . . . 0.0 111.223 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.35 148.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 126.077 1.751 . . . . 0.0 109.611 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.16 154.61 51.57 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.608 1.563 . . . . 0.0 109.505 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -126.89 119.59 22.53 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 108.403 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -56.33 -8.06 2.39 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.55 3.5 . . . . 0.0 117.326 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -40.07 62.27 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.223 1.409 . . . . 0.0 111.057 177.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.9 p -98.94 -30.43 12.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.204 1.802 . . . . 0.0 113.777 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 55.4 13.4 0.91 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.486 2.315 . . . . 0.0 114.89 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.1 p -77.66 169.47 18.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.91 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 mm -104.94 143.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -143.14 166.39 24.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.496 1.918 . . . . 0.0 110.576 168.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -74.82 128.34 35.33 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.028 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -45.27 -48.14 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.32 1.848 . . . . 0.0 109.756 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 76.0 p -68.86 -24.74 64.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -41.71 50.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.641 1.109 . . . . 0.0 110.784 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.1 tp -64.4 -44.94 89.69 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -54.9 -41.57 71.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.732 1.613 . . . . 0.0 111.864 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -61.1 -51.05 70.75 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.604 -0.685 . . . . 0.0 112.088 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.11 -35.72 80.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.166 0.984 . . . . 0.0 112.075 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.519 HG22 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -83.83 -15.52 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.858 1.263 . . . . 0.0 113.156 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -95.61 -13.17 24.58 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.149 -0.969 . . . . 0.0 111.606 168.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -57.57 3.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.143 1.777 . . . . 0.0 111.364 169.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.6 p -133.39 -21.83 2.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.905 1.282 . . . . 0.0 112.515 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -11.03 63.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.114 0.864 . . . . 0.0 113.316 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -64.35 156.11 30.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.724 1.762 . . . . 0.0 114.092 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.89 130.55 72.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.856 1.263 . . . . 0.0 108.573 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.76 -8.29 2.92 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.222 3.281 . . . . 0.0 118.647 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.88 -44.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.111 1.365 . . . . 0.0 112.282 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.6 p -98.33 -7.56 28.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.16 0.984 . . . . 0.0 112.754 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.305 0.5 OUTLIER 45.44 29.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.812 2.845 . . . . 0.0 115.686 -175.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -71.47 139.19 83.87 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.042 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.06 136.91 33.37 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.538 2.159 . . . . 0.0 112.62 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.3 mp 73.96 147.15 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.106 2.962 . . . . 0.0 112.065 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -145.89 -57.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.798 1.639 . . . . 0.0 110.596 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.519 ' H ' HG22 ' A' ' 32' ' ' VAL . 3.1 tt -62.85 -26.87 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -70.01 -6.45 33.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.416 1.086 . . . . 0.0 112.181 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.75 9.57 6.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.364 1.866 . . . . 0.0 112.337 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 10.5 tt -59.8 150.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.032 1.733 . . . . 0.0 114.906 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.4 t -123.99 95.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 128.209 2.603 . . . . 0.0 108.321 169.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -86.37 119.48 26.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 124.827 1.251 . . . . 0.0 108.401 174.081 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.3 m -55.32 134.38 50.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.47 -16.11 61.8 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.86 -58.73 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.73 0.812 . . . . 0.0 110.742 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -124.77 -10.53 7.26 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.76 16.29 79.37 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 119.024 0.829 . . . . 0.0 113.261 174.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -66.92 160.91 25.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.897 2.479 . . . . 0.0 110.613 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.0 112.98 16.45 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.49 106.2 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.756 2.304 . . . . 0.0 112.306 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -57.71 -45.87 85.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.659 1.584 . . . . 0.0 111.287 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -122.98 92.43 49.18 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.166 1.386 . . . . 0.0 109.949 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.64 123.99 13.35 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.617 2.878 . . . . 0.0 111.383 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.21 151.36 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.255 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tt -134.51 149.03 50.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.71 1.604 . . . . 0.0 110.794 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 t -113.39 131.74 22.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.698 1.199 . . . . 0.0 108.118 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.58 -5.48 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.439 2.093 . . . . 0.0 114.289 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -55.0 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.175 1.39 . . . . 0.0 111.042 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.8 p -79.75 -35.93 38.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.378 1.471 . . . . 0.0 112.694 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 59.86 11.25 2.46 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.906 2.882 . . . . 0.0 114.307 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.5 p -77.03 175.98 9.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 128.281 2.632 . . . . 0.0 111.793 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.13 132.61 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 108.449 171.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -129.38 173.63 10.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.074 1.749 . . . . 0.0 110.243 168.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 151.8 41.87 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.368 172.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -56.91 -52.08 66.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.569 1.077 . . . . 0.0 108.679 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -76.19 -24.24 54.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.6 mt -72.27 -44.32 62.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.864 0.756 . . . . 0.0 111.465 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 tp -63.81 -45.14 91.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -53.85 -38.54 64.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.238 1.415 . . . . 0.0 111.693 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -62.16 -51.61 67.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.479 -0.763 . . . . 0.0 111.885 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -67.26 -37.28 83.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.457 1.103 . . . . 0.0 112.377 -173.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.45 HG22 ' H ' ' A' ' 47' ' ' ILE . 2.9 p -81.57 -20.0 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.504 1.122 . . . . 0.0 112.398 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -81.59 -25.39 35.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.764 1.626 . . . . 0.0 111.077 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -56.0 5.58 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.261 1.824 . . . . 0.0 111.307 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.6 p -135.25 -21.4 1.6 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.885 1.274 . . . . 0.0 112.458 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -14.57 35.65 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.743 1.163 . . . . 0.0 113.857 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -67.22 151.47 47.48 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.026 1.413 . . . . 0.0 111.629 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -68.53 140.06 92.07 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.103 -0.998 . . . . 0.0 110.108 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -57.2 -14.39 15.13 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.095 3.197 . . . . 0.0 117.565 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.15 -50.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.88 1.272 . . . . 0.0 112.141 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 p -86.06 -11.23 53.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.63 0.772 . . . . 0.0 112.548 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.296 0.5 OUTLIER 45.07 30.53 0.61 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.077 2.551 . . . . 0.0 115.191 -171.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -70.76 132.22 87.18 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.431 -0.793 . . . . 0.0 109.653 172.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.02 137.18 36.93 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.729 2.286 . . . . 0.0 112.221 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 mp 69.25 139.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 128.191 2.597 . . . . 0.0 112.291 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 t -139.01 -55.12 0.6 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.556 1.542 . . . . 0.0 111.235 -169.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.45 ' H ' HG22 ' A' ' 32' ' ' VAL . 9.3 tp -59.84 -30.38 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.645 1.978 . . . . 0.0 115.104 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -71.54 -4.06 24.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.645 1.178 . . . . 0.0 112.363 171.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -127.94 9.81 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.643 1.577 . . . . 0.0 112.427 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 tp -58.87 144.08 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 114.947 -169.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.94 103.12 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.793 2.437 . . . . 0.0 109.741 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.56 123.69 33.3 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.153 . . . . 0.0 112.405 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 125.858 1.663 . . . . 0.0 108.92 172.975 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -59.33 139.1 57.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -168.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.42 -17.44 60.79 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -82.47 -59.21 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.498 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -124.82 -3.39 7.71 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.15 13.92 83.14 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 119.156 0.889 . . . . 0.0 114.812 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -78.59 163.87 25.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.296 2.638 . . . . 0.0 111.358 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.59 111.73 15.82 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.72 118.59 5.67 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.424 2.083 . . . . 0.0 112.844 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -61.28 -35.95 78.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.383 1.473 . . . . 0.0 111.604 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -129.76 91.26 40.8 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.21 1.404 . . . . 0.0 110.65 171.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.12 127.13 22.13 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.016 3.144 . . . . 0.0 112.136 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.18 143.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 126.664 1.986 . . . . 0.0 110.005 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tt -131.4 158.05 41.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.66 1.584 . . . . 0.0 110.504 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.5 t -129.69 130.0 23.17 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.756 1.623 . . . . 0.0 108.36 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.11 -16.22 12.11 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.812 3.008 . . . . 0.0 116.318 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -82.37 -47.13 12.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.153 1.381 . . . . 0.0 111.693 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.6 p -79.04 -35.75 42.16 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.014 1.326 . . . . 0.0 113.084 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.292 15.2 ptm180 50.37 11.6 0.08 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.409 3.084 . . . . 0.0 115.358 -169.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.1 p -75.51 173.73 10.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.159 2.584 . . . . 0.0 111.054 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.27 116.14 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.155 -0.965 . . . . 0.0 108.559 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -114.27 175.01 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.627 1.971 . . . . 0.0 111.25 172.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -75.39 149.16 38.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.055 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -54.79 -49.71 70.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -71.32 -32.66 68.86 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 mt -71.5 -44.31 64.92 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.142 0.577 . . . . 0.0 111.524 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.11 -44.0 93.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -54.7 -39.88 68.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.57 1.548 . . . . 0.0 111.357 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -61.71 -51.38 68.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.212 0.605 . . . . 0.0 111.573 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -67.46 -35.78 79.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.028 0.918 . . . . 0.0 112.114 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.504 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.3 p -83.97 -15.28 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.955 1.302 . . . . 0.0 113.185 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -96.13 -12.63 24.47 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 121.072 -1.018 . . . . 0.0 111.486 168.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -57.65 3.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.996 1.718 . . . . 0.0 111.291 169.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -132.5 -22.34 2.19 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.025 1.33 . . . . 0.0 112.538 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.39 -11.26 63.95 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.218 0.913 . . . . 0.0 113.151 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.79 155.42 30.4 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.552 1.676 . . . . 0.0 113.862 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.33 130.96 57.34 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -66.57 -4.28 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.042 3.161 . . . . 0.0 116.243 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.82 -41.44 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.207 1.403 . . . . 0.0 111.776 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -105.03 -9.24 17.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.054 1.342 . . . . 0.0 113.662 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.373 0.0 OUTLIER 50.02 22.4 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.732 2.813 . . . . 0.0 115.635 -169.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.58 132.15 94.95 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.456 -0.777 . . . . 0.0 110.503 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 130.54 18.57 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.759 2.306 . . . . 0.0 112.398 -172.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.26 38.8 mt 71.8 139.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 129.092 2.957 . . . . 0.0 113.378 -173.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 t -137.36 -51.58 0.65 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.302 2.241 . . . . 0.0 110.59 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.504 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.3 tp -55.47 -34.66 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 127.801 2.44 . . . . 0.0 115.193 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -66.03 -9.56 31.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.393 1.477 . . . . 0.0 112.066 172.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -133.2 10.28 4.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.714 1.606 . . . . 0.0 112.941 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.44 147.35 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.6 t -121.84 91.95 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 128.011 2.524 . . . . 0.0 108.531 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -77.03 126.92 31.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.06 -1.025 . . . . 0.0 110.693 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.2 mt . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 125.328 1.451 . . . . 0.0 109.696 -177.613 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.292 0.568 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -56.12 138.13 50.25 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -168.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.72 -23.86 64.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.13 -46.94 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.681 1.192 . . . . 0.0 112.12 -169.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 t -123.66 -17.81 6.3 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.22 13.86 82.87 Favored Glycine 0 N--CA 1.47 0.953 0 O-C-N 121.277 -0.889 . . . . 0.0 114.642 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -72.2 162.96 28.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.841 2.857 . . . . 0.0 111.285 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -76.54 106.73 3.62 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 168.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -61.04 119.15 6.16 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.293 1.995 . . . . 0.0 114.247 -168.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.2 mmt-85 -71.19 -34.84 71.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.309 1.044 . . . . 0.0 111.867 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -122.89 83.95 50.05 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.16 1.384 . . . . 0.0 110.382 169.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.3 121.61 9.88 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.132 3.221 . . . . 0.0 111.744 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.83 142.15 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 127.144 2.178 . . . . 0.0 110.876 -169.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -133.03 157.59 44.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.424 2.289 . . . . 0.0 110.075 -173.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 p -131.92 149.26 72.84 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.563 1.145 . . . . 0.0 110.681 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.61 -7.31 20.95 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.239 2.626 . . . . 0.0 113.921 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -56.06 3.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.703 1.201 . . . . 0.0 110.428 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 98.9 p -66.38 -37.21 84.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.964 1.306 . . . . 0.0 113.63 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 55.61 4.5 0.11 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 127.665 2.386 . . . . 0.0 116.272 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 t -86.68 179.59 6.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.362 2.665 . . . . 0.0 111.68 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.46 116.51 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.23 172.11 7.11 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.312 1.845 . . . . 0.0 111.94 170.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -83.33 136.17 34.46 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.817 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.5 -43.85 45.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.305 1.842 . . . . 0.0 110.444 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 t -61.04 -39.62 90.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.883 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.69 -42.2 64.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.319 1.048 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.38 -44.57 94.35 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.68 -43.77 69.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.973 0.909 . . . . 0.0 110.72 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -59.13 -55.46 34.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.19 -0.319 . . . . 0.0 111.851 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -65.45 -33.42 75.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.226 1.012 . . . . 0.0 112.331 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.558 HG22 ' H ' ' A' ' 47' ' ' ILE . 1.4 p -86.62 -13.46 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 113.348 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -99.55 -10.95 21.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.774 1.23 . . . . 0.0 111.618 168.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.59 -56.3 4.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.968 2.107 . . . . 0.0 110.897 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.2 p -134.57 -23.2 1.64 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.972 1.309 . . . . 0.0 112.727 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.72 -12.55 63.15 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.677 1.132 . . . . 0.0 113.086 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -63.72 156.51 26.83 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.145 1.473 . . . . 0.0 113.984 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -82.08 130.58 59.6 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 167.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.38 -4.78 10.02 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.004 3.136 . . . . 0.0 117.321 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.0 mt -116.33 -49.36 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.568 1.147 . . . . 0.0 110.912 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.9 p -91.31 -12.87 33.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.398 1.079 . . . . 0.0 113.796 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.381 0.0 OUTLIER 50.67 23.83 1.49 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.334 2.654 . . . . 0.0 115.193 -169.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -68.34 137.2 91.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.57 140.18 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.337 2.025 . . . . 0.0 112.742 -172.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 mt 66.33 128.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 128.954 2.901 . . . . 0.0 114.704 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -129.24 -45.4 1.24 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.032 1.733 . . . . 0.0 111.544 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.558 ' H ' HG22 ' A' ' 32' ' ' VAL . 11.1 tp -58.97 -35.2 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.982 2.113 . . . . 0.0 114.507 172.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.61 -8.88 38.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.304 1.442 . . . . 0.0 111.84 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.39 8.69 6.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.627 1.571 . . . . 0.0 112.99 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.93 137.4 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.726 1.251 . . . . 0.0 114.236 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -119.66 91.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.045 2.138 . . . . 0.0 108.82 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -76.19 115.93 16.39 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.027 -1.046 . . . . 0.0 110.074 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.07 -177.35 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.458 0.647 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 0.5 OUTLIER -56.88 135.67 55.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -168.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.97 64.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.995 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.91 -49.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.473 1.509 . . . . 0.0 112.164 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -126.23 -23.33 3.88 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.51 18.83 78.77 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.138 0.875 . . . . 0.0 113.394 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -65.93 155.2 37.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.661 2.784 . . . . 0.0 111.452 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.54 109.16 2.47 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.079 0.952 . . . . 0.0 109.481 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.05 120.36 8.18 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.944 2.429 . . . . 0.0 113.708 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -81.72 -49.08 10.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.506 1.922 . . . . 0.0 110.294 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -128.82 85.86 59.06 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 126.57 1.948 . . . . 0.0 109.545 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.32 138.31 83.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.655 2.903 . . . . 0.0 111.411 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.88 154.15 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 125.369 1.467 . . . . 0.0 109.969 -170.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -136.49 155.4 50.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.413 1.485 . . . . 0.0 110.173 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 t -125.15 136.55 28.3 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 125.647 1.579 . . . . 0.0 108.116 169.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.48 -10.48 27.92 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.766 2.311 . . . . 0.0 113.796 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.85 -67.69 0.62 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.859 2.064 . . . . 0.0 111.48 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.8 m -64.37 -37.0 85.98 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.365 1.066 . . . . 0.0 112.826 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 63.6 -1.53 0.59 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.845 2.458 . . . . 0.0 115.107 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.5 p -77.64 177.12 8.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.585 2.354 . . . . 0.0 111.939 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 mm -106.61 141.62 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -136.71 167.86 20.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.763 1.625 . . . . 0.0 110.27 168.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -78.35 130.51 36.25 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -43.08 40.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.696 1.998 . . . . 0.0 110.468 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 t -60.21 -43.14 96.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.78 -40.26 41.38 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 110.961 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.76 -48.66 79.69 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -58.26 -42.18 85.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.833 0.288 . . . . 0.0 111.062 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -58.43 -49.55 76.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.175 0.512 . . . . 0.0 111.926 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -64.23 -35.19 80.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.696 1.198 . . . . 0.0 111.879 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.468 HG11 ' H ' ' A' ' 47' ' ' ILE . 43.5 t -94.0 -13.55 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 112.093 -172.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -91.39 -12.71 34.03 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 119.813 -1.805 . . . . 0.0 110.391 167.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.89 -65.71 0.91 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.95 2.1 . . . . 0.0 110.995 169.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.7 p -126.6 -15.12 5.62 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.069 1.348 . . . . 0.0 113.632 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.36 -18.02 25.93 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.923 0.773 . . . . 0.0 113.822 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -68.24 149.09 49.92 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.266 1.533 . . . . 0.0 112.772 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.5 142.48 94.34 Favored Pre-proline 0 CA--C 1.549 0.939 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 169.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.75 -5.57 17.12 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.254 2.636 . . . . 0.0 114.841 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mm -118.55 -52.45 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.716 1.206 . . . . 0.0 110.566 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -89.96 -13.47 36.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.328 0.4 OUTLIER 45.84 31.07 0.97 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.208 2.203 . . . . 0.0 114.462 -169.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -75.29 135.68 72.68 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.041 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.07 140.74 42.23 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.175 2.583 . . . . 0.0 113.049 -170.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 mt 65.1 149.14 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.365 3.066 . . . . 0.0 114.192 -172.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.86 -54.18 0.4 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.301 1.84 . . . . 0.0 111.85 -173.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.468 ' H ' HG11 ' A' ' 32' ' ' VAL . 10.1 tp -61.37 -30.87 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.646 1.978 . . . . 0.0 114.82 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.86 -9.37 44.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.309 1.444 . . . . 0.0 112.0 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -130.61 12.88 5.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.853 1.661 . . . . 0.0 112.483 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.6 tp -57.44 141.39 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.492 1.517 . . . . 0.0 114.118 -172.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.86 92.61 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.958 2.103 . . . . 0.0 109.792 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.3 126.14 30.36 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.853 -1.154 . . . . 0.0 112.257 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.7 mm . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 125.441 1.496 . . . . 0.0 108.783 -177.064 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.167 0.508 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 3.0 m -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -168.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.51 -17.11 62.36 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.69 -49.97 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.269 1.428 . . . . 0.0 111.522 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.7 p -116.28 -24.47 7.93 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.11 12.39 80.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 115.406 0.922 . . . . 0.0 115.406 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.96 166.59 17.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.424 2.29 . . . . 0.0 112.198 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.75 107.42 7.35 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.72 114.9 1.53 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.469 2.779 . . . . 0.0 117.33 -168.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -62.55 -44.93 95.11 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.158 1.383 . . . . 0.0 110.492 169.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm-85 -126.67 94.77 39.35 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.161 1.784 . . . . 0.0 109.678 169.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.72 125.92 17.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.066 3.178 . . . . 0.0 111.036 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.34 142.71 28.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 126.302 1.841 . . . . 0.0 110.366 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tt -131.63 157.75 42.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.523 1.529 . . . . 0.0 110.889 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -134.51 125.9 17.9 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.634 1.574 . . . . 0.0 108.609 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -53.72 -11.65 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 125.172 3.914 . . . . 0.0 117.309 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.71 -55.46 5.84 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.805 1.242 . . . . 0.0 111.178 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 m -79.8 -37.34 35.44 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.505 1.522 . . . . 0.0 112.366 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm-85 56.23 7.97 0.37 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 128.114 2.566 . . . . 0.0 115.429 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.1 p -74.26 174.22 9.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.65 2.38 . . . . 0.0 110.395 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.38 118.1 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -112.76 171.14 7.71 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.428 1.891 . . . . 0.0 111.406 173.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -80.01 134.62 36.24 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.3 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -45.67 -46.64 14.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.742 2.017 . . . . 0.0 110.249 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -63.66 -33.35 75.43 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.966 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.38 -45.22 40.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.288 1.035 . . . . 0.0 110.73 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -63.33 -45.04 93.15 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -56.19 -42.77 77.66 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.867 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -59.25 -51.64 69.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.409 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.49 -34.29 76.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.147 1.379 . . . . 0.0 112.239 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.515 HG23 ' H ' ' A' ' 47' ' ' ILE . 2.2 p -83.1 -18.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.252 1.021 . . . . 0.0 112.872 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -85.77 -22.74 27.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.089 1.355 . . . . 0.0 111.363 168.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.42 4.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.558 1.943 . . . . 0.0 111.59 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.2 p -133.38 -21.38 2.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.029 1.332 . . . . 0.0 112.451 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.14 58.84 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.231 0.92 . . . . 0.0 113.341 -171.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.44 156.06 30.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.389 1.595 . . . . 0.0 113.709 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.74 131.36 54.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.53 -4.89 10.4 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.862 3.041 . . . . 0.0 117.15 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.85 -53.2 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.736 1.214 . . . . 0.0 110.709 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.3 p -88.64 -12.07 43.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.517 1.127 . . . . 0.0 113.89 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 52.58 21.27 1.76 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.313 2.645 . . . . 0.0 115.12 -169.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.69 122.17 75.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.673 0.789 . . . . 0.0 111.048 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.9 130.26 39.68 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.469 2.779 . . . . 0.0 114.145 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.265 34.8 mt 72.0 132.69 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.272 3.029 . . . . 0.0 113.265 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.7 t -132.95 -46.71 0.86 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.126 2.171 . . . . 0.0 111.135 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.515 ' H ' HG23 ' A' ' 32' ' ' VAL . 10.2 tp -56.57 -33.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.85 2.06 . . . . 0.0 114.354 171.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.13 -7.54 24.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.621 1.568 . . . . 0.0 112.077 171.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -130.83 6.65 4.69 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.3 tt -60.05 138.98 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 122.723 1.249 . . . . 0.0 113.696 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.97 88.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.112 2.165 . . . . 0.0 108.235 169.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.25 140.12 44.78 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.871 -1.143 . . . . 0.0 111.598 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.546 0.817 0 C-N-CA 125.637 1.575 . . . . 0.0 108.935 169.879 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 121.434 0.635 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.6 m -58.8 145.44 40.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -168.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.09 81.0 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.121 0.962 . . . . 0.0 111.335 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -80.15 -53.39 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.595 1.958 . . . . 0.0 112.771 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.0 m -123.23 -8.74 8.16 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.84 16.2 78.13 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 118.891 0.769 . . . . 0.0 114.543 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -76.18 164.53 26.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.581 2.753 . . . . 0.0 111.428 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.71 106.83 5.35 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 168.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.6 129.21 19.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.183 1.922 . . . . 0.0 113.594 -169.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -45.08 94.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.711 1.604 . . . . 0.0 110.159 169.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -122.83 91.05 49.92 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.587 1.555 . . . . 0.0 110.643 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.1 124.94 17.07 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.795 2.997 . . . . 0.0 111.451 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.16 145.46 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 127.25 2.22 . . . . 0.0 110.395 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.5 tp -131.94 153.77 49.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.68 1.992 . . . . 0.0 110.812 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 t -136.76 125.58 15.22 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.046 . . . . 0.0 106.205 168.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -67.81 -6.58 17.25 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.985 2.456 . . . . 0.0 114.169 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -61.38 1.92 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.748 1.619 . . . . 0.0 110.78 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 m -81.98 -10.41 59.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.268 15.2 ptp180 43.63 41.71 3.68 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.773 2.829 . . . . 0.0 117.041 169.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -133.98 172.35 12.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.239 2.216 . . . . 0.0 110.224 170.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.56 114.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.57 170.93 7.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.557 2.343 . . . . 0.0 110.638 176.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -73.48 149.49 42.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.765 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -53.44 -44.14 68.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -62.2 -41.02 97.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.802 1.241 . . . . 0.0 112.894 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.38 -45.87 61.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.139 0.576 . . . . 0.0 110.316 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -64.17 -43.69 94.38 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.86 -42.5 72.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.848 1.259 . . . . 0.0 111.453 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -59.9 -52.62 64.66 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.106 -0.371 . . . . 0.0 111.588 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.09 -34.46 77.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.169 0.985 . . . . 0.0 112.15 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.461 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -84.44 -14.27 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.333 1.053 . . . . 0.0 113.235 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.18 -11.27 22.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.408 1.083 . . . . 0.0 111.843 168.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -56.09 5.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.764 2.025 . . . . 0.0 110.841 169.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.2 p -135.19 -22.73 1.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.745 1.218 . . . . 0.0 112.726 -176.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.09 -11.28 65.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.483 1.039 . . . . 0.0 113.025 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -63.83 157.35 24.8 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.309 1.554 . . . . 0.0 113.518 -174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -80.94 135.87 51.3 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.511 1.124 . . . . 0.0 108.037 167.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.64 -8.23 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 N-CA-C 118.905 2.617 . . . . 0.0 118.905 -168.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.74 -44.78 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 121.09 1.768 . . . . 0.0 111.564 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -84.19 -13.12 53.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 44.89 30.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.677 2.391 . . . . 0.0 114.766 -170.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.61 134.37 88.49 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.641 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.11 135.56 27.52 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.512 2.142 . . . . 0.0 112.296 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 mp 70.72 144.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.97 2.508 . . . . 0.0 111.861 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -145.09 -52.4 0.28 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.723 2.009 . . . . 0.0 110.646 -169.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.461 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.0 tp -57.62 -32.87 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.553 2.341 . . . . 0.0 115.628 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -67.82 -8.26 34.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.394 1.078 . . . . 0.0 112.086 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.13 11.22 4.61 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.291 1.836 . . . . 0.0 112.532 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 tt -59.39 142.01 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.842 1.306 . . . . 0.0 113.475 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.33 97.84 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 127.839 2.456 . . . . 0.0 109.023 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.92 112.25 9.87 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.74 -1.225 . . . . 0.0 110.452 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.9 mm . . . . . 0 N--CA 1.476 0.828 0 C-N-CA 125.571 1.548 . . . . 0.0 111.227 -177.629 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 121.343 0.592 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 m -58.9 136.01 57.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -168.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.58 -21.46 64.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -94.74 -49.7 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.879 1.671 . . . . 0.0 111.923 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -126.84 -16.95 5.05 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.72 13.61 83.37 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.926 -1.109 . . . . 0.0 114.72 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -69.41 164.08 23.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.885 2.874 . . . . 0.0 112.088 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -82.4 110.19 20.21 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.64 138.33 37.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.155 1.903 . . . . 0.0 113.823 -169.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -84.59 -41.3 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.433 2.293 . . . . 0.0 109.894 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -121.68 86.17 44.83 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.994 1.718 . . . . 0.0 108.832 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.02 124.75 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.886 3.057 . . . . 0.0 109.685 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.03 142.89 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 125.84 1.656 . . . . 0.0 110.494 -169.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -133.12 154.45 50.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.421 1.488 . . . . 0.0 110.568 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 t -131.9 128.73 21.66 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 127.049 2.139 . . . . 0.0 106.054 168.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.39 -7.57 18.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.35 2.7 . . . . 0.0 115.004 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -74.61 -63.34 1.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.288 1.035 . . . . 0.0 110.921 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -64.08 -36.46 84.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.86 1.264 . . . . 0.0 111.814 170.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.353 11.1 ptp180 47.92 17.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 129.741 3.216 . . . . 0.0 116.092 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.3 p -77.99 174.44 11.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.312 2.645 . . . . 0.0 109.82 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 116.51 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.14 169.01 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.787 2.035 . . . . 0.0 111.644 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.83 131.28 39.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -47.92 -45.51 30.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.948 1.699 . . . . 0.0 110.047 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 m -59.97 -35.18 74.44 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.46 -39.88 31.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.255 0.622 . . . . 0.0 111.089 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -62.69 -46.11 89.65 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -56.2 -40.39 73.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.551 1.54 . . . . 0.0 112.023 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -60.91 -52.52 64.68 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.513 -0.742 . . . . 0.0 111.83 170.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -67.37 -34.7 77.84 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.204 1.002 . . . . 0.0 111.849 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.9 p -82.84 -18.36 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.631 1.172 . . . . 0.0 113.033 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -91.38 -15.4 29.04 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 121.07 -1.019 . . . . 0.0 111.636 168.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.87 -56.41 4.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.388 1.875 . . . . 0.0 111.702 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -132.93 -21.84 2.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.086 1.354 . . . . 0.0 112.395 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.11 -12.13 55.24 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.27 0.938 . . . . 0.0 113.575 -171.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -66.58 156.07 36.06 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.589 1.694 . . . . 0.0 113.927 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.95 135.09 59.24 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 166.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.89 -4.05 11.64 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.211 2.607 . . . . 0.0 115.018 -170.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.28 -50.65 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 110.714 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -87.25 -13.01 44.98 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.384 0.0 OUTLIER 49.68 21.33 0.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.338 2.655 . . . . 0.0 115.138 -168.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -68.32 129.13 93.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.234 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.87 135.72 33.39 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.833 2.356 . . . . 0.0 112.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.27 39.1 mt 70.86 141.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 129.405 3.082 . . . . 0.0 113.082 -171.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -140.99 -53.86 0.48 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 110.58 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.506 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -61.76 -24.75 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -16.54 62.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.466 1.906 . . . . 0.0 111.674 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.12 10.27 8.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.675 1.99 . . . . 0.0 112.161 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 11.3 tt -58.48 139.89 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 122.955 1.359 . . . . 0.0 114.404 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -120.75 91.78 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.834 2.454 . . . . 0.0 108.406 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -75.55 121.6 22.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.979 -1.076 . . . . 0.0 110.356 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 126.09 1.756 . . . . 0.0 108.559 173.275 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.2 m -59.08 138.69 57.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -168.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.59 61.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.824 -0.547 . . . . 0.0 112.422 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.65 -51.35 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.804 1.242 . . . . 0.0 111.455 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -124.27 -10.51 7.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.0 11.88 84.43 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 119.018 0.826 . . . . 0.0 114.947 170.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -72.62 161.08 31.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.605 2.762 . . . . 0.0 111.176 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.1 t -76.33 106.68 3.49 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 168.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.51 118.25 5.11 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.608 2.205 . . . . 0.0 114.385 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.02 -47.06 84.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.865 1.266 . . . . 0.0 111.343 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -129.62 90.25 44.3 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.233 1.413 . . . . 0.0 109.339 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.83 149.53 86.59 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.185 2.59 . . . . 0.0 113.38 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.44 155.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 110.46 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.98 154.07 48.24 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.653 1.181 . . . . 0.0 110.608 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -117.36 134.11 23.14 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 125.658 1.583 . . . . 0.0 108.986 169.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.09 -4.7 14.77 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.359 2.706 . . . . 0.0 113.762 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -86.72 -48.84 7.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 110.535 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.4 p -97.62 -24.16 15.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 114.861 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.12 4.08 1.13 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 129.164 2.986 . . . . 0.0 116.685 170.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -71.8 174.43 6.89 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.992 1.717 . . . . 0.0 110.248 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.9 mt -119.34 116.1 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.57 165.71 12.0 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.53 1.532 . . . . 0.0 111.25 174.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -75.17 134.6 41.19 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -52.83 -41.53 64.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.872 1.669 . . . . 0.0 109.845 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -61.61 -37.15 82.89 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.3 -43.13 52.7 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.564 0.746 . . . . 0.0 110.648 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.27 -45.58 83.94 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 119.221 -0.418 . . . . 0.0 109.922 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.9 -41.86 68.08 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.182 0.993 . . . . 0.0 111.793 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.51 -52.92 63.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.986 0.514 . . . . 0.0 111.761 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.24 -36.02 80.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.35 1.06 . . . . 0.0 112.076 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 47' ' ' ILE . 2.4 p -84.94 -18.72 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.282 1.033 . . . . 0.0 112.884 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -91.04 -14.8 30.67 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.988 -1.07 . . . . 0.0 111.576 168.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -60.11 2.39 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.641 1.576 . . . . 0.0 110.555 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.9 p -137.4 -16.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.695 1.198 . . . . 0.0 113.104 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.6 -15.63 34.97 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.768 1.175 . . . . 0.0 114.007 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -67.33 149.03 50.88 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.928 1.364 . . . . 0.0 111.52 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.99 143.49 91.76 Favored Pre-proline 0 CA--C 1.548 0.904 0 O-C-N 120.936 -1.102 . . . . 0.0 108.791 168.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -4.66 14.13 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.304 2.669 . . . . 0.0 114.684 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.8 -52.34 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.453 1.501 . . . . 0.0 110.851 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -85.38 -15.06 44.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.391 0.0 OUTLIER 49.17 22.4 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.055 2.542 . . . . 0.0 114.609 -168.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -73.89 130.79 82.55 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.099 -1.001 . . . . 0.0 109.696 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.79 141.15 48.49 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.426 2.751 . . . . 0.0 113.705 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.3 mt 65.89 132.43 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 129.928 3.291 . . . . 0.0 113.756 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -131.96 -48.0 0.94 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.262 1.825 . . . . 0.0 111.456 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.503 ' H ' HG23 ' A' ' 32' ' ' VAL . 10.3 tp -60.13 -32.79 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.05 1.74 . . . . 0.0 114.405 173.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.06 -7.73 38.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.248 1.419 . . . . 0.0 112.162 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -126.96 7.58 6.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.015 1.726 . . . . 0.0 112.531 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.1 tp -58.39 142.0 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.43 89.66 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 107.567 169.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -75.16 141.43 43.66 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.026 -1.046 . . . . 0.0 112.5 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.2 mm . . . . . 0 N--CA 1.471 0.614 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 -175.143 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 120.785 0.326 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.4 m -57.34 130.07 44.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.37 62.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.56 -56.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.962 0.905 . . . . 0.0 110.984 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 -13.78 8.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.31 9.57 86.4 Favored Glycine 0 N--CA 1.47 0.915 0 O-C-N 121.486 -0.759 . . . . 0.0 114.994 170.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -71.05 162.75 28.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.47 2.708 . . . . 0.0 111.745 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.59 107.43 5.23 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.722 1.209 . . . . 0.0 107.812 168.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.91 116.28 3.01 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.965 2.443 . . . . 0.0 114.972 -169.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -75.36 -36.39 60.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.997 0.919 . . . . 0.0 111.477 169.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -121.47 81.51 39.06 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 125.725 1.61 . . . . 0.0 109.723 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.1 126.27 19.8 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.257 3.305 . . . . 0.0 111.27 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.91 153.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.483 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -131.11 150.44 52.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.047 2.139 . . . . 0.0 109.677 -171.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.3 t -125.63 125.22 24.99 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.911 1.684 . . . . 0.0 107.738 169.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.46 -7.68 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.82 3.68 . . . . 0.0 116.613 173.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.39 -67.19 0.85 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.336 1.854 . . . . 0.0 111.127 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.2 m -70.14 -31.65 69.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.383 1.073 . . . . 0.0 113.396 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 62.22 7.31 2.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.216 2.606 . . . . 0.0 115.715 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.5 p -75.94 174.0 10.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.172 2.589 . . . . 0.0 111.755 170.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.4 mt -121.05 117.05 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 120.98 -1.075 . . . . 0.0 108.468 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -117.08 175.55 5.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.473 1.909 . . . . 0.0 112.219 178.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.22 130.7 36.32 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.308 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -53.37 -41.01 65.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.673 1.589 . . . . 0.0 110.64 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -57.5 -44.04 84.69 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.053 0.846 . . . . 0.0 112.748 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . 0.311 1.0 OUTLIER -94.45 -25.14 17.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.934 0.894 . . . . 0.0 113.291 -173.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.36 -52.52 57.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 167.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.25 -39.76 79.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.124 0.57 . . . . 0.0 111.351 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -56.84 -52.57 64.57 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.304 0.502 . . . . 0.0 112.239 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -64.92 -29.54 70.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.125 1.77 . . . . 0.0 112.336 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.1 t -93.31 -5.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 125.904 1.682 . . . . 0.0 112.047 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -98.76 -17.57 18.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.152 -1.593 . . . . 0.0 110.606 167.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -63.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.904 2.482 . . . . 0.0 111.327 170.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.6 p -126.56 -21.88 4.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.962 1.305 . . . . 0.0 113.104 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.06 -18.59 26.57 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 123.656 0.646 . . . . 0.0 114.1 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.08 145.72 54.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.795 1.297 . . . . 0.0 111.685 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 149.49 90.49 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.19 -0.944 . . . . 0.0 111.131 169.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.92 -17.66 60.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.858 2.372 . . . . 0.0 115.988 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.0 mm -125.62 -48.3 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.068 0.947 . . . . 0.0 110.978 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.8 p -82.43 -14.81 54.51 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.359 0.0 OUTLIER 51.7 19.78 0.98 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.033 2.533 . . . . 0.0 114.535 -169.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.61 124.6 88.81 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.914 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.44 133.59 43.5 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.737 2.958 . . . . 0.0 114.533 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 mt 66.0 143.16 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.143 2.977 . . . . 0.0 114.323 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.15 -41.14 0.66 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.284 1.833 . . . . 0.0 111.823 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.21 -33.71 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.656 1.583 . . . . 0.0 113.965 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.5 -5.45 28.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.253 1.421 . . . . 0.0 112.146 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.52 8.15 6.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 tp -58.87 126.79 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.088 1.755 . . . . 0.0 114.959 -169.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -120.63 85.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.4 1.88 . . . . 0.0 110.221 171.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -80.01 118.57 21.86 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.954 -1.092 . . . . 0.0 112.073 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.2 mt . . . . . 0 CA--C 1.538 0.503 0 C-N-CA 126.612 1.965 . . . . 0.0 109.085 -175.036 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 121.572 0.701 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.0 t -63.52 139.07 58.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.058 1.409 . . . . 0.0 113.698 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.84 -15.56 47.78 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.072 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -76.91 -56.67 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.915 174.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m -134.54 -6.03 2.54 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.94 7.43 70.65 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.91 1.232 . . . . 0.0 114.109 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -56.29 137.98 51.35 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.301 2.64 . . . . 0.0 111.11 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.31 108.85 3.18 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.908 1.283 . . . . 0.0 107.663 169.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.74 128.02 28.6 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.586 2.191 . . . . 0.0 114.872 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -75.25 -46.05 36.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 108.782 169.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -124.32 91.16 49.93 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 127.212 2.205 . . . . 0.0 108.162 172.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.64 130.72 38.48 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.839 3.026 . . . . 0.0 111.4 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.9 144.02 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.971 1.708 . . . . 0.0 110.218 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.2 tp -131.65 154.32 49.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.5 1.92 . . . . 0.0 110.248 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 t -135.03 135.03 22.2 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.867 2.067 . . . . 0.0 107.703 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.87 -8.4 23.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -80.89 -64.19 1.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.978 1.711 . . . . 0.0 111.649 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -67.84 -32.73 73.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.883 0.873 . . . . 0.0 112.43 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 -2.0 0.51 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.351 2.66 . . . . 0.0 115.191 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.5 p -73.5 169.1 17.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.777 2.431 . . . . 0.0 112.617 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -112.76 116.55 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.7 168.96 9.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.588 1.555 . . . . 0.0 111.613 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.3 131.91 42.47 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.135 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -46.86 53.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.597 1.559 . . . . 0.0 110.283 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 t -62.18 -40.05 94.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -39.74 53.62 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.137 -0.977 . . . . 0.0 111.666 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.6 tp -60.64 -45.22 94.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.643 0.656 . . . . 0.0 109.302 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.72 -38.82 70.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.013 0.925 . . . . 0.0 111.544 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.37 -49.57 73.34 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.768 -0.582 . . . . 0.0 111.827 173.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -67.95 -35.26 78.09 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.052 0.929 . . . . 0.0 112.221 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 47' ' ' ILE . 1.6 p -82.84 -15.95 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.369 1.068 . . . . 0.0 112.984 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.19 -14.05 25.99 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.166 -0.959 . . . . 0.0 111.519 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.88 -57.63 3.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.874 1.67 . . . . 0.0 111.373 170.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.9 -22.12 1.86 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.847 1.259 . . . . 0.0 112.539 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.11 60.14 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.226 0.917 . . . . 0.0 113.459 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.99 155.01 37.86 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.24 1.52 . . . . 0.0 113.449 -172.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.07 141.24 74.33 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 166.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.73 -7.47 18.33 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.159 2.573 . . . . 0.0 115.432 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.0 mt -126.8 -46.94 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.636 1.107 . . . . 0.0 111.879 -175.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.0 p -83.69 -12.78 55.42 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.343 0.3 OUTLIER 48.44 23.5 0.6 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.008 2.523 . . . . 0.0 115.083 -169.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.94 118.04 44.99 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.25 1.02 . . . . 0.0 110.644 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.39 132.65 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.474 2.782 . . . . 0.0 113.843 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.72 137.71 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.518 3.127 . . . . 0.0 112.864 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.69 -44.91 0.48 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.315 1.846 . . . . 0.0 111.164 -171.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.454 ' H ' HG22 ' A' ' 32' ' ' VAL . 10.6 tp -58.89 -31.2 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 126.837 2.055 . . . . 0.0 115.568 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -14.74 62.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.369 1.868 . . . . 0.0 112.071 170.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -124.6 13.08 8.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.82 2.048 . . . . 0.0 112.035 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.7 tp -56.32 125.01 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.575 1.55 . . . . 0.0 112.947 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.98 92.33 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.421 1.489 . . . . 0.0 109.26 170.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -78.63 123.11 26.77 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.055 -1.028 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 CA--C 1.537 0.465 0 C-N-CA 125.636 1.575 . . . . 0.0 109.655 -179.898 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.675 0.75 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.19 146.11 51.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -169.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.21 68.57 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.98 -48.22 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 110.968 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -135.3 -11.5 2.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.22 12.07 79.64 Favored Glycine 0 N--CA 1.469 0.881 0 O-C-N 121.228 -0.92 . . . . 0.0 113.961 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -51.2 136.22 24.62 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 128.341 2.656 . . . . 0.0 111.509 171.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -66.42 110.2 4.46 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 168.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.85 105.16 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.996 2.464 . . . . 0.0 115.846 -169.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -59.33 -41.2 88.56 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.309 1.843 . . . . 0.0 111.109 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -132.69 94.8 20.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.054 1.741 . . . . 0.0 108.678 169.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 135.3 62.3 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.662 2.908 . . . . 0.0 112.153 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.31 146.05 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.408 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.53 152.75 49.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.533 1.133 . . . . 0.0 110.611 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 t -120.37 133.3 23.98 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 125.744 1.618 . . . . 0.0 109.646 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.71 -19.62 25.05 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.313 2.675 . . . . 0.0 114.395 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -93.87 -58.96 2.1 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.921 1.689 . . . . 0.0 111.93 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.0 m -78.53 -16.59 57.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 58.32 -16.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 129.887 3.275 . . . . 0.0 118.627 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 t -74.48 173.39 10.41 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.363 1.465 . . . . 0.0 110.924 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 mm -106.79 118.91 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.258 1.423 . . . . 0.0 108.736 175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.26 170.61 7.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 111.38 173.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 139.81 43.35 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.41 -45.68 62.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 109.393 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m -66.72 -42.04 86.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.907 0.883 . . . . 0.0 113.201 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.31 -40.36 64.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.565 0.746 . . . . 0.0 111.534 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.8 tp -61.35 -49.23 77.8 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -55.61 -41.78 73.97 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.017 0.527 . . . . 0.0 110.681 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.16 -53.65 55.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.034 0.534 . . . . 0.0 111.695 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -61.75 -35.18 77.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.349 1.071 . . . . 0.0 111.849 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.491 HG13 ' H ' ' A' ' 47' ' ' ILE . 41.7 t -93.75 -6.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 124.444 1.097 . . . . 0.0 112.258 -173.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -100.49 -10.59 20.93 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.937 -1.727 . . . . 0.0 110.81 167.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.108 2.563 . . . . 0.0 110.019 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -128.37 -21.77 3.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.38 1.472 . . . . 0.0 113.229 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.11 24.18 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.725 0.679 . . . . 0.0 113.758 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.74 147.72 52.93 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.588 1.194 . . . . 0.0 111.534 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.71 147.27 89.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.95 -1.094 . . . . 0.0 110.374 169.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.52 -10.75 27.32 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.909 2.406 . . . . 0.0 114.457 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.59 -46.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.312 0.96 . . . . 0.0 111.609 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.8 p -85.84 -10.4 55.46 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.327 0.3 OUTLIER 48.06 24.96 0.71 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.772 2.429 . . . . 0.0 115.671 -170.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.47 119.34 59.04 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.138 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.77 128.03 26.88 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.742 2.961 . . . . 0.0 114.334 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt 65.37 141.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.885 2.874 . . . . 0.0 114.664 -172.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.29 -54.54 0.75 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.723 1.609 . . . . 0.0 112.614 -173.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.491 ' H ' HG13 ' A' ' 32' ' ' VAL . 7.8 tp -61.62 -32.04 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.808 1.643 . . . . 0.0 114.066 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -68.87 -7.09 31.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 112.078 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -133.31 12.67 4.19 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.8 1.64 . . . . 0.0 112.122 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.7 tp -59.22 150.1 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.623 1.969 . . . . 0.0 115.305 -171.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.53 87.54 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.224 1.81 . . . . 0.0 108.385 169.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -75.8 137.44 40.52 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.921 -1.112 . . . . 0.0 111.596 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 125.49 1.516 . . . . 0.0 109.962 178.879 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.389 0.614 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.8 t -66.77 144.05 56.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.619 1.199 . . . . 0.0 113.915 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.12 -15.35 38.7 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.389 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -77.56 -53.62 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.122 0.569 . . . . 0.0 110.008 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 m -136.72 -5.84 1.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.71 6.91 82.36 Favored Glycine 0 N--CA 1.473 1.103 0 CA-C-N 120.069 1.304 . . . . 0.0 115.493 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.55 147.14 46.48 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.69 2.396 . . . . 0.0 110.819 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.57 108.78 3.2 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.1 115.11 3.29 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.459 2.106 . . . . 0.0 112.717 -169.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -63.74 -34.99 79.12 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.612 1.165 . . . . 0.0 111.708 170.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.8 mtm-85 -123.63 87.09 52.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.323 1.849 . . . . 0.0 109.501 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.57 128.69 22.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.888 3.058 . . . . 0.0 111.736 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 152.09 20.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.245 1.418 . . . . 0.0 110.503 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -139.24 155.53 47.71 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.977 1.311 . . . . 0.0 110.407 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 p -123.81 146.96 52.19 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 109.029 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.22 -10.23 28.43 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 121.917 1.744 . . . . 0.0 113.183 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -59.51 2.75 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.081 1.753 . . . . 0.0 111.366 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.2 m -79.59 -32.51 41.96 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 112.072 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 59.94 1.72 0.34 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.467 2.307 . . . . 0.0 115.437 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 p -73.07 173.46 9.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.117 2.567 . . . . 0.0 111.679 170.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.33 116.22 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.84 173.44 6.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 126.287 1.835 . . . . 0.0 110.452 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.12 143.54 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.111 -0.993 . . . . 0.0 109.554 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.59 -46.18 66.81 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.13 1.372 . . . . 0.0 108.815 171.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -67.81 -42.79 80.99 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.6 -40.79 66.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.151 0.887 . . . . 0.0 111.439 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.92 -47.56 84.38 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -56.05 -42.99 77.44 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.695 0.398 . . . . 0.0 110.552 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -57.85 -52.13 66.75 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.688 0.795 . . . . 0.0 111.491 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.46 -36.21 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.025 1.33 . . . . 0.0 111.967 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 47' ' ' ILE . 43.1 t -91.78 -6.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.016 1.326 . . . . 0.0 112.232 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -101.96 -10.77 19.48 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 119.994 -1.691 . . . . 0.0 110.567 167.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -61.6 1.9 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.034 2.134 . . . . 0.0 110.226 169.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.4 p -130.41 -16.75 3.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.983 1.313 . . . . 0.0 113.58 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.22 -19.64 30.14 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-O 119.507 -0.607 . . . . 0.0 113.656 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.56 148.83 51.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.827 1.314 . . . . 0.0 113.216 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.76 140.82 84.15 Favored Pre-proline 0 CA--C 1.549 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 110.83 169.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -60.42 -12.22 19.69 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.883 3.055 . . . . 0.0 117.594 -170.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mt -129.87 -42.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.38 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -86.87 -16.66 35.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.709 0.804 . . . . 0.0 112.26 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.317 0.5 OUTLIER 43.01 32.25 0.4 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.066 2.546 . . . . 0.0 114.798 -169.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -81.59 145.67 55.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 118.925 -0.559 . . . . 0.0 110.113 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.61 142.89 36.97 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.712 2.275 . . . . 0.0 114.042 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.2 mt 65.44 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 130.152 3.381 . . . . 0.0 115.019 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.1 t -129.63 -52.12 1.16 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.217 1.807 . . . . 0.0 112.037 -172.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.472 ' H ' HG12 ' A' ' 32' ' ' VAL . 8.8 tp -60.33 -31.57 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.039 1.736 . . . . 0.0 114.298 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -69.38 -8.47 46.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.187 1.395 . . . . 0.0 112.147 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -127.62 11.46 6.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.192 1.797 . . . . 0.0 112.328 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.5 tp -58.78 145.35 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.781 1.632 . . . . 0.0 115.276 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.53 91.87 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.541 2.336 . . . . 0.0 108.477 169.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -77.15 112.36 13.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.956 -1.09 . . . . 0.0 111.361 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.0 mm . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 125.197 1.399 . . . . 0.0 111.728 -177.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 121.514 0.673 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 3.0 m -60.65 138.6 58.05 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.91 -14.83 61.55 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.49 -53.13 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.908 1.283 . . . . 0.0 111.727 -170.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 m -118.69 -14.3 9.56 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.85 16.11 81.05 Favored Glycine 0 N--CA 1.467 0.719 0 O-C-N 121.79 -0.569 . . . . 0.0 114.022 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -91.42 174.04 7.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.409 1.884 . . . . 0.0 113.577 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.33 114.35 28.87 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 125.55 10.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.177 1.918 . . . . 0.0 113.825 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -57.64 -50.72 72.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 111.257 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.48 100.72 14.92 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.812 1.645 . . . . 0.0 110.101 170.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.87 131.78 39.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.664 2.909 . . . . 0.0 111.678 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.16 145.9 23.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 127.894 2.478 . . . . 0.0 110.321 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tt -134.19 159.4 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.248 1.819 . . . . 0.0 110.041 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 p -128.88 152.41 79.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 110.932 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.91 -5.01 16.22 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.241 2.627 . . . . 0.0 113.564 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -70.87 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.21 1.404 . . . . 0.0 110.551 174.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -75.17 -29.66 60.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 113.056 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 56.11 5.54 0.18 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.951 2.1 . . . . 0.0 115.278 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.6 p -70.59 171.6 10.01 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.584 2.353 . . . . 0.0 111.183 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.56 115.96 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -113.78 171.91 7.3 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.09 2.156 . . . . 0.0 111.467 173.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -81.29 137.72 35.77 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -42.98 -49.92 5.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 128.289 2.636 . . . . 0.0 110.363 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.95 71.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.801 -171.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -76.31 -45.0 34.36 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.8 0.84 . . . . 0.0 110.348 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.28 -48.72 74.6 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.94 -45.06 78.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.718 0.407 . . . . 0.0 110.837 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -59.11 -50.69 73.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.282 0.492 . . . . 0.0 111.824 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.38 -34.35 77.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.149 0.976 . . . . 0.0 111.513 -174.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 47' ' ' ILE . 48.2 t -95.55 -9.89 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.874 1.27 . . . . 0.0 112.314 -173.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -94.44 -13.27 26.38 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 119.909 -1.745 . . . . 0.0 110.441 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.77 -66.64 0.84 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.136 2.574 . . . . 0.0 111.466 169.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.4 p -119.76 -20.31 7.68 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.387 1.475 . . . . 0.0 113.024 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.53 -20.57 13.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.087 0.851 . . . . 0.0 113.896 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.0 148.66 50.73 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.059 1.43 . . . . 0.0 112.423 -170.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.71 144.69 88.74 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.08 -1.013 . . . . 0.0 109.649 168.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.95 -6.84 18.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.678 2.918 . . . . 0.0 116.142 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mt -127.37 -49.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.605 1.162 . . . . 0.0 111.485 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.5 p -83.58 -14.6 51.72 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.339 0.2 OUTLIER 49.52 23.72 0.98 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.528 2.331 . . . . 0.0 114.981 -169.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.28 133.63 91.34 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.3 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.17 135.3 34.09 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.874 2.383 . . . . 0.0 112.715 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.0 mt 67.82 144.34 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.363 3.065 . . . . 0.0 113.998 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.8 t -141.04 -49.52 0.42 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.949 2.099 . . . . 0.0 112.364 -174.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.51 ' H ' HG12 ' A' ' 32' ' ' VAL . 44.5 mm -58.65 -33.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.834 2.054 . . . . 0.0 113.808 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.3 -8.78 19.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.75 1.22 . . . . 0.0 112.419 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -132.48 9.17 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.431 1.893 . . . . 0.0 113.183 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.25 139.4 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.831 1.252 . . . . 0.0 114.16 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.14 92.43 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.26 2.224 . . . . 0.0 109.0 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -72.71 130.58 40.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.787 -1.196 . . . . 0.0 110.88 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 124.66 1.184 . . . . 0.0 109.04 179.792 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 111.048 0.018 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.8 t -69.25 147.8 50.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.726 1.25 . . . . 0.0 112.629 -170.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.91 -23.12 25.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.79 . . . . 0.0 112.531 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.16 -45.19 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.951 0.9 . . . . 0.0 111.163 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 t -126.21 -40.14 2.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.687 0.795 . . . . 0.0 112.701 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.34 20.03 36.71 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 121.702 0.612 . . . . 0.0 113.95 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -78.25 168.34 20.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.012 1.325 . . . . 0.0 110.982 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.29 112.83 17.41 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 133.82 20.98 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.649 2.233 . . . . 0.0 112.484 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.12 -34.58 73.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.949 1.3 . . . . 0.0 111.824 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -124.23 83.35 56.62 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.657 1.583 . . . . 0.0 111.067 173.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.54 125.56 18.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.734 2.956 . . . . 0.0 112.273 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 145.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.943 2.097 . . . . 0.0 110.507 -173.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.81 156.3 42.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.15 1.78 . . . . 0.0 109.841 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -127.11 143.54 47.37 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.919 1.288 . . . . 0.0 108.251 169.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.18 0.82 5.39 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.605 2.87 . . . . 0.0 113.866 -172.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -92.69 -67.85 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.202 1.801 . . . . 0.0 109.878 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -56.44 -41.64 76.79 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 59.25 5.67 0.62 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.258 2.223 . . . . 0.0 114.378 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.9 p -77.35 177.02 8.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.761 2.424 . . . . 0.0 111.579 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -122.68 114.54 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.49 171.22 7.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.436 1.894 . . . . 0.0 111.233 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.8 144.19 49.25 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.818 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -56.76 -44.37 81.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 109.707 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -68.18 -36.51 79.72 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.56 -38.76 65.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 0.0 112.022 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -44.48 96.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.948 0.795 . . . . 0.0 109.24 171.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -54.62 -41.23 69.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.5 0.72 . . . . 0.0 110.917 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -58.98 -53.43 58.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.465 0.706 . . . . 0.0 111.398 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.62 -36.65 81.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.366 1.079 . . . . 0.0 112.348 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.66 -10.86 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.772 1.229 . . . . 0.0 112.999 -175.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -102.1 -10.46 19.65 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.95 -1.094 . . . . 0.0 111.462 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -55.54 5.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.125 1.77 . . . . 0.0 110.691 169.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.4 p -133.98 -22.87 1.8 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.787 1.235 . . . . 0.0 112.426 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.6 -12.89 59.96 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.144 0.878 . . . . 0.0 113.081 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.32 154.88 40.29 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.586 1.693 . . . . 0.0 113.621 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.39 135.09 90.93 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.24 -5.31 12.21 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 121.871 1.714 . . . . 0.0 113.633 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mm -123.12 -45.38 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.197 1.362 . . . . 0.0 111.485 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 p -99.78 -4.93 29.51 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.546 0.739 . . . . 0.0 112.934 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.362 0.0 OUTLIER 45.1 23.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.483 3.113 . . . . 0.0 116.596 -172.041 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -69.82 137.16 87.66 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.58 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.84 130.87 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.933 2.422 . . . . 0.0 112.069 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.253 35.3 mt 70.45 146.29 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.375 3.07 . . . . 0.0 113.411 -170.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 t -143.7 -56.77 0.39 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.342 1.857 . . . . 0.0 110.69 -170.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.433 ' H ' HG22 ' A' ' 32' ' ' VAL . 3.0 tt -59.69 -25.49 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 126.497 1.919 . . . . 0.0 116.041 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.78 -9.35 43.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.001 1.32 . . . . 0.0 112.157 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -126.66 9.21 7.03 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.058 . . . . 0.0 112.626 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.7 tt -58.3 147.11 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.097 1.759 . . . . 0.0 115.403 -172.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.7 97.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 128.635 2.774 . . . . 0.0 109.775 171.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.95 132.1 36.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.356 -1.465 . . . . 0.0 112.309 174.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.596 1.158 . . . . 0.0 110.605 179.746 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.052 0.453 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.7 t -68.34 140.23 55.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 123.074 1.416 . . . . 0.0 113.329 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.18 -20.05 42.02 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.69 -53.32 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.556 0.742 . . . . 0.0 110.871 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -132.24 -16.8 2.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.51 6.65 60.94 Favored Glycine 0 N--CA 1.468 0.797 0 O-C-N 121.295 -0.878 . . . . 0.0 114.822 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -69.08 161.1 29.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.46 1.504 . . . . 0.0 112.583 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.3 119.24 72.56 Favored Pre-proline 0 N--CA 1.473 0.684 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 169.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.83 125.2 9.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.13 1.887 . . . . 0.0 112.191 -171.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -64.6 -41.65 96.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.074 1.349 . . . . 0.0 110.452 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -124.72 92.76 47.3 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 0.0 109.393 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.37 127.78 24.03 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.547 2.832 . . . . 0.0 111.444 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.86 148.72 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.46 1.504 . . . . 0.0 110.682 -176.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.35 155.52 50.1 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.6 1.56 . . . . 0.0 111.689 -175.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 t -127.88 133.42 25.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 C-N-CA 126.64 1.976 . . . . 0.0 107.409 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.5 -10.0 27.25 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.041 2.494 . . . . 0.0 114.409 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -75.9 -63.64 1.26 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.013 1.725 . . . . 0.0 111.578 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.6 m -66.32 -36.05 81.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.008 0.923 . . . . 0.0 112.167 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 61.05 3.61 0.71 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.534 2.733 . . . . 0.0 114.912 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 p -75.23 174.88 8.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.932 2.493 . . . . 0.0 111.947 171.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.47 117.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.39 168.04 9.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.056 1.742 . . . . 0.0 111.109 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -67.7 135.09 52.21 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.051 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -57.99 -43.51 86.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.952 0.796 . . . . 0.0 109.919 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 m -62.21 -41.91 98.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.467 1.107 . . . . 0.0 113.824 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.93 -38.25 57.85 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.129 0.877 . . . . 0.0 111.988 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 tp -60.3 -45.86 91.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 170.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -54.87 -37.98 66.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -62.16 -52.08 65.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.631 -0.668 . . . . 0.0 111.708 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.61 -35.62 79.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.114 0.959 . . . . 0.0 112.248 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 p -82.87 -15.46 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.837 1.255 . . . . 0.0 113.027 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -94.88 -13.48 25.42 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.714 -1.241 . . . . 0.0 111.543 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -57.21 4.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.439 170.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -133.18 -22.18 2.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.9 1.28 . . . . 0.0 112.609 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.32 -11.38 58.44 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.191 0.9 . . . . 0.0 113.656 -171.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -65.65 153.62 41.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.154 1.477 . . . . 0.0 113.164 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.8 86.08 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -67.63 -7.27 18.87 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.075 2.517 . . . . 0.0 115.414 -171.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mt -127.38 -47.21 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.441 1.096 . . . . 0.0 111.795 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.2 p -83.96 -12.64 55.03 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.342 0.3 OUTLIER 48.22 24.54 0.69 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.994 2.517 . . . . 0.0 115.237 -169.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.48 119.25 61.2 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.12 0.968 . . . . 0.0 110.589 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.03 133.55 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.598 2.865 . . . . 0.0 114.054 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.7 mp 71.04 141.41 0.05 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.318 3.047 . . . . 0.0 112.845 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.57 -45.84 0.41 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.386 1.874 . . . . 0.0 111.392 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.407 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.2 mm -61.7 -31.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 114.654 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -12.53 53.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.259 1.824 . . . . 0.0 112.445 170.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -124.38 8.33 8.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.974 1.71 . . . . 0.0 112.719 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.4 tp -58.56 132.55 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.133 1.373 . . . . 0.0 113.878 -172.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.97 94.44 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.069 2.147 . . . . 0.0 109.115 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -74.97 134.71 41.44 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.578 -1.326 . . . . 0.0 110.845 172.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 123.575 0.75 . . . . 0.0 110.277 179.059 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.514 0.673 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.5 t -60.87 137.63 58.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.973 1.368 . . . . 0.0 112.652 -169.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.58 -16.97 40.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.172 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.3 mt -82.77 -47.66 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.476 1.51 . . . . 0.0 110.538 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 p -128.9 -30.18 2.27 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.3 61.18 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 114.764 0.665 . . . . 0.0 114.764 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -53.5 137.38 36.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.458 1.903 . . . . 0.0 110.689 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.77 105.73 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.3 117.16 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.892 2.395 . . . . 0.0 113.663 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -74.36 -42.35 59.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.706 1.602 . . . . 0.0 110.519 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -126.42 90.1 50.69 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.063 2.145 . . . . 0.0 107.682 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -62.69 129.1 25.21 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.704 2.936 . . . . 0.0 111.857 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.02 153.74 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.452 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.44 156.87 47.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.406 1.882 . . . . 0.0 110.08 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -123.17 127.8 25.52 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.501 1.52 . . . . 0.0 108.34 168.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.69 -12.0 2.69 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.816 3.678 . . . . 0.0 117.217 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -62.54 1.66 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.927 1.291 . . . . 0.0 110.964 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 m -69.29 -38.12 78.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.704 1.602 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 57.47 10.88 1.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.938 2.495 . . . . 0.0 114.985 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.2 p -75.14 170.87 15.17 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.135 2.574 . . . . 0.0 111.057 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.21 116.51 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.76 168.96 9.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.409 1.884 . . . . 0.0 111.194 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -67.87 137.12 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.492 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -51.66 -46.12 63.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.728 1.211 . . . . 0.0 109.661 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -59.88 -42.07 92.95 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.05 0.843 . . . . 0.0 112.562 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -44.7 67.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.0 tp -65.71 -38.85 90.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.546 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.49 -40.32 90.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.502 0.721 . . . . 0.0 111.587 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.53 -50.17 73.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.077 0.951 . . . . 0.0 111.582 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -67.06 -37.36 83.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.128 0.966 . . . . 0.0 111.317 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 47' ' ' ILE . 2.4 p -83.07 -18.48 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -89.86 -15.68 31.69 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.015 -1.053 . . . . 0.0 112.011 168.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -58.08 3.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.866 1.666 . . . . 0.0 110.978 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.9 p -137.59 -16.87 1.32 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 112.635 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.45 57.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.273 0.939 . . . . 0.0 113.524 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -63.12 153.91 32.73 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.23 1.515 . . . . 0.0 113.48 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.29 129.26 75.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.528 1.131 . . . . 0.0 108.209 167.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.0 -13.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.793 3.662 . . . . 0.0 119.718 -169.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.29 -41.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.141 1.337 . . . . 0.0 112.358 -171.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -92.21 -10.69 37.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.947 0.899 . . . . 0.0 112.576 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.311 0.5 OUTLIER 44.2 31.15 0.52 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.749 2.82 . . . . 0.0 115.355 -171.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.87 134.32 94.04 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.672 172.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.04 133.24 28.37 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.651 2.234 . . . . 0.0 111.628 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 mp 73.86 144.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 128.458 2.703 . . . . 0.0 112.488 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -147.5 -40.42 0.18 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.779 2.431 . . . . 0.0 110.24 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.436 ' H ' HG23 ' A' ' 32' ' ' VAL . 8.6 tp -58.91 -36.18 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.361 1.864 . . . . 0.0 114.677 177.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -67.6 -7.68 28.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.121 1.368 . . . . 0.0 112.123 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.41 4.73 5.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.183 1.393 . . . . 0.0 113.318 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 tt -66.64 137.8 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 122.313 1.054 . . . . 0.0 113.675 -169.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.2 96.95 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.839 2.056 . . . . 0.0 111.23 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -72.59 123.63 23.6 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.55 -1.344 . . . . 0.0 110.462 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.2 mm . . . . . 0 N--CA 1.474 0.738 0 C-N-CA 125.323 1.449 . . . . 0.0 110.707 -174.913 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -119.15 152.67 36.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.093 1.757 . . . . 0.0 112.033 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.19 138.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.741 1.258 . . . . 0.0 113.409 -168.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.72 49.13 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.116 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.6 -58.23 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.095 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.3 m -135.95 -5.58 2.15 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.48 7.35 79.36 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-N 119.961 1.255 . . . . 0.0 115.444 172.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.4 141.67 58.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.018 2.527 . . . . 0.0 111.783 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.04 114.63 19.1 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 169.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 145.66 37.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 114.038 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -91.89 -31.39 15.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.772 2.029 . . . . 0.0 110.136 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -126.42 83.25 64.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 126.29 1.836 . . . . 0.0 109.482 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.99 127.48 25.19 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.036 3.157 . . . . 0.0 110.637 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.3 t -141.63 143.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 126.413 1.885 . . . . 0.0 110.842 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -125.29 157.4 36.73 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.979 1.712 . . . . 0.0 110.296 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 t -127.51 133.35 24.99 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.699 1.599 . . . . 0.0 108.619 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -55.05 -13.61 6.88 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.931 3.088 . . . . 0.0 117.058 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -95.88 -56.99 2.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.142 0.883 . . . . 0.0 111.619 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.7 p -63.78 -37.95 89.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.252 1.821 . . . . 0.0 114.264 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 58.62 1.14 0.17 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 128.965 2.906 . . . . 0.0 116.923 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -69.52 177.38 2.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.556 1.942 . . . . 0.0 110.04 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.45 115.81 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 169.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.67 169.21 9.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 112.282 172.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -74.25 131.02 40.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.389 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.42 -42.65 64.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.684 1.593 . . . . 0.0 110.622 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -63.55 -40.42 96.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.83 -35.18 60.06 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.443 -0.786 . . . . 0.0 111.336 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.17 -44.79 94.47 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 119.091 -0.481 . . . . 0.0 109.714 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -54.94 -38.93 68.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.646 0.778 . . . . 0.0 111.401 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.69 -53.32 58.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.122 0.487 . . . . 0.0 112.112 171.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.18 -34.78 78.25 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.984 0.897 . . . . 0.0 112.328 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.461 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.1 p -83.07 -17.36 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.739 1.215 . . . . 0.0 112.795 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -92.81 -14.65 27.5 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.854 -1.154 . . . . 0.0 111.405 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -56.96 4.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.995 1.718 . . . . 0.0 111.677 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -133.67 -21.61 1.95 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.938 1.295 . . . . 0.0 112.505 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.85 -11.9 55.11 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.086 0.85 . . . . 0.0 113.658 -172.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -67.17 154.51 41.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.222 1.511 . . . . 0.0 113.317 -170.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.63 133.94 79.45 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.11 -14.08 7.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.157 3.238 . . . . 0.0 118.002 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.97 -48.84 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.712 1.142 . . . . 0.0 111.548 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.3 p -85.84 -11.12 54.18 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.333 0.3 OUTLIER 48.71 24.75 0.85 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.049 2.54 . . . . 0.0 115.295 -169.743 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.13 118.44 49.65 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.24 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.96 132.52 52.71 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.448 2.765 . . . . 0.0 113.91 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp 72.19 144.59 0.07 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 128.822 2.849 . . . . 0.0 111.864 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.9 t -143.32 -61.5 0.41 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.662 1.585 . . . . 0.0 111.151 -169.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.461 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -62.72 -26.89 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.69 -5.95 33.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.446 1.098 . . . . 0.0 112.301 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -128.67 11.85 6.26 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.47 1.908 . . . . 0.0 112.328 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 7.1 tt -57.8 143.62 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.756 1.622 . . . . 0.0 114.697 -171.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.66 86.22 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.207 2.203 . . . . 0.0 109.15 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -72.02 125.92 28.45 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.014 . . . . 0.0 111.412 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.25 78.45 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.309 1.844 . . . . 0.0 109.196 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.8 m -61.9 151.76 78.78 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 125.158 1.383 . . . . 0.0 112.543 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.9 -11.23 25.51 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.307 2.671 . . . . 0.0 114.315 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 126.734 2.013 . . . . 0.0 112.859 -177.774 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 tpp . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.15 145.56 29.2 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.828 1.651 . . . . 0.0 112.066 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.2 m -59.7 137.55 58.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -168.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.38 -25.0 63.05 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.088 0.471 . . . . 0.0 112.174 174.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.41 -51.58 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.037 1.735 . . . . 0.0 111.584 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 p -123.33 -18.7 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.19 11.31 84.5 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.68 167.45 13.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.112 2.565 . . . . 0.0 113.157 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.0 t -83.45 107.91 11.5 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.76 127.61 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.484 2.123 . . . . 0.0 113.624 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -71.1 -39.47 72.07 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.096 1.358 . . . . 0.0 111.065 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -124.7 86.83 55.42 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.792 1.237 . . . . 0.0 109.969 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.18 127.33 25.6 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.009 3.139 . . . . 0.0 110.712 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.5 t -140.01 142.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.415 1.886 . . . . 0.0 109.858 -170.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.56 157.4 46.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.801 1.641 . . . . 0.0 110.923 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -132.03 128.32 21.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.959 1.704 . . . . 0.0 108.221 169.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.68 -12.59 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.502 3.468 . . . . 0.0 116.714 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -83.79 -58.11 2.93 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.106 1.363 . . . . 0.0 110.567 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -27.16 68.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.035 1.734 . . . . 0.0 114.705 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 46.35 45.74 13.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 126.344 1.858 . . . . 0.0 113.959 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -136.71 174.5 10.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.145 2.578 . . . . 0.0 109.401 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.52 116.75 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -111.47 168.18 9.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 111.472 173.609 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.97 131.11 41.09 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.778 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -46.88 -45.48 20.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.807 1.643 . . . . 0.0 109.739 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -59.29 -37.87 78.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -40.12 33.86 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.008 0.523 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.5 tp -63.11 -45.68 90.9 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -55.6 -42.62 75.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.484 1.514 . . . . 0.0 111.798 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -59.15 -53.07 62.49 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.293 -0.879 . . . . 0.0 111.408 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -67.37 -34.26 76.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.913 1.285 . . . . 0.0 112.427 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.02 -17.35 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.264 1.025 . . . . 0.0 112.845 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.61 -21.03 24.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.963 1.305 . . . . 0.0 111.426 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -57.64 3.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.348 1.859 . . . . 0.0 111.451 175.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.3 p -133.27 -21.53 2.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.143 1.377 . . . . 0.0 112.45 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.84 -12.45 57.18 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.248 0.927 . . . . 0.0 113.387 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.24 156.44 34.23 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.492 1.646 . . . . 0.0 113.267 -170.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.42 134.96 57.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 167.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.87 -5.21 12.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.993 2.462 . . . . 0.0 115.377 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.9 mt -121.55 -48.08 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.904 1.282 . . . . 0.0 111.506 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.9 p -88.75 -12.34 42.44 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.356 0.3 OUTLIER 47.42 25.17 0.57 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.053 2.541 . . . . 0.0 115.149 -169.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.72 129.96 90.77 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.495 -0.764 . . . . 0.0 110.243 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 134.47 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.958 2.438 . . . . 0.0 112.541 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.267 41.0 mt 71.79 133.92 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.695 3.198 . . . . 0.0 113.371 -175.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.12 -45.03 0.71 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.88 2.072 . . . . 0.0 111.424 -169.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.517 ' H ' HG23 ' A' ' 32' ' ' VAL . 11.1 tp -58.33 -35.12 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.476 1.911 . . . . 0.0 114.469 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.18 -8.21 36.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.499 1.519 . . . . 0.0 111.912 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.71 7.21 5.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.442 1.497 . . . . 0.0 113.1 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.3 145.36 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.895 1.331 . . . . 0.0 114.492 -169.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.25 96.53 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.168 2.587 . . . . 0.0 108.548 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.37 117.57 27.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.976 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -83.05 154.28 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.377 1.471 . . . . 0.0 109.463 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.3 149.64 82.35 Favored Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 121.051 -1.03 . . . . 0.0 112.921 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.43 -11.39 24.56 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.494 2.796 . . . . 0.0 114.046 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 126.849 2.06 . . . . 0.0 113.089 -176.788 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt -101.65 150.92 22.61 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.187 1.395 . . . . 0.0 111.378 171.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.5 t -64.89 141.3 58.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.98 1.371 . . . . 0.0 113.482 -168.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.64 -18.51 31.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.47 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.68 -52.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.328 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -140.19 -6.62 1.22 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.31 74.81 Favored Glycine 0 N--CA 1.474 1.205 0 O-C-N 120.842 -1.161 . . . . 0.0 115.263 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.07 142.67 41.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.822 2.449 . . . . 0.0 110.969 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.17 108.41 2.47 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.73 109.99 0.5 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.816 2.344 . . . . 0.0 114.367 -169.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -60.5 -48.83 80.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.556 1.142 . . . . 0.0 110.781 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -119.21 88.59 37.75 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 126.231 1.812 . . . . 0.0 109.235 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 127.65 23.74 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.029 3.153 . . . . 0.0 111.588 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.55 144.32 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 126.163 1.785 . . . . 0.0 110.104 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -133.37 149.74 51.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.401 1.88 . . . . 0.0 110.555 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 t -132.67 117.64 15.33 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.91 -12.82 5.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.327 3.351 . . . . 0.0 116.693 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -47.19 60.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.764 1.225 . . . . 0.0 112.086 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -96.77 -19.76 18.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.867 1.267 . . . . 0.0 112.592 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 64.3 -3.94 0.46 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 128.941 2.896 . . . . 0.0 116.031 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 p -72.83 168.13 19.51 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.792 2.037 . . . . 0.0 113.037 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 mm -115.11 115.96 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.32 171.98 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.05 1.74 . . . . 0.0 111.514 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.12 138.27 43.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.88 -46.41 51.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.672 1.589 . . . . 0.0 109.559 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.77 -40.83 69.01 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.487 -0.758 . . . . 0.0 111.483 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.49 -44.1 95.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.428 0.558 . . . . 0.0 109.575 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.77 -39.26 70.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.479 0.712 . . . . 0.0 111.442 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.36 -45.65 83.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.662 -0.649 . . . . 0.0 111.904 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -69.63 -37.83 76.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.312 1.045 . . . . 0.0 112.241 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.437 HG22 ' H ' ' A' ' 47' ' ' ILE . 2.5 p -79.63 -18.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.251 1.02 . . . . 0.0 112.688 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -79.2 -30.25 43.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.9 2.08 . . . . 0.0 110.269 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -55.26 6.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.109 1.764 . . . . 0.0 111.675 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.7 p -134.24 -21.18 1.84 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.162 1.385 . . . . 0.0 112.175 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.71 -10.63 61.7 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.998 0.808 . . . . 0.0 113.193 -170.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.16 155.4 35.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.467 1.634 . . . . 0.0 113.257 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -78.11 136.69 61.38 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -55.79 -17.37 18.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.82 3.013 . . . . 0.0 118.584 -169.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.8 mt -126.71 -46.29 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 120.253 1.388 . . . . 0.0 111.819 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -81.42 -13.35 58.35 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.309 0.5 OUTLIER 44.66 30.29 0.5 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.927 2.491 . . . . 0.0 114.633 -170.744 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.23 135.64 89.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.769 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.14 135.83 28.05 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.661 2.241 . . . . 0.0 112.246 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp 70.1 147.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 0.0 111.673 -172.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 t -146.38 -48.47 0.2 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.503 1.921 . . . . 0.0 110.621 -169.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.437 ' H ' HG22 ' A' ' 32' ' ' VAL . 9.3 tp -56.89 -31.39 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 127.279 2.231 . . . . 0.0 114.986 174.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.2 -6.89 25.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.93 1.292 . . . . 0.0 112.129 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.29 8.87 4.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.627 1.571 . . . . 0.0 112.813 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 tt -60.31 137.1 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.806 1.289 . . . . 0.0 113.106 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.93 97.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 127.379 2.272 . . . . 0.0 108.575 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -76.24 124.06 26.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.915 -1.116 . . . . 0.0 109.778 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm -82.2 90.56 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.697 1.199 . . . . 0.0 109.908 -174.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.22 117.58 31.47 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.187 1.395 . . . . 0.0 110.103 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.7 -16.06 18.91 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.079 2.519 . . . . 0.0 114.295 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 126.737 2.015 . . . . 0.0 113.878 -177.769 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttm . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.4 mt -112.76 163.22 14.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.535 1.534 . . . . 0.0 111.497 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 1.8 m -48.94 125.42 10.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -167.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.21 62.1 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.98 -57.58 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.947 2.099 . . . . 0.0 111.056 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -126.78 -11.3 6.08 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 75.14 14.27 82.0 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.587 1.085 . . . . 0.0 114.519 171.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -71.84 163.77 27.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.929 2.892 . . . . 0.0 111.516 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.8 110.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.0 126.68 12.73 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.013 1.809 . . . . 0.0 112.224 -169.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -78.46 -33.61 48.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.263 1.425 . . . . 0.0 111.84 170.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -129.93 83.89 62.4 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.688 1.595 . . . . 0.0 109.72 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.13 132.95 52.27 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.582 2.855 . . . . 0.0 111.223 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.35 148.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 126.077 1.751 . . . . 0.0 109.611 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.16 154.61 51.57 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.608 1.563 . . . . 0.0 109.505 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -126.89 119.59 22.53 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 108.403 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -56.33 -8.06 2.39 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.55 3.5 . . . . 0.0 117.326 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -40.07 62.27 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.223 1.409 . . . . 0.0 111.057 177.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.9 p -98.94 -30.43 12.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.204 1.802 . . . . 0.0 113.777 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 55.4 13.4 0.91 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.486 2.315 . . . . 0.0 114.89 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.1 p -77.66 169.47 18.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.91 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 mm -104.94 143.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -143.14 166.39 24.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.496 1.918 . . . . 0.0 110.576 168.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -74.82 128.34 35.33 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.028 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -45.27 -48.14 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.32 1.848 . . . . 0.0 109.756 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 76.0 p -68.86 -24.74 64.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -41.71 50.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.641 1.109 . . . . 0.0 110.784 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.1 tp -64.4 -44.94 89.69 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -54.9 -41.57 71.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.732 1.613 . . . . 0.0 111.864 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -61.1 -51.05 70.75 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.604 -0.685 . . . . 0.0 112.088 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.11 -35.72 80.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.166 0.984 . . . . 0.0 112.075 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.519 HG22 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -83.83 -15.52 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.858 1.263 . . . . 0.0 113.156 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -95.61 -13.17 24.58 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.149 -0.969 . . . . 0.0 111.606 168.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -57.57 3.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.143 1.777 . . . . 0.0 111.364 169.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.6 p -133.39 -21.83 2.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.905 1.282 . . . . 0.0 112.515 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -11.03 63.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.114 0.864 . . . . 0.0 113.316 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -64.35 156.11 30.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.724 1.762 . . . . 0.0 114.092 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.89 130.55 72.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.856 1.263 . . . . 0.0 108.573 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.76 -8.29 2.92 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.222 3.281 . . . . 0.0 118.647 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.88 -44.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.111 1.365 . . . . 0.0 112.282 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.6 p -98.33 -7.56 28.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.16 0.984 . . . . 0.0 112.754 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.305 0.5 OUTLIER 45.44 29.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.812 2.845 . . . . 0.0 115.686 -175.116 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -71.47 139.19 83.87 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.042 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.06 136.91 33.37 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.538 2.159 . . . . 0.0 112.62 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.3 mp 73.96 147.15 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.106 2.962 . . . . 0.0 112.065 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -145.89 -57.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.798 1.639 . . . . 0.0 110.596 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.519 ' H ' HG22 ' A' ' 32' ' ' VAL . 3.1 tt -62.85 -26.87 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -70.01 -6.45 33.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.416 1.086 . . . . 0.0 112.181 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.75 9.57 6.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.364 1.866 . . . . 0.0 112.337 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 10.5 tt -59.8 150.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.032 1.733 . . . . 0.0 114.906 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.4 t -123.99 95.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 128.209 2.603 . . . . 0.0 108.321 169.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -86.37 119.48 26.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp -83.42 97.27 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.827 1.251 . . . . 0.0 108.401 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 p -53.56 121.09 25.09 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.153 0.981 . . . . 0.0 111.733 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.78 -15.38 24.02 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.942 2.428 . . . . 0.0 114.336 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.473 0.683 0 C-N-CA 126.347 1.859 . . . . 0.0 112.387 179.774 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 ptm . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.19 153.68 19.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.461 1.505 . . . . 0.0 111.579 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.3 m -55.32 134.38 50.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.47 -16.11 61.8 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.86 -58.73 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.73 0.812 . . . . 0.0 110.742 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -124.77 -10.53 7.26 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.76 16.29 79.37 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 119.024 0.829 . . . . 0.0 113.261 174.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -66.92 160.91 25.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.897 2.479 . . . . 0.0 110.613 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.0 112.98 16.45 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.49 106.2 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.756 2.304 . . . . 0.0 112.306 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -57.71 -45.87 85.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.659 1.584 . . . . 0.0 111.287 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -122.98 92.43 49.18 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.166 1.386 . . . . 0.0 109.949 170.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.64 123.99 13.35 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.617 2.878 . . . . 0.0 111.383 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.21 151.36 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.255 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tt -134.51 149.03 50.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.71 1.604 . . . . 0.0 110.794 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 t -113.39 131.74 22.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.698 1.199 . . . . 0.0 108.118 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.58 -5.48 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.439 2.093 . . . . 0.0 114.289 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -55.0 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.175 1.39 . . . . 0.0 111.042 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.8 p -79.75 -35.93 38.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.378 1.471 . . . . 0.0 112.694 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 59.86 11.25 2.46 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.906 2.882 . . . . 0.0 114.307 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.5 p -77.03 175.98 9.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 128.281 2.632 . . . . 0.0 111.793 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.13 132.61 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 108.449 171.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -129.38 173.63 10.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.074 1.749 . . . . 0.0 110.243 168.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 151.8 41.87 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.368 172.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.1 ttpp -56.91 -52.08 66.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.569 1.077 . . . . 0.0 108.679 171.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -76.19 -24.24 54.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.6 mt -72.27 -44.32 62.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.864 0.756 . . . . 0.0 111.465 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 tp -63.81 -45.14 91.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -53.85 -38.54 64.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.238 1.415 . . . . 0.0 111.693 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -62.16 -51.61 67.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.479 -0.763 . . . . 0.0 111.885 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -67.26 -37.28 83.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.457 1.103 . . . . 0.0 112.377 -173.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.45 HG22 ' H ' ' A' ' 47' ' ' ILE . 2.9 p -81.57 -20.0 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.504 1.122 . . . . 0.0 112.398 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -81.59 -25.39 35.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.764 1.626 . . . . 0.0 111.077 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -56.0 5.58 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.261 1.824 . . . . 0.0 111.307 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.6 p -135.25 -21.4 1.6 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.885 1.274 . . . . 0.0 112.458 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -14.57 35.65 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.743 1.163 . . . . 0.0 113.857 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -67.22 151.47 47.48 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.026 1.413 . . . . 0.0 111.629 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -68.53 140.06 92.07 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.103 -0.998 . . . . 0.0 110.108 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -57.2 -14.39 15.13 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.095 3.197 . . . . 0.0 117.565 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.15 -50.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.88 1.272 . . . . 0.0 112.141 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 p -86.06 -11.23 53.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.63 0.772 . . . . 0.0 112.548 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.296 0.5 OUTLIER 45.07 30.53 0.61 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.077 2.551 . . . . 0.0 115.191 -171.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -70.76 132.22 87.18 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.431 -0.793 . . . . 0.0 109.653 172.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.02 137.18 36.93 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.729 2.286 . . . . 0.0 112.221 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 mp 69.25 139.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 128.191 2.597 . . . . 0.0 112.291 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 t -139.01 -55.12 0.6 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.556 1.542 . . . . 0.0 111.235 -169.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.45 ' H ' HG22 ' A' ' 32' ' ' VAL . 9.3 tp -59.84 -30.38 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.645 1.978 . . . . 0.0 115.104 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -71.54 -4.06 24.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.645 1.178 . . . . 0.0 112.363 171.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -127.94 9.81 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.643 1.577 . . . . 0.0 112.427 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.6 tp -58.87 144.08 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 114.947 -169.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.94 103.12 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.793 2.437 . . . . 0.0 109.741 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.56 123.69 33.3 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.153 . . . . 0.0 112.405 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -86.45 151.1 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 125.858 1.663 . . . . 0.0 108.92 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -59.04 132.74 87.27 Favored Pre-proline 0 N--CA 1.477 0.913 0 O-C-N 120.862 -1.149 . . . . 0.0 112.515 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.97 -13.17 15.92 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.233 2.622 . . . . 0.0 114.079 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 127.567 2.347 . . . . 0.0 114.199 179.682 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 pp -132.23 142.97 49.61 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.923 1.689 . . . . 0.0 110.853 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -59.33 139.1 57.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -168.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.42 -17.44 60.79 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -82.47 -59.21 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.498 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -124.82 -3.39 7.71 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.15 13.92 83.14 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 119.156 0.889 . . . . 0.0 114.812 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -78.59 163.87 25.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.296 2.638 . . . . 0.0 111.358 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.59 111.73 15.82 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.72 118.59 5.67 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.424 2.083 . . . . 0.0 112.844 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -61.28 -35.95 78.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.383 1.473 . . . . 0.0 111.604 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -129.76 91.26 40.8 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.21 1.404 . . . . 0.0 110.65 171.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.12 127.13 22.13 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.016 3.144 . . . . 0.0 112.136 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.18 143.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 126.664 1.986 . . . . 0.0 110.005 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tt -131.4 158.05 41.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.66 1.584 . . . . 0.0 110.504 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.5 t -129.69 130.0 23.17 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.756 1.623 . . . . 0.0 108.36 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.11 -16.22 12.11 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.812 3.008 . . . . 0.0 116.318 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -82.37 -47.13 12.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.153 1.381 . . . . 0.0 111.693 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.6 p -79.04 -35.75 42.16 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.014 1.326 . . . . 0.0 113.084 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.292 15.2 ptm180 50.37 11.6 0.08 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.409 3.084 . . . . 0.0 115.358 -169.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.1 p -75.51 173.73 10.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.159 2.584 . . . . 0.0 111.054 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.27 116.14 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.155 -0.965 . . . . 0.0 108.559 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -114.27 175.01 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.627 1.971 . . . . 0.0 111.25 172.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -75.39 149.16 38.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.055 174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -54.79 -49.71 70.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -71.32 -32.66 68.86 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.3 mt -71.5 -44.31 64.92 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.142 0.577 . . . . 0.0 111.524 174.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.11 -44.0 93.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.7 tt0 -54.7 -39.88 68.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.57 1.548 . . . . 0.0 111.357 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -61.71 -51.38 68.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.212 0.605 . . . . 0.0 111.573 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -67.46 -35.78 79.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.028 0.918 . . . . 0.0 112.114 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.504 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.3 p -83.97 -15.28 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.955 1.302 . . . . 0.0 113.185 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -96.13 -12.63 24.47 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 121.072 -1.018 . . . . 0.0 111.486 168.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -57.65 3.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.996 1.718 . . . . 0.0 111.291 169.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -132.5 -22.34 2.19 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.025 1.33 . . . . 0.0 112.538 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.39 -11.26 63.95 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.218 0.913 . . . . 0.0 113.151 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.79 155.42 30.4 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.552 1.676 . . . . 0.0 113.862 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.33 130.96 57.34 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -66.57 -4.28 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.042 3.161 . . . . 0.0 116.243 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.82 -41.44 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.207 1.403 . . . . 0.0 111.776 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -105.03 -9.24 17.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.054 1.342 . . . . 0.0 113.662 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.373 0.0 OUTLIER 50.02 22.4 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.732 2.813 . . . . 0.0 115.635 -169.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.58 132.15 94.95 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.456 -0.777 . . . . 0.0 110.503 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 130.54 18.57 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.759 2.306 . . . . 0.0 112.398 -172.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.26 38.8 mt 71.8 139.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 129.092 2.957 . . . . 0.0 113.378 -173.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 t -137.36 -51.58 0.65 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.302 2.241 . . . . 0.0 110.59 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.504 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.3 tp -55.47 -34.66 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 127.801 2.44 . . . . 0.0 115.193 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -66.03 -9.56 31.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.393 1.477 . . . . 0.0 112.066 172.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -133.2 10.28 4.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.714 1.606 . . . . 0.0 112.941 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.44 147.35 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.6 t -121.84 91.95 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 128.011 2.524 . . . . 0.0 108.531 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -77.03 126.92 31.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.06 -1.025 . . . . 0.0 110.693 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.2 mt -98.65 148.03 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.328 1.451 . . . . 0.0 109.696 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.49 117.9 29.03 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.185 1.394 . . . . 0.0 110.343 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -57.64 -24.67 63.76 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.581 2.854 . . . . 0.0 116.428 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 126.123 1.769 . . . . 0.0 112.498 179.655 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.83 148.81 24.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.169 1.388 . . . . 0.0 111.352 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -56.12 138.13 50.25 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -168.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.72 -23.86 64.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 174.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.13 -46.94 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.681 1.192 . . . . 0.0 112.12 -169.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 t -123.66 -17.81 6.3 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.22 13.86 82.87 Favored Glycine 0 N--CA 1.47 0.953 0 O-C-N 121.277 -0.889 . . . . 0.0 114.642 174.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -72.2 162.96 28.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.841 2.857 . . . . 0.0 111.285 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -76.54 106.73 3.62 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 168.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -61.04 119.15 6.16 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.293 1.995 . . . . 0.0 114.247 -168.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.2 mmt-85 -71.19 -34.84 71.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.309 1.044 . . . . 0.0 111.867 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -122.89 83.95 50.05 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.16 1.384 . . . . 0.0 110.382 169.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.3 121.61 9.88 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.132 3.221 . . . . 0.0 111.744 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.83 142.15 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 127.144 2.178 . . . . 0.0 110.876 -169.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -133.03 157.59 44.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.424 2.289 . . . . 0.0 110.075 -173.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 p -131.92 149.26 72.84 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.563 1.145 . . . . 0.0 110.681 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.61 -7.31 20.95 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.239 2.626 . . . . 0.0 113.921 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -56.06 3.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.703 1.201 . . . . 0.0 110.428 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 98.9 p -66.38 -37.21 84.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.964 1.306 . . . . 0.0 113.63 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 55.61 4.5 0.11 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 127.665 2.386 . . . . 0.0 116.272 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 t -86.68 179.59 6.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.362 2.665 . . . . 0.0 111.68 170.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.46 116.51 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.23 172.11 7.11 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.312 1.845 . . . . 0.0 111.94 170.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -83.33 136.17 34.46 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.817 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.5 -43.85 45.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.305 1.842 . . . . 0.0 110.444 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 t -61.04 -39.62 90.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.883 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.69 -42.2 64.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.319 1.048 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.38 -44.57 94.35 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.68 -43.77 69.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.973 0.909 . . . . 0.0 110.72 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -59.13 -55.46 34.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.19 -0.319 . . . . 0.0 111.851 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -65.45 -33.42 75.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.226 1.012 . . . . 0.0 112.331 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.558 HG22 ' H ' ' A' ' 47' ' ' ILE . 1.4 p -86.62 -13.46 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 113.348 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -99.55 -10.95 21.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.774 1.23 . . . . 0.0 111.618 168.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.59 -56.3 4.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.968 2.107 . . . . 0.0 110.897 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.2 p -134.57 -23.2 1.64 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.972 1.309 . . . . 0.0 112.727 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.72 -12.55 63.15 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.677 1.132 . . . . 0.0 113.086 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -63.72 156.51 26.83 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.145 1.473 . . . . 0.0 113.984 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -82.08 130.58 59.6 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 167.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.38 -4.78 10.02 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.004 3.136 . . . . 0.0 117.321 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.0 mt -116.33 -49.36 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.568 1.147 . . . . 0.0 110.912 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.9 p -91.31 -12.87 33.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.398 1.079 . . . . 0.0 113.796 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.381 0.0 OUTLIER 50.67 23.83 1.49 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.334 2.654 . . . . 0.0 115.193 -169.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -68.34 137.2 91.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.57 140.18 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.337 2.025 . . . . 0.0 112.742 -172.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 mt 66.33 128.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 128.954 2.901 . . . . 0.0 114.704 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -129.24 -45.4 1.24 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.032 1.733 . . . . 0.0 111.544 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.558 ' H ' HG22 ' A' ' 32' ' ' VAL . 11.1 tp -58.97 -35.2 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.982 2.113 . . . . 0.0 114.507 172.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.61 -8.88 38.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.304 1.442 . . . . 0.0 111.84 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.39 8.69 6.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.627 1.571 . . . . 0.0 112.99 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.93 137.4 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.726 1.251 . . . . 0.0 114.236 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -119.66 91.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.045 2.138 . . . . 0.0 108.82 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -76.19 115.93 16.39 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.027 -1.046 . . . . 0.0 110.074 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -80.44 -25.88 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.07 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 t -23.56 98.57 0.06 OUTLIER Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 130.44 3.496 . . . . 0.0 114.34 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -59.05 -24.01 71.52 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 124.057 3.172 . . . . 0.0 115.936 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 126.122 1.769 . . . . 0.0 112.878 -175.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.7 mt -101.8 154.11 19.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.379 1.471 . . . . 0.0 111.564 172.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.431 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 0.5 OUTLIER -56.88 135.67 55.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -168.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.97 64.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.995 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.91 -49.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.473 1.509 . . . . 0.0 112.164 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -126.23 -23.33 3.88 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.431 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.51 18.83 78.77 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.138 0.875 . . . . 0.0 113.394 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -65.93 155.2 37.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.661 2.784 . . . . 0.0 111.452 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.54 109.16 2.47 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.079 0.952 . . . . 0.0 109.481 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.05 120.36 8.18 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.944 2.429 . . . . 0.0 113.708 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -81.72 -49.08 10.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.506 1.922 . . . . 0.0 110.294 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -128.82 85.86 59.06 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 126.57 1.948 . . . . 0.0 109.545 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.32 138.31 83.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.655 2.903 . . . . 0.0 111.411 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -145.88 154.15 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 125.369 1.467 . . . . 0.0 109.969 -170.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -136.49 155.4 50.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.413 1.485 . . . . 0.0 110.173 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 t -125.15 136.55 28.3 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 125.647 1.579 . . . . 0.0 108.116 169.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.48 -10.48 27.92 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.766 2.311 . . . . 0.0 113.796 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.85 -67.69 0.62 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.859 2.064 . . . . 0.0 111.48 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.8 m -64.37 -37.0 85.98 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.365 1.066 . . . . 0.0 112.826 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 63.6 -1.53 0.59 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.845 2.458 . . . . 0.0 115.107 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.5 p -77.64 177.12 8.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.585 2.354 . . . . 0.0 111.939 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 mm -106.61 141.62 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.4 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -136.71 167.86 20.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.763 1.625 . . . . 0.0 110.27 168.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -78.35 130.51 36.25 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -43.08 40.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.696 1.998 . . . . 0.0 110.468 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 t -60.21 -43.14 96.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.78 -40.26 41.38 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 110.961 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.76 -48.66 79.69 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -58.26 -42.18 85.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.833 0.288 . . . . 0.0 111.062 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -58.43 -49.55 76.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.175 0.512 . . . . 0.0 111.926 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -64.23 -35.19 80.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.696 1.198 . . . . 0.0 111.879 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.468 HG11 ' H ' ' A' ' 47' ' ' ILE . 43.5 t -94.0 -13.55 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 112.093 -172.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -91.39 -12.71 34.03 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 119.813 -1.805 . . . . 0.0 110.391 167.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.89 -65.71 0.91 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.95 2.1 . . . . 0.0 110.995 169.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.7 p -126.6 -15.12 5.62 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.069 1.348 . . . . 0.0 113.632 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.36 -18.02 25.93 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.923 0.773 . . . . 0.0 113.822 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -68.24 149.09 49.92 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.266 1.533 . . . . 0.0 112.772 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.5 142.48 94.34 Favored Pre-proline 0 CA--C 1.549 0.939 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 169.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.75 -5.57 17.12 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.254 2.636 . . . . 0.0 114.841 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mm -118.55 -52.45 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.716 1.206 . . . . 0.0 110.566 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -89.96 -13.47 36.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.328 0.4 OUTLIER 45.84 31.07 0.97 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.208 2.203 . . . . 0.0 114.462 -169.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -75.29 135.68 72.68 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.041 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.07 140.74 42.23 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.175 2.583 . . . . 0.0 113.049 -170.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 mt 65.1 149.14 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.365 3.066 . . . . 0.0 114.192 -172.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -142.86 -54.18 0.4 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.301 1.84 . . . . 0.0 111.85 -173.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.468 ' H ' HG11 ' A' ' 32' ' ' VAL . 10.1 tp -61.37 -30.87 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.646 1.978 . . . . 0.0 114.82 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.86 -9.37 44.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.309 1.444 . . . . 0.0 112.0 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -130.61 12.88 5.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.853 1.661 . . . . 0.0 112.483 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.6 tp -57.44 141.39 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.492 1.517 . . . . 0.0 114.118 -172.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.86 92.61 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.958 2.103 . . . . 0.0 109.792 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -78.3 126.14 30.36 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.853 -1.154 . . . . 0.0 112.257 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.7 mm -96.6 57.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.441 1.496 . . . . 0.0 108.783 -177.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.3 t -52.82 112.46 3.52 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 126.564 1.946 . . . . 0.0 112.079 -169.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.98 -29.91 75.72 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 123.839 3.026 . . . . 0.0 115.77 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 126.0 1.72 . . . . 0.0 112.639 -178.66 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 pp -102.26 149.33 24.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.632 1.573 . . . . 0.0 111.446 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 3.0 m -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -168.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.51 -17.11 62.36 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.69 -49.97 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.269 1.428 . . . . 0.0 111.522 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.7 p -116.28 -24.47 7.93 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.11 12.39 80.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 115.406 0.922 . . . . 0.0 115.406 179.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.96 166.59 17.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.424 2.29 . . . . 0.0 112.198 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.75 107.42 7.35 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.72 114.9 1.53 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.469 2.779 . . . . 0.0 117.33 -168.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -62.55 -44.93 95.11 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.158 1.383 . . . . 0.0 110.492 169.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm-85 -126.67 94.77 39.35 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.161 1.784 . . . . 0.0 109.678 169.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.72 125.92 17.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.066 3.178 . . . . 0.0 111.036 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.34 142.71 28.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 126.302 1.841 . . . . 0.0 110.366 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tt -131.63 157.75 42.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.523 1.529 . . . . 0.0 110.889 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -134.51 125.9 17.9 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.634 1.574 . . . . 0.0 108.609 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -53.72 -11.65 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 125.172 3.914 . . . . 0.0 117.309 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.71 -55.46 5.84 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.805 1.242 . . . . 0.0 111.178 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 m -79.8 -37.34 35.44 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.505 1.522 . . . . 0.0 112.366 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm-85 56.23 7.97 0.37 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 128.114 2.566 . . . . 0.0 115.429 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.1 p -74.26 174.22 9.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.65 2.38 . . . . 0.0 110.395 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.38 118.1 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -112.76 171.14 7.71 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.428 1.891 . . . . 0.0 111.406 173.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -80.01 134.62 36.24 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.3 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -45.67 -46.64 14.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.742 2.017 . . . . 0.0 110.249 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -63.66 -33.35 75.43 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.966 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.38 -45.22 40.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.288 1.035 . . . . 0.0 110.73 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -63.33 -45.04 93.15 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -56.19 -42.77 77.66 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.867 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -59.25 -51.64 69.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.409 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.49 -34.29 76.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.147 1.379 . . . . 0.0 112.239 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.515 HG23 ' H ' ' A' ' 47' ' ' ILE . 2.2 p -83.1 -18.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.252 1.021 . . . . 0.0 112.872 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -85.77 -22.74 27.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.089 1.355 . . . . 0.0 111.363 168.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.42 4.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.558 1.943 . . . . 0.0 111.59 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.2 p -133.38 -21.38 2.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.029 1.332 . . . . 0.0 112.451 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.14 58.84 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.231 0.92 . . . . 0.0 113.341 -171.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.44 156.06 30.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.389 1.595 . . . . 0.0 113.709 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.74 131.36 54.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.53 -4.89 10.4 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.862 3.041 . . . . 0.0 117.15 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.85 -53.2 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.736 1.214 . . . . 0.0 110.709 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.3 p -88.64 -12.07 43.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.517 1.127 . . . . 0.0 113.89 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 52.58 21.27 1.76 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.313 2.645 . . . . 0.0 115.12 -169.465 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.69 122.17 75.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.673 0.789 . . . . 0.0 111.048 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.9 130.26 39.68 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.469 2.779 . . . . 0.0 114.145 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.265 34.8 mt 72.0 132.69 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.272 3.029 . . . . 0.0 113.265 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.7 t -132.95 -46.71 0.86 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.126 2.171 . . . . 0.0 111.135 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.515 ' H ' HG23 ' A' ' 32' ' ' VAL . 10.2 tp -56.57 -33.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.85 2.06 . . . . 0.0 114.354 171.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.13 -7.54 24.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.621 1.568 . . . . 0.0 112.077 171.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -130.83 6.65 4.69 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.3 tt -60.05 138.98 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 122.723 1.249 . . . . 0.0 113.696 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.97 88.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.112 2.165 . . . . 0.0 108.235 169.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.25 140.12 44.78 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.871 -1.143 . . . . 0.0 111.598 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.2 153.41 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 125.637 1.575 . . . . 0.0 108.935 169.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.97 153.55 79.84 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 125.512 1.525 . . . . 0.0 111.804 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.97 -34.37 76.5 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.842 3.028 . . . . 0.0 115.596 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 C--O 1.239 0.545 0 C-N-CA 125.212 1.405 . . . . 0.0 111.801 175.202 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -100.34 143.53 30.42 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.329 1.452 . . . . 0.0 112.202 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.6 m -58.8 145.44 40.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -168.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.02 -37.09 81.0 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.121 0.962 . . . . 0.0 111.335 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -80.15 -53.39 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.595 1.958 . . . . 0.0 112.771 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.0 m -123.23 -8.74 8.16 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.84 16.2 78.13 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 118.891 0.769 . . . . 0.0 114.543 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -76.18 164.53 26.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.581 2.753 . . . . 0.0 111.428 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.71 106.83 5.35 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 168.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.6 129.21 19.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.183 1.922 . . . . 0.0 113.594 -169.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -45.08 94.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.711 1.604 . . . . 0.0 110.159 169.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -122.83 91.05 49.92 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.587 1.555 . . . . 0.0 110.643 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.1 124.94 17.07 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.795 2.997 . . . . 0.0 111.451 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.16 145.46 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 127.25 2.22 . . . . 0.0 110.395 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.5 tp -131.94 153.77 49.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.68 1.992 . . . . 0.0 110.812 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 t -136.76 125.58 15.22 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.046 . . . . 0.0 106.205 168.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -67.81 -6.58 17.25 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.985 2.456 . . . . 0.0 114.169 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -61.38 1.92 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.748 1.619 . . . . 0.0 110.78 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 m -81.98 -10.41 59.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.268 15.2 ptp180 43.63 41.71 3.68 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.773 2.829 . . . . 0.0 117.041 169.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.8 t -133.98 172.35 12.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.239 2.216 . . . . 0.0 110.224 170.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.56 114.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.57 170.93 7.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.557 2.343 . . . . 0.0 110.638 176.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -73.48 149.49 42.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.765 175.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -53.44 -44.14 68.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -62.2 -41.02 97.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.802 1.241 . . . . 0.0 112.894 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.0 mt -71.38 -45.87 61.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.139 0.576 . . . . 0.0 110.316 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -64.17 -43.69 94.38 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.86 -42.5 72.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.848 1.259 . . . . 0.0 111.453 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -59.9 -52.62 64.66 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.106 -0.371 . . . . 0.0 111.588 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.09 -34.46 77.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.169 0.985 . . . . 0.0 112.15 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.461 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -84.44 -14.27 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.333 1.053 . . . . 0.0 113.235 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.18 -11.27 22.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.408 1.083 . . . . 0.0 111.843 168.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -56.09 5.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.764 2.025 . . . . 0.0 110.841 169.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.2 p -135.19 -22.73 1.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.745 1.218 . . . . 0.0 112.726 -176.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.09 -11.28 65.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.483 1.039 . . . . 0.0 113.025 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -63.83 157.35 24.8 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.309 1.554 . . . . 0.0 113.518 -174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -80.94 135.87 51.3 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.511 1.124 . . . . 0.0 108.037 167.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.64 -8.23 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 N-CA-C 118.905 2.617 . . . . 0.0 118.905 -168.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.74 -44.78 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 121.09 1.768 . . . . 0.0 111.564 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -84.19 -13.12 53.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 44.89 30.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.677 2.391 . . . . 0.0 114.766 -170.392 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.61 134.37 88.49 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.641 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.11 135.56 27.52 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.512 2.142 . . . . 0.0 112.296 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 mp 70.72 144.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.97 2.508 . . . . 0.0 111.861 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -145.09 -52.4 0.28 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.723 2.009 . . . . 0.0 110.646 -169.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.461 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.0 tp -57.62 -32.87 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.553 2.341 . . . . 0.0 115.628 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -67.82 -8.26 34.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.394 1.078 . . . . 0.0 112.086 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.13 11.22 4.61 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.291 1.836 . . . . 0.0 112.532 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 tt -59.39 142.01 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.842 1.306 . . . . 0.0 113.475 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.33 97.84 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 127.839 2.456 . . . . 0.0 109.023 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.92 112.25 9.87 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.74 -1.225 . . . . 0.0 110.452 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.64 -29.6 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.571 1.548 . . . . 0.0 111.227 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.4 133.98 62.13 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.234 1.414 . . . . 0.0 111.459 171.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.38 -16.76 35.0 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.866 2.377 . . . . 0.0 114.27 -177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 127.166 2.186 . . . . 0.0 114.025 173.38 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ptm . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.88 153.53 42.48 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.727 2.011 . . . . 0.0 112.482 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.7 m -58.9 136.01 57.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -168.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.58 -21.46 64.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -94.74 -49.7 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.879 1.671 . . . . 0.0 111.923 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -126.84 -16.95 5.05 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.72 13.61 83.37 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.926 -1.109 . . . . 0.0 114.72 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -69.41 164.08 23.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.885 2.874 . . . . 0.0 112.088 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -82.4 110.19 20.21 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.64 138.33 37.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.155 1.903 . . . . 0.0 113.823 -169.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -84.59 -41.3 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.433 2.293 . . . . 0.0 109.894 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -121.68 86.17 44.83 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.994 1.718 . . . . 0.0 108.832 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.02 124.75 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.886 3.057 . . . . 0.0 109.685 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.03 142.89 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 125.84 1.656 . . . . 0.0 110.494 -169.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -133.12 154.45 50.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.421 1.488 . . . . 0.0 110.568 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 t -131.9 128.73 21.66 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 127.049 2.139 . . . . 0.0 106.054 168.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.39 -7.57 18.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.35 2.7 . . . . 0.0 115.004 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -74.61 -63.34 1.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.288 1.035 . . . . 0.0 110.921 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -64.08 -36.46 84.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.86 1.264 . . . . 0.0 111.814 170.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.353 11.1 ptp180 47.92 17.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 129.741 3.216 . . . . 0.0 116.092 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.3 p -77.99 174.44 11.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.312 2.645 . . . . 0.0 109.82 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 116.51 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -114.14 169.01 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.787 2.035 . . . . 0.0 111.644 174.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.83 131.28 39.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -47.92 -45.51 30.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.948 1.699 . . . . 0.0 110.047 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 m -59.97 -35.18 74.44 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.46 -39.88 31.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.255 0.622 . . . . 0.0 111.089 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -62.69 -46.11 89.65 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -56.2 -40.39 73.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.551 1.54 . . . . 0.0 112.023 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -60.91 -52.52 64.68 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.513 -0.742 . . . . 0.0 111.83 170.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -67.37 -34.7 77.84 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.204 1.002 . . . . 0.0 111.849 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.9 p -82.84 -18.36 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.631 1.172 . . . . 0.0 113.033 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -91.38 -15.4 29.04 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 121.07 -1.019 . . . . 0.0 111.636 168.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.87 -56.41 4.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.388 1.875 . . . . 0.0 111.702 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -132.93 -21.84 2.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.086 1.354 . . . . 0.0 112.395 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.11 -12.13 55.24 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.27 0.938 . . . . 0.0 113.575 -171.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -66.58 156.07 36.06 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.589 1.694 . . . . 0.0 113.927 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.95 135.09 59.24 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 166.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.89 -4.05 11.64 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.211 2.607 . . . . 0.0 115.018 -170.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.28 -50.65 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 110.714 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -87.25 -13.01 44.98 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.384 0.0 OUTLIER 49.68 21.33 0.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.338 2.655 . . . . 0.0 115.138 -168.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -68.32 129.13 93.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.234 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.87 135.72 33.39 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.833 2.356 . . . . 0.0 112.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.27 39.1 mt 70.86 141.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 129.405 3.082 . . . . 0.0 113.082 -171.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -140.99 -53.86 0.48 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 110.58 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.506 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -61.76 -24.75 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -16.54 62.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.466 1.906 . . . . 0.0 111.674 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.12 10.27 8.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.675 1.99 . . . . 0.0 112.161 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 11.3 tt -58.48 139.89 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 122.955 1.359 . . . . 0.0 114.404 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -120.75 91.78 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.834 2.454 . . . . 0.0 108.406 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -75.55 121.6 22.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.979 -1.076 . . . . 0.0 110.356 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.79 155.5 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.09 1.756 . . . . 0.0 108.559 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -57.34 134.39 81.44 Favored Pre-proline 0 N--CA 1.478 0.931 0 O-C-N 121.126 -0.984 . . . . 0.0 112.198 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.03 -14.45 18.98 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.211 2.608 . . . . 0.0 114.024 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 125.917 1.687 . . . . 0.0 112.153 177.742 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.35 146.53 27.91 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.41 1.484 . . . . 0.0 111.095 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 3.2 m -59.08 138.69 57.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -168.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.59 61.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.824 -0.547 . . . . 0.0 112.422 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.65 -51.35 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.804 1.242 . . . . 0.0 111.455 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -124.27 -10.51 7.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.0 11.88 84.43 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 119.018 0.826 . . . . 0.0 114.947 170.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -72.62 161.08 31.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.605 2.762 . . . . 0.0 111.176 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.1 t -76.33 106.68 3.49 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 168.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.51 118.25 5.11 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.608 2.205 . . . . 0.0 114.385 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.02 -47.06 84.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.865 1.266 . . . . 0.0 111.343 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -129.62 90.25 44.3 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.233 1.413 . . . . 0.0 109.339 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.83 149.53 86.59 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.185 2.59 . . . . 0.0 113.38 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.44 155.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 110.46 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.98 154.07 48.24 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.653 1.181 . . . . 0.0 110.608 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -117.36 134.11 23.14 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 125.658 1.583 . . . . 0.0 108.986 169.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.09 -4.7 14.77 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.359 2.706 . . . . 0.0 113.762 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -86.72 -48.84 7.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 110.535 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.4 p -97.62 -24.16 15.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 114.861 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.12 4.08 1.13 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 129.164 2.986 . . . . 0.0 116.685 170.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -71.8 174.43 6.89 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.992 1.717 . . . . 0.0 110.248 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.9 mt -119.34 116.1 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.57 165.71 12.0 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.53 1.532 . . . . 0.0 111.25 174.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -75.17 134.6 41.19 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -52.83 -41.53 64.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.872 1.669 . . . . 0.0 109.845 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -61.61 -37.15 82.89 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.3 -43.13 52.7 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.564 0.746 . . . . 0.0 110.648 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.27 -45.58 83.94 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 119.221 -0.418 . . . . 0.0 109.922 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.9 -41.86 68.08 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.182 0.993 . . . . 0.0 111.793 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.51 -52.92 63.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.986 0.514 . . . . 0.0 111.761 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.24 -36.02 80.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.35 1.06 . . . . 0.0 112.076 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG23 ' H ' ' A' ' 47' ' ' ILE . 2.4 p -84.94 -18.72 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.282 1.033 . . . . 0.0 112.884 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -91.04 -14.8 30.67 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.988 -1.07 . . . . 0.0 111.576 168.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -60.11 2.39 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.641 1.576 . . . . 0.0 110.555 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.9 p -137.4 -16.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.695 1.198 . . . . 0.0 113.104 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 83.6 -15.63 34.97 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.768 1.175 . . . . 0.0 114.007 179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -67.33 149.03 50.88 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.928 1.364 . . . . 0.0 111.52 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.99 143.49 91.76 Favored Pre-proline 0 CA--C 1.548 0.904 0 O-C-N 120.936 -1.102 . . . . 0.0 108.791 168.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -4.66 14.13 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.304 2.669 . . . . 0.0 114.684 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.8 -52.34 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.453 1.501 . . . . 0.0 110.851 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -85.38 -15.06 44.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.391 0.0 OUTLIER 49.17 22.4 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.055 2.542 . . . . 0.0 114.609 -168.83 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -73.89 130.79 82.55 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.099 -1.001 . . . . 0.0 109.696 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.79 141.15 48.49 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.426 2.751 . . . . 0.0 113.705 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.3 mt 65.89 132.43 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 129.928 3.291 . . . . 0.0 113.756 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -131.96 -48.0 0.94 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.262 1.825 . . . . 0.0 111.456 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.503 ' H ' HG23 ' A' ' 32' ' ' VAL . 10.3 tp -60.13 -32.79 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.05 1.74 . . . . 0.0 114.405 173.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.06 -7.73 38.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.248 1.419 . . . . 0.0 112.162 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -126.96 7.58 6.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.015 1.726 . . . . 0.0 112.531 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.1 tp -58.39 142.0 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.43 89.66 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 107.567 169.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -75.16 141.43 43.66 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.026 -1.046 . . . . 0.0 112.5 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.2 mm -105.38 142.44 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.8 t -66.49 124.42 88.2 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.114 0.966 . . . . 0.0 110.168 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.63 -10.06 20.09 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.36 2.707 . . . . 0.0 115.454 -171.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 125.335 1.454 . . . . 0.0 112.918 -178.539 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -131.98 142.36 49.57 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.301 1.84 . . . . 0.0 110.309 169.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.4 m -57.34 130.07 44.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.37 62.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.56 -56.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.962 0.905 . . . . 0.0 110.984 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 -13.78 8.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.31 9.57 86.4 Favored Glycine 0 N--CA 1.47 0.915 0 O-C-N 121.486 -0.759 . . . . 0.0 114.994 170.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -71.05 162.75 28.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.47 2.708 . . . . 0.0 111.745 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.59 107.43 5.23 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.722 1.209 . . . . 0.0 107.812 168.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.91 116.28 3.01 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.965 2.443 . . . . 0.0 114.972 -169.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -75.36 -36.39 60.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.997 0.919 . . . . 0.0 111.477 169.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -121.47 81.51 39.06 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 125.725 1.61 . . . . 0.0 109.723 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.1 126.27 19.8 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.257 3.305 . . . . 0.0 111.27 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.0 p -141.91 153.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.483 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -131.11 150.44 52.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.047 2.139 . . . . 0.0 109.677 -171.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.3 t -125.63 125.22 24.99 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.911 1.684 . . . . 0.0 107.738 169.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.46 -7.68 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.82 3.68 . . . . 0.0 116.613 173.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.39 -67.19 0.85 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.336 1.854 . . . . 0.0 111.127 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.2 m -70.14 -31.65 69.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.383 1.073 . . . . 0.0 113.396 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 62.22 7.31 2.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.216 2.606 . . . . 0.0 115.715 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.5 p -75.94 174.0 10.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.172 2.589 . . . . 0.0 111.755 170.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.4 mt -121.05 117.05 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 120.98 -1.075 . . . . 0.0 108.468 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -117.08 175.55 5.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.473 1.909 . . . . 0.0 112.219 178.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.22 130.7 36.32 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.308 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -53.37 -41.01 65.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.673 1.589 . . . . 0.0 110.64 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -57.5 -44.04 84.69 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.053 0.846 . . . . 0.0 112.748 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . 0.311 1.0 OUTLIER -94.45 -25.14 17.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.934 0.894 . . . . 0.0 113.291 -173.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.36 -52.52 57.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 167.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.25 -39.76 79.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.124 0.57 . . . . 0.0 111.351 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -56.84 -52.57 64.57 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.304 0.502 . . . . 0.0 112.239 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -64.92 -29.54 70.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.125 1.77 . . . . 0.0 112.336 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 42.1 t -93.31 -5.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 125.904 1.682 . . . . 0.0 112.047 -177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -98.76 -17.57 18.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.152 -1.593 . . . . 0.0 110.606 167.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -63.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.904 2.482 . . . . 0.0 111.327 170.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.6 p -126.56 -21.88 4.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.962 1.305 . . . . 0.0 113.104 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.06 -18.59 26.57 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 123.656 0.646 . . . . 0.0 114.1 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.08 145.72 54.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.795 1.297 . . . . 0.0 111.685 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 149.49 90.49 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.19 -0.944 . . . . 0.0 111.131 169.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.92 -17.66 60.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.858 2.372 . . . . 0.0 115.988 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.0 mm -125.62 -48.3 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.068 0.947 . . . . 0.0 110.978 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.8 p -82.43 -14.81 54.51 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.359 0.0 OUTLIER 51.7 19.78 0.98 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.033 2.533 . . . . 0.0 114.535 -169.515 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.61 124.6 88.81 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.914 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.44 133.59 43.5 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.737 2.958 . . . . 0.0 114.533 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 mt 66.0 143.16 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.143 2.977 . . . . 0.0 114.323 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.15 -41.14 0.66 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.284 1.833 . . . . 0.0 111.823 -174.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.21 -33.71 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.656 1.583 . . . . 0.0 113.965 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.5 -5.45 28.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.253 1.421 . . . . 0.0 112.146 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.52 8.15 6.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 4.5 tp -58.87 126.79 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.088 1.755 . . . . 0.0 114.959 -169.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -120.63 85.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.4 1.88 . . . . 0.0 110.221 171.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -80.01 118.57 21.86 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.954 -1.092 . . . . 0.0 112.073 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.2 mt -82.45 127.17 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.612 1.965 . . . . 0.0 109.085 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.99 116.23 17.8 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.427 1.091 . . . . 0.0 110.457 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.81 -18.61 14.85 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.866 2.377 . . . . 0.0 113.884 -175.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.471 0.618 0 C-N-CA 126.087 1.755 . . . . 0.0 113.01 -178.472 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.1 mt -119.13 148.43 43.08 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.146 1.778 . . . . 0.0 110.451 170.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.0 t -63.52 139.07 58.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.058 1.409 . . . . 0.0 113.698 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.84 -15.56 47.78 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.072 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -76.91 -56.67 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.915 174.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m -134.54 -6.03 2.54 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.94 7.43 70.65 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.91 1.232 . . . . 0.0 114.109 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -56.29 137.98 51.35 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.301 2.64 . . . . 0.0 111.11 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.31 108.85 3.18 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.908 1.283 . . . . 0.0 107.663 169.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.74 128.02 28.6 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.586 2.191 . . . . 0.0 114.872 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -75.25 -46.05 36.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 108.782 169.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -124.32 91.16 49.93 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 127.212 2.205 . . . . 0.0 108.162 172.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.64 130.72 38.48 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.839 3.026 . . . . 0.0 111.4 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.9 144.02 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.971 1.708 . . . . 0.0 110.218 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.2 tp -131.65 154.32 49.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.5 1.92 . . . . 0.0 110.248 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 t -135.03 135.03 22.2 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.867 2.067 . . . . 0.0 107.703 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.87 -8.4 23.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -80.89 -64.19 1.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.978 1.711 . . . . 0.0 111.649 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -67.84 -32.73 73.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.883 0.873 . . . . 0.0 112.43 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 -2.0 0.51 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.351 2.66 . . . . 0.0 115.191 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.5 p -73.5 169.1 17.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.777 2.431 . . . . 0.0 112.617 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -112.76 116.55 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.7 168.96 9.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.588 1.555 . . . . 0.0 111.613 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.3 131.91 42.47 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.135 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -46.86 53.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.597 1.559 . . . . 0.0 110.283 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 t -62.18 -40.05 94.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -39.74 53.62 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.137 -0.977 . . . . 0.0 111.666 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.6 tp -60.64 -45.22 94.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.643 0.656 . . . . 0.0 109.302 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -55.72 -38.82 70.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.013 0.925 . . . . 0.0 111.544 179.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.37 -49.57 73.34 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.768 -0.582 . . . . 0.0 111.827 173.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -67.95 -35.26 78.09 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.052 0.929 . . . . 0.0 112.221 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG22 ' H ' ' A' ' 47' ' ' ILE . 1.6 p -82.84 -15.95 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.369 1.068 . . . . 0.0 112.984 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.19 -14.05 25.99 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.166 -0.959 . . . . 0.0 111.519 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.88 -57.63 3.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.874 1.67 . . . . 0.0 111.373 170.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.9 -22.12 1.86 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.847 1.259 . . . . 0.0 112.539 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.11 60.14 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.226 0.917 . . . . 0.0 113.459 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.99 155.01 37.86 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.24 1.52 . . . . 0.0 113.449 -172.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.07 141.24 74.33 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 166.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.73 -7.47 18.33 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.159 2.573 . . . . 0.0 115.432 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.0 mt -126.8 -46.94 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.636 1.107 . . . . 0.0 111.879 -175.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.0 p -83.69 -12.78 55.42 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.343 0.3 OUTLIER 48.44 23.5 0.6 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.008 2.523 . . . . 0.0 115.083 -169.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.94 118.04 44.99 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.25 1.02 . . . . 0.0 110.644 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.39 132.65 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.474 2.782 . . . . 0.0 113.843 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.72 137.71 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.518 3.127 . . . . 0.0 112.864 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.69 -44.91 0.48 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.315 1.846 . . . . 0.0 111.164 -171.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.454 ' H ' HG22 ' A' ' 32' ' ' VAL . 10.6 tp -58.89 -31.2 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 126.837 2.055 . . . . 0.0 115.568 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -14.74 62.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.369 1.868 . . . . 0.0 112.071 170.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -124.6 13.08 8.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.82 2.048 . . . . 0.0 112.035 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.7 tp -56.32 125.01 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.575 1.55 . . . . 0.0 112.947 -175.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.98 92.33 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.421 1.489 . . . . 0.0 109.26 170.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -78.63 123.11 26.77 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.055 -1.028 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.9 mm -83.95 128.03 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.636 1.575 . . . . 0.0 109.655 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.7 t -67.7 115.83 31.53 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.045 0.938 . . . . 0.0 109.541 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.68 -18.13 19.84 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.791 2.327 . . . . 0.0 114.096 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 125.892 1.677 . . . . 0.0 113.018 -179.222 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt -101.65 148.64 25.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.552 1.541 . . . . 0.0 111.369 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.19 146.11 51.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -169.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.21 68.57 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.98 -48.22 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 110.968 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -135.3 -11.5 2.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.22 12.07 79.64 Favored Glycine 0 N--CA 1.469 0.881 0 O-C-N 121.228 -0.92 . . . . 0.0 113.961 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -51.2 136.22 24.62 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 128.341 2.656 . . . . 0.0 111.509 171.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -66.42 110.2 4.46 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 168.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.85 105.16 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.996 2.464 . . . . 0.0 115.846 -169.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -59.33 -41.2 88.56 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.309 1.843 . . . . 0.0 111.109 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -132.69 94.8 20.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.054 1.741 . . . . 0.0 108.678 169.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 135.3 62.3 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.662 2.908 . . . . 0.0 112.153 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.31 146.05 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.408 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.53 152.75 49.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.533 1.133 . . . . 0.0 110.611 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 t -120.37 133.3 23.98 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 125.744 1.618 . . . . 0.0 109.646 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.71 -19.62 25.05 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.313 2.675 . . . . 0.0 114.395 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -93.87 -58.96 2.1 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.921 1.689 . . . . 0.0 111.93 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.0 m -78.53 -16.59 57.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 58.32 -16.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 129.887 3.275 . . . . 0.0 118.627 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 t -74.48 173.39 10.41 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.363 1.465 . . . . 0.0 110.924 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 mm -106.79 118.91 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.258 1.423 . . . . 0.0 108.736 175.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.26 170.61 7.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 111.38 173.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 139.81 43.35 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.41 -45.68 62.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 109.393 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m -66.72 -42.04 86.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.907 0.883 . . . . 0.0 113.201 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.31 -40.36 64.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.565 0.746 . . . . 0.0 111.534 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.8 tp -61.35 -49.23 77.8 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -55.61 -41.78 73.97 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.017 0.527 . . . . 0.0 110.681 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.16 -53.65 55.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.034 0.534 . . . . 0.0 111.695 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -61.75 -35.18 77.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.349 1.071 . . . . 0.0 111.849 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.491 HG13 ' H ' ' A' ' 47' ' ' ILE . 41.7 t -93.75 -6.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 124.444 1.097 . . . . 0.0 112.258 -173.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -100.49 -10.59 20.93 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.937 -1.727 . . . . 0.0 110.81 167.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.108 2.563 . . . . 0.0 110.019 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -128.37 -21.77 3.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.38 1.472 . . . . 0.0 113.229 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.11 24.18 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.725 0.679 . . . . 0.0 113.758 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.74 147.72 52.93 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.588 1.194 . . . . 0.0 111.534 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.71 147.27 89.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.95 -1.094 . . . . 0.0 110.374 169.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.52 -10.75 27.32 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.909 2.406 . . . . 0.0 114.457 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.59 -46.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.312 0.96 . . . . 0.0 111.609 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.8 p -85.84 -10.4 55.46 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.327 0.3 OUTLIER 48.06 24.96 0.71 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.772 2.429 . . . . 0.0 115.671 -170.227 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.47 119.34 59.04 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.138 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.77 128.03 26.88 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.742 2.961 . . . . 0.0 114.334 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt 65.37 141.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.885 2.874 . . . . 0.0 114.664 -172.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.29 -54.54 0.75 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.723 1.609 . . . . 0.0 112.614 -173.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.491 ' H ' HG13 ' A' ' 32' ' ' VAL . 7.8 tp -61.62 -32.04 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.808 1.643 . . . . 0.0 114.066 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -68.87 -7.09 31.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 112.078 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -133.31 12.67 4.19 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.8 1.64 . . . . 0.0 112.122 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 9.7 tp -59.22 150.1 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.623 1.969 . . . . 0.0 115.305 -171.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.53 87.54 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.224 1.81 . . . . 0.0 108.385 169.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -75.8 137.44 40.52 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.921 -1.112 . . . . 0.0 111.596 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -115.09 146.08 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.49 1.516 . . . . 0.0 109.962 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.0 m -70.06 143.19 91.17 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 120.901 -1.124 . . . . 0.0 112.473 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.62 -16.25 18.97 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.021 2.481 . . . . 0.0 113.945 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 125.982 1.713 . . . . 0.0 112.122 178.403 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.5 mt -111.4 147.31 35.5 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.62 1.568 . . . . 0.0 111.074 170.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.8 t -66.77 144.05 56.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.619 1.199 . . . . 0.0 113.915 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.12 -15.35 38.7 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.389 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -77.56 -53.62 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.122 0.569 . . . . 0.0 110.008 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 m -136.72 -5.84 1.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.71 6.91 82.36 Favored Glycine 0 N--CA 1.473 1.103 0 CA-C-N 120.069 1.304 . . . . 0.0 115.493 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.55 147.14 46.48 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.69 2.396 . . . . 0.0 110.819 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.57 108.78 3.2 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.1 115.11 3.29 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.459 2.106 . . . . 0.0 112.717 -169.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -63.74 -34.99 79.12 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.612 1.165 . . . . 0.0 111.708 170.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.8 mtm-85 -123.63 87.09 52.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.323 1.849 . . . . 0.0 109.501 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.57 128.69 22.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.888 3.058 . . . . 0.0 111.736 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 152.09 20.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.245 1.418 . . . . 0.0 110.503 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -139.24 155.53 47.71 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.977 1.311 . . . . 0.0 110.407 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 p -123.81 146.96 52.19 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 109.029 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.22 -10.23 28.43 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 121.917 1.744 . . . . 0.0 113.183 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -59.51 2.75 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.081 1.753 . . . . 0.0 111.366 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.2 m -79.59 -32.51 41.96 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 112.072 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 59.94 1.72 0.34 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.467 2.307 . . . . 0.0 115.437 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 p -73.07 173.46 9.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.117 2.567 . . . . 0.0 111.679 170.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.33 116.22 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.84 173.44 6.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 126.287 1.835 . . . . 0.0 110.452 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.12 143.54 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.111 -0.993 . . . . 0.0 109.554 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.59 -46.18 66.81 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.13 1.372 . . . . 0.0 108.815 171.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -67.81 -42.79 80.99 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.6 -40.79 66.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.151 0.887 . . . . 0.0 111.439 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.92 -47.56 84.38 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -56.05 -42.99 77.44 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.695 0.398 . . . . 0.0 110.552 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -57.85 -52.13 66.75 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.688 0.795 . . . . 0.0 111.491 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.46 -36.21 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.025 1.33 . . . . 0.0 111.967 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.472 HG12 ' H ' ' A' ' 47' ' ' ILE . 43.1 t -91.78 -6.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.016 1.326 . . . . 0.0 112.232 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -101.96 -10.77 19.48 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 119.994 -1.691 . . . . 0.0 110.567 167.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -61.6 1.9 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.034 2.134 . . . . 0.0 110.226 169.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.4 p -130.41 -16.75 3.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.983 1.313 . . . . 0.0 113.58 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.22 -19.64 30.14 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-O 119.507 -0.607 . . . . 0.0 113.656 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.56 148.83 51.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.827 1.314 . . . . 0.0 113.216 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.76 140.82 84.15 Favored Pre-proline 0 CA--C 1.549 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 110.83 169.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -60.42 -12.22 19.69 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.883 3.055 . . . . 0.0 117.594 -170.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mt -129.87 -42.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.38 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -86.87 -16.66 35.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.709 0.804 . . . . 0.0 112.26 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.317 0.5 OUTLIER 43.01 32.25 0.4 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.066 2.546 . . . . 0.0 114.798 -169.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -81.59 145.67 55.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 118.925 -0.559 . . . . 0.0 110.113 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.61 142.89 36.97 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.712 2.275 . . . . 0.0 114.042 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.2 mt 65.44 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 130.152 3.381 . . . . 0.0 115.019 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.1 t -129.63 -52.12 1.16 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.217 1.807 . . . . 0.0 112.037 -172.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.472 ' H ' HG12 ' A' ' 32' ' ' VAL . 8.8 tp -60.33 -31.57 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.039 1.736 . . . . 0.0 114.298 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -69.38 -8.47 46.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.187 1.395 . . . . 0.0 112.147 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -127.62 11.46 6.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.192 1.797 . . . . 0.0 112.328 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 8.5 tp -58.78 145.35 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.781 1.632 . . . . 0.0 115.276 -169.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.53 91.87 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.541 2.336 . . . . 0.0 108.477 169.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -77.15 112.36 13.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.956 -1.09 . . . . 0.0 111.361 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.0 mm -82.21 -15.15 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 125.197 1.399 . . . . 0.0 111.728 -177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.9 t -40.66 110.69 0.71 Allowed Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 128.252 2.621 . . . . 0.0 112.484 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.26 -14.91 20.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.024 2.483 . . . . 0.0 114.594 -171.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 C--O 1.241 0.643 0 C-N-CA 125.435 1.494 . . . . 0.0 112.266 178.489 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -99.48 146.91 25.84 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.365 1.466 . . . . 0.0 111.979 176.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 3.0 m -60.65 138.6 58.05 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.91 -14.83 61.55 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.49 -53.13 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.908 1.283 . . . . 0.0 111.727 -170.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 m -118.69 -14.3 9.56 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.85 16.11 81.05 Favored Glycine 0 N--CA 1.467 0.719 0 O-C-N 121.79 -0.569 . . . . 0.0 114.022 169.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -91.42 174.04 7.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.409 1.884 . . . . 0.0 113.577 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.33 114.35 28.87 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 125.55 10.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.177 1.918 . . . . 0.0 113.825 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -57.64 -50.72 72.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 111.257 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.48 100.72 14.92 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.812 1.645 . . . . 0.0 110.101 170.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.87 131.78 39.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.664 2.909 . . . . 0.0 111.678 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.16 145.9 23.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 127.894 2.478 . . . . 0.0 110.321 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tt -134.19 159.4 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.248 1.819 . . . . 0.0 110.041 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 p -128.88 152.41 79.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 110.932 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.91 -5.01 16.22 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.241 2.627 . . . . 0.0 113.564 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -70.87 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.21 1.404 . . . . 0.0 110.551 174.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -75.17 -29.66 60.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 113.056 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 56.11 5.54 0.18 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.951 2.1 . . . . 0.0 115.278 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.6 p -70.59 171.6 10.01 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.584 2.353 . . . . 0.0 111.183 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.56 115.96 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.409 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -113.78 171.91 7.3 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.09 2.156 . . . . 0.0 111.467 173.936 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -81.29 137.72 35.77 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -42.98 -49.92 5.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 128.289 2.636 . . . . 0.0 110.363 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.95 71.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.801 -171.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -76.31 -45.0 34.36 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.8 0.84 . . . . 0.0 110.348 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.28 -48.72 74.6 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.94 -45.06 78.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.718 0.407 . . . . 0.0 110.837 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -59.11 -50.69 73.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.282 0.492 . . . . 0.0 111.824 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.38 -34.35 77.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.149 0.976 . . . . 0.0 111.513 -174.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 47' ' ' ILE . 48.2 t -95.55 -9.89 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.874 1.27 . . . . 0.0 112.314 -173.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -94.44 -13.27 26.38 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 119.909 -1.745 . . . . 0.0 110.441 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.77 -66.64 0.84 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.136 2.574 . . . . 0.0 111.466 169.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.4 p -119.76 -20.31 7.68 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.387 1.475 . . . . 0.0 113.024 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.53 -20.57 13.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.087 0.851 . . . . 0.0 113.896 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.0 148.66 50.73 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.059 1.43 . . . . 0.0 112.423 -170.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.71 144.69 88.74 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.08 -1.013 . . . . 0.0 109.649 168.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.95 -6.84 18.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.678 2.918 . . . . 0.0 116.142 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mt -127.37 -49.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.605 1.162 . . . . 0.0 111.485 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.5 p -83.58 -14.6 51.72 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.339 0.2 OUTLIER 49.52 23.72 0.98 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.528 2.331 . . . . 0.0 114.981 -169.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.28 133.63 91.34 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.3 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.17 135.3 34.09 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.874 2.383 . . . . 0.0 112.715 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.0 mt 67.82 144.34 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.363 3.065 . . . . 0.0 113.998 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.8 t -141.04 -49.52 0.42 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.949 2.099 . . . . 0.0 112.364 -174.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.51 ' H ' HG12 ' A' ' 32' ' ' VAL . 44.5 mm -58.65 -33.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.834 2.054 . . . . 0.0 113.808 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.3 -8.78 19.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.75 1.22 . . . . 0.0 112.419 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -132.48 9.17 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.431 1.893 . . . . 0.0 113.183 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.25 139.4 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.831 1.252 . . . . 0.0 114.16 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.14 92.43 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.26 2.224 . . . . 0.0 109.0 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -72.71 130.58 40.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.787 -1.196 . . . . 0.0 110.88 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mm -83.49 76.64 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.66 1.184 . . . . 0.0 109.04 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -63.28 151.03 87.99 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.86 1.264 . . . . 0.0 112.706 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.73 -10.11 19.96 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.428 2.752 . . . . 0.0 114.063 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 126.558 1.943 . . . . 0.0 113.433 -176.858 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 tp -100.09 116.75 32.84 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.284 1.434 . . . . 0.0 111.048 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.8 t -69.25 147.8 50.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.726 1.25 . . . . 0.0 112.629 -170.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.91 -23.12 25.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.79 . . . . 0.0 112.531 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.16 -45.19 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.951 0.9 . . . . 0.0 111.163 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 t -126.21 -40.14 2.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.687 0.795 . . . . 0.0 112.701 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.34 20.03 36.71 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 121.702 0.612 . . . . 0.0 113.95 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -78.25 168.34 20.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.012 1.325 . . . . 0.0 110.982 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.29 112.83 17.41 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 133.82 20.98 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.649 2.233 . . . . 0.0 112.484 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.12 -34.58 73.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.949 1.3 . . . . 0.0 111.824 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -124.23 83.35 56.62 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.657 1.583 . . . . 0.0 111.067 173.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.54 125.56 18.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.734 2.956 . . . . 0.0 112.273 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 145.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.943 2.097 . . . . 0.0 110.507 -173.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.81 156.3 42.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.15 1.78 . . . . 0.0 109.841 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -127.11 143.54 47.37 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.919 1.288 . . . . 0.0 108.251 169.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.18 0.82 5.39 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.605 2.87 . . . . 0.0 113.866 -172.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -92.69 -67.85 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.202 1.801 . . . . 0.0 109.878 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -56.44 -41.64 76.79 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 59.25 5.67 0.62 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.258 2.223 . . . . 0.0 114.378 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.9 p -77.35 177.02 8.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.761 2.424 . . . . 0.0 111.579 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -122.68 114.54 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.49 171.22 7.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.436 1.894 . . . . 0.0 111.233 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.8 144.19 49.25 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.818 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -56.76 -44.37 81.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 109.707 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -68.18 -36.51 79.72 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.56 -38.76 65.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 0.0 112.022 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -44.48 96.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.948 0.795 . . . . 0.0 109.24 171.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -54.62 -41.23 69.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.5 0.72 . . . . 0.0 110.917 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -58.98 -53.43 58.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.465 0.706 . . . . 0.0 111.398 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.62 -36.65 81.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.366 1.079 . . . . 0.0 112.348 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.433 HG22 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.66 -10.86 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.772 1.229 . . . . 0.0 112.999 -175.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -102.1 -10.46 19.65 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.95 -1.094 . . . . 0.0 111.462 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -55.54 5.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.125 1.77 . . . . 0.0 110.691 169.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.4 p -133.98 -22.87 1.8 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.787 1.235 . . . . 0.0 112.426 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.6 -12.89 59.96 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.144 0.878 . . . . 0.0 113.081 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.32 154.88 40.29 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.586 1.693 . . . . 0.0 113.621 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.39 135.09 90.93 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.24 -5.31 12.21 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 121.871 1.714 . . . . 0.0 113.633 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mm -123.12 -45.38 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.197 1.362 . . . . 0.0 111.485 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 p -99.78 -4.93 29.51 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.546 0.739 . . . . 0.0 112.934 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.362 0.0 OUTLIER 45.1 23.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.483 3.113 . . . . 0.0 116.596 -172.041 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -69.82 137.16 87.66 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.58 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.84 130.87 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.933 2.422 . . . . 0.0 112.069 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.253 35.3 mt 70.45 146.29 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.375 3.07 . . . . 0.0 113.411 -170.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 t -143.7 -56.77 0.39 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.342 1.857 . . . . 0.0 110.69 -170.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.433 ' H ' HG22 ' A' ' 32' ' ' VAL . 3.0 tt -59.69 -25.49 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 126.497 1.919 . . . . 0.0 116.041 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.78 -9.35 43.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.001 1.32 . . . . 0.0 112.157 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -126.66 9.21 7.03 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.058 . . . . 0.0 112.626 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.402 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.7 tt -58.3 147.11 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.097 1.759 . . . . 0.0 115.403 -172.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.7 97.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 128.635 2.774 . . . . 0.0 109.775 171.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.95 132.1 36.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.356 -1.465 . . . . 0.0 112.309 174.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.54 -35.67 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.596 1.158 . . . . 0.0 110.605 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 t -60.56 119.27 42.07 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.31 1.444 . . . . 0.0 111.617 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.5 -12.83 22.68 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.391 2.727 . . . . 0.0 114.369 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 127.354 2.261 . . . . 0.0 113.83 179.362 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.24 147.64 51.1 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.865 2.066 . . . . 0.0 110.72 170.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.7 t -68.34 140.23 55.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 123.074 1.416 . . . . 0.0 113.329 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.18 -20.05 42.02 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.69 -53.32 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.556 0.742 . . . . 0.0 110.871 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -132.24 -16.8 2.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.51 6.65 60.94 Favored Glycine 0 N--CA 1.468 0.797 0 O-C-N 121.295 -0.878 . . . . 0.0 114.822 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -69.08 161.1 29.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.46 1.504 . . . . 0.0 112.583 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.3 119.24 72.56 Favored Pre-proline 0 N--CA 1.473 0.684 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 169.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.83 125.2 9.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.13 1.887 . . . . 0.0 112.191 -171.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -64.6 -41.65 96.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.074 1.349 . . . . 0.0 110.452 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -124.72 92.76 47.3 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 0.0 109.393 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.37 127.78 24.03 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.547 2.832 . . . . 0.0 111.444 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -139.86 148.72 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.46 1.504 . . . . 0.0 110.682 -176.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.35 155.52 50.1 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.6 1.56 . . . . 0.0 111.689 -175.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 t -127.88 133.42 25.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 C-N-CA 126.64 1.976 . . . . 0.0 107.409 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.5 -10.0 27.25 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.041 2.494 . . . . 0.0 114.409 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -75.9 -63.64 1.26 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.013 1.725 . . . . 0.0 111.578 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.6 m -66.32 -36.05 81.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.008 0.923 . . . . 0.0 112.167 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 61.05 3.61 0.71 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.534 2.733 . . . . 0.0 114.912 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 p -75.23 174.88 8.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.932 2.493 . . . . 0.0 111.947 171.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.47 117.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.39 168.04 9.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.056 1.742 . . . . 0.0 111.109 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -67.7 135.09 52.21 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.051 169.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -57.99 -43.51 86.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.952 0.796 . . . . 0.0 109.919 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 m -62.21 -41.91 98.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.467 1.107 . . . . 0.0 113.824 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.93 -38.25 57.85 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.129 0.877 . . . . 0.0 111.988 -179.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 tp -60.3 -45.86 91.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 170.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -54.87 -37.98 66.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 178.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -62.16 -52.08 65.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.631 -0.668 . . . . 0.0 111.708 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.61 -35.62 79.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.114 0.959 . . . . 0.0 112.248 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 p -82.87 -15.46 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.837 1.255 . . . . 0.0 113.027 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -94.88 -13.48 25.42 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.714 -1.241 . . . . 0.0 111.543 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -57.21 4.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.439 170.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -133.18 -22.18 2.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.9 1.28 . . . . 0.0 112.609 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.32 -11.38 58.44 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.191 0.9 . . . . 0.0 113.656 -171.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -65.65 153.62 41.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.154 1.477 . . . . 0.0 113.164 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.8 86.08 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -67.63 -7.27 18.87 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.075 2.517 . . . . 0.0 115.414 -171.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mt -127.38 -47.21 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.441 1.096 . . . . 0.0 111.795 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.2 p -83.96 -12.64 55.03 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.342 0.3 OUTLIER 48.22 24.54 0.69 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.994 2.517 . . . . 0.0 115.237 -169.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.48 119.25 61.2 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.12 0.968 . . . . 0.0 110.589 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.03 133.55 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.598 2.865 . . . . 0.0 114.054 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.7 mp 71.04 141.41 0.05 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.318 3.047 . . . . 0.0 112.845 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.57 -45.84 0.41 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.386 1.874 . . . . 0.0 111.392 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.407 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.2 mm -61.7 -31.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 114.654 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -12.53 53.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.259 1.824 . . . . 0.0 112.445 170.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -124.38 8.33 8.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.974 1.71 . . . . 0.0 112.719 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.407 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.4 tp -58.56 132.55 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.133 1.373 . . . . 0.0 113.878 -172.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.97 94.44 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.069 2.147 . . . . 0.0 109.115 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -74.97 134.71 41.44 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.578 -1.326 . . . . 0.0 110.845 172.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.02 -33.88 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.575 0.75 . . . . 0.0 110.277 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.02 149.56 93.48 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.115 0.966 . . . . 0.0 112.516 176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -74.08 -27.52 11.81 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.829 2.352 . . . . 0.0 112.881 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.7 p . . . . . 0 C--O 1.24 0.564 0 C-N-CA 126.578 1.951 . . . . 0.0 111.322 176.259 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 CA--C 1.542 0.673 0 CA-C-O 120.675 0.274 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.8 mt -120.36 156.18 31.87 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.777 1.631 . . . . 0.0 112.432 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.5 t -60.87 137.63 58.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.973 1.368 . . . . 0.0 112.652 -169.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.58 -16.97 40.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.172 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.3 mt -82.77 -47.66 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.476 1.51 . . . . 0.0 110.538 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 p -128.9 -30.18 2.27 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.3 61.18 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 114.764 0.665 . . . . 0.0 114.764 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -53.5 137.38 36.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.458 1.903 . . . . 0.0 110.689 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.77 105.73 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.3 117.16 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.892 2.395 . . . . 0.0 113.663 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -74.36 -42.35 59.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.706 1.602 . . . . 0.0 110.519 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -126.42 90.1 50.69 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.063 2.145 . . . . 0.0 107.682 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -62.69 129.1 25.21 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.704 2.936 . . . . 0.0 111.857 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.02 153.74 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.452 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.44 156.87 47.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.406 1.882 . . . . 0.0 110.08 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -123.17 127.8 25.52 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.501 1.52 . . . . 0.0 108.34 168.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.69 -12.0 2.69 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.816 3.678 . . . . 0.0 117.217 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -62.54 1.66 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.927 1.291 . . . . 0.0 110.964 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 m -69.29 -38.12 78.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.704 1.602 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 57.47 10.88 1.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.938 2.495 . . . . 0.0 114.985 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.2 p -75.14 170.87 15.17 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.135 2.574 . . . . 0.0 111.057 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.21 116.51 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -113.76 168.96 9.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.409 1.884 . . . . 0.0 111.194 175.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -67.87 137.12 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.492 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -51.66 -46.12 63.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.728 1.211 . . . . 0.0 109.661 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -59.88 -42.07 92.95 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.05 0.843 . . . . 0.0 112.562 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -44.7 67.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 54.0 tp -65.71 -38.85 90.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.546 176.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.49 -40.32 90.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.502 0.721 . . . . 0.0 111.587 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.53 -50.17 73.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.077 0.951 . . . . 0.0 111.582 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -67.06 -37.36 83.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.128 0.966 . . . . 0.0 111.317 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.436 HG23 ' H ' ' A' ' 47' ' ' ILE . 2.4 p -83.07 -18.48 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -175.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -89.86 -15.68 31.69 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.015 -1.053 . . . . 0.0 112.011 168.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -58.08 3.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.866 1.666 . . . . 0.0 110.978 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.9 p -137.59 -16.87 1.32 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 112.635 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.45 57.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.273 0.939 . . . . 0.0 113.524 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -63.12 153.91 32.73 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.23 1.515 . . . . 0.0 113.48 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.29 129.26 75.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.528 1.131 . . . . 0.0 108.209 167.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.0 -13.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.793 3.662 . . . . 0.0 119.718 -169.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.29 -41.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.141 1.337 . . . . 0.0 112.358 -171.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -92.21 -10.69 37.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.947 0.899 . . . . 0.0 112.576 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.311 0.5 OUTLIER 44.2 31.15 0.52 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.749 2.82 . . . . 0.0 115.355 -171.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.87 134.32 94.04 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.672 172.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.04 133.24 28.37 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.651 2.234 . . . . 0.0 111.628 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 mp 73.86 144.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 128.458 2.703 . . . . 0.0 112.488 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -147.5 -40.42 0.18 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.779 2.431 . . . . 0.0 110.24 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.436 ' H ' HG23 ' A' ' 32' ' ' VAL . 8.6 tp -58.91 -36.18 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.361 1.864 . . . . 0.0 114.677 177.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -67.6 -7.68 28.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.121 1.368 . . . . 0.0 112.123 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.41 4.73 5.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.183 1.393 . . . . 0.0 113.318 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 tt -66.64 137.8 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 122.313 1.054 . . . . 0.0 113.675 -169.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.2 96.95 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.839 2.056 . . . . 0.0 111.23 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -72.59 123.63 23.6 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.55 -1.344 . . . . 0.0 110.462 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.53 -35.86 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.323 1.449 . . . . 0.0 110.707 -174.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.18 97.14 20.36 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 125.802 1.641 . . . . 0.0 107.37 170.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.02 -6.38 17.3 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.592 2.861 . . . . 0.0 114.524 -174.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.473 0.722 0 C-N-CA 126.931 2.092 . . . . 0.0 114.36 -176.028 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.192 0.52 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.19 138.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.741 1.258 . . . . 0.0 113.409 -168.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.72 49.13 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.116 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.6 -58.23 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.095 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.3 m -135.95 -5.58 2.15 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.48 7.35 79.36 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-N 119.961 1.255 . . . . 0.0 115.444 172.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.4 141.67 58.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.018 2.527 . . . . 0.0 111.783 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.04 114.63 19.1 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 169.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 145.66 37.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 114.038 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -91.89 -31.39 15.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.772 2.029 . . . . 0.0 110.136 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -126.42 83.25 64.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 126.29 1.836 . . . . 0.0 109.482 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.99 127.48 25.19 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.036 3.157 . . . . 0.0 110.637 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.3 t -141.63 143.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 126.413 1.885 . . . . 0.0 110.842 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -125.29 157.4 36.73 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.979 1.712 . . . . 0.0 110.296 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 t -127.51 133.35 24.99 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.699 1.599 . . . . 0.0 108.619 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -55.05 -13.61 6.88 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.931 3.088 . . . . 0.0 117.058 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -95.88 -56.99 2.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.142 0.883 . . . . 0.0 111.619 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.7 p -63.78 -37.95 89.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.252 1.821 . . . . 0.0 114.264 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 58.62 1.14 0.17 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 128.965 2.906 . . . . 0.0 116.923 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -69.52 177.38 2.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.556 1.942 . . . . 0.0 110.04 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.45 115.81 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 169.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.67 169.21 9.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 112.282 172.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -74.25 131.02 40.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.389 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.42 -42.65 64.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.684 1.593 . . . . 0.0 110.622 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -63.55 -40.42 96.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.83 -35.18 60.06 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.443 -0.786 . . . . 0.0 111.336 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.17 -44.79 94.47 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 119.091 -0.481 . . . . 0.0 109.714 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' HA ' HG12 ' A' ' 32' ' ' VAL . 41.2 tt0 -54.94 -38.93 68.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.646 0.778 . . . . 0.0 111.401 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.69 -53.32 58.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.122 0.487 . . . . 0.0 112.112 171.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.18 -34.78 78.25 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.984 0.897 . . . . 0.0 112.328 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.1 p -83.07 -17.36 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.739 1.215 . . . . 0.0 112.795 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -92.81 -14.65 27.5 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.854 -1.154 . . . . 0.0 111.405 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -56.96 4.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.995 1.718 . . . . 0.0 111.677 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -133.67 -21.61 1.95 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.938 1.295 . . . . 0.0 112.505 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 83.85 -11.9 55.11 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.086 0.85 . . . . 0.0 113.658 -172.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -67.17 154.51 41.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.222 1.511 . . . . 0.0 113.317 -170.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.63 133.94 79.45 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.11 -14.08 7.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.157 3.238 . . . . 0.0 118.002 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.97 -48.84 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.712 1.142 . . . . 0.0 111.548 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.3 p -85.84 -11.12 54.18 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.333 0.3 OUTLIER 48.71 24.75 0.85 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.049 2.54 . . . . 0.0 115.295 -169.743 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.13 118.44 49.65 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.24 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.96 132.52 52.71 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.448 2.765 . . . . 0.0 113.91 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp 72.19 144.59 0.07 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 128.822 2.849 . . . . 0.0 111.864 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.9 t -143.32 -61.5 0.41 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.662 1.585 . . . . 0.0 111.151 -169.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.484 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -62.72 -26.89 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.69 -5.95 33.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.446 1.098 . . . . 0.0 112.301 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -128.67 11.85 6.26 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.47 1.908 . . . . 0.0 112.328 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 7.1 tt -57.8 143.62 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.756 1.622 . . . . 0.0 114.697 -171.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.66 86.22 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.207 2.203 . . . . 0.0 109.15 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -72.02 125.92 28.45 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.014 . . . . 0.0 111.412 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 126.309 1.844 . . . . 0.0 109.196 -175.725 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.479 0.657 . . . . 0.0 112.066 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 2.2 m -59.7 137.55 58.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -168.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -70.38 -25.0 63.05 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.088 0.471 . . . . 0.0 112.174 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.41 -51.58 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.037 1.735 . . . . 0.0 111.584 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 p -123.33 -18.7 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 80.19 11.31 84.5 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.68 167.45 13.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.112 2.565 . . . . 0.0 113.157 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.0 t -83.45 107.91 11.5 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.76 127.61 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.484 2.123 . . . . 0.0 113.624 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -71.1 -39.47 72.07 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.096 1.358 . . . . 0.0 111.065 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -124.7 86.83 55.42 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.792 1.237 . . . . 0.0 109.969 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.18 127.33 25.6 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.009 3.139 . . . . 0.0 110.712 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.5 t -140.01 142.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.415 1.886 . . . . 0.0 109.858 -170.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.56 157.4 46.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.801 1.641 . . . . 0.0 110.923 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -132.03 128.32 21.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.959 1.704 . . . . 0.0 108.221 169.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.68 -12.59 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.502 3.468 . . . . 0.0 116.714 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -83.79 -58.11 2.93 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.106 1.363 . . . . 0.0 110.567 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -27.16 68.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.035 1.734 . . . . 0.0 114.705 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 46.35 45.74 13.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 126.344 1.858 . . . . 0.0 113.959 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 4' ' ' ALA . 14.8 t -136.71 174.5 10.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.145 2.578 . . . . 0.0 109.401 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.52 116.75 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -111.47 168.18 9.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 111.472 173.609 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.97 131.11 41.09 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.778 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -46.88 -45.48 20.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.807 1.643 . . . . 0.0 109.739 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -59.29 -37.87 78.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -40.12 33.86 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.008 0.523 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.5 tp -63.11 -45.68 90.9 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -55.6 -42.62 75.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.484 1.514 . . . . 0.0 111.798 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -59.15 -53.07 62.49 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.293 -0.879 . . . . 0.0 111.408 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -67.37 -34.26 76.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.913 1.285 . . . . 0.0 112.427 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.02 -17.35 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.264 1.025 . . . . 0.0 112.845 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.61 -21.03 24.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.963 1.305 . . . . 0.0 111.426 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -57.64 3.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.348 1.859 . . . . 0.0 111.451 175.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.3 p -133.27 -21.53 2.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.143 1.377 . . . . 0.0 112.45 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.84 -12.45 57.18 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.248 0.927 . . . . 0.0 113.387 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.24 156.44 34.23 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.492 1.646 . . . . 0.0 113.267 -170.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.42 134.96 57.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 167.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.87 -5.21 12.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.993 2.462 . . . . 0.0 115.377 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.9 mt -121.55 -48.08 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.904 1.282 . . . . 0.0 111.506 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.9 p -88.75 -12.34 42.44 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.356 0.3 OUTLIER 47.42 25.17 0.57 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.053 2.541 . . . . 0.0 115.149 -169.228 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.72 129.96 90.77 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.495 -0.764 . . . . 0.0 110.243 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 134.47 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.958 2.438 . . . . 0.0 112.541 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.267 41.0 mt 71.79 133.92 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.695 3.198 . . . . 0.0 113.371 -175.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.12 -45.03 0.71 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.88 2.072 . . . . 0.0 111.424 -169.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.484 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.1 tp -58.33 -35.12 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.476 1.911 . . . . 0.0 114.469 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.18 -8.21 36.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.499 1.519 . . . . 0.0 111.912 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.71 7.21 5.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.442 1.497 . . . . 0.0 113.1 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.3 145.36 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.895 1.331 . . . . 0.0 114.492 -169.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.25 96.53 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.168 2.587 . . . . 0.0 108.548 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.37 117.57 27.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.976 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 125.377 1.471 . . . . 0.0 109.463 172.806 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.652 0.739 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.5 t -64.89 141.3 58.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.98 1.371 . . . . 0.0 113.482 -168.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.64 -18.51 31.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.47 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.68 -52.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.328 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -140.19 -6.62 1.22 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.31 74.81 Favored Glycine 0 N--CA 1.474 1.205 0 O-C-N 120.842 -1.161 . . . . 0.0 115.263 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.07 142.67 41.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.822 2.449 . . . . 0.0 110.969 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.17 108.41 2.47 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.73 109.99 0.5 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.816 2.344 . . . . 0.0 114.367 -169.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -60.5 -48.83 80.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.556 1.142 . . . . 0.0 110.781 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -119.21 88.59 37.75 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 126.231 1.812 . . . . 0.0 109.235 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 127.65 23.74 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.029 3.153 . . . . 0.0 111.588 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.55 144.32 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 126.163 1.785 . . . . 0.0 110.104 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -133.37 149.74 51.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.401 1.88 . . . . 0.0 110.555 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 t -132.67 117.64 15.33 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.91 -12.82 5.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.327 3.351 . . . . 0.0 116.693 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -47.19 60.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.764 1.225 . . . . 0.0 112.086 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -96.77 -19.76 18.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.867 1.267 . . . . 0.0 112.592 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 64.3 -3.94 0.46 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 128.941 2.896 . . . . 0.0 116.031 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 p -72.83 168.13 19.51 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.792 2.037 . . . . 0.0 113.037 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 mm -115.11 115.96 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.32 171.98 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.05 1.74 . . . . 0.0 111.514 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.12 138.27 43.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.88 -46.41 51.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.672 1.589 . . . . 0.0 109.559 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.77 -40.83 69.01 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.487 -0.758 . . . . 0.0 111.483 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.49 -44.1 95.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.428 0.558 . . . . 0.0 109.575 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.77 -39.26 70.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.479 0.712 . . . . 0.0 111.442 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.36 -45.65 83.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.662 -0.649 . . . . 0.0 111.904 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -69.63 -37.83 76.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.312 1.045 . . . . 0.0 112.241 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.413 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.5 p -79.63 -18.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.251 1.02 . . . . 0.0 112.688 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -79.2 -30.25 43.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.9 2.08 . . . . 0.0 110.269 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -55.26 6.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.109 1.764 . . . . 0.0 111.675 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.7 p -134.24 -21.18 1.84 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.162 1.385 . . . . 0.0 112.175 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 84.71 -10.63 61.7 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.998 0.808 . . . . 0.0 113.193 -170.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.16 155.4 35.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.467 1.634 . . . . 0.0 113.257 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -78.11 136.69 61.38 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -55.79 -17.37 18.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.82 3.013 . . . . 0.0 118.584 -169.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.8 mt -126.71 -46.29 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 120.253 1.388 . . . . 0.0 111.819 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -81.42 -13.35 58.35 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.309 0.5 OUTLIER 44.66 30.29 0.5 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.927 2.491 . . . . 0.0 114.633 -170.744 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.23 135.64 89.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.769 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.14 135.83 28.05 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.661 2.241 . . . . 0.0 112.246 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp 70.1 147.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 0.0 111.673 -172.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 t -146.38 -48.47 0.2 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.503 1.921 . . . . 0.0 110.621 -169.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.413 ' H ' HG21 ' A' ' 32' ' ' VAL . 9.3 tp -56.89 -31.39 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 127.279 2.231 . . . . 0.0 114.986 174.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.2 -6.89 25.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.93 1.292 . . . . 0.0 112.129 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.29 8.87 4.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.627 1.571 . . . . 0.0 112.813 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 tt -60.31 137.1 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.806 1.289 . . . . 0.0 113.106 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.93 97.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 127.379 2.272 . . . . 0.0 108.575 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -76.24 124.06 26.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.915 -1.116 . . . . 0.0 109.778 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 124.697 1.199 . . . . 0.0 109.908 -174.052 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.036 0.446 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.53 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 1.8 m -48.94 125.42 10.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -167.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.21 62.1 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.98 -57.58 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.947 2.099 . . . . 0.0 111.056 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -126.78 -11.3 6.08 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.53 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 75.14 14.27 82.0 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.587 1.085 . . . . 0.0 114.519 171.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -71.84 163.77 27.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.929 2.892 . . . . 0.0 111.516 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.8 110.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.0 126.68 12.73 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.013 1.809 . . . . 0.0 112.224 -169.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -78.46 -33.61 48.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.263 1.425 . . . . 0.0 111.84 170.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -129.93 83.89 62.4 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.688 1.595 . . . . 0.0 109.72 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.13 132.95 52.27 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.582 2.855 . . . . 0.0 111.223 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.35 148.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 126.077 1.751 . . . . 0.0 109.611 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.16 154.61 51.57 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.608 1.563 . . . . 0.0 109.505 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -126.89 119.59 22.53 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 108.403 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -56.33 -8.06 2.39 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.55 3.5 . . . . 0.0 117.326 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -40.07 62.27 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.223 1.409 . . . . 0.0 111.057 177.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.9 p -98.94 -30.43 12.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.204 1.802 . . . . 0.0 113.777 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 55.4 13.4 0.91 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.486 2.315 . . . . 0.0 114.89 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.1 p -77.66 169.47 18.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.91 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 mm -104.94 143.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -143.14 166.39 24.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.496 1.918 . . . . 0.0 110.576 168.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -74.82 128.34 35.33 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.028 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -45.27 -48.14 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.32 1.848 . . . . 0.0 109.756 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 76.0 p -68.86 -24.74 64.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -41.71 50.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.641 1.109 . . . . 0.0 110.784 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.1 tp -64.4 -44.94 89.69 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -54.9 -41.57 71.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.732 1.613 . . . . 0.0 111.864 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -61.1 -51.05 70.75 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.604 -0.685 . . . . 0.0 112.088 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.11 -35.72 80.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.166 0.984 . . . . 0.0 112.075 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -83.83 -15.52 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.858 1.263 . . . . 0.0 113.156 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -95.61 -13.17 24.58 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.149 -0.969 . . . . 0.0 111.606 168.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -57.57 3.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.143 1.777 . . . . 0.0 111.364 169.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.6 p -133.39 -21.83 2.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.905 1.282 . . . . 0.0 112.515 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -11.03 63.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.114 0.864 . . . . 0.0 113.316 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -64.35 156.11 30.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.724 1.762 . . . . 0.0 114.092 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.89 130.55 72.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.856 1.263 . . . . 0.0 108.573 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.76 -8.29 2.92 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.222 3.281 . . . . 0.0 118.647 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.88 -44.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.111 1.365 . . . . 0.0 112.282 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.6 p -98.33 -7.56 28.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.16 0.984 . . . . 0.0 112.754 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.305 0.5 OUTLIER 45.44 29.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.812 2.845 . . . . 0.0 115.686 -175.116 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -71.47 139.19 83.87 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.042 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.06 136.91 33.37 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.538 2.159 . . . . 0.0 112.62 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.3 mp 73.96 147.15 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.106 2.962 . . . . 0.0 112.065 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -145.89 -57.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.798 1.639 . . . . 0.0 110.596 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.1 tt -62.85 -26.87 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -70.01 -6.45 33.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.416 1.086 . . . . 0.0 112.181 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.75 9.57 6.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.364 1.866 . . . . 0.0 112.337 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.471 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 10.5 tt -59.8 150.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.032 1.733 . . . . 0.0 114.906 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.4 t -123.99 95.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 128.209 2.603 . . . . 0.0 108.321 169.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -86.37 119.48 26.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 124.827 1.251 . . . . 0.0 108.401 174.081 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.3 m -55.32 134.38 50.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.47 -16.11 61.8 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.86 -58.73 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.73 0.812 . . . . 0.0 110.742 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -124.77 -10.53 7.26 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.76 16.29 79.37 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 119.024 0.829 . . . . 0.0 113.261 174.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -66.92 160.91 25.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.897 2.479 . . . . 0.0 110.613 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.0 112.98 16.45 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.49 106.2 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.756 2.304 . . . . 0.0 112.306 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -57.71 -45.87 85.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.659 1.584 . . . . 0.0 111.287 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.402 ' HD2' ' HE3' ' A' ' 25' ' ' LYS . 8.1 mtm180 -122.98 92.43 49.18 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.166 1.386 . . . . 0.0 109.949 170.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.64 123.99 13.35 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.617 2.878 . . . . 0.0 111.383 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.21 151.36 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.255 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tt -134.51 149.03 50.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.71 1.604 . . . . 0.0 110.794 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 t -113.39 131.74 22.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.698 1.199 . . . . 0.0 108.118 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.58 -5.48 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.439 2.093 . . . . 0.0 114.289 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -55.0 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.175 1.39 . . . . 0.0 111.042 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.8 p -79.75 -35.93 38.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.378 1.471 . . . . 0.0 112.694 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 59.86 11.25 2.46 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.906 2.882 . . . . 0.0 114.307 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.5 p -77.03 175.98 9.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 128.281 2.632 . . . . 0.0 111.793 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.13 132.61 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 108.449 171.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -129.38 173.63 10.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.074 1.749 . . . . 0.0 110.243 168.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 151.8 41.87 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.368 172.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE3' ' HD2' ' A' ' 12' ' ' ARG . 17.1 ttpp -56.91 -52.08 66.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.569 1.077 . . . . 0.0 108.679 171.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -76.19 -24.24 54.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.6 mt -72.27 -44.32 62.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.864 0.756 . . . . 0.0 111.465 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 tp -63.81 -45.14 91.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -53.85 -38.54 64.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.238 1.415 . . . . 0.0 111.693 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -62.16 -51.61 67.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.479 -0.763 . . . . 0.0 111.885 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -67.26 -37.28 83.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.457 1.103 . . . . 0.0 112.377 -173.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.467 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.9 p -81.57 -20.0 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.504 1.122 . . . . 0.0 112.398 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -81.59 -25.39 35.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.764 1.626 . . . . 0.0 111.077 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -56.0 5.58 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.261 1.824 . . . . 0.0 111.307 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.6 p -135.25 -21.4 1.6 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.885 1.274 . . . . 0.0 112.458 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -14.57 35.65 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.743 1.163 . . . . 0.0 113.857 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -67.22 151.47 47.48 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.026 1.413 . . . . 0.0 111.629 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -68.53 140.06 92.07 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.103 -0.998 . . . . 0.0 110.108 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -57.2 -14.39 15.13 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.095 3.197 . . . . 0.0 117.565 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.15 -50.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.88 1.272 . . . . 0.0 112.141 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 p -86.06 -11.23 53.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.63 0.772 . . . . 0.0 112.548 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.296 0.5 OUTLIER 45.07 30.53 0.61 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.077 2.551 . . . . 0.0 115.191 -171.3 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -70.76 132.22 87.18 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.431 -0.793 . . . . 0.0 109.653 172.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.02 137.18 36.93 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.729 2.286 . . . . 0.0 112.221 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 mp 69.25 139.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 128.191 2.597 . . . . 0.0 112.291 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 t -139.01 -55.12 0.6 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.556 1.542 . . . . 0.0 111.235 -169.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.467 ' H ' HG21 ' A' ' 32' ' ' VAL . 9.3 tp -59.84 -30.38 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.645 1.978 . . . . 0.0 115.104 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -71.54 -4.06 24.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.645 1.178 . . . . 0.0 112.363 171.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -127.94 9.81 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.643 1.577 . . . . 0.0 112.427 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 7.6 tp -58.87 144.08 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 114.947 -169.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.94 103.12 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.793 2.437 . . . . 0.0 109.741 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.56 123.69 33.3 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.153 . . . . 0.0 112.405 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 125.858 1.663 . . . . 0.0 108.92 172.975 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -59.33 139.1 57.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -168.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.42 -17.44 60.79 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -82.47 -59.21 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.498 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -124.82 -3.39 7.71 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.15 13.92 83.14 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 119.156 0.889 . . . . 0.0 114.812 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -78.59 163.87 25.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.296 2.638 . . . . 0.0 111.358 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.59 111.73 15.82 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.72 118.59 5.67 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.424 2.083 . . . . 0.0 112.844 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -61.28 -35.95 78.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.383 1.473 . . . . 0.0 111.604 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -129.76 91.26 40.8 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.21 1.404 . . . . 0.0 110.65 171.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.12 127.13 22.13 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.016 3.144 . . . . 0.0 112.136 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.18 143.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 126.664 1.986 . . . . 0.0 110.005 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tt -131.4 158.05 41.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.66 1.584 . . . . 0.0 110.504 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.5 t -129.69 130.0 23.17 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.756 1.623 . . . . 0.0 108.36 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.11 -16.22 12.11 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.812 3.008 . . . . 0.0 116.318 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -82.37 -47.13 12.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.153 1.381 . . . . 0.0 111.693 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.6 p -79.04 -35.75 42.16 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.014 1.326 . . . . 0.0 113.084 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.292 15.2 ptm180 50.37 11.6 0.08 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.409 3.084 . . . . 0.0 115.358 -169.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.1 p -75.51 173.73 10.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.159 2.584 . . . . 0.0 111.054 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.27 116.14 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.155 -0.965 . . . . 0.0 108.559 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -114.27 175.01 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.627 1.971 . . . . 0.0 111.25 172.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 15.1 tt0 -75.39 149.16 38.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.055 174.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -54.79 -49.71 70.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -71.32 -32.66 68.86 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.417 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 9.3 mt -71.5 -44.31 64.92 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.142 0.577 . . . . 0.0 111.524 174.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.11 -44.0 93.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HA ' HG12 ' A' ' 32' ' ' VAL . 47.7 tt0 -54.7 -39.88 68.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.57 1.548 . . . . 0.0 111.357 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -61.71 -51.38 68.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.212 0.605 . . . . 0.0 111.573 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -67.46 -35.78 79.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.028 0.918 . . . . 0.0 112.114 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.3 p -83.97 -15.28 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.955 1.302 . . . . 0.0 113.185 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -96.13 -12.63 24.47 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 121.072 -1.018 . . . . 0.0 111.486 168.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -57.65 3.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.996 1.718 . . . . 0.0 111.291 169.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -132.5 -22.34 2.19 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.025 1.33 . . . . 0.0 112.538 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.39 -11.26 63.95 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.218 0.913 . . . . 0.0 113.151 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.79 155.42 30.4 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.552 1.676 . . . . 0.0 113.862 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.33 130.96 57.34 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -66.57 -4.28 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.042 3.161 . . . . 0.0 116.243 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.82 -41.44 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.207 1.403 . . . . 0.0 111.776 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -105.03 -9.24 17.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.054 1.342 . . . . 0.0 113.662 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.373 0.0 OUTLIER 50.02 22.4 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.732 2.813 . . . . 0.0 115.635 -169.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.58 132.15 94.95 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.456 -0.777 . . . . 0.0 110.503 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 130.54 18.57 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.759 2.306 . . . . 0.0 112.398 -172.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.26 38.8 mt 71.8 139.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 129.092 2.957 . . . . 0.0 113.378 -173.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 t -137.36 -51.58 0.65 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.302 2.241 . . . . 0.0 110.59 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.3 tp -55.47 -34.66 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 127.801 2.44 . . . . 0.0 115.193 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -66.03 -9.56 31.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.393 1.477 . . . . 0.0 112.066 172.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -133.2 10.28 4.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.714 1.606 . . . . 0.0 112.941 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.44 147.35 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.6 t -121.84 91.95 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 128.011 2.524 . . . . 0.0 108.531 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -77.03 126.92 31.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.06 -1.025 . . . . 0.0 110.693 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.2 mt . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 125.328 1.451 . . . . 0.0 109.696 -177.613 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.292 0.568 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -56.12 138.13 50.25 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -168.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -68.72 -23.86 64.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 174.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.13 -46.94 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.681 1.192 . . . . 0.0 112.12 -169.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 t -123.66 -17.81 6.3 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.22 13.86 82.87 Favored Glycine 0 N--CA 1.47 0.953 0 O-C-N 121.277 -0.889 . . . . 0.0 114.642 174.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -72.2 162.96 28.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.841 2.857 . . . . 0.0 111.285 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -76.54 106.73 3.62 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 168.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -61.04 119.15 6.16 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.293 1.995 . . . . 0.0 114.247 -168.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.2 mmt-85 -71.19 -34.84 71.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.309 1.044 . . . . 0.0 111.867 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -122.89 83.95 50.05 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.16 1.384 . . . . 0.0 110.382 169.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.3 121.61 9.88 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.132 3.221 . . . . 0.0 111.744 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.83 142.15 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 127.144 2.178 . . . . 0.0 110.876 -169.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -133.03 157.59 44.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.424 2.289 . . . . 0.0 110.075 -173.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 p -131.92 149.26 72.84 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.563 1.145 . . . . 0.0 110.681 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.61 -7.31 20.95 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.239 2.626 . . . . 0.0 113.921 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -56.06 3.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.703 1.201 . . . . 0.0 110.428 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 98.9 p -66.38 -37.21 84.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.964 1.306 . . . . 0.0 113.63 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 55.61 4.5 0.11 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 127.665 2.386 . . . . 0.0 116.272 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 4' ' ' ALA . 8.0 t -86.68 179.59 6.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.362 2.665 . . . . 0.0 111.68 170.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.46 116.51 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.23 172.11 7.11 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.312 1.845 . . . . 0.0 111.94 170.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -83.33 136.17 34.46 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.817 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.5 -43.85 45.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.305 1.842 . . . . 0.0 110.444 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 t -61.04 -39.62 90.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.883 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.69 -42.2 64.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.319 1.048 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.38 -44.57 94.35 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.68 -43.77 69.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.973 0.909 . . . . 0.0 110.72 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -59.13 -55.46 34.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.19 -0.319 . . . . 0.0 111.851 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -65.45 -33.42 75.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.226 1.012 . . . . 0.0 112.331 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.515 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.4 p -86.62 -13.46 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 113.348 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -99.55 -10.95 21.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.774 1.23 . . . . 0.0 111.618 168.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.59 -56.3 4.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.968 2.107 . . . . 0.0 110.897 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.2 p -134.57 -23.2 1.64 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.972 1.309 . . . . 0.0 112.727 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.72 -12.55 63.15 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.677 1.132 . . . . 0.0 113.086 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -63.72 156.51 26.83 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.145 1.473 . . . . 0.0 113.984 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -82.08 130.58 59.6 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 167.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.38 -4.78 10.02 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.004 3.136 . . . . 0.0 117.321 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.0 mt -116.33 -49.36 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.568 1.147 . . . . 0.0 110.912 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.9 p -91.31 -12.87 33.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.398 1.079 . . . . 0.0 113.796 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.381 0.0 OUTLIER 50.67 23.83 1.49 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.334 2.654 . . . . 0.0 115.193 -169.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -68.34 137.2 91.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.57 140.18 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.337 2.025 . . . . 0.0 112.742 -172.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 mt 66.33 128.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 128.954 2.901 . . . . 0.0 114.704 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -129.24 -45.4 1.24 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.032 1.733 . . . . 0.0 111.544 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.515 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.1 tp -58.97 -35.2 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.982 2.113 . . . . 0.0 114.507 172.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.61 -8.88 38.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.304 1.442 . . . . 0.0 111.84 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.39 8.69 6.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.627 1.571 . . . . 0.0 112.99 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.93 137.4 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.726 1.251 . . . . 0.0 114.236 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -119.66 91.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.045 2.138 . . . . 0.0 108.82 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -76.19 115.93 16.39 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.027 -1.046 . . . . 0.0 110.074 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.07 -177.35 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.458 0.647 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 0.5 OUTLIER -56.88 135.67 55.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -168.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.97 64.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.995 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.91 -49.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.473 1.509 . . . . 0.0 112.164 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -126.23 -23.33 3.88 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.483 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.51 18.83 78.77 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.138 0.875 . . . . 0.0 113.394 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -65.93 155.2 37.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.661 2.784 . . . . 0.0 111.452 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.54 109.16 2.47 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.079 0.952 . . . . 0.0 109.481 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.05 120.36 8.18 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.944 2.429 . . . . 0.0 113.708 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -81.72 -49.08 10.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.506 1.922 . . . . 0.0 110.294 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -128.82 85.86 59.06 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 126.57 1.948 . . . . 0.0 109.545 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.32 138.31 83.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.655 2.903 . . . . 0.0 111.411 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -145.88 154.15 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 125.369 1.467 . . . . 0.0 109.969 -170.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -136.49 155.4 50.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.413 1.485 . . . . 0.0 110.173 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 t -125.15 136.55 28.3 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 125.647 1.579 . . . . 0.0 108.116 169.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.48 -10.48 27.92 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.766 2.311 . . . . 0.0 113.796 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.85 -67.69 0.62 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.859 2.064 . . . . 0.0 111.48 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.8 m -64.37 -37.0 85.98 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.365 1.066 . . . . 0.0 112.826 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 63.6 -1.53 0.59 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.845 2.458 . . . . 0.0 115.107 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.5 p -77.64 177.12 8.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.585 2.354 . . . . 0.0 111.939 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 mm -106.61 141.62 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -136.71 167.86 20.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.763 1.625 . . . . 0.0 110.27 168.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -78.35 130.51 36.25 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -43.08 40.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.696 1.998 . . . . 0.0 110.468 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 t -60.21 -43.14 96.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.78 -40.26 41.38 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 110.961 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.76 -48.66 79.69 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -58.26 -42.18 85.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.833 0.288 . . . . 0.0 111.062 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -58.43 -49.55 76.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.175 0.512 . . . . 0.0 111.926 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -64.23 -35.19 80.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.696 1.198 . . . . 0.0 111.879 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG21 ' CB ' ' A' ' 46' ' ' SER . 43.5 t -94.0 -13.55 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 112.093 -172.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -91.39 -12.71 34.03 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 119.813 -1.805 . . . . 0.0 110.391 167.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.89 -65.71 0.91 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.95 2.1 . . . . 0.0 110.995 169.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.7 p -126.6 -15.12 5.62 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.069 1.348 . . . . 0.0 113.632 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.36 -18.02 25.93 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.923 0.773 . . . . 0.0 113.822 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -68.24 149.09 49.92 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.266 1.533 . . . . 0.0 112.772 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.5 142.48 94.34 Favored Pre-proline 0 CA--C 1.549 0.939 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 169.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.75 -5.57 17.12 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.254 2.636 . . . . 0.0 114.841 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mm -118.55 -52.45 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.716 1.206 . . . . 0.0 110.566 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -89.96 -13.47 36.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.328 0.4 OUTLIER 45.84 31.07 0.97 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.208 2.203 . . . . 0.0 114.462 -169.035 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -75.29 135.68 72.68 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.041 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.07 140.74 42.23 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.175 2.583 . . . . 0.0 113.049 -170.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 mt 65.1 149.14 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.365 3.066 . . . . 0.0 114.192 -172.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.506 ' CB ' HG21 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -142.86 -54.18 0.4 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.301 1.84 . . . . 0.0 111.85 -173.402 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.414 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 10.1 tp -61.37 -30.87 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.646 1.978 . . . . 0.0 114.82 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.86 -9.37 44.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.309 1.444 . . . . 0.0 112.0 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -130.61 12.88 5.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.853 1.661 . . . . 0.0 112.483 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.6 tp -57.44 141.39 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.492 1.517 . . . . 0.0 114.118 -172.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.86 92.61 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.958 2.103 . . . . 0.0 109.792 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' HG23 ' A' ' 14' ' ' VAL . 1.5 mp0 -78.3 126.14 30.36 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.853 -1.154 . . . . 0.0 112.257 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.7 mm . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 125.441 1.496 . . . . 0.0 108.783 -177.064 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.167 0.508 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.471 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 3.0 m -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -168.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.51 -17.11 62.36 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.69 -49.97 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.269 1.428 . . . . 0.0 111.522 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.7 p -116.28 -24.47 7.93 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 82.11 12.39 80.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 115.406 0.922 . . . . 0.0 115.406 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.96 166.59 17.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.424 2.29 . . . . 0.0 112.198 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.75 107.42 7.35 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.72 114.9 1.53 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.469 2.779 . . . . 0.0 117.33 -168.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -62.55 -44.93 95.11 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.158 1.383 . . . . 0.0 110.492 169.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm-85 -126.67 94.77 39.35 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.161 1.784 . . . . 0.0 109.678 169.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.72 125.92 17.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.066 3.178 . . . . 0.0 111.036 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.34 142.71 28.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 126.302 1.841 . . . . 0.0 110.366 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tt -131.63 157.75 42.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.523 1.529 . . . . 0.0 110.889 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -134.51 125.9 17.9 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.634 1.574 . . . . 0.0 108.609 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -53.72 -11.65 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 125.172 3.914 . . . . 0.0 117.309 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.71 -55.46 5.84 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.805 1.242 . . . . 0.0 111.178 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 m -79.8 -37.34 35.44 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.505 1.522 . . . . 0.0 112.366 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm-85 56.23 7.97 0.37 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 128.114 2.566 . . . . 0.0 115.429 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.1 p -74.26 174.22 9.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.65 2.38 . . . . 0.0 110.395 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.38 118.1 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -112.76 171.14 7.71 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.428 1.891 . . . . 0.0 111.406 173.361 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -80.01 134.62 36.24 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.3 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -45.67 -46.64 14.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.742 2.017 . . . . 0.0 110.249 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -63.66 -33.35 75.43 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.966 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.38 -45.22 40.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.288 1.035 . . . . 0.0 110.73 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -63.33 -45.04 93.15 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -56.19 -42.77 77.66 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.867 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -59.25 -51.64 69.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.409 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.49 -34.29 76.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.147 1.379 . . . . 0.0 112.239 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.2 p -83.1 -18.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.252 1.021 . . . . 0.0 112.872 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -85.77 -22.74 27.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.089 1.355 . . . . 0.0 111.363 168.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.42 4.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.558 1.943 . . . . 0.0 111.59 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.2 p -133.38 -21.38 2.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.029 1.332 . . . . 0.0 112.451 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.14 58.84 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.231 0.92 . . . . 0.0 113.341 -171.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.44 156.06 30.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.389 1.595 . . . . 0.0 113.709 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.74 131.36 54.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.53 -4.89 10.4 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.862 3.041 . . . . 0.0 117.15 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.85 -53.2 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.736 1.214 . . . . 0.0 110.709 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.3 p -88.64 -12.07 43.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.517 1.127 . . . . 0.0 113.89 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 52.58 21.27 1.76 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.313 2.645 . . . . 0.0 115.12 -169.465 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.69 122.17 75.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.673 0.789 . . . . 0.0 111.048 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.9 130.26 39.68 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.469 2.779 . . . . 0.0 114.145 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.265 34.8 mt 72.0 132.69 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.272 3.029 . . . . 0.0 113.265 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.7 t -132.95 -46.71 0.86 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.126 2.171 . . . . 0.0 111.135 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 10.2 tp -56.57 -33.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.85 2.06 . . . . 0.0 114.354 171.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.13 -7.54 24.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.621 1.568 . . . . 0.0 112.077 171.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -130.83 6.65 4.69 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.3 tt -60.05 138.98 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 122.723 1.249 . . . . 0.0 113.696 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.97 88.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.112 2.165 . . . . 0.0 108.235 169.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.25 140.12 44.78 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.871 -1.143 . . . . 0.0 111.598 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.546 0.817 0 C-N-CA 125.637 1.575 . . . . 0.0 108.935 169.879 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 121.434 0.635 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.6 m -58.8 145.44 40.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -168.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -68.02 -37.09 81.0 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.121 0.962 . . . . 0.0 111.335 173.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -80.15 -53.39 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.595 1.958 . . . . 0.0 112.771 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.0 m -123.23 -8.74 8.16 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.84 16.2 78.13 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 118.891 0.769 . . . . 0.0 114.543 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -76.18 164.53 26.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.581 2.753 . . . . 0.0 111.428 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.71 106.83 5.35 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 168.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.6 129.21 19.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.183 1.922 . . . . 0.0 113.594 -169.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -45.08 94.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.711 1.604 . . . . 0.0 110.159 169.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -122.83 91.05 49.92 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.587 1.555 . . . . 0.0 110.643 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.1 124.94 17.07 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.795 2.997 . . . . 0.0 111.451 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.16 145.46 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 127.25 2.22 . . . . 0.0 110.395 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.5 tp -131.94 153.77 49.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.68 1.992 . . . . 0.0 110.812 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 t -136.76 125.58 15.22 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.046 . . . . 0.0 106.205 168.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -67.81 -6.58 17.25 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.985 2.456 . . . . 0.0 114.169 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -61.38 1.92 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.748 1.619 . . . . 0.0 110.78 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 m -81.98 -10.41 59.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.268 15.2 ptp180 43.63 41.71 3.68 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.773 2.829 . . . . 0.0 117.041 169.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.402 HG21 ' HB2' ' A' ' 4' ' ' ALA . 14.8 t -133.98 172.35 12.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.239 2.216 . . . . 0.0 110.224 170.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.56 114.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.57 170.93 7.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.557 2.343 . . . . 0.0 110.638 176.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 12.2 tt0 -73.48 149.49 42.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.765 175.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -53.44 -44.14 68.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -62.2 -41.02 97.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.802 1.241 . . . . 0.0 112.894 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 8.0 mt -71.38 -45.87 61.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.139 0.576 . . . . 0.0 110.316 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -64.17 -43.69 94.38 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.86 -42.5 72.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.848 1.259 . . . . 0.0 111.453 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -59.9 -52.62 64.66 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.106 -0.371 . . . . 0.0 111.588 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.09 -34.46 77.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.169 0.985 . . . . 0.0 112.15 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -84.44 -14.27 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.333 1.053 . . . . 0.0 113.235 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.18 -11.27 22.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.408 1.083 . . . . 0.0 111.843 168.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -56.09 5.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.764 2.025 . . . . 0.0 110.841 169.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.2 p -135.19 -22.73 1.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.745 1.218 . . . . 0.0 112.726 -176.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.09 -11.28 65.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.483 1.039 . . . . 0.0 113.025 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -63.83 157.35 24.8 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.309 1.554 . . . . 0.0 113.518 -174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -80.94 135.87 51.3 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.511 1.124 . . . . 0.0 108.037 167.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.64 -8.23 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 N-CA-C 118.905 2.617 . . . . 0.0 118.905 -168.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.74 -44.78 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 121.09 1.768 . . . . 0.0 111.564 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -84.19 -13.12 53.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 44.89 30.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.677 2.391 . . . . 0.0 114.766 -170.392 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.61 134.37 88.49 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.641 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.11 135.56 27.52 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.512 2.142 . . . . 0.0 112.296 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 mp 70.72 144.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.97 2.508 . . . . 0.0 111.861 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -145.09 -52.4 0.28 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.723 2.009 . . . . 0.0 110.646 -169.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.426 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.0 tp -57.62 -32.87 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.553 2.341 . . . . 0.0 115.628 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -67.82 -8.26 34.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.394 1.078 . . . . 0.0 112.086 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.13 11.22 4.61 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.291 1.836 . . . . 0.0 112.532 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 tt -59.39 142.01 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.842 1.306 . . . . 0.0 113.475 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.33 97.84 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 127.839 2.456 . . . . 0.0 109.023 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.92 112.25 9.87 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.74 -1.225 . . . . 0.0 110.452 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.9 mm . . . . . 0 N--CA 1.476 0.828 0 C-N-CA 125.571 1.548 . . . . 0.0 111.227 -177.629 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 121.343 0.592 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.497 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 2.7 m -58.9 136.01 57.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -168.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.58 -21.46 64.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -94.74 -49.7 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.879 1.671 . . . . 0.0 111.923 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -126.84 -16.95 5.05 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.497 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.72 13.61 83.37 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.926 -1.109 . . . . 0.0 114.72 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -69.41 164.08 23.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.885 2.874 . . . . 0.0 112.088 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -82.4 110.19 20.21 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.64 138.33 37.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.155 1.903 . . . . 0.0 113.823 -169.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -84.59 -41.3 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.433 2.293 . . . . 0.0 109.894 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -121.68 86.17 44.83 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.994 1.718 . . . . 0.0 108.832 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.02 124.75 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.886 3.057 . . . . 0.0 109.685 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.03 142.89 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 125.84 1.656 . . . . 0.0 110.494 -169.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -133.12 154.45 50.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.421 1.488 . . . . 0.0 110.568 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 t -131.9 128.73 21.66 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 127.049 2.139 . . . . 0.0 106.054 168.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.39 -7.57 18.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.35 2.7 . . . . 0.0 115.004 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -74.61 -63.34 1.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.288 1.035 . . . . 0.0 110.921 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -64.08 -36.46 84.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.86 1.264 . . . . 0.0 111.814 170.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.353 11.1 ptp180 47.92 17.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 129.741 3.216 . . . . 0.0 116.092 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.3 p -77.99 174.44 11.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.312 2.645 . . . . 0.0 109.82 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 116.51 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -114.14 169.01 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.787 2.035 . . . . 0.0 111.644 174.907 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.83 131.28 39.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -47.92 -45.51 30.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.948 1.699 . . . . 0.0 110.047 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 m -59.97 -35.18 74.44 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.46 -39.88 31.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.255 0.622 . . . . 0.0 111.089 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -62.69 -46.11 89.65 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -56.2 -40.39 73.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.551 1.54 . . . . 0.0 112.023 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -60.91 -52.52 64.68 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.513 -0.742 . . . . 0.0 111.83 170.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -67.37 -34.7 77.84 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.204 1.002 . . . . 0.0 111.849 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.507 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.9 p -82.84 -18.36 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.631 1.172 . . . . 0.0 113.033 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -91.38 -15.4 29.04 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 121.07 -1.019 . . . . 0.0 111.636 168.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.87 -56.41 4.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.388 1.875 . . . . 0.0 111.702 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -132.93 -21.84 2.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.086 1.354 . . . . 0.0 112.395 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.11 -12.13 55.24 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.27 0.938 . . . . 0.0 113.575 -171.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -66.58 156.07 36.06 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.589 1.694 . . . . 0.0 113.927 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.95 135.09 59.24 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 166.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.89 -4.05 11.64 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.211 2.607 . . . . 0.0 115.018 -170.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.28 -50.65 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 110.714 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -87.25 -13.01 44.98 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.384 0.0 OUTLIER 49.68 21.33 0.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.338 2.655 . . . . 0.0 115.138 -168.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -68.32 129.13 93.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.234 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.87 135.72 33.39 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.833 2.356 . . . . 0.0 112.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.27 39.1 mt 70.86 141.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 129.405 3.082 . . . . 0.0 113.082 -171.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -140.99 -53.86 0.48 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 110.58 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.507 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -61.76 -24.75 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -16.54 62.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.466 1.906 . . . . 0.0 111.674 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.12 10.27 8.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.675 1.99 . . . . 0.0 112.161 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.471 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 11.3 tt -58.48 139.89 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 122.955 1.359 . . . . 0.0 114.404 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -120.75 91.78 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.834 2.454 . . . . 0.0 108.406 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -75.55 121.6 22.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.979 -1.076 . . . . 0.0 110.356 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 126.09 1.756 . . . . 0.0 108.559 173.275 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 3.2 m -59.08 138.69 57.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -168.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.59 61.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.824 -0.547 . . . . 0.0 112.422 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.65 -51.35 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.804 1.242 . . . . 0.0 111.455 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -124.27 -10.51 7.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.0 11.88 84.43 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 119.018 0.826 . . . . 0.0 114.947 170.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -72.62 161.08 31.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.605 2.762 . . . . 0.0 111.176 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.1 t -76.33 106.68 3.49 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 168.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.51 118.25 5.11 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.608 2.205 . . . . 0.0 114.385 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.02 -47.06 84.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.865 1.266 . . . . 0.0 111.343 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -129.62 90.25 44.3 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.233 1.413 . . . . 0.0 109.339 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.83 149.53 86.59 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.185 2.59 . . . . 0.0 113.38 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.44 155.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 110.46 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.98 154.07 48.24 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.653 1.181 . . . . 0.0 110.608 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -117.36 134.11 23.14 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 125.658 1.583 . . . . 0.0 108.986 169.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.09 -4.7 14.77 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.359 2.706 . . . . 0.0 113.762 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -86.72 -48.84 7.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 110.535 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.4 p -97.62 -24.16 15.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 114.861 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.12 4.08 1.13 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 129.164 2.986 . . . . 0.0 116.685 170.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -71.8 174.43 6.89 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.992 1.717 . . . . 0.0 110.248 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.9 mt -119.34 116.1 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -112.57 165.71 12.0 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.53 1.532 . . . . 0.0 111.25 174.05 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -75.17 134.6 41.19 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -52.83 -41.53 64.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.872 1.669 . . . . 0.0 109.845 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -61.61 -37.15 82.89 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.3 -43.13 52.7 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.564 0.746 . . . . 0.0 110.648 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.27 -45.58 83.94 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 119.221 -0.418 . . . . 0.0 109.922 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.9 -41.86 68.08 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.182 0.993 . . . . 0.0 111.793 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.51 -52.92 63.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.986 0.514 . . . . 0.0 111.761 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.24 -36.02 80.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.35 1.06 . . . . 0.0 112.076 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.469 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.4 p -84.94 -18.72 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.282 1.033 . . . . 0.0 112.884 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -91.04 -14.8 30.67 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.988 -1.07 . . . . 0.0 111.576 168.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -60.11 2.39 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.641 1.576 . . . . 0.0 110.555 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.9 p -137.4 -16.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.695 1.198 . . . . 0.0 113.104 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 83.6 -15.63 34.97 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.768 1.175 . . . . 0.0 114.007 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -67.33 149.03 50.88 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.928 1.364 . . . . 0.0 111.52 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.99 143.49 91.76 Favored Pre-proline 0 CA--C 1.548 0.904 0 O-C-N 120.936 -1.102 . . . . 0.0 108.791 168.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -4.66 14.13 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.304 2.669 . . . . 0.0 114.684 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.8 -52.34 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.453 1.501 . . . . 0.0 110.851 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -85.38 -15.06 44.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.391 0.0 OUTLIER 49.17 22.4 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.055 2.542 . . . . 0.0 114.609 -168.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -73.89 130.79 82.55 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.099 -1.001 . . . . 0.0 109.696 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.79 141.15 48.49 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.426 2.751 . . . . 0.0 113.705 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.3 mt 65.89 132.43 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 129.928 3.291 . . . . 0.0 113.756 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -131.96 -48.0 0.94 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.262 1.825 . . . . 0.0 111.456 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.469 ' H ' HG21 ' A' ' 32' ' ' VAL . 10.3 tp -60.13 -32.79 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.05 1.74 . . . . 0.0 114.405 173.222 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.06 -7.73 38.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.248 1.419 . . . . 0.0 112.162 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -126.96 7.58 6.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.015 1.726 . . . . 0.0 112.531 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.406 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 6.1 tp -58.39 142.0 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.43 89.66 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 107.567 169.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -75.16 141.43 43.66 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.026 -1.046 . . . . 0.0 112.5 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.2 mm . . . . . 0 N--CA 1.471 0.614 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 -175.143 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 120.785 0.326 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.4 m -57.34 130.07 44.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.37 62.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.56 -56.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.962 0.905 . . . . 0.0 110.984 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 -13.78 8.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 80.31 9.57 86.4 Favored Glycine 0 N--CA 1.47 0.915 0 O-C-N 121.486 -0.759 . . . . 0.0 114.994 170.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -71.05 162.75 28.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.47 2.708 . . . . 0.0 111.745 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.59 107.43 5.23 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.722 1.209 . . . . 0.0 107.812 168.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.91 116.28 3.01 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.965 2.443 . . . . 0.0 114.972 -169.463 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -75.36 -36.39 60.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.997 0.919 . . . . 0.0 111.477 169.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -121.47 81.51 39.06 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 125.725 1.61 . . . . 0.0 109.723 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.1 126.27 19.8 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.257 3.305 . . . . 0.0 111.27 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 50' ' ' ILE . 9.0 p -141.91 153.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.483 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -131.11 150.44 52.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.047 2.139 . . . . 0.0 109.677 -171.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.3 t -125.63 125.22 24.99 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.911 1.684 . . . . 0.0 107.738 169.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.46 -7.68 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.82 3.68 . . . . 0.0 116.613 173.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.39 -67.19 0.85 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.336 1.854 . . . . 0.0 111.127 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.2 m -70.14 -31.65 69.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.383 1.073 . . . . 0.0 113.396 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 62.22 7.31 2.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.216 2.606 . . . . 0.0 115.715 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.5 p -75.94 174.0 10.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.172 2.589 . . . . 0.0 111.755 170.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.4 mt -121.05 117.05 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 120.98 -1.075 . . . . 0.0 108.468 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -117.08 175.55 5.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.473 1.909 . . . . 0.0 112.219 178.555 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.22 130.7 36.32 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.308 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -53.37 -41.01 65.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.673 1.589 . . . . 0.0 110.64 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -57.5 -44.04 84.69 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.053 0.846 . . . . 0.0 112.748 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . 0.311 1.0 OUTLIER -94.45 -25.14 17.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.934 0.894 . . . . 0.0 113.291 -173.661 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.36 -52.52 57.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 167.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.25 -39.76 79.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.124 0.57 . . . . 0.0 111.351 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -56.84 -52.57 64.57 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.304 0.502 . . . . 0.0 112.239 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -64.92 -29.54 70.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.125 1.77 . . . . 0.0 112.336 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.481 HG21 ' CB ' ' A' ' 46' ' ' SER . 42.1 t -93.31 -5.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 125.904 1.682 . . . . 0.0 112.047 -177.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -98.76 -17.57 18.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.152 -1.593 . . . . 0.0 110.606 167.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -63.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.904 2.482 . . . . 0.0 111.327 170.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.6 p -126.56 -21.88 4.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.962 1.305 . . . . 0.0 113.104 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.06 -18.59 26.57 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 123.656 0.646 . . . . 0.0 114.1 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.08 145.72 54.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.795 1.297 . . . . 0.0 111.685 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 149.49 90.49 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.19 -0.944 . . . . 0.0 111.131 169.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.92 -17.66 60.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.858 2.372 . . . . 0.0 115.988 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.0 mm -125.62 -48.3 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.068 0.947 . . . . 0.0 110.978 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.8 p -82.43 -14.81 54.51 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.359 0.0 OUTLIER 51.7 19.78 0.98 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.033 2.533 . . . . 0.0 114.535 -169.515 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.61 124.6 88.81 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.914 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.44 133.59 43.5 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.737 2.958 . . . . 0.0 114.533 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 mt 66.0 143.16 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.143 2.977 . . . . 0.0 114.323 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.481 ' CB ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -136.15 -41.14 0.66 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.284 1.833 . . . . 0.0 111.823 -174.212 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.21 -33.71 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.656 1.583 . . . . 0.0 113.965 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.5 -5.45 28.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.253 1.421 . . . . 0.0 112.146 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.52 8.15 6.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 14' ' ' VAL . 4.5 tp -58.87 126.79 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.088 1.755 . . . . 0.0 114.959 -169.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -120.63 85.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.4 1.88 . . . . 0.0 110.221 171.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -80.01 118.57 21.86 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.954 -1.092 . . . . 0.0 112.073 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.2 mt . . . . . 0 CA--C 1.538 0.503 0 C-N-CA 126.612 1.965 . . . . 0.0 109.085 -175.036 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 121.572 0.701 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.0 t -63.52 139.07 58.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.058 1.409 . . . . 0.0 113.698 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.84 -15.56 47.78 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.072 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -76.91 -56.67 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.915 174.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m -134.54 -6.03 2.54 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.94 7.43 70.65 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.91 1.232 . . . . 0.0 114.109 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -56.29 137.98 51.35 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.301 2.64 . . . . 0.0 111.11 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.31 108.85 3.18 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.908 1.283 . . . . 0.0 107.663 169.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.74 128.02 28.6 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.586 2.191 . . . . 0.0 114.872 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -75.25 -46.05 36.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 108.782 169.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -124.32 91.16 49.93 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 127.212 2.205 . . . . 0.0 108.162 172.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.64 130.72 38.48 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.839 3.026 . . . . 0.0 111.4 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.9 144.02 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.971 1.708 . . . . 0.0 110.218 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.2 tp -131.65 154.32 49.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.5 1.92 . . . . 0.0 110.248 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 t -135.03 135.03 22.2 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.867 2.067 . . . . 0.0 107.703 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.87 -8.4 23.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -80.89 -64.19 1.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.978 1.711 . . . . 0.0 111.649 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -67.84 -32.73 73.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.883 0.873 . . . . 0.0 112.43 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 -2.0 0.51 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.351 2.66 . . . . 0.0 115.191 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.5 p -73.5 169.1 17.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.777 2.431 . . . . 0.0 112.617 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -112.76 116.55 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.7 168.96 9.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.588 1.555 . . . . 0.0 111.613 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.3 131.91 42.47 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.135 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -46.86 53.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.597 1.559 . . . . 0.0 110.283 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 t -62.18 -40.05 94.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -39.74 53.62 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.137 -0.977 . . . . 0.0 111.666 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.6 tp -60.64 -45.22 94.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.643 0.656 . . . . 0.0 109.302 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.424 ' HA ' HG12 ' A' ' 32' ' ' VAL . 39.0 tt0 -55.72 -38.82 70.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.013 0.925 . . . . 0.0 111.544 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.37 -49.57 73.34 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.768 -0.582 . . . . 0.0 111.827 173.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -67.95 -35.26 78.09 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.052 0.929 . . . . 0.0 112.221 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 29' ' ' GLU . 1.6 p -82.84 -15.95 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.369 1.068 . . . . 0.0 112.984 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.19 -14.05 25.99 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.166 -0.959 . . . . 0.0 111.519 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.88 -57.63 3.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.874 1.67 . . . . 0.0 111.373 170.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.9 -22.12 1.86 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.847 1.259 . . . . 0.0 112.539 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.11 60.14 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.226 0.917 . . . . 0.0 113.459 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.99 155.01 37.86 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.24 1.52 . . . . 0.0 113.449 -172.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.07 141.24 74.33 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 166.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.73 -7.47 18.33 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.159 2.573 . . . . 0.0 115.432 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.0 mt -126.8 -46.94 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.636 1.107 . . . . 0.0 111.879 -175.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.0 p -83.69 -12.78 55.42 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.343 0.3 OUTLIER 48.44 23.5 0.6 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.008 2.523 . . . . 0.0 115.083 -169.138 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.94 118.04 44.99 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.25 1.02 . . . . 0.0 110.644 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.39 132.65 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.474 2.782 . . . . 0.0 113.843 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.72 137.71 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.518 3.127 . . . . 0.0 112.864 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.69 -44.91 0.48 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.315 1.846 . . . . 0.0 111.164 -171.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 10.6 tp -58.89 -31.2 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 126.837 2.055 . . . . 0.0 115.568 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -14.74 62.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.369 1.868 . . . . 0.0 112.071 170.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -124.6 13.08 8.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.82 2.048 . . . . 0.0 112.035 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 6.7 tp -56.32 125.01 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.575 1.55 . . . . 0.0 112.947 -175.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.98 92.33 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.421 1.489 . . . . 0.0 109.26 170.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -78.63 123.11 26.77 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.055 -1.028 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 CA--C 1.537 0.465 0 C-N-CA 125.636 1.575 . . . . 0.0 109.655 -179.898 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.675 0.75 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.19 146.11 51.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -169.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.21 68.57 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.98 -48.22 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 110.968 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -135.3 -11.5 2.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.22 12.07 79.64 Favored Glycine 0 N--CA 1.469 0.881 0 O-C-N 121.228 -0.92 . . . . 0.0 113.961 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -51.2 136.22 24.62 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 128.341 2.656 . . . . 0.0 111.509 171.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -66.42 110.2 4.46 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 168.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.85 105.16 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.996 2.464 . . . . 0.0 115.846 -169.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -59.33 -41.2 88.56 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.309 1.843 . . . . 0.0 111.109 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -132.69 94.8 20.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.054 1.741 . . . . 0.0 108.678 169.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 135.3 62.3 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.662 2.908 . . . . 0.0 112.153 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.31 146.05 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.408 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.53 152.75 49.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.533 1.133 . . . . 0.0 110.611 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 t -120.37 133.3 23.98 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 125.744 1.618 . . . . 0.0 109.646 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.71 -19.62 25.05 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.313 2.675 . . . . 0.0 114.395 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -93.87 -58.96 2.1 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.921 1.689 . . . . 0.0 111.93 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.0 m -78.53 -16.59 57.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 58.32 -16.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 129.887 3.275 . . . . 0.0 118.627 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 t -74.48 173.39 10.41 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.363 1.465 . . . . 0.0 110.924 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 mm -106.79 118.91 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.258 1.423 . . . . 0.0 108.736 175.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.26 170.61 7.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 111.38 173.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 139.81 43.35 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.41 -45.68 62.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 109.393 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m -66.72 -42.04 86.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.907 0.883 . . . . 0.0 113.201 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.31 -40.36 64.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.565 0.746 . . . . 0.0 111.534 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.8 tp -61.35 -49.23 77.8 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -55.61 -41.78 73.97 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.017 0.527 . . . . 0.0 110.681 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.16 -53.65 55.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.034 0.534 . . . . 0.0 111.695 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -61.75 -35.18 77.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.349 1.071 . . . . 0.0 111.849 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.473 HG11 ' H ' ' A' ' 47' ' ' ILE . 41.7 t -93.75 -6.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 124.444 1.097 . . . . 0.0 112.258 -173.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -100.49 -10.59 20.93 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.937 -1.727 . . . . 0.0 110.81 167.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.108 2.563 . . . . 0.0 110.019 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -128.37 -21.77 3.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.38 1.472 . . . . 0.0 113.229 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.11 24.18 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.725 0.679 . . . . 0.0 113.758 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.74 147.72 52.93 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.588 1.194 . . . . 0.0 111.534 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.71 147.27 89.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.95 -1.094 . . . . 0.0 110.374 169.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.52 -10.75 27.32 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.909 2.406 . . . . 0.0 114.457 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.59 -46.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.312 0.96 . . . . 0.0 111.609 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.8 p -85.84 -10.4 55.46 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.327 0.3 OUTLIER 48.06 24.96 0.71 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.772 2.429 . . . . 0.0 115.671 -170.227 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.47 119.34 59.04 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.138 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.77 128.03 26.88 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.742 2.961 . . . . 0.0 114.334 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt 65.37 141.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.885 2.874 . . . . 0.0 114.664 -172.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.464 ' CB ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -136.29 -54.54 0.75 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.723 1.609 . . . . 0.0 112.614 -173.503 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.473 ' H ' HG11 ' A' ' 32' ' ' VAL . 7.8 tp -61.62 -32.04 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.808 1.643 . . . . 0.0 114.066 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -68.87 -7.09 31.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 112.078 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -133.31 12.67 4.19 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.8 1.64 . . . . 0.0 112.122 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 9.7 tp -59.22 150.1 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.623 1.969 . . . . 0.0 115.305 -171.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.53 87.54 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.224 1.81 . . . . 0.0 108.385 169.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -75.8 137.44 40.52 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.921 -1.112 . . . . 0.0 111.596 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 125.49 1.516 . . . . 0.0 109.962 178.879 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.389 0.614 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.8 t -66.77 144.05 56.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.619 1.199 . . . . 0.0 113.915 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.12 -15.35 38.7 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.389 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -77.56 -53.62 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.122 0.569 . . . . 0.0 110.008 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 m -136.72 -5.84 1.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.71 6.91 82.36 Favored Glycine 0 N--CA 1.473 1.103 0 CA-C-N 120.069 1.304 . . . . 0.0 115.493 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.55 147.14 46.48 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.69 2.396 . . . . 0.0 110.819 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.57 108.78 3.2 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.1 115.11 3.29 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.459 2.106 . . . . 0.0 112.717 -169.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -63.74 -34.99 79.12 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.612 1.165 . . . . 0.0 111.708 170.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.8 mtm-85 -123.63 87.09 52.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.323 1.849 . . . . 0.0 109.501 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.57 128.69 22.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.888 3.058 . . . . 0.0 111.736 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 152.09 20.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.245 1.418 . . . . 0.0 110.503 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -139.24 155.53 47.71 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.977 1.311 . . . . 0.0 110.407 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 p -123.81 146.96 52.19 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 109.029 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.22 -10.23 28.43 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 121.917 1.744 . . . . 0.0 113.183 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -59.51 2.75 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.081 1.753 . . . . 0.0 111.366 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.2 m -79.59 -32.51 41.96 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 112.072 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 59.94 1.72 0.34 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.467 2.307 . . . . 0.0 115.437 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 p -73.07 173.46 9.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.117 2.567 . . . . 0.0 111.679 170.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.33 116.22 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.84 173.44 6.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 126.287 1.835 . . . . 0.0 110.452 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.12 143.54 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.111 -0.993 . . . . 0.0 109.554 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.59 -46.18 66.81 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.13 1.372 . . . . 0.0 108.815 171.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -67.81 -42.79 80.99 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.6 -40.79 66.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.151 0.887 . . . . 0.0 111.439 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.92 -47.56 84.38 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -56.05 -42.99 77.44 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.695 0.398 . . . . 0.0 110.552 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -57.85 -52.13 66.75 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.688 0.795 . . . . 0.0 111.491 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.46 -36.21 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.025 1.33 . . . . 0.0 111.967 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 46' ' ' SER . 43.1 t -91.78 -6.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.016 1.326 . . . . 0.0 112.232 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -101.96 -10.77 19.48 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 119.994 -1.691 . . . . 0.0 110.567 167.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -61.6 1.9 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.034 2.134 . . . . 0.0 110.226 169.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.4 p -130.41 -16.75 3.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.983 1.313 . . . . 0.0 113.58 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.22 -19.64 30.14 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-O 119.507 -0.607 . . . . 0.0 113.656 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.56 148.83 51.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.827 1.314 . . . . 0.0 113.216 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.76 140.82 84.15 Favored Pre-proline 0 CA--C 1.549 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 110.83 169.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -60.42 -12.22 19.69 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.883 3.055 . . . . 0.0 117.594 -170.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mt -129.87 -42.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.38 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -86.87 -16.66 35.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.709 0.804 . . . . 0.0 112.26 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.317 0.5 OUTLIER 43.01 32.25 0.4 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.066 2.546 . . . . 0.0 114.798 -169.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -81.59 145.67 55.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 118.925 -0.559 . . . . 0.0 110.113 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.61 142.89 36.97 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.712 2.275 . . . . 0.0 114.042 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.2 mt 65.44 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 130.152 3.381 . . . . 0.0 115.019 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.514 ' HB3' HG21 ' A' ' 32' ' ' VAL . 3.1 t -129.63 -52.12 1.16 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.217 1.807 . . . . 0.0 112.037 -172.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.445 ' H ' HG11 ' A' ' 32' ' ' VAL . 8.8 tp -60.33 -31.57 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.039 1.736 . . . . 0.0 114.298 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -69.38 -8.47 46.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.187 1.395 . . . . 0.0 112.147 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -127.62 11.46 6.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.192 1.797 . . . . 0.0 112.328 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.5 tp -58.78 145.35 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.781 1.632 . . . . 0.0 115.276 -169.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.53 91.87 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.541 2.336 . . . . 0.0 108.477 169.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -77.15 112.36 13.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.956 -1.09 . . . . 0.0 111.361 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.0 mm . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 125.197 1.399 . . . . 0.0 111.728 -177.962 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 121.514 0.673 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 3.0 m -60.65 138.6 58.05 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.91 -14.83 61.55 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.49 -53.13 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.908 1.283 . . . . 0.0 111.727 -170.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 m -118.69 -14.3 9.56 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.85 16.11 81.05 Favored Glycine 0 N--CA 1.467 0.719 0 O-C-N 121.79 -0.569 . . . . 0.0 114.022 169.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -91.42 174.04 7.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.409 1.884 . . . . 0.0 113.577 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.33 114.35 28.87 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 125.55 10.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.177 1.918 . . . . 0.0 113.825 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -57.64 -50.72 72.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 111.257 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.48 100.72 14.92 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.812 1.645 . . . . 0.0 110.101 170.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.87 131.78 39.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.664 2.909 . . . . 0.0 111.678 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.16 145.9 23.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 127.894 2.478 . . . . 0.0 110.321 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tt -134.19 159.4 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.248 1.819 . . . . 0.0 110.041 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 p -128.88 152.41 79.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 110.932 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.91 -5.01 16.22 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.241 2.627 . . . . 0.0 113.564 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -70.87 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.21 1.404 . . . . 0.0 110.551 174.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -75.17 -29.66 60.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 113.056 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 56.11 5.54 0.18 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.951 2.1 . . . . 0.0 115.278 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.6 p -70.59 171.6 10.01 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.584 2.353 . . . . 0.0 111.183 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.56 115.96 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -113.78 171.91 7.3 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.09 2.156 . . . . 0.0 111.467 173.936 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -81.29 137.72 35.77 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -42.98 -49.92 5.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 128.289 2.636 . . . . 0.0 110.363 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.95 71.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.801 -171.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -76.31 -45.0 34.36 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.8 0.84 . . . . 0.0 110.348 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.28 -48.72 74.6 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.94 -45.06 78.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.718 0.407 . . . . 0.0 110.837 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -59.11 -50.69 73.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.282 0.492 . . . . 0.0 111.824 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.38 -34.35 77.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.149 0.976 . . . . 0.0 111.513 -174.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' A' ' 46' ' ' SER . 48.2 t -95.55 -9.89 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.874 1.27 . . . . 0.0 112.314 -173.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -94.44 -13.27 26.38 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 119.909 -1.745 . . . . 0.0 110.441 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.77 -66.64 0.84 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.136 2.574 . . . . 0.0 111.466 169.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.4 p -119.76 -20.31 7.68 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.387 1.475 . . . . 0.0 113.024 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.53 -20.57 13.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.087 0.851 . . . . 0.0 113.896 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.0 148.66 50.73 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.059 1.43 . . . . 0.0 112.423 -170.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.71 144.69 88.74 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.08 -1.013 . . . . 0.0 109.649 168.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.95 -6.84 18.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.678 2.918 . . . . 0.0 116.142 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mt -127.37 -49.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.605 1.162 . . . . 0.0 111.485 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.5 p -83.58 -14.6 51.72 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.339 0.2 OUTLIER 49.52 23.72 0.98 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.528 2.331 . . . . 0.0 114.981 -169.301 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.28 133.63 91.34 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.3 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.17 135.3 34.09 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.874 2.383 . . . . 0.0 112.715 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.0 mt 67.82 144.34 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.363 3.065 . . . . 0.0 113.998 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.562 ' HB3' HG21 ' A' ' 32' ' ' VAL . 3.8 t -141.04 -49.52 0.42 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.949 2.099 . . . . 0.0 112.364 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.498 ' H ' HG11 ' A' ' 32' ' ' VAL . 44.5 mm -58.65 -33.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.834 2.054 . . . . 0.0 113.808 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.3 -8.78 19.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.75 1.22 . . . . 0.0 112.419 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -132.48 9.17 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.431 1.893 . . . . 0.0 113.183 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.25 139.4 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.831 1.252 . . . . 0.0 114.16 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.14 92.43 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.26 2.224 . . . . 0.0 109.0 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -72.71 130.58 40.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.787 -1.196 . . . . 0.0 110.88 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 124.66 1.184 . . . . 0.0 109.04 179.792 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 111.048 0.018 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.8 t -69.25 147.8 50.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.726 1.25 . . . . 0.0 112.629 -170.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.91 -23.12 25.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.79 . . . . 0.0 112.531 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.16 -45.19 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.951 0.9 . . . . 0.0 111.163 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 t -126.21 -40.14 2.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.687 0.795 . . . . 0.0 112.701 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.34 20.03 36.71 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 121.702 0.612 . . . . 0.0 113.95 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -78.25 168.34 20.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.012 1.325 . . . . 0.0 110.982 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.29 112.83 17.41 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 133.82 20.98 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.649 2.233 . . . . 0.0 112.484 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.12 -34.58 73.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.949 1.3 . . . . 0.0 111.824 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -124.23 83.35 56.62 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.657 1.583 . . . . 0.0 111.067 173.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.54 125.56 18.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.734 2.956 . . . . 0.0 112.273 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 145.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.943 2.097 . . . . 0.0 110.507 -173.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.81 156.3 42.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.15 1.78 . . . . 0.0 109.841 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -127.11 143.54 47.37 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.919 1.288 . . . . 0.0 108.251 169.038 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.18 0.82 5.39 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.605 2.87 . . . . 0.0 113.866 -172.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -92.69 -67.85 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.202 1.801 . . . . 0.0 109.878 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -56.44 -41.64 76.79 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 59.25 5.67 0.62 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.258 2.223 . . . . 0.0 114.378 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.9 p -77.35 177.02 8.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.761 2.424 . . . . 0.0 111.579 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -122.68 114.54 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.49 171.22 7.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.436 1.894 . . . . 0.0 111.233 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.8 144.19 49.25 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.818 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -56.76 -44.37 81.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 109.707 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -68.18 -36.51 79.72 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.56 -38.76 65.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 0.0 112.022 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -44.48 96.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.948 0.795 . . . . 0.0 109.24 171.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -54.62 -41.23 69.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.5 0.72 . . . . 0.0 110.917 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -58.98 -53.43 58.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.465 0.706 . . . . 0.0 111.398 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.62 -36.65 81.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.366 1.079 . . . . 0.0 112.348 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.471 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.66 -10.86 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.772 1.229 . . . . 0.0 112.999 -175.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -102.1 -10.46 19.65 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.95 -1.094 . . . . 0.0 111.462 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -55.54 5.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.125 1.77 . . . . 0.0 110.691 169.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.4 p -133.98 -22.87 1.8 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.787 1.235 . . . . 0.0 112.426 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.6 -12.89 59.96 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.144 0.878 . . . . 0.0 113.081 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.32 154.88 40.29 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.586 1.693 . . . . 0.0 113.621 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.39 135.09 90.93 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.24 -5.31 12.21 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 121.871 1.714 . . . . 0.0 113.633 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mm -123.12 -45.38 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.197 1.362 . . . . 0.0 111.485 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 p -99.78 -4.93 29.51 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.546 0.739 . . . . 0.0 112.934 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.362 0.0 OUTLIER 45.1 23.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.483 3.113 . . . . 0.0 116.596 -172.041 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -69.82 137.16 87.66 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.58 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.84 130.87 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.933 2.422 . . . . 0.0 112.069 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.253 35.3 mt 70.45 146.29 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.375 3.07 . . . . 0.0 113.411 -170.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 t -143.7 -56.77 0.39 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.342 1.857 . . . . 0.0 110.69 -170.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.471 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.0 tt -59.69 -25.49 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 126.497 1.919 . . . . 0.0 116.041 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.78 -9.35 43.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.001 1.32 . . . . 0.0 112.157 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -126.66 9.21 7.03 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.058 . . . . 0.0 112.626 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.7 tt -58.3 147.11 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.097 1.759 . . . . 0.0 115.403 -172.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.7 97.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 128.635 2.774 . . . . 0.0 109.775 171.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.95 132.1 36.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.356 -1.465 . . . . 0.0 112.309 174.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.596 1.158 . . . . 0.0 110.605 179.746 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.052 0.453 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.7 t -68.34 140.23 55.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 123.074 1.416 . . . . 0.0 113.329 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.18 -20.05 42.02 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.69 -53.32 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.556 0.742 . . . . 0.0 110.871 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -132.24 -16.8 2.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.51 6.65 60.94 Favored Glycine 0 N--CA 1.468 0.797 0 O-C-N 121.295 -0.878 . . . . 0.0 114.822 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -69.08 161.1 29.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.46 1.504 . . . . 0.0 112.583 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.3 119.24 72.56 Favored Pre-proline 0 N--CA 1.473 0.684 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 169.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.83 125.2 9.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.13 1.887 . . . . 0.0 112.191 -171.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -64.6 -41.65 96.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.074 1.349 . . . . 0.0 110.452 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -124.72 92.76 47.3 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 0.0 109.393 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.37 127.78 24.03 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.547 2.832 . . . . 0.0 111.444 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -139.86 148.72 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.46 1.504 . . . . 0.0 110.682 -176.399 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.35 155.52 50.1 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.6 1.56 . . . . 0.0 111.689 -175.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 t -127.88 133.42 25.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 C-N-CA 126.64 1.976 . . . . 0.0 107.409 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.5 -10.0 27.25 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.041 2.494 . . . . 0.0 114.409 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -75.9 -63.64 1.26 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.013 1.725 . . . . 0.0 111.578 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.6 m -66.32 -36.05 81.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.008 0.923 . . . . 0.0 112.167 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 61.05 3.61 0.71 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.534 2.733 . . . . 0.0 114.912 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 p -75.23 174.88 8.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.932 2.493 . . . . 0.0 111.947 171.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.47 117.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.39 168.04 9.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.056 1.742 . . . . 0.0 111.109 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.446 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 5.5 tp10 -67.7 135.09 52.21 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.051 169.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -57.99 -43.51 86.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.952 0.796 . . . . 0.0 109.919 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 m -62.21 -41.91 98.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.467 1.107 . . . . 0.0 113.824 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -75.93 -38.25 57.85 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.129 0.877 . . . . 0.0 111.988 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 tp -60.3 -45.86 91.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 170.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 32' ' ' VAL . 34.4 tt0 -54.87 -37.98 66.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -62.16 -52.08 65.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.631 -0.668 . . . . 0.0 111.708 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.61 -35.62 79.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.114 0.959 . . . . 0.0 112.248 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 29' ' ' GLU . 2.9 p -82.87 -15.46 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.837 1.255 . . . . 0.0 113.027 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -94.88 -13.48 25.42 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.714 -1.241 . . . . 0.0 111.543 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -57.21 4.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.439 170.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -133.18 -22.18 2.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.9 1.28 . . . . 0.0 112.609 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.32 -11.38 58.44 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.191 0.9 . . . . 0.0 113.656 -171.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -65.65 153.62 41.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.154 1.477 . . . . 0.0 113.164 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.8 86.08 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -67.63 -7.27 18.87 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.075 2.517 . . . . 0.0 115.414 -171.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mt -127.38 -47.21 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.441 1.096 . . . . 0.0 111.795 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.2 p -83.96 -12.64 55.03 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.342 0.3 OUTLIER 48.22 24.54 0.69 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.994 2.517 . . . . 0.0 115.237 -169.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.48 119.25 61.2 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.12 0.968 . . . . 0.0 110.589 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.03 133.55 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.598 2.865 . . . . 0.0 114.054 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.7 mp 71.04 141.41 0.05 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.318 3.047 . . . . 0.0 112.845 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.57 -45.84 0.41 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.386 1.874 . . . . 0.0 111.392 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.424 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.2 mm -61.7 -31.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 114.654 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -12.53 53.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.259 1.824 . . . . 0.0 112.445 170.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -124.38 8.33 8.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.974 1.71 . . . . 0.0 112.719 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.424 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.4 tp -58.56 132.55 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.133 1.373 . . . . 0.0 113.878 -172.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.97 94.44 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.069 2.147 . . . . 0.0 109.115 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 14' ' ' VAL . 2.6 mt-10 -74.97 134.71 41.44 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.578 -1.326 . . . . 0.0 110.845 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 123.575 0.75 . . . . 0.0 110.277 179.059 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.514 0.673 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 13.5 t -60.87 137.63 58.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.973 1.368 . . . . 0.0 112.652 -169.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.58 -16.97 40.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.172 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.3 mt -82.77 -47.66 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.476 1.51 . . . . 0.0 110.538 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 p -128.9 -30.18 2.27 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.3 61.18 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 114.764 0.665 . . . . 0.0 114.764 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -53.5 137.38 36.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.458 1.903 . . . . 0.0 110.689 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.77 105.73 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.3 117.16 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.892 2.395 . . . . 0.0 113.663 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -74.36 -42.35 59.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.706 1.602 . . . . 0.0 110.519 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -126.42 90.1 50.69 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.063 2.145 . . . . 0.0 107.682 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -62.69 129.1 25.21 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.704 2.936 . . . . 0.0 111.857 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.02 153.74 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.452 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.44 156.87 47.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.406 1.882 . . . . 0.0 110.08 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -123.17 127.8 25.52 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.501 1.52 . . . . 0.0 108.34 168.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.69 -12.0 2.69 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.816 3.678 . . . . 0.0 117.217 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -62.54 1.66 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.927 1.291 . . . . 0.0 110.964 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 m -69.29 -38.12 78.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.704 1.602 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 57.47 10.88 1.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.938 2.495 . . . . 0.0 114.985 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.2 p -75.14 170.87 15.17 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.135 2.574 . . . . 0.0 111.057 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.21 116.51 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.431 ' CE1' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -113.76 168.96 9.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.409 1.884 . . . . 0.0 111.194 175.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -67.87 137.12 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.492 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -51.66 -46.12 63.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.728 1.211 . . . . 0.0 109.661 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -59.88 -42.07 92.95 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.05 0.843 . . . . 0.0 112.562 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -44.7 67.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.431 HD22 ' CE1' ' A' ' 23' ' ' PHE . 54.0 tp -65.71 -38.85 90.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.546 176.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.49 -40.32 90.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.502 0.721 . . . . 0.0 111.587 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.53 -50.17 73.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.077 0.951 . . . . 0.0 111.582 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -67.06 -37.36 83.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.128 0.966 . . . . 0.0 111.317 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.07 -18.48 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -89.86 -15.68 31.69 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.015 -1.053 . . . . 0.0 112.011 168.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -58.08 3.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.866 1.666 . . . . 0.0 110.978 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.9 p -137.59 -16.87 1.32 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 112.635 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.45 57.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.273 0.939 . . . . 0.0 113.524 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -63.12 153.91 32.73 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.23 1.515 . . . . 0.0 113.48 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.29 129.26 75.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.528 1.131 . . . . 0.0 108.209 167.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.0 -13.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.793 3.662 . . . . 0.0 119.718 -169.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.29 -41.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.141 1.337 . . . . 0.0 112.358 -171.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -92.21 -10.69 37.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.947 0.899 . . . . 0.0 112.576 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.311 0.5 OUTLIER 44.2 31.15 0.52 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.749 2.82 . . . . 0.0 115.355 -171.586 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.87 134.32 94.04 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.672 172.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.04 133.24 28.37 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.651 2.234 . . . . 0.0 111.628 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 mp 73.86 144.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 128.458 2.703 . . . . 0.0 112.488 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -147.5 -40.42 0.18 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.779 2.431 . . . . 0.0 110.24 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 tp -58.91 -36.18 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.361 1.864 . . . . 0.0 114.677 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -67.6 -7.68 28.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.121 1.368 . . . . 0.0 112.123 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.41 4.73 5.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.183 1.393 . . . . 0.0 113.318 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 tt -66.64 137.8 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 122.313 1.054 . . . . 0.0 113.675 -169.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.2 96.95 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.839 2.056 . . . . 0.0 111.23 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -72.59 123.63 23.6 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.55 -1.344 . . . . 0.0 110.462 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.2 mm . . . . . 0 N--CA 1.474 0.738 0 C-N-CA 125.323 1.449 . . . . 0.0 110.707 -174.913 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -119.15 152.67 36.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.093 1.757 . . . . 0.0 112.033 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.19 138.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.741 1.258 . . . . 0.0 113.409 -168.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.72 49.13 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.116 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.6 -58.23 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.095 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.3 m -135.95 -5.58 2.15 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.48 7.35 79.36 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-N 119.961 1.255 . . . . 0.0 115.444 172.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.4 141.67 58.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.018 2.527 . . . . 0.0 111.783 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.04 114.63 19.1 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 169.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 145.66 37.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 114.038 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -91.89 -31.39 15.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.772 2.029 . . . . 0.0 110.136 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -126.42 83.25 64.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 126.29 1.836 . . . . 0.0 109.482 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.99 127.48 25.19 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.036 3.157 . . . . 0.0 110.637 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.3 t -141.63 143.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 126.413 1.885 . . . . 0.0 110.842 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -125.29 157.4 36.73 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.979 1.712 . . . . 0.0 110.296 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 t -127.51 133.35 24.99 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.699 1.599 . . . . 0.0 108.619 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -55.05 -13.61 6.88 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.931 3.088 . . . . 0.0 117.058 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -95.88 -56.99 2.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.142 0.883 . . . . 0.0 111.619 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.7 p -63.78 -37.95 89.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.252 1.821 . . . . 0.0 114.264 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 58.62 1.14 0.17 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 128.965 2.906 . . . . 0.0 116.923 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -69.52 177.38 2.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.556 1.942 . . . . 0.0 110.04 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.45 115.81 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 169.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.67 169.21 9.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 112.282 172.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -74.25 131.02 40.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.389 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.42 -42.65 64.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.684 1.593 . . . . 0.0 110.622 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -63.55 -40.42 96.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.83 -35.18 60.06 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.443 -0.786 . . . . 0.0 111.336 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.17 -44.79 94.47 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 119.091 -0.481 . . . . 0.0 109.714 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' HA ' HG12 ' A' ' 32' ' ' VAL . 41.2 tt0 -54.94 -38.93 68.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.646 0.778 . . . . 0.0 111.401 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.69 -53.32 58.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.122 0.487 . . . . 0.0 112.112 171.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.18 -34.78 78.25 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.984 0.897 . . . . 0.0 112.328 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.1 p -83.07 -17.36 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.739 1.215 . . . . 0.0 112.795 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -92.81 -14.65 27.5 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.854 -1.154 . . . . 0.0 111.405 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -56.96 4.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.995 1.718 . . . . 0.0 111.677 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -133.67 -21.61 1.95 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.938 1.295 . . . . 0.0 112.505 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 83.85 -11.9 55.11 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.086 0.85 . . . . 0.0 113.658 -172.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -67.17 154.51 41.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.222 1.511 . . . . 0.0 113.317 -170.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.63 133.94 79.45 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.11 -14.08 7.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.157 3.238 . . . . 0.0 118.002 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.97 -48.84 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.712 1.142 . . . . 0.0 111.548 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.3 p -85.84 -11.12 54.18 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.333 0.3 OUTLIER 48.71 24.75 0.85 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.049 2.54 . . . . 0.0 115.295 -169.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.13 118.44 49.65 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.24 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.96 132.52 52.71 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.448 2.765 . . . . 0.0 113.91 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp 72.19 144.59 0.07 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 128.822 2.849 . . . . 0.0 111.864 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.9 t -143.32 -61.5 0.41 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.662 1.585 . . . . 0.0 111.151 -169.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.484 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -62.72 -26.89 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.69 -5.95 33.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.446 1.098 . . . . 0.0 112.301 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -128.67 11.85 6.26 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.47 1.908 . . . . 0.0 112.328 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 7.1 tt -57.8 143.62 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.756 1.622 . . . . 0.0 114.697 -171.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.66 86.22 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.207 2.203 . . . . 0.0 109.15 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -72.02 125.92 28.45 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.014 . . . . 0.0 111.412 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.25 78.45 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.309 1.844 . . . . 0.0 109.196 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.8 m -61.9 151.76 78.78 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 125.158 1.383 . . . . 0.0 112.543 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.9 -11.23 25.51 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.307 2.671 . . . . 0.0 114.315 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 126.734 2.013 . . . . 0.0 112.859 -177.774 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 tpp . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.15 145.56 29.2 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.828 1.651 . . . . 0.0 112.066 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 2.2 m -59.7 137.55 58.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -168.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -70.38 -25.0 63.05 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.088 0.471 . . . . 0.0 112.174 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.41 -51.58 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.037 1.735 . . . . 0.0 111.584 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 p -123.33 -18.7 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 80.19 11.31 84.5 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.68 167.45 13.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.112 2.565 . . . . 0.0 113.157 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.0 t -83.45 107.91 11.5 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.76 127.61 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.484 2.123 . . . . 0.0 113.624 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -71.1 -39.47 72.07 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.096 1.358 . . . . 0.0 111.065 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -124.7 86.83 55.42 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.792 1.237 . . . . 0.0 109.969 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.18 127.33 25.6 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.009 3.139 . . . . 0.0 110.712 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.5 t -140.01 142.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.415 1.886 . . . . 0.0 109.858 -170.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.56 157.4 46.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.801 1.641 . . . . 0.0 110.923 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -132.03 128.32 21.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.959 1.704 . . . . 0.0 108.221 169.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.68 -12.59 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.502 3.468 . . . . 0.0 116.714 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -83.79 -58.11 2.93 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.106 1.363 . . . . 0.0 110.567 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -27.16 68.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.035 1.734 . . . . 0.0 114.705 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 46.35 45.74 13.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 126.344 1.858 . . . . 0.0 113.959 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 4' ' ' ALA . 14.8 t -136.71 174.5 10.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.145 2.578 . . . . 0.0 109.401 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.52 116.75 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -111.47 168.18 9.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 111.472 173.609 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.97 131.11 41.09 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.778 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -46.88 -45.48 20.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.807 1.643 . . . . 0.0 109.739 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -59.29 -37.87 78.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -40.12 33.86 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.008 0.523 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.5 tp -63.11 -45.68 90.9 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -55.6 -42.62 75.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.484 1.514 . . . . 0.0 111.798 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -59.15 -53.07 62.49 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.293 -0.879 . . . . 0.0 111.408 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -67.37 -34.26 76.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.913 1.285 . . . . 0.0 112.427 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.02 -17.35 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.264 1.025 . . . . 0.0 112.845 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.61 -21.03 24.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.963 1.305 . . . . 0.0 111.426 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -57.64 3.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.348 1.859 . . . . 0.0 111.451 175.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.3 p -133.27 -21.53 2.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.143 1.377 . . . . 0.0 112.45 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.84 -12.45 57.18 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.248 0.927 . . . . 0.0 113.387 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.24 156.44 34.23 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.492 1.646 . . . . 0.0 113.267 -170.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.42 134.96 57.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 167.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.87 -5.21 12.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.993 2.462 . . . . 0.0 115.377 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.9 mt -121.55 -48.08 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.904 1.282 . . . . 0.0 111.506 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.9 p -88.75 -12.34 42.44 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.356 0.3 OUTLIER 47.42 25.17 0.57 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.053 2.541 . . . . 0.0 115.149 -169.228 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.72 129.96 90.77 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.495 -0.764 . . . . 0.0 110.243 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 134.47 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.958 2.438 . . . . 0.0 112.541 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.267 41.0 mt 71.79 133.92 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.695 3.198 . . . . 0.0 113.371 -175.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.12 -45.03 0.71 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.88 2.072 . . . . 0.0 111.424 -169.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.484 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.1 tp -58.33 -35.12 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.476 1.911 . . . . 0.0 114.469 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.18 -8.21 36.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.499 1.519 . . . . 0.0 111.912 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.71 7.21 5.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.442 1.497 . . . . 0.0 113.1 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.3 145.36 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.895 1.331 . . . . 0.0 114.492 -169.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.25 96.53 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.168 2.587 . . . . 0.0 108.548 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.37 117.57 27.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.976 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -83.05 154.28 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.377 1.471 . . . . 0.0 109.463 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.3 149.64 82.35 Favored Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 121.051 -1.03 . . . . 0.0 112.921 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.43 -11.39 24.56 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.494 2.796 . . . . 0.0 114.046 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 126.849 2.06 . . . . 0.0 113.089 -176.788 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt -101.65 150.92 22.61 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.187 1.395 . . . . 0.0 111.378 171.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.5 t -64.89 141.3 58.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.98 1.371 . . . . 0.0 113.482 -168.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.64 -18.51 31.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.47 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.68 -52.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.328 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -140.19 -6.62 1.22 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.31 74.81 Favored Glycine 0 N--CA 1.474 1.205 0 O-C-N 120.842 -1.161 . . . . 0.0 115.263 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.07 142.67 41.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.822 2.449 . . . . 0.0 110.969 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.17 108.41 2.47 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.73 109.99 0.5 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.816 2.344 . . . . 0.0 114.367 -169.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -60.5 -48.83 80.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.556 1.142 . . . . 0.0 110.781 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -119.21 88.59 37.75 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 126.231 1.812 . . . . 0.0 109.235 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 127.65 23.74 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.029 3.153 . . . . 0.0 111.588 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.55 144.32 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 126.163 1.785 . . . . 0.0 110.104 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -133.37 149.74 51.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.401 1.88 . . . . 0.0 110.555 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 t -132.67 117.64 15.33 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.91 -12.82 5.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.327 3.351 . . . . 0.0 116.693 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -47.19 60.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.764 1.225 . . . . 0.0 112.086 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -96.77 -19.76 18.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.867 1.267 . . . . 0.0 112.592 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 64.3 -3.94 0.46 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 128.941 2.896 . . . . 0.0 116.031 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 p -72.83 168.13 19.51 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.792 2.037 . . . . 0.0 113.037 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 mm -115.11 115.96 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.32 171.98 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.05 1.74 . . . . 0.0 111.514 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.12 138.27 43.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.88 -46.41 51.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.672 1.589 . . . . 0.0 109.559 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.77 -40.83 69.01 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.487 -0.758 . . . . 0.0 111.483 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.49 -44.1 95.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.428 0.558 . . . . 0.0 109.575 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.77 -39.26 70.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.479 0.712 . . . . 0.0 111.442 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.36 -45.65 83.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.662 -0.649 . . . . 0.0 111.904 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -69.63 -37.83 76.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.312 1.045 . . . . 0.0 112.241 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.5 p -79.63 -18.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.251 1.02 . . . . 0.0 112.688 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -79.2 -30.25 43.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.9 2.08 . . . . 0.0 110.269 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -55.26 6.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.109 1.764 . . . . 0.0 111.675 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.7 p -134.24 -21.18 1.84 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.162 1.385 . . . . 0.0 112.175 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 84.71 -10.63 61.7 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.998 0.808 . . . . 0.0 113.193 -170.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.16 155.4 35.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.467 1.634 . . . . 0.0 113.257 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -78.11 136.69 61.38 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -55.79 -17.37 18.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.82 3.013 . . . . 0.0 118.584 -169.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.8 mt -126.71 -46.29 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 120.253 1.388 . . . . 0.0 111.819 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -81.42 -13.35 58.35 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.309 0.5 OUTLIER 44.66 30.29 0.5 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.927 2.491 . . . . 0.0 114.633 -170.744 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.23 135.64 89.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.769 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.14 135.83 28.05 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.661 2.241 . . . . 0.0 112.246 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp 70.1 147.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 0.0 111.673 -172.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 t -146.38 -48.47 0.2 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.503 1.921 . . . . 0.0 110.621 -169.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.413 ' H ' HG21 ' A' ' 32' ' ' VAL . 9.3 tp -56.89 -31.39 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 127.279 2.231 . . . . 0.0 114.986 174.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.2 -6.89 25.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.93 1.292 . . . . 0.0 112.129 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.29 8.87 4.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.627 1.571 . . . . 0.0 112.813 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 tt -60.31 137.1 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.806 1.289 . . . . 0.0 113.106 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.93 97.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 127.379 2.272 . . . . 0.0 108.575 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -76.24 124.06 26.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.915 -1.116 . . . . 0.0 109.778 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm -82.2 90.56 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.697 1.199 . . . . 0.0 109.908 -174.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.22 117.58 31.47 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.187 1.395 . . . . 0.0 110.103 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.7 -16.06 18.91 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.079 2.519 . . . . 0.0 114.295 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 126.737 2.015 . . . . 0.0 113.878 -177.769 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttm . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.4 mt -112.76 163.22 14.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.535 1.534 . . . . 0.0 111.497 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.53 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 1.8 m -48.94 125.42 10.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -167.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.21 62.1 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.98 -57.58 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.947 2.099 . . . . 0.0 111.056 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -126.78 -11.3 6.08 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.53 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 75.14 14.27 82.0 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.587 1.085 . . . . 0.0 114.519 171.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -71.84 163.77 27.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.929 2.892 . . . . 0.0 111.516 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.8 110.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.0 126.68 12.73 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.013 1.809 . . . . 0.0 112.224 -169.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -78.46 -33.61 48.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.263 1.425 . . . . 0.0 111.84 170.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -129.93 83.89 62.4 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.688 1.595 . . . . 0.0 109.72 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.13 132.95 52.27 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.582 2.855 . . . . 0.0 111.223 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.35 148.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 126.077 1.751 . . . . 0.0 109.611 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.16 154.61 51.57 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.608 1.563 . . . . 0.0 109.505 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -126.89 119.59 22.53 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 108.403 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -56.33 -8.06 2.39 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.55 3.5 . . . . 0.0 117.326 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -40.07 62.27 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.223 1.409 . . . . 0.0 111.057 177.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.9 p -98.94 -30.43 12.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.204 1.802 . . . . 0.0 113.777 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 55.4 13.4 0.91 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.486 2.315 . . . . 0.0 114.89 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.1 p -77.66 169.47 18.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.91 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 mm -104.94 143.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -143.14 166.39 24.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.496 1.918 . . . . 0.0 110.576 168.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -74.82 128.34 35.33 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.028 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -45.27 -48.14 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.32 1.848 . . . . 0.0 109.756 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 76.0 p -68.86 -24.74 64.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -41.71 50.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.641 1.109 . . . . 0.0 110.784 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.1 tp -64.4 -44.94 89.69 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -54.9 -41.57 71.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.732 1.613 . . . . 0.0 111.864 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -61.1 -51.05 70.75 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.604 -0.685 . . . . 0.0 112.088 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.11 -35.72 80.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.166 0.984 . . . . 0.0 112.075 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -83.83 -15.52 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.858 1.263 . . . . 0.0 113.156 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -95.61 -13.17 24.58 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.149 -0.969 . . . . 0.0 111.606 168.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -57.57 3.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.143 1.777 . . . . 0.0 111.364 169.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.6 p -133.39 -21.83 2.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.905 1.282 . . . . 0.0 112.515 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -11.03 63.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.114 0.864 . . . . 0.0 113.316 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -64.35 156.11 30.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.724 1.762 . . . . 0.0 114.092 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.89 130.55 72.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.856 1.263 . . . . 0.0 108.573 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.76 -8.29 2.92 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.222 3.281 . . . . 0.0 118.647 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.88 -44.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.111 1.365 . . . . 0.0 112.282 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.6 p -98.33 -7.56 28.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.16 0.984 . . . . 0.0 112.754 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.305 0.5 OUTLIER 45.44 29.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.812 2.845 . . . . 0.0 115.686 -175.116 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -71.47 139.19 83.87 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.042 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.06 136.91 33.37 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.538 2.159 . . . . 0.0 112.62 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.3 mp 73.96 147.15 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.106 2.962 . . . . 0.0 112.065 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -145.89 -57.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.798 1.639 . . . . 0.0 110.596 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.1 tt -62.85 -26.87 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -70.01 -6.45 33.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.416 1.086 . . . . 0.0 112.181 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.75 9.57 6.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.364 1.866 . . . . 0.0 112.337 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.471 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 10.5 tt -59.8 150.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.032 1.733 . . . . 0.0 114.906 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.4 t -123.99 95.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 128.209 2.603 . . . . 0.0 108.321 169.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -86.37 119.48 26.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp -83.42 97.27 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.827 1.251 . . . . 0.0 108.401 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 p -53.56 121.09 25.09 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.153 0.981 . . . . 0.0 111.733 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.78 -15.38 24.02 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.942 2.428 . . . . 0.0 114.336 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.473 0.683 0 C-N-CA 126.347 1.859 . . . . 0.0 112.387 179.774 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 ptm . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.19 153.68 19.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.461 1.505 . . . . 0.0 111.579 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.3 m -55.32 134.38 50.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.47 -16.11 61.8 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.86 -58.73 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.73 0.812 . . . . 0.0 110.742 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -124.77 -10.53 7.26 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.76 16.29 79.37 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 119.024 0.829 . . . . 0.0 113.261 174.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -66.92 160.91 25.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.897 2.479 . . . . 0.0 110.613 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.0 112.98 16.45 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.49 106.2 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.756 2.304 . . . . 0.0 112.306 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -57.71 -45.87 85.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.659 1.584 . . . . 0.0 111.287 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.402 ' HD2' ' HE3' ' A' ' 25' ' ' LYS . 8.1 mtm180 -122.98 92.43 49.18 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.166 1.386 . . . . 0.0 109.949 170.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.64 123.99 13.35 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.617 2.878 . . . . 0.0 111.383 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.21 151.36 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.255 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tt -134.51 149.03 50.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.71 1.604 . . . . 0.0 110.794 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 t -113.39 131.74 22.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.698 1.199 . . . . 0.0 108.118 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.58 -5.48 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.439 2.093 . . . . 0.0 114.289 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -55.0 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.175 1.39 . . . . 0.0 111.042 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.8 p -79.75 -35.93 38.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.378 1.471 . . . . 0.0 112.694 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 59.86 11.25 2.46 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.906 2.882 . . . . 0.0 114.307 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.5 p -77.03 175.98 9.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 128.281 2.632 . . . . 0.0 111.793 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.13 132.61 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 108.449 171.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -129.38 173.63 10.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.074 1.749 . . . . 0.0 110.243 168.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 151.8 41.87 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.368 172.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE3' ' HD2' ' A' ' 12' ' ' ARG . 17.1 ttpp -56.91 -52.08 66.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.569 1.077 . . . . 0.0 108.679 171.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -76.19 -24.24 54.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.6 mt -72.27 -44.32 62.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.864 0.756 . . . . 0.0 111.465 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 tp -63.81 -45.14 91.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -53.85 -38.54 64.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.238 1.415 . . . . 0.0 111.693 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -62.16 -51.61 67.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.479 -0.763 . . . . 0.0 111.885 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -67.26 -37.28 83.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.457 1.103 . . . . 0.0 112.377 -173.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.467 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.9 p -81.57 -20.0 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.504 1.122 . . . . 0.0 112.398 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -81.59 -25.39 35.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.764 1.626 . . . . 0.0 111.077 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -56.0 5.58 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.261 1.824 . . . . 0.0 111.307 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.6 p -135.25 -21.4 1.6 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.885 1.274 . . . . 0.0 112.458 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -14.57 35.65 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.743 1.163 . . . . 0.0 113.857 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -67.22 151.47 47.48 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.026 1.413 . . . . 0.0 111.629 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -68.53 140.06 92.07 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.103 -0.998 . . . . 0.0 110.108 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -57.2 -14.39 15.13 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.095 3.197 . . . . 0.0 117.565 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.15 -50.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.88 1.272 . . . . 0.0 112.141 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 p -86.06 -11.23 53.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.63 0.772 . . . . 0.0 112.548 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.296 0.5 OUTLIER 45.07 30.53 0.61 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.077 2.551 . . . . 0.0 115.191 -171.3 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -70.76 132.22 87.18 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.431 -0.793 . . . . 0.0 109.653 172.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.02 137.18 36.93 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.729 2.286 . . . . 0.0 112.221 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 mp 69.25 139.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 128.191 2.597 . . . . 0.0 112.291 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 t -139.01 -55.12 0.6 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.556 1.542 . . . . 0.0 111.235 -169.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.467 ' H ' HG21 ' A' ' 32' ' ' VAL . 9.3 tp -59.84 -30.38 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.645 1.978 . . . . 0.0 115.104 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -71.54 -4.06 24.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.645 1.178 . . . . 0.0 112.363 171.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -127.94 9.81 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.643 1.577 . . . . 0.0 112.427 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 7.6 tp -58.87 144.08 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 114.947 -169.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.94 103.12 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.793 2.437 . . . . 0.0 109.741 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.56 123.69 33.3 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.153 . . . . 0.0 112.405 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -86.45 151.1 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 125.858 1.663 . . . . 0.0 108.92 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -59.04 132.74 87.27 Favored Pre-proline 0 N--CA 1.477 0.913 0 O-C-N 120.862 -1.149 . . . . 0.0 112.515 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.97 -13.17 15.92 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.233 2.622 . . . . 0.0 114.079 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 127.567 2.347 . . . . 0.0 114.199 179.682 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 pp -132.23 142.97 49.61 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.923 1.689 . . . . 0.0 110.853 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -59.33 139.1 57.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -168.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.42 -17.44 60.79 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -82.47 -59.21 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.498 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -124.82 -3.39 7.71 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.15 13.92 83.14 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 119.156 0.889 . . . . 0.0 114.812 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -78.59 163.87 25.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.296 2.638 . . . . 0.0 111.358 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.59 111.73 15.82 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.72 118.59 5.67 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.424 2.083 . . . . 0.0 112.844 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -61.28 -35.95 78.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.383 1.473 . . . . 0.0 111.604 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -129.76 91.26 40.8 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.21 1.404 . . . . 0.0 110.65 171.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.12 127.13 22.13 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.016 3.144 . . . . 0.0 112.136 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.18 143.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 126.664 1.986 . . . . 0.0 110.005 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tt -131.4 158.05 41.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.66 1.584 . . . . 0.0 110.504 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.5 t -129.69 130.0 23.17 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.756 1.623 . . . . 0.0 108.36 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.11 -16.22 12.11 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.812 3.008 . . . . 0.0 116.318 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -82.37 -47.13 12.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.153 1.381 . . . . 0.0 111.693 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.6 p -79.04 -35.75 42.16 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.014 1.326 . . . . 0.0 113.084 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.292 15.2 ptm180 50.37 11.6 0.08 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.409 3.084 . . . . 0.0 115.358 -169.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.1 p -75.51 173.73 10.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.159 2.584 . . . . 0.0 111.054 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.27 116.14 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.155 -0.965 . . . . 0.0 108.559 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -114.27 175.01 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.627 1.971 . . . . 0.0 111.25 172.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 15.1 tt0 -75.39 149.16 38.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.055 174.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -54.79 -49.71 70.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -71.32 -32.66 68.86 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.417 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 9.3 mt -71.5 -44.31 64.92 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.142 0.577 . . . . 0.0 111.524 174.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.11 -44.0 93.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HA ' HG12 ' A' ' 32' ' ' VAL . 47.7 tt0 -54.7 -39.88 68.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.57 1.548 . . . . 0.0 111.357 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -61.71 -51.38 68.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.212 0.605 . . . . 0.0 111.573 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -67.46 -35.78 79.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.028 0.918 . . . . 0.0 112.114 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.3 p -83.97 -15.28 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.955 1.302 . . . . 0.0 113.185 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -96.13 -12.63 24.47 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 121.072 -1.018 . . . . 0.0 111.486 168.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -57.65 3.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.996 1.718 . . . . 0.0 111.291 169.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -132.5 -22.34 2.19 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.025 1.33 . . . . 0.0 112.538 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.39 -11.26 63.95 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.218 0.913 . . . . 0.0 113.151 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.79 155.42 30.4 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.552 1.676 . . . . 0.0 113.862 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.33 130.96 57.34 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -66.57 -4.28 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.042 3.161 . . . . 0.0 116.243 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.82 -41.44 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.207 1.403 . . . . 0.0 111.776 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -105.03 -9.24 17.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.054 1.342 . . . . 0.0 113.662 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.373 0.0 OUTLIER 50.02 22.4 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.732 2.813 . . . . 0.0 115.635 -169.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.58 132.15 94.95 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.456 -0.777 . . . . 0.0 110.503 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 130.54 18.57 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.759 2.306 . . . . 0.0 112.398 -172.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.26 38.8 mt 71.8 139.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 129.092 2.957 . . . . 0.0 113.378 -173.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 t -137.36 -51.58 0.65 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.302 2.241 . . . . 0.0 110.59 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.3 tp -55.47 -34.66 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 127.801 2.44 . . . . 0.0 115.193 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -66.03 -9.56 31.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.393 1.477 . . . . 0.0 112.066 172.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -133.2 10.28 4.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.714 1.606 . . . . 0.0 112.941 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.44 147.35 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.6 t -121.84 91.95 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 128.011 2.524 . . . . 0.0 108.531 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -77.03 126.92 31.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.06 -1.025 . . . . 0.0 110.693 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.2 mt -98.65 148.03 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.328 1.451 . . . . 0.0 109.696 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.49 117.9 29.03 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.185 1.394 . . . . 0.0 110.343 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -57.64 -24.67 63.76 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.581 2.854 . . . . 0.0 116.428 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 126.123 1.769 . . . . 0.0 112.498 179.655 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.83 148.81 24.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.169 1.388 . . . . 0.0 111.352 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -56.12 138.13 50.25 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -168.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -68.72 -23.86 64.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 174.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.13 -46.94 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.681 1.192 . . . . 0.0 112.12 -169.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 t -123.66 -17.81 6.3 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.22 13.86 82.87 Favored Glycine 0 N--CA 1.47 0.953 0 O-C-N 121.277 -0.889 . . . . 0.0 114.642 174.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -72.2 162.96 28.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.841 2.857 . . . . 0.0 111.285 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -76.54 106.73 3.62 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 168.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -61.04 119.15 6.16 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.293 1.995 . . . . 0.0 114.247 -168.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.2 mmt-85 -71.19 -34.84 71.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.309 1.044 . . . . 0.0 111.867 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -122.89 83.95 50.05 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.16 1.384 . . . . 0.0 110.382 169.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.3 121.61 9.88 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.132 3.221 . . . . 0.0 111.744 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.83 142.15 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 127.144 2.178 . . . . 0.0 110.876 -169.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -133.03 157.59 44.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.424 2.289 . . . . 0.0 110.075 -173.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 p -131.92 149.26 72.84 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.563 1.145 . . . . 0.0 110.681 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.61 -7.31 20.95 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.239 2.626 . . . . 0.0 113.921 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -56.06 3.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.703 1.201 . . . . 0.0 110.428 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 98.9 p -66.38 -37.21 84.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.964 1.306 . . . . 0.0 113.63 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 55.61 4.5 0.11 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 127.665 2.386 . . . . 0.0 116.272 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 4' ' ' ALA . 8.0 t -86.68 179.59 6.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.362 2.665 . . . . 0.0 111.68 170.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.46 116.51 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.23 172.11 7.11 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.312 1.845 . . . . 0.0 111.94 170.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -83.33 136.17 34.46 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.817 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.5 -43.85 45.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.305 1.842 . . . . 0.0 110.444 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 t -61.04 -39.62 90.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.883 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.69 -42.2 64.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.319 1.048 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.38 -44.57 94.35 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.68 -43.77 69.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.973 0.909 . . . . 0.0 110.72 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -59.13 -55.46 34.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.19 -0.319 . . . . 0.0 111.851 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -65.45 -33.42 75.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.226 1.012 . . . . 0.0 112.331 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.515 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.4 p -86.62 -13.46 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 113.348 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -99.55 -10.95 21.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.774 1.23 . . . . 0.0 111.618 168.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.59 -56.3 4.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.968 2.107 . . . . 0.0 110.897 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.2 p -134.57 -23.2 1.64 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.972 1.309 . . . . 0.0 112.727 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.72 -12.55 63.15 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.677 1.132 . . . . 0.0 113.086 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -63.72 156.51 26.83 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.145 1.473 . . . . 0.0 113.984 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -82.08 130.58 59.6 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 167.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.38 -4.78 10.02 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.004 3.136 . . . . 0.0 117.321 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.0 mt -116.33 -49.36 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.568 1.147 . . . . 0.0 110.912 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.9 p -91.31 -12.87 33.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.398 1.079 . . . . 0.0 113.796 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.381 0.0 OUTLIER 50.67 23.83 1.49 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.334 2.654 . . . . 0.0 115.193 -169.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -68.34 137.2 91.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.57 140.18 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.337 2.025 . . . . 0.0 112.742 -172.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 mt 66.33 128.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 128.954 2.901 . . . . 0.0 114.704 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -129.24 -45.4 1.24 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.032 1.733 . . . . 0.0 111.544 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.515 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.1 tp -58.97 -35.2 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.982 2.113 . . . . 0.0 114.507 172.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.61 -8.88 38.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.304 1.442 . . . . 0.0 111.84 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.39 8.69 6.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.627 1.571 . . . . 0.0 112.99 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.93 137.4 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.726 1.251 . . . . 0.0 114.236 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -119.66 91.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.045 2.138 . . . . 0.0 108.82 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -76.19 115.93 16.39 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.027 -1.046 . . . . 0.0 110.074 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -80.44 -25.88 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.07 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 t -23.56 98.57 0.06 OUTLIER Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 130.44 3.496 . . . . 0.0 114.34 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -59.05 -24.01 71.52 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 124.057 3.172 . . . . 0.0 115.936 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 126.122 1.769 . . . . 0.0 112.878 -175.951 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.7 mt -101.8 154.11 19.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.379 1.471 . . . . 0.0 111.564 172.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 0.5 OUTLIER -56.88 135.67 55.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -168.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.97 64.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.995 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.91 -49.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.473 1.509 . . . . 0.0 112.164 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -126.23 -23.33 3.88 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.483 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.51 18.83 78.77 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.138 0.875 . . . . 0.0 113.394 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -65.93 155.2 37.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.661 2.784 . . . . 0.0 111.452 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.54 109.16 2.47 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.079 0.952 . . . . 0.0 109.481 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.05 120.36 8.18 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.944 2.429 . . . . 0.0 113.708 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -81.72 -49.08 10.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.506 1.922 . . . . 0.0 110.294 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -128.82 85.86 59.06 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 126.57 1.948 . . . . 0.0 109.545 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.32 138.31 83.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.655 2.903 . . . . 0.0 111.411 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -145.88 154.15 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 125.369 1.467 . . . . 0.0 109.969 -170.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -136.49 155.4 50.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.413 1.485 . . . . 0.0 110.173 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 t -125.15 136.55 28.3 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 125.647 1.579 . . . . 0.0 108.116 169.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.48 -10.48 27.92 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.766 2.311 . . . . 0.0 113.796 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.85 -67.69 0.62 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.859 2.064 . . . . 0.0 111.48 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.8 m -64.37 -37.0 85.98 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.365 1.066 . . . . 0.0 112.826 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 63.6 -1.53 0.59 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.845 2.458 . . . . 0.0 115.107 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.5 p -77.64 177.12 8.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.585 2.354 . . . . 0.0 111.939 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 mm -106.61 141.62 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -136.71 167.86 20.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.763 1.625 . . . . 0.0 110.27 168.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -78.35 130.51 36.25 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -43.08 40.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.696 1.998 . . . . 0.0 110.468 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 t -60.21 -43.14 96.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.78 -40.26 41.38 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 110.961 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.76 -48.66 79.69 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -58.26 -42.18 85.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.833 0.288 . . . . 0.0 111.062 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -58.43 -49.55 76.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.175 0.512 . . . . 0.0 111.926 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -64.23 -35.19 80.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.696 1.198 . . . . 0.0 111.879 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG21 ' CB ' ' A' ' 46' ' ' SER . 43.5 t -94.0 -13.55 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 112.093 -172.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -91.39 -12.71 34.03 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 119.813 -1.805 . . . . 0.0 110.391 167.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.89 -65.71 0.91 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.95 2.1 . . . . 0.0 110.995 169.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.7 p -126.6 -15.12 5.62 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.069 1.348 . . . . 0.0 113.632 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.36 -18.02 25.93 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.923 0.773 . . . . 0.0 113.822 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -68.24 149.09 49.92 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.266 1.533 . . . . 0.0 112.772 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.5 142.48 94.34 Favored Pre-proline 0 CA--C 1.549 0.939 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 169.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.75 -5.57 17.12 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.254 2.636 . . . . 0.0 114.841 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mm -118.55 -52.45 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.716 1.206 . . . . 0.0 110.566 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -89.96 -13.47 36.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.328 0.4 OUTLIER 45.84 31.07 0.97 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.208 2.203 . . . . 0.0 114.462 -169.035 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -75.29 135.68 72.68 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.041 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.07 140.74 42.23 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.175 2.583 . . . . 0.0 113.049 -170.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 mt 65.1 149.14 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.365 3.066 . . . . 0.0 114.192 -172.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.506 ' CB ' HG21 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -142.86 -54.18 0.4 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.301 1.84 . . . . 0.0 111.85 -173.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.414 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 10.1 tp -61.37 -30.87 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.646 1.978 . . . . 0.0 114.82 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.86 -9.37 44.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.309 1.444 . . . . 0.0 112.0 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -130.61 12.88 5.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.853 1.661 . . . . 0.0 112.483 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.6 tp -57.44 141.39 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.492 1.517 . . . . 0.0 114.118 -172.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.86 92.61 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.958 2.103 . . . . 0.0 109.792 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' HG23 ' A' ' 14' ' ' VAL . 1.5 mp0 -78.3 126.14 30.36 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.853 -1.154 . . . . 0.0 112.257 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.7 mm -96.6 57.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.441 1.496 . . . . 0.0 108.783 -177.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.3 t -52.82 112.46 3.52 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 126.564 1.946 . . . . 0.0 112.079 -169.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.98 -29.91 75.72 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 123.839 3.026 . . . . 0.0 115.77 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 126.0 1.72 . . . . 0.0 112.639 -178.66 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 pp -102.26 149.33 24.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.632 1.573 . . . . 0.0 111.446 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.471 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 3.0 m -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -168.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.51 -17.11 62.36 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.69 -49.97 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.269 1.428 . . . . 0.0 111.522 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.7 p -116.28 -24.47 7.93 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 82.11 12.39 80.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 115.406 0.922 . . . . 0.0 115.406 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.96 166.59 17.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.424 2.29 . . . . 0.0 112.198 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.75 107.42 7.35 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.72 114.9 1.53 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.469 2.779 . . . . 0.0 117.33 -168.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -62.55 -44.93 95.11 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.158 1.383 . . . . 0.0 110.492 169.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm-85 -126.67 94.77 39.35 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.161 1.784 . . . . 0.0 109.678 169.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.72 125.92 17.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.066 3.178 . . . . 0.0 111.036 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.34 142.71 28.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 126.302 1.841 . . . . 0.0 110.366 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tt -131.63 157.75 42.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.523 1.529 . . . . 0.0 110.889 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -134.51 125.9 17.9 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.634 1.574 . . . . 0.0 108.609 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -53.72 -11.65 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 125.172 3.914 . . . . 0.0 117.309 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.71 -55.46 5.84 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.805 1.242 . . . . 0.0 111.178 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 m -79.8 -37.34 35.44 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.505 1.522 . . . . 0.0 112.366 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm-85 56.23 7.97 0.37 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 128.114 2.566 . . . . 0.0 115.429 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.1 p -74.26 174.22 9.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.65 2.38 . . . . 0.0 110.395 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.38 118.1 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -112.76 171.14 7.71 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.428 1.891 . . . . 0.0 111.406 173.361 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -80.01 134.62 36.24 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.3 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -45.67 -46.64 14.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.742 2.017 . . . . 0.0 110.249 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -63.66 -33.35 75.43 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.966 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.38 -45.22 40.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.288 1.035 . . . . 0.0 110.73 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -63.33 -45.04 93.15 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -56.19 -42.77 77.66 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.867 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -59.25 -51.64 69.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.409 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.49 -34.29 76.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.147 1.379 . . . . 0.0 112.239 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.2 p -83.1 -18.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.252 1.021 . . . . 0.0 112.872 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -85.77 -22.74 27.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.089 1.355 . . . . 0.0 111.363 168.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.42 4.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.558 1.943 . . . . 0.0 111.59 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.2 p -133.38 -21.38 2.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.029 1.332 . . . . 0.0 112.451 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.14 58.84 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.231 0.92 . . . . 0.0 113.341 -171.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.44 156.06 30.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.389 1.595 . . . . 0.0 113.709 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.74 131.36 54.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.53 -4.89 10.4 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.862 3.041 . . . . 0.0 117.15 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.85 -53.2 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.736 1.214 . . . . 0.0 110.709 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.3 p -88.64 -12.07 43.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.517 1.127 . . . . 0.0 113.89 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 52.58 21.27 1.76 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.313 2.645 . . . . 0.0 115.12 -169.465 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.69 122.17 75.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.673 0.789 . . . . 0.0 111.048 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.9 130.26 39.68 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.469 2.779 . . . . 0.0 114.145 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.265 34.8 mt 72.0 132.69 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.272 3.029 . . . . 0.0 113.265 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.7 t -132.95 -46.71 0.86 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.126 2.171 . . . . 0.0 111.135 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 10.2 tp -56.57 -33.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.85 2.06 . . . . 0.0 114.354 171.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.13 -7.54 24.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.621 1.568 . . . . 0.0 112.077 171.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -130.83 6.65 4.69 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.3 tt -60.05 138.98 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 122.723 1.249 . . . . 0.0 113.696 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.97 88.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.112 2.165 . . . . 0.0 108.235 169.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.25 140.12 44.78 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.871 -1.143 . . . . 0.0 111.598 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.2 153.41 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 125.637 1.575 . . . . 0.0 108.935 169.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.97 153.55 79.84 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 125.512 1.525 . . . . 0.0 111.804 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.97 -34.37 76.5 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.842 3.028 . . . . 0.0 115.596 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 C--O 1.239 0.545 0 C-N-CA 125.212 1.405 . . . . 0.0 111.801 175.202 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 2' ' ' LEU . 1.8 pt? -100.34 143.53 30.42 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.329 1.452 . . . . 0.0 112.202 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.6 m -58.8 145.44 40.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -168.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -68.02 -37.09 81.0 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.121 0.962 . . . . 0.0 111.335 173.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -80.15 -53.39 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.595 1.958 . . . . 0.0 112.771 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.0 m -123.23 -8.74 8.16 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.84 16.2 78.13 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 118.891 0.769 . . . . 0.0 114.543 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -76.18 164.53 26.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.581 2.753 . . . . 0.0 111.428 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.71 106.83 5.35 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 168.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.6 129.21 19.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.183 1.922 . . . . 0.0 113.594 -169.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -45.08 94.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.711 1.604 . . . . 0.0 110.159 169.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -122.83 91.05 49.92 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.587 1.555 . . . . 0.0 110.643 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.1 124.94 17.07 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.795 2.997 . . . . 0.0 111.451 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.16 145.46 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 127.25 2.22 . . . . 0.0 110.395 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.5 tp -131.94 153.77 49.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.68 1.992 . . . . 0.0 110.812 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 t -136.76 125.58 15.22 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.046 . . . . 0.0 106.205 168.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -67.81 -6.58 17.25 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.985 2.456 . . . . 0.0 114.169 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -61.38 1.92 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.748 1.619 . . . . 0.0 110.78 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 m -81.98 -10.41 59.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.268 15.2 ptp180 43.63 41.71 3.68 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.773 2.829 . . . . 0.0 117.041 169.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.402 HG21 ' HB2' ' A' ' 4' ' ' ALA . 14.8 t -133.98 172.35 12.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.239 2.216 . . . . 0.0 110.224 170.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.56 114.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.57 170.93 7.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.557 2.343 . . . . 0.0 110.638 176.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 12.2 tt0 -73.48 149.49 42.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.765 175.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -53.44 -44.14 68.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -62.2 -41.02 97.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.802 1.241 . . . . 0.0 112.894 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 8.0 mt -71.38 -45.87 61.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.139 0.576 . . . . 0.0 110.316 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -64.17 -43.69 94.38 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.86 -42.5 72.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.848 1.259 . . . . 0.0 111.453 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -59.9 -52.62 64.66 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.106 -0.371 . . . . 0.0 111.588 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.09 -34.46 77.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.169 0.985 . . . . 0.0 112.15 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -84.44 -14.27 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.333 1.053 . . . . 0.0 113.235 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.18 -11.27 22.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.408 1.083 . . . . 0.0 111.843 168.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -56.09 5.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.764 2.025 . . . . 0.0 110.841 169.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.2 p -135.19 -22.73 1.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.745 1.218 . . . . 0.0 112.726 -176.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.09 -11.28 65.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.483 1.039 . . . . 0.0 113.025 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -63.83 157.35 24.8 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.309 1.554 . . . . 0.0 113.518 -174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -80.94 135.87 51.3 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.511 1.124 . . . . 0.0 108.037 167.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.64 -8.23 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 N-CA-C 118.905 2.617 . . . . 0.0 118.905 -168.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.74 -44.78 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 121.09 1.768 . . . . 0.0 111.564 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -84.19 -13.12 53.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 44.89 30.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.677 2.391 . . . . 0.0 114.766 -170.392 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.61 134.37 88.49 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.641 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.11 135.56 27.52 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.512 2.142 . . . . 0.0 112.296 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 mp 70.72 144.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.97 2.508 . . . . 0.0 111.861 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -145.09 -52.4 0.28 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.723 2.009 . . . . 0.0 110.646 -169.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.426 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.0 tp -57.62 -32.87 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.553 2.341 . . . . 0.0 115.628 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -67.82 -8.26 34.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.394 1.078 . . . . 0.0 112.086 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.13 11.22 4.61 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.291 1.836 . . . . 0.0 112.532 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 tt -59.39 142.01 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.842 1.306 . . . . 0.0 113.475 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.33 97.84 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 127.839 2.456 . . . . 0.0 109.023 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.92 112.25 9.87 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.74 -1.225 . . . . 0.0 110.452 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.64 -29.6 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.571 1.548 . . . . 0.0 111.227 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.4 133.98 62.13 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.234 1.414 . . . . 0.0 111.459 171.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.38 -16.76 35.0 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.866 2.377 . . . . 0.0 114.27 -177.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 127.166 2.186 . . . . 0.0 114.025 173.38 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ptm . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 2' ' ' LEU . 1.8 pt? -124.88 153.53 42.48 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.727 2.011 . . . . 0.0 112.482 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.497 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 2.7 m -58.9 136.01 57.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -168.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.58 -21.46 64.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -94.74 -49.7 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.879 1.671 . . . . 0.0 111.923 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -126.84 -16.95 5.05 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.497 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.72 13.61 83.37 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.926 -1.109 . . . . 0.0 114.72 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -69.41 164.08 23.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.885 2.874 . . . . 0.0 112.088 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -82.4 110.19 20.21 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.64 138.33 37.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.155 1.903 . . . . 0.0 113.823 -169.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -84.59 -41.3 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.433 2.293 . . . . 0.0 109.894 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -121.68 86.17 44.83 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.994 1.718 . . . . 0.0 108.832 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.02 124.75 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.886 3.057 . . . . 0.0 109.685 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.03 142.89 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 125.84 1.656 . . . . 0.0 110.494 -169.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -133.12 154.45 50.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.421 1.488 . . . . 0.0 110.568 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 t -131.9 128.73 21.66 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 127.049 2.139 . . . . 0.0 106.054 168.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.39 -7.57 18.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.35 2.7 . . . . 0.0 115.004 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -74.61 -63.34 1.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.288 1.035 . . . . 0.0 110.921 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -64.08 -36.46 84.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.86 1.264 . . . . 0.0 111.814 170.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.353 11.1 ptp180 47.92 17.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 129.741 3.216 . . . . 0.0 116.092 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.3 p -77.99 174.44 11.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.312 2.645 . . . . 0.0 109.82 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 116.51 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -114.14 169.01 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.787 2.035 . . . . 0.0 111.644 174.907 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.83 131.28 39.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -47.92 -45.51 30.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.948 1.699 . . . . 0.0 110.047 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 m -59.97 -35.18 74.44 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.46 -39.88 31.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.255 0.622 . . . . 0.0 111.089 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -62.69 -46.11 89.65 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -56.2 -40.39 73.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.551 1.54 . . . . 0.0 112.023 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -60.91 -52.52 64.68 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.513 -0.742 . . . . 0.0 111.83 170.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -67.37 -34.7 77.84 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.204 1.002 . . . . 0.0 111.849 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.507 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.9 p -82.84 -18.36 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.631 1.172 . . . . 0.0 113.033 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -91.38 -15.4 29.04 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 121.07 -1.019 . . . . 0.0 111.636 168.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.87 -56.41 4.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.388 1.875 . . . . 0.0 111.702 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -132.93 -21.84 2.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.086 1.354 . . . . 0.0 112.395 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.11 -12.13 55.24 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.27 0.938 . . . . 0.0 113.575 -171.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -66.58 156.07 36.06 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.589 1.694 . . . . 0.0 113.927 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.95 135.09 59.24 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 166.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.89 -4.05 11.64 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.211 2.607 . . . . 0.0 115.018 -170.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.28 -50.65 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 110.714 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -87.25 -13.01 44.98 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.384 0.0 OUTLIER 49.68 21.33 0.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.338 2.655 . . . . 0.0 115.138 -168.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -68.32 129.13 93.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.234 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.87 135.72 33.39 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.833 2.356 . . . . 0.0 112.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.27 39.1 mt 70.86 141.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 129.405 3.082 . . . . 0.0 113.082 -171.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -140.99 -53.86 0.48 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 110.58 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.507 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -61.76 -24.75 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -16.54 62.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.466 1.906 . . . . 0.0 111.674 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.12 10.27 8.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.675 1.99 . . . . 0.0 112.161 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.471 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 11.3 tt -58.48 139.89 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 122.955 1.359 . . . . 0.0 114.404 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -120.75 91.78 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.834 2.454 . . . . 0.0 108.406 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -75.55 121.6 22.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.979 -1.076 . . . . 0.0 110.356 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.79 155.5 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.09 1.756 . . . . 0.0 108.559 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -57.34 134.39 81.44 Favored Pre-proline 0 N--CA 1.478 0.931 0 O-C-N 121.126 -0.984 . . . . 0.0 112.198 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.03 -14.45 18.98 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.211 2.608 . . . . 0.0 114.024 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 125.917 1.687 . . . . 0.0 112.153 177.742 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.35 146.53 27.91 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.41 1.484 . . . . 0.0 111.095 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 3.2 m -59.08 138.69 57.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -168.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.59 61.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.824 -0.547 . . . . 0.0 112.422 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.65 -51.35 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.804 1.242 . . . . 0.0 111.455 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -124.27 -10.51 7.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.0 11.88 84.43 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 119.018 0.826 . . . . 0.0 114.947 170.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -72.62 161.08 31.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.605 2.762 . . . . 0.0 111.176 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.1 t -76.33 106.68 3.49 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 168.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.51 118.25 5.11 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.608 2.205 . . . . 0.0 114.385 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.02 -47.06 84.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.865 1.266 . . . . 0.0 111.343 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -129.62 90.25 44.3 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.233 1.413 . . . . 0.0 109.339 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.83 149.53 86.59 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.185 2.59 . . . . 0.0 113.38 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.44 155.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 110.46 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.98 154.07 48.24 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.653 1.181 . . . . 0.0 110.608 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -117.36 134.11 23.14 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 125.658 1.583 . . . . 0.0 108.986 169.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.09 -4.7 14.77 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.359 2.706 . . . . 0.0 113.762 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -86.72 -48.84 7.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 110.535 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.4 p -97.62 -24.16 15.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 114.861 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.12 4.08 1.13 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 129.164 2.986 . . . . 0.0 116.685 170.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -71.8 174.43 6.89 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.992 1.717 . . . . 0.0 110.248 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.9 mt -119.34 116.1 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -112.57 165.71 12.0 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.53 1.532 . . . . 0.0 111.25 174.05 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -75.17 134.6 41.19 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -52.83 -41.53 64.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.872 1.669 . . . . 0.0 109.845 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -61.61 -37.15 82.89 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.3 -43.13 52.7 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.564 0.746 . . . . 0.0 110.648 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.27 -45.58 83.94 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 119.221 -0.418 . . . . 0.0 109.922 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.9 -41.86 68.08 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.182 0.993 . . . . 0.0 111.793 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.51 -52.92 63.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.986 0.514 . . . . 0.0 111.761 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.24 -36.02 80.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.35 1.06 . . . . 0.0 112.076 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.469 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.4 p -84.94 -18.72 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.282 1.033 . . . . 0.0 112.884 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -91.04 -14.8 30.67 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.988 -1.07 . . . . 0.0 111.576 168.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -60.11 2.39 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.641 1.576 . . . . 0.0 110.555 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.9 p -137.4 -16.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.695 1.198 . . . . 0.0 113.104 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 83.6 -15.63 34.97 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.768 1.175 . . . . 0.0 114.007 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -67.33 149.03 50.88 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.928 1.364 . . . . 0.0 111.52 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.99 143.49 91.76 Favored Pre-proline 0 CA--C 1.548 0.904 0 O-C-N 120.936 -1.102 . . . . 0.0 108.791 168.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -4.66 14.13 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.304 2.669 . . . . 0.0 114.684 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.8 -52.34 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.453 1.501 . . . . 0.0 110.851 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -85.38 -15.06 44.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.391 0.0 OUTLIER 49.17 22.4 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.055 2.542 . . . . 0.0 114.609 -168.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -73.89 130.79 82.55 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.099 -1.001 . . . . 0.0 109.696 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.79 141.15 48.49 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.426 2.751 . . . . 0.0 113.705 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.3 mt 65.89 132.43 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 129.928 3.291 . . . . 0.0 113.756 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -131.96 -48.0 0.94 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.262 1.825 . . . . 0.0 111.456 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.469 ' H ' HG21 ' A' ' 32' ' ' VAL . 10.3 tp -60.13 -32.79 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.05 1.74 . . . . 0.0 114.405 173.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.06 -7.73 38.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.248 1.419 . . . . 0.0 112.162 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -126.96 7.58 6.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.015 1.726 . . . . 0.0 112.531 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.406 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 6.1 tp -58.39 142.0 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.43 89.66 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 107.567 169.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -75.16 141.43 43.66 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.026 -1.046 . . . . 0.0 112.5 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.2 mm -105.38 142.44 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.8 t -66.49 124.42 88.2 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.114 0.966 . . . . 0.0 110.168 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.63 -10.06 20.09 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.36 2.707 . . . . 0.0 115.454 -171.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 125.335 1.454 . . . . 0.0 112.918 -178.539 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -131.98 142.36 49.57 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.301 1.84 . . . . 0.0 110.309 169.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.4 m -57.34 130.07 44.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.37 62.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.56 -56.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.962 0.905 . . . . 0.0 110.984 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 -13.78 8.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 80.31 9.57 86.4 Favored Glycine 0 N--CA 1.47 0.915 0 O-C-N 121.486 -0.759 . . . . 0.0 114.994 170.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -71.05 162.75 28.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.47 2.708 . . . . 0.0 111.745 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.59 107.43 5.23 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.722 1.209 . . . . 0.0 107.812 168.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.91 116.28 3.01 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.965 2.443 . . . . 0.0 114.972 -169.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -75.36 -36.39 60.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.997 0.919 . . . . 0.0 111.477 169.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -121.47 81.51 39.06 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 125.725 1.61 . . . . 0.0 109.723 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.1 126.27 19.8 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.257 3.305 . . . . 0.0 111.27 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 50' ' ' ILE . 9.0 p -141.91 153.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.483 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -131.11 150.44 52.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.047 2.139 . . . . 0.0 109.677 -171.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.3 t -125.63 125.22 24.99 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.911 1.684 . . . . 0.0 107.738 169.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.46 -7.68 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.82 3.68 . . . . 0.0 116.613 173.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.39 -67.19 0.85 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.336 1.854 . . . . 0.0 111.127 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.2 m -70.14 -31.65 69.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.383 1.073 . . . . 0.0 113.396 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 62.22 7.31 2.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.216 2.606 . . . . 0.0 115.715 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.5 p -75.94 174.0 10.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.172 2.589 . . . . 0.0 111.755 170.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.4 mt -121.05 117.05 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 120.98 -1.075 . . . . 0.0 108.468 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -117.08 175.55 5.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.473 1.909 . . . . 0.0 112.219 178.555 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.22 130.7 36.32 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.308 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -53.37 -41.01 65.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.673 1.589 . . . . 0.0 110.64 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -57.5 -44.04 84.69 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.053 0.846 . . . . 0.0 112.748 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . 0.311 1.0 OUTLIER -94.45 -25.14 17.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.934 0.894 . . . . 0.0 113.291 -173.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.36 -52.52 57.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 167.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.25 -39.76 79.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.124 0.57 . . . . 0.0 111.351 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -56.84 -52.57 64.57 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.304 0.502 . . . . 0.0 112.239 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -64.92 -29.54 70.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.125 1.77 . . . . 0.0 112.336 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.481 HG21 ' CB ' ' A' ' 46' ' ' SER . 42.1 t -93.31 -5.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 125.904 1.682 . . . . 0.0 112.047 -177.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -98.76 -17.57 18.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.152 -1.593 . . . . 0.0 110.606 167.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -63.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.904 2.482 . . . . 0.0 111.327 170.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.6 p -126.56 -21.88 4.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.962 1.305 . . . . 0.0 113.104 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.06 -18.59 26.57 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 123.656 0.646 . . . . 0.0 114.1 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.08 145.72 54.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.795 1.297 . . . . 0.0 111.685 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 149.49 90.49 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.19 -0.944 . . . . 0.0 111.131 169.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.92 -17.66 60.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.858 2.372 . . . . 0.0 115.988 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.0 mm -125.62 -48.3 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.068 0.947 . . . . 0.0 110.978 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.8 p -82.43 -14.81 54.51 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.359 0.0 OUTLIER 51.7 19.78 0.98 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.033 2.533 . . . . 0.0 114.535 -169.515 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.61 124.6 88.81 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.914 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.44 133.59 43.5 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.737 2.958 . . . . 0.0 114.533 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 mt 66.0 143.16 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.143 2.977 . . . . 0.0 114.323 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.481 ' CB ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -136.15 -41.14 0.66 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.284 1.833 . . . . 0.0 111.823 -174.212 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.21 -33.71 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.656 1.583 . . . . 0.0 113.965 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.5 -5.45 28.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.253 1.421 . . . . 0.0 112.146 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.52 8.15 6.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 14' ' ' VAL . 4.5 tp -58.87 126.79 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.088 1.755 . . . . 0.0 114.959 -169.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -120.63 85.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.4 1.88 . . . . 0.0 110.221 171.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -80.01 118.57 21.86 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.954 -1.092 . . . . 0.0 112.073 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.2 mt -82.45 127.17 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.612 1.965 . . . . 0.0 109.085 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.99 116.23 17.8 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.427 1.091 . . . . 0.0 110.457 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.81 -18.61 14.85 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.866 2.377 . . . . 0.0 113.884 -175.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.471 0.618 0 C-N-CA 126.087 1.755 . . . . 0.0 113.01 -178.472 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.1 mt -119.13 148.43 43.08 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.146 1.778 . . . . 0.0 110.451 170.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.0 t -63.52 139.07 58.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.058 1.409 . . . . 0.0 113.698 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.84 -15.56 47.78 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.072 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -76.91 -56.67 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.915 174.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m -134.54 -6.03 2.54 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.94 7.43 70.65 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.91 1.232 . . . . 0.0 114.109 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -56.29 137.98 51.35 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.301 2.64 . . . . 0.0 111.11 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.31 108.85 3.18 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.908 1.283 . . . . 0.0 107.663 169.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.74 128.02 28.6 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.586 2.191 . . . . 0.0 114.872 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -75.25 -46.05 36.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 108.782 169.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -124.32 91.16 49.93 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 127.212 2.205 . . . . 0.0 108.162 172.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.64 130.72 38.48 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.839 3.026 . . . . 0.0 111.4 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.9 144.02 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.971 1.708 . . . . 0.0 110.218 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.2 tp -131.65 154.32 49.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.5 1.92 . . . . 0.0 110.248 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 t -135.03 135.03 22.2 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.867 2.067 . . . . 0.0 107.703 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.87 -8.4 23.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -80.89 -64.19 1.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.978 1.711 . . . . 0.0 111.649 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -67.84 -32.73 73.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.883 0.873 . . . . 0.0 112.43 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 -2.0 0.51 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.351 2.66 . . . . 0.0 115.191 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.5 p -73.5 169.1 17.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.777 2.431 . . . . 0.0 112.617 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -112.76 116.55 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.7 168.96 9.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.588 1.555 . . . . 0.0 111.613 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.3 131.91 42.47 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.135 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -46.86 53.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.597 1.559 . . . . 0.0 110.283 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 t -62.18 -40.05 94.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -39.74 53.62 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.137 -0.977 . . . . 0.0 111.666 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.6 tp -60.64 -45.22 94.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.643 0.656 . . . . 0.0 109.302 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.424 ' HA ' HG12 ' A' ' 32' ' ' VAL . 39.0 tt0 -55.72 -38.82 70.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.013 0.925 . . . . 0.0 111.544 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.37 -49.57 73.34 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.768 -0.582 . . . . 0.0 111.827 173.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -67.95 -35.26 78.09 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.052 0.929 . . . . 0.0 112.221 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 29' ' ' GLU . 1.6 p -82.84 -15.95 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.369 1.068 . . . . 0.0 112.984 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.19 -14.05 25.99 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.166 -0.959 . . . . 0.0 111.519 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.88 -57.63 3.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.874 1.67 . . . . 0.0 111.373 170.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.9 -22.12 1.86 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.847 1.259 . . . . 0.0 112.539 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.11 60.14 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.226 0.917 . . . . 0.0 113.459 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.99 155.01 37.86 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.24 1.52 . . . . 0.0 113.449 -172.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.07 141.24 74.33 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 166.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.73 -7.47 18.33 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.159 2.573 . . . . 0.0 115.432 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.0 mt -126.8 -46.94 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.636 1.107 . . . . 0.0 111.879 -175.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.0 p -83.69 -12.78 55.42 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.343 0.3 OUTLIER 48.44 23.5 0.6 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.008 2.523 . . . . 0.0 115.083 -169.138 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.94 118.04 44.99 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.25 1.02 . . . . 0.0 110.644 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.39 132.65 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.474 2.782 . . . . 0.0 113.843 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.72 137.71 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.518 3.127 . . . . 0.0 112.864 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.69 -44.91 0.48 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.315 1.846 . . . . 0.0 111.164 -171.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 10.6 tp -58.89 -31.2 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 126.837 2.055 . . . . 0.0 115.568 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -14.74 62.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.369 1.868 . . . . 0.0 112.071 170.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -124.6 13.08 8.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.82 2.048 . . . . 0.0 112.035 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 6.7 tp -56.32 125.01 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.575 1.55 . . . . 0.0 112.947 -175.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.98 92.33 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.421 1.489 . . . . 0.0 109.26 170.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -78.63 123.11 26.77 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.055 -1.028 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.9 mm -83.95 128.03 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.636 1.575 . . . . 0.0 109.655 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.7 t -67.7 115.83 31.53 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.045 0.938 . . . . 0.0 109.541 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.68 -18.13 19.84 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.791 2.327 . . . . 0.0 114.096 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 125.892 1.677 . . . . 0.0 113.018 -179.222 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt -101.65 148.64 25.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.552 1.541 . . . . 0.0 111.369 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.19 146.11 51.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -169.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.21 68.57 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.98 -48.22 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 110.968 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -135.3 -11.5 2.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.22 12.07 79.64 Favored Glycine 0 N--CA 1.469 0.881 0 O-C-N 121.228 -0.92 . . . . 0.0 113.961 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -51.2 136.22 24.62 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 128.341 2.656 . . . . 0.0 111.509 171.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -66.42 110.2 4.46 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 168.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.85 105.16 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.996 2.464 . . . . 0.0 115.846 -169.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -59.33 -41.2 88.56 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.309 1.843 . . . . 0.0 111.109 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -132.69 94.8 20.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.054 1.741 . . . . 0.0 108.678 169.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 135.3 62.3 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.662 2.908 . . . . 0.0 112.153 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.31 146.05 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.408 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.53 152.75 49.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.533 1.133 . . . . 0.0 110.611 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 t -120.37 133.3 23.98 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 125.744 1.618 . . . . 0.0 109.646 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.71 -19.62 25.05 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.313 2.675 . . . . 0.0 114.395 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -93.87 -58.96 2.1 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.921 1.689 . . . . 0.0 111.93 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.0 m -78.53 -16.59 57.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 58.32 -16.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 129.887 3.275 . . . . 0.0 118.627 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 t -74.48 173.39 10.41 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.363 1.465 . . . . 0.0 110.924 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 mm -106.79 118.91 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.258 1.423 . . . . 0.0 108.736 175.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.26 170.61 7.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 111.38 173.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 139.81 43.35 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.41 -45.68 62.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 109.393 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m -66.72 -42.04 86.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.907 0.883 . . . . 0.0 113.201 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.31 -40.36 64.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.565 0.746 . . . . 0.0 111.534 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.8 tp -61.35 -49.23 77.8 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -55.61 -41.78 73.97 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.017 0.527 . . . . 0.0 110.681 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.16 -53.65 55.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.034 0.534 . . . . 0.0 111.695 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -61.75 -35.18 77.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.349 1.071 . . . . 0.0 111.849 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.473 HG11 ' H ' ' A' ' 47' ' ' ILE . 41.7 t -93.75 -6.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 124.444 1.097 . . . . 0.0 112.258 -173.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -100.49 -10.59 20.93 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.937 -1.727 . . . . 0.0 110.81 167.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.108 2.563 . . . . 0.0 110.019 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -128.37 -21.77 3.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.38 1.472 . . . . 0.0 113.229 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.11 24.18 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.725 0.679 . . . . 0.0 113.758 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.74 147.72 52.93 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.588 1.194 . . . . 0.0 111.534 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.71 147.27 89.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.95 -1.094 . . . . 0.0 110.374 169.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.52 -10.75 27.32 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.909 2.406 . . . . 0.0 114.457 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.59 -46.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.312 0.96 . . . . 0.0 111.609 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.8 p -85.84 -10.4 55.46 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.327 0.3 OUTLIER 48.06 24.96 0.71 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.772 2.429 . . . . 0.0 115.671 -170.227 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.47 119.34 59.04 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.138 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.77 128.03 26.88 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.742 2.961 . . . . 0.0 114.334 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt 65.37 141.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.885 2.874 . . . . 0.0 114.664 -172.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.464 ' CB ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -136.29 -54.54 0.75 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.723 1.609 . . . . 0.0 112.614 -173.503 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.473 ' H ' HG11 ' A' ' 32' ' ' VAL . 7.8 tp -61.62 -32.04 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.808 1.643 . . . . 0.0 114.066 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -68.87 -7.09 31.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 112.078 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -133.31 12.67 4.19 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.8 1.64 . . . . 0.0 112.122 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 9.7 tp -59.22 150.1 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.623 1.969 . . . . 0.0 115.305 -171.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.53 87.54 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.224 1.81 . . . . 0.0 108.385 169.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -75.8 137.44 40.52 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.921 -1.112 . . . . 0.0 111.596 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -115.09 146.08 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.49 1.516 . . . . 0.0 109.962 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.0 m -70.06 143.19 91.17 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 120.901 -1.124 . . . . 0.0 112.473 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.62 -16.25 18.97 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.021 2.481 . . . . 0.0 113.945 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 125.982 1.713 . . . . 0.0 112.122 178.403 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.5 mt -111.4 147.31 35.5 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.62 1.568 . . . . 0.0 111.074 170.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.8 t -66.77 144.05 56.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.619 1.199 . . . . 0.0 113.915 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.12 -15.35 38.7 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.389 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -77.56 -53.62 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.122 0.569 . . . . 0.0 110.008 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 m -136.72 -5.84 1.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.71 6.91 82.36 Favored Glycine 0 N--CA 1.473 1.103 0 CA-C-N 120.069 1.304 . . . . 0.0 115.493 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.55 147.14 46.48 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.69 2.396 . . . . 0.0 110.819 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.57 108.78 3.2 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.1 115.11 3.29 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.459 2.106 . . . . 0.0 112.717 -169.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -63.74 -34.99 79.12 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.612 1.165 . . . . 0.0 111.708 170.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.8 mtm-85 -123.63 87.09 52.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.323 1.849 . . . . 0.0 109.501 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.57 128.69 22.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.888 3.058 . . . . 0.0 111.736 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 152.09 20.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.245 1.418 . . . . 0.0 110.503 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -139.24 155.53 47.71 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.977 1.311 . . . . 0.0 110.407 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 p -123.81 146.96 52.19 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 109.029 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.22 -10.23 28.43 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 121.917 1.744 . . . . 0.0 113.183 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -59.51 2.75 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.081 1.753 . . . . 0.0 111.366 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.2 m -79.59 -32.51 41.96 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 112.072 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 59.94 1.72 0.34 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.467 2.307 . . . . 0.0 115.437 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 p -73.07 173.46 9.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.117 2.567 . . . . 0.0 111.679 170.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.33 116.22 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.84 173.44 6.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 126.287 1.835 . . . . 0.0 110.452 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.12 143.54 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.111 -0.993 . . . . 0.0 109.554 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.59 -46.18 66.81 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.13 1.372 . . . . 0.0 108.815 171.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -67.81 -42.79 80.99 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.6 -40.79 66.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.151 0.887 . . . . 0.0 111.439 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.92 -47.56 84.38 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -56.05 -42.99 77.44 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.695 0.398 . . . . 0.0 110.552 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -57.85 -52.13 66.75 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.688 0.795 . . . . 0.0 111.491 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.46 -36.21 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.025 1.33 . . . . 0.0 111.967 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 46' ' ' SER . 43.1 t -91.78 -6.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.016 1.326 . . . . 0.0 112.232 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -101.96 -10.77 19.48 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 119.994 -1.691 . . . . 0.0 110.567 167.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -61.6 1.9 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.034 2.134 . . . . 0.0 110.226 169.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.4 p -130.41 -16.75 3.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.983 1.313 . . . . 0.0 113.58 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.22 -19.64 30.14 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-O 119.507 -0.607 . . . . 0.0 113.656 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.56 148.83 51.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.827 1.314 . . . . 0.0 113.216 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.76 140.82 84.15 Favored Pre-proline 0 CA--C 1.549 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 110.83 169.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -60.42 -12.22 19.69 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.883 3.055 . . . . 0.0 117.594 -170.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mt -129.87 -42.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.38 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -86.87 -16.66 35.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.709 0.804 . . . . 0.0 112.26 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.317 0.5 OUTLIER 43.01 32.25 0.4 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.066 2.546 . . . . 0.0 114.798 -169.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -81.59 145.67 55.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 118.925 -0.559 . . . . 0.0 110.113 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.61 142.89 36.97 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.712 2.275 . . . . 0.0 114.042 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.2 mt 65.44 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 130.152 3.381 . . . . 0.0 115.019 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.514 ' HB3' HG21 ' A' ' 32' ' ' VAL . 3.1 t -129.63 -52.12 1.16 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.217 1.807 . . . . 0.0 112.037 -172.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.445 ' H ' HG11 ' A' ' 32' ' ' VAL . 8.8 tp -60.33 -31.57 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.039 1.736 . . . . 0.0 114.298 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -69.38 -8.47 46.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.187 1.395 . . . . 0.0 112.147 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -127.62 11.46 6.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.192 1.797 . . . . 0.0 112.328 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.5 tp -58.78 145.35 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.781 1.632 . . . . 0.0 115.276 -169.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.53 91.87 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.541 2.336 . . . . 0.0 108.477 169.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -77.15 112.36 13.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.956 -1.09 . . . . 0.0 111.361 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.0 mm -82.21 -15.15 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 125.197 1.399 . . . . 0.0 111.728 -177.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.9 t -40.66 110.69 0.71 Allowed Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 128.252 2.621 . . . . 0.0 112.484 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.26 -14.91 20.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.024 2.483 . . . . 0.0 114.594 -171.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 C--O 1.241 0.643 0 C-N-CA 125.435 1.494 . . . . 0.0 112.266 178.489 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 2' ' ' LEU . 1.9 pt? -99.48 146.91 25.84 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.365 1.466 . . . . 0.0 111.979 176.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 3.0 m -60.65 138.6 58.05 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.91 -14.83 61.55 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.49 -53.13 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.908 1.283 . . . . 0.0 111.727 -170.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 m -118.69 -14.3 9.56 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.85 16.11 81.05 Favored Glycine 0 N--CA 1.467 0.719 0 O-C-N 121.79 -0.569 . . . . 0.0 114.022 169.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -91.42 174.04 7.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.409 1.884 . . . . 0.0 113.577 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.33 114.35 28.87 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 125.55 10.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.177 1.918 . . . . 0.0 113.825 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -57.64 -50.72 72.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 111.257 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.48 100.72 14.92 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.812 1.645 . . . . 0.0 110.101 170.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.87 131.78 39.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.664 2.909 . . . . 0.0 111.678 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.16 145.9 23.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 127.894 2.478 . . . . 0.0 110.321 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tt -134.19 159.4 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.248 1.819 . . . . 0.0 110.041 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 p -128.88 152.41 79.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 110.932 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.91 -5.01 16.22 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.241 2.627 . . . . 0.0 113.564 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -70.87 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.21 1.404 . . . . 0.0 110.551 174.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -75.17 -29.66 60.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 113.056 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 56.11 5.54 0.18 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.951 2.1 . . . . 0.0 115.278 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.6 p -70.59 171.6 10.01 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.584 2.353 . . . . 0.0 111.183 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.56 115.96 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -113.78 171.91 7.3 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.09 2.156 . . . . 0.0 111.467 173.936 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -81.29 137.72 35.77 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -42.98 -49.92 5.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 128.289 2.636 . . . . 0.0 110.363 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.95 71.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.801 -171.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -76.31 -45.0 34.36 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.8 0.84 . . . . 0.0 110.348 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.28 -48.72 74.6 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.94 -45.06 78.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.718 0.407 . . . . 0.0 110.837 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -59.11 -50.69 73.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.282 0.492 . . . . 0.0 111.824 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.38 -34.35 77.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.149 0.976 . . . . 0.0 111.513 -174.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' A' ' 46' ' ' SER . 48.2 t -95.55 -9.89 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.874 1.27 . . . . 0.0 112.314 -173.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -94.44 -13.27 26.38 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 119.909 -1.745 . . . . 0.0 110.441 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.77 -66.64 0.84 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.136 2.574 . . . . 0.0 111.466 169.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.4 p -119.76 -20.31 7.68 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.387 1.475 . . . . 0.0 113.024 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.53 -20.57 13.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.087 0.851 . . . . 0.0 113.896 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.0 148.66 50.73 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.059 1.43 . . . . 0.0 112.423 -170.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.71 144.69 88.74 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.08 -1.013 . . . . 0.0 109.649 168.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.95 -6.84 18.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.678 2.918 . . . . 0.0 116.142 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mt -127.37 -49.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.605 1.162 . . . . 0.0 111.485 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.5 p -83.58 -14.6 51.72 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.339 0.2 OUTLIER 49.52 23.72 0.98 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.528 2.331 . . . . 0.0 114.981 -169.301 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.28 133.63 91.34 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.3 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.17 135.3 34.09 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.874 2.383 . . . . 0.0 112.715 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.0 mt 67.82 144.34 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.363 3.065 . . . . 0.0 113.998 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.562 ' HB3' HG21 ' A' ' 32' ' ' VAL . 3.8 t -141.04 -49.52 0.42 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.949 2.099 . . . . 0.0 112.364 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.498 ' H ' HG11 ' A' ' 32' ' ' VAL . 44.5 mm -58.65 -33.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.834 2.054 . . . . 0.0 113.808 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.3 -8.78 19.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.75 1.22 . . . . 0.0 112.419 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -132.48 9.17 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.431 1.893 . . . . 0.0 113.183 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.25 139.4 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.831 1.252 . . . . 0.0 114.16 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.14 92.43 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.26 2.224 . . . . 0.0 109.0 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -72.71 130.58 40.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.787 -1.196 . . . . 0.0 110.88 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mm -83.49 76.64 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.66 1.184 . . . . 0.0 109.04 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -63.28 151.03 87.99 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.86 1.264 . . . . 0.0 112.706 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.73 -10.11 19.96 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.428 2.752 . . . . 0.0 114.063 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 126.558 1.943 . . . . 0.0 113.433 -176.858 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 tp -100.09 116.75 32.84 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.284 1.434 . . . . 0.0 111.048 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.8 t -69.25 147.8 50.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.726 1.25 . . . . 0.0 112.629 -170.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.91 -23.12 25.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.79 . . . . 0.0 112.531 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.16 -45.19 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.951 0.9 . . . . 0.0 111.163 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 t -126.21 -40.14 2.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.687 0.795 . . . . 0.0 112.701 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.34 20.03 36.71 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 121.702 0.612 . . . . 0.0 113.95 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -78.25 168.34 20.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.012 1.325 . . . . 0.0 110.982 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.29 112.83 17.41 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 133.82 20.98 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.649 2.233 . . . . 0.0 112.484 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.12 -34.58 73.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.949 1.3 . . . . 0.0 111.824 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -124.23 83.35 56.62 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.657 1.583 . . . . 0.0 111.067 173.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.54 125.56 18.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.734 2.956 . . . . 0.0 112.273 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 145.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.943 2.097 . . . . 0.0 110.507 -173.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.81 156.3 42.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.15 1.78 . . . . 0.0 109.841 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -127.11 143.54 47.37 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.919 1.288 . . . . 0.0 108.251 169.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.18 0.82 5.39 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.605 2.87 . . . . 0.0 113.866 -172.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -92.69 -67.85 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.202 1.801 . . . . 0.0 109.878 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -56.44 -41.64 76.79 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 59.25 5.67 0.62 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.258 2.223 . . . . 0.0 114.378 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.9 p -77.35 177.02 8.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.761 2.424 . . . . 0.0 111.579 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -122.68 114.54 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.49 171.22 7.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.436 1.894 . . . . 0.0 111.233 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.8 144.19 49.25 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.818 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -56.76 -44.37 81.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 109.707 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -68.18 -36.51 79.72 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.56 -38.76 65.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 0.0 112.022 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -44.48 96.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.948 0.795 . . . . 0.0 109.24 171.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -54.62 -41.23 69.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.5 0.72 . . . . 0.0 110.917 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -58.98 -53.43 58.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.465 0.706 . . . . 0.0 111.398 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.62 -36.65 81.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.366 1.079 . . . . 0.0 112.348 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.471 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.66 -10.86 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.772 1.229 . . . . 0.0 112.999 -175.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -102.1 -10.46 19.65 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.95 -1.094 . . . . 0.0 111.462 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -55.54 5.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.125 1.77 . . . . 0.0 110.691 169.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.4 p -133.98 -22.87 1.8 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.787 1.235 . . . . 0.0 112.426 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.6 -12.89 59.96 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.144 0.878 . . . . 0.0 113.081 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.32 154.88 40.29 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.586 1.693 . . . . 0.0 113.621 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.39 135.09 90.93 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.24 -5.31 12.21 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 121.871 1.714 . . . . 0.0 113.633 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mm -123.12 -45.38 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.197 1.362 . . . . 0.0 111.485 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 p -99.78 -4.93 29.51 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.546 0.739 . . . . 0.0 112.934 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.362 0.0 OUTLIER 45.1 23.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.483 3.113 . . . . 0.0 116.596 -172.041 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -69.82 137.16 87.66 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.58 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.84 130.87 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.933 2.422 . . . . 0.0 112.069 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.253 35.3 mt 70.45 146.29 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.375 3.07 . . . . 0.0 113.411 -170.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 t -143.7 -56.77 0.39 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.342 1.857 . . . . 0.0 110.69 -170.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.471 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.0 tt -59.69 -25.49 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 126.497 1.919 . . . . 0.0 116.041 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.78 -9.35 43.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.001 1.32 . . . . 0.0 112.157 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -126.66 9.21 7.03 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.058 . . . . 0.0 112.626 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.7 tt -58.3 147.11 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.097 1.759 . . . . 0.0 115.403 -172.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.7 97.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 128.635 2.774 . . . . 0.0 109.775 171.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.95 132.1 36.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.356 -1.465 . . . . 0.0 112.309 174.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.54 -35.67 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.596 1.158 . . . . 0.0 110.605 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 t -60.56 119.27 42.07 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.31 1.444 . . . . 0.0 111.617 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.5 -12.83 22.68 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.391 2.727 . . . . 0.0 114.369 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 127.354 2.261 . . . . 0.0 113.83 179.362 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.24 147.64 51.1 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.865 2.066 . . . . 0.0 110.72 170.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.7 t -68.34 140.23 55.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 123.074 1.416 . . . . 0.0 113.329 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.18 -20.05 42.02 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.69 -53.32 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.556 0.742 . . . . 0.0 110.871 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -132.24 -16.8 2.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.51 6.65 60.94 Favored Glycine 0 N--CA 1.468 0.797 0 O-C-N 121.295 -0.878 . . . . 0.0 114.822 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -69.08 161.1 29.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.46 1.504 . . . . 0.0 112.583 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.3 119.24 72.56 Favored Pre-proline 0 N--CA 1.473 0.684 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 169.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.83 125.2 9.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.13 1.887 . . . . 0.0 112.191 -171.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -64.6 -41.65 96.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.074 1.349 . . . . 0.0 110.452 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -124.72 92.76 47.3 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 0.0 109.393 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.37 127.78 24.03 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.547 2.832 . . . . 0.0 111.444 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -139.86 148.72 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.46 1.504 . . . . 0.0 110.682 -176.399 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.35 155.52 50.1 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.6 1.56 . . . . 0.0 111.689 -175.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 t -127.88 133.42 25.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 C-N-CA 126.64 1.976 . . . . 0.0 107.409 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.5 -10.0 27.25 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.041 2.494 . . . . 0.0 114.409 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -75.9 -63.64 1.26 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.013 1.725 . . . . 0.0 111.578 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.6 m -66.32 -36.05 81.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.008 0.923 . . . . 0.0 112.167 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 61.05 3.61 0.71 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.534 2.733 . . . . 0.0 114.912 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 p -75.23 174.88 8.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.932 2.493 . . . . 0.0 111.947 171.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.47 117.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.39 168.04 9.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.056 1.742 . . . . 0.0 111.109 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.446 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 5.5 tp10 -67.7 135.09 52.21 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.051 169.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -57.99 -43.51 86.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.952 0.796 . . . . 0.0 109.919 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 m -62.21 -41.91 98.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.467 1.107 . . . . 0.0 113.824 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -75.93 -38.25 57.85 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.129 0.877 . . . . 0.0 111.988 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 tp -60.3 -45.86 91.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 170.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 32' ' ' VAL . 34.4 tt0 -54.87 -37.98 66.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -62.16 -52.08 65.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.631 -0.668 . . . . 0.0 111.708 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.61 -35.62 79.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.114 0.959 . . . . 0.0 112.248 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 29' ' ' GLU . 2.9 p -82.87 -15.46 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.837 1.255 . . . . 0.0 113.027 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -94.88 -13.48 25.42 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.714 -1.241 . . . . 0.0 111.543 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -57.21 4.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.439 170.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -133.18 -22.18 2.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.9 1.28 . . . . 0.0 112.609 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.32 -11.38 58.44 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.191 0.9 . . . . 0.0 113.656 -171.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -65.65 153.62 41.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.154 1.477 . . . . 0.0 113.164 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.8 86.08 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -67.63 -7.27 18.87 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.075 2.517 . . . . 0.0 115.414 -171.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mt -127.38 -47.21 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.441 1.096 . . . . 0.0 111.795 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.2 p -83.96 -12.64 55.03 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.342 0.3 OUTLIER 48.22 24.54 0.69 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.994 2.517 . . . . 0.0 115.237 -169.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.48 119.25 61.2 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.12 0.968 . . . . 0.0 110.589 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.03 133.55 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.598 2.865 . . . . 0.0 114.054 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.7 mp 71.04 141.41 0.05 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.318 3.047 . . . . 0.0 112.845 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.57 -45.84 0.41 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.386 1.874 . . . . 0.0 111.392 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.424 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.2 mm -61.7 -31.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 114.654 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -12.53 53.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.259 1.824 . . . . 0.0 112.445 170.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -124.38 8.33 8.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.974 1.71 . . . . 0.0 112.719 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.424 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.4 tp -58.56 132.55 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.133 1.373 . . . . 0.0 113.878 -172.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.97 94.44 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.069 2.147 . . . . 0.0 109.115 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 14' ' ' VAL . 2.6 mt-10 -74.97 134.71 41.44 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.578 -1.326 . . . . 0.0 110.845 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.02 -33.88 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.575 0.75 . . . . 0.0 110.277 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.02 149.56 93.48 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.115 0.966 . . . . 0.0 112.516 176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -74.08 -27.52 11.81 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.829 2.352 . . . . 0.0 112.881 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.7 p . . . . . 0 C--O 1.24 0.564 0 C-N-CA 126.578 1.951 . . . . 0.0 111.322 176.259 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 CA--C 1.542 0.673 0 CA-C-O 120.675 0.274 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.8 mt -120.36 156.18 31.87 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.777 1.631 . . . . 0.0 112.432 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 13.5 t -60.87 137.63 58.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.973 1.368 . . . . 0.0 112.652 -169.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.58 -16.97 40.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.172 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.3 mt -82.77 -47.66 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.476 1.51 . . . . 0.0 110.538 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 p -128.9 -30.18 2.27 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.3 61.18 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 114.764 0.665 . . . . 0.0 114.764 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -53.5 137.38 36.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.458 1.903 . . . . 0.0 110.689 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.77 105.73 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.3 117.16 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.892 2.395 . . . . 0.0 113.663 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -74.36 -42.35 59.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.706 1.602 . . . . 0.0 110.519 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -126.42 90.1 50.69 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.063 2.145 . . . . 0.0 107.682 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -62.69 129.1 25.21 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.704 2.936 . . . . 0.0 111.857 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.02 153.74 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.452 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.44 156.87 47.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.406 1.882 . . . . 0.0 110.08 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -123.17 127.8 25.52 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.501 1.52 . . . . 0.0 108.34 168.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.69 -12.0 2.69 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.816 3.678 . . . . 0.0 117.217 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -62.54 1.66 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.927 1.291 . . . . 0.0 110.964 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 m -69.29 -38.12 78.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.704 1.602 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 57.47 10.88 1.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.938 2.495 . . . . 0.0 114.985 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.2 p -75.14 170.87 15.17 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.135 2.574 . . . . 0.0 111.057 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.21 116.51 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' CE1' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -113.76 168.96 9.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.409 1.884 . . . . 0.0 111.194 175.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -67.87 137.12 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.492 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -51.66 -46.12 63.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.728 1.211 . . . . 0.0 109.661 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -59.88 -42.07 92.95 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.05 0.843 . . . . 0.0 112.562 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -44.7 67.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.431 HD22 ' CE1' ' A' ' 23' ' ' PHE . 54.0 tp -65.71 -38.85 90.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.546 176.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.49 -40.32 90.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.502 0.721 . . . . 0.0 111.587 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.53 -50.17 73.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.077 0.951 . . . . 0.0 111.582 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -67.06 -37.36 83.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.128 0.966 . . . . 0.0 111.317 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.07 -18.48 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -89.86 -15.68 31.69 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.015 -1.053 . . . . 0.0 112.011 168.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -58.08 3.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.866 1.666 . . . . 0.0 110.978 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.9 p -137.59 -16.87 1.32 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 112.635 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.45 57.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.273 0.939 . . . . 0.0 113.524 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -63.12 153.91 32.73 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.23 1.515 . . . . 0.0 113.48 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.29 129.26 75.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.528 1.131 . . . . 0.0 108.209 167.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.0 -13.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.793 3.662 . . . . 0.0 119.718 -169.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.29 -41.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.141 1.337 . . . . 0.0 112.358 -171.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -92.21 -10.69 37.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.947 0.899 . . . . 0.0 112.576 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.311 0.5 OUTLIER 44.2 31.15 0.52 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.749 2.82 . . . . 0.0 115.355 -171.586 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.87 134.32 94.04 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.672 172.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.04 133.24 28.37 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.651 2.234 . . . . 0.0 111.628 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 mp 73.86 144.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 128.458 2.703 . . . . 0.0 112.488 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -147.5 -40.42 0.18 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.779 2.431 . . . . 0.0 110.24 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 tp -58.91 -36.18 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.361 1.864 . . . . 0.0 114.677 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -67.6 -7.68 28.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.121 1.368 . . . . 0.0 112.123 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.41 4.73 5.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.183 1.393 . . . . 0.0 113.318 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 tt -66.64 137.8 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 122.313 1.054 . . . . 0.0 113.675 -169.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.2 96.95 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.839 2.056 . . . . 0.0 111.23 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -72.59 123.63 23.6 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.55 -1.344 . . . . 0.0 110.462 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.53 -35.86 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.323 1.449 . . . . 0.0 110.707 -174.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.18 97.14 20.36 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 125.802 1.641 . . . . 0.0 107.37 170.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.02 -6.38 17.3 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.592 2.861 . . . . 0.0 114.524 -174.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.473 0.722 0 C-N-CA 126.931 2.092 . . . . 0.0 114.36 -176.028 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.469 0.5 0 CA-C-O 121.192 0.52 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.19 138.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.741 1.258 . . . . 0.0 113.409 -168.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.72 49.13 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.116 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.6 -58.23 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.095 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.3 m -135.95 -5.58 2.15 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.48 7.35 79.36 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-N 119.961 1.255 . . . . 0.0 115.444 172.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.4 141.67 58.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.018 2.527 . . . . 0.0 111.783 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.04 114.63 19.1 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 169.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 145.66 37.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 114.038 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -91.89 -31.39 15.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.772 2.029 . . . . 0.0 110.136 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -126.42 83.25 64.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 126.29 1.836 . . . . 0.0 109.482 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.99 127.48 25.19 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.036 3.157 . . . . 0.0 110.637 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.3 t -141.63 143.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 126.413 1.885 . . . . 0.0 110.842 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -125.29 157.4 36.73 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.979 1.712 . . . . 0.0 110.296 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 t -127.51 133.35 24.99 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.699 1.599 . . . . 0.0 108.619 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -55.05 -13.61 6.88 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.931 3.088 . . . . 0.0 117.058 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -95.88 -56.99 2.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.142 0.883 . . . . 0.0 111.619 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.7 p -63.78 -37.95 89.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.252 1.821 . . . . 0.0 114.264 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 58.62 1.14 0.17 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 128.965 2.906 . . . . 0.0 116.923 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -69.52 177.38 2.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.556 1.942 . . . . 0.0 110.04 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.45 115.81 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 169.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.67 169.21 9.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 112.282 172.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -74.25 131.02 40.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.389 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.42 -42.65 64.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.684 1.593 . . . . 0.0 110.622 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -63.55 -40.42 96.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.83 -35.18 60.06 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.443 -0.786 . . . . 0.0 111.336 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.17 -44.79 94.47 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 119.091 -0.481 . . . . 0.0 109.714 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.405 ' HA ' HG12 ' A' ' 32' ' ' VAL . 41.2 tt0 -54.94 -38.93 68.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.646 0.778 . . . . 0.0 111.401 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.69 -53.32 58.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.122 0.487 . . . . 0.0 112.112 171.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.18 -34.78 78.25 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.984 0.897 . . . . 0.0 112.328 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.1 p -83.07 -17.36 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.739 1.215 . . . . 0.0 112.795 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -92.81 -14.65 27.5 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.854 -1.154 . . . . 0.0 111.405 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -56.96 4.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.995 1.718 . . . . 0.0 111.677 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -133.67 -21.61 1.95 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.938 1.295 . . . . 0.0 112.505 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 83.85 -11.9 55.11 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.086 0.85 . . . . 0.0 113.658 -172.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -67.17 154.51 41.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.222 1.511 . . . . 0.0 113.317 -170.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.63 133.94 79.45 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.11 -14.08 7.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.157 3.238 . . . . 0.0 118.002 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.97 -48.84 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.712 1.142 . . . . 0.0 111.548 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.3 p -85.84 -11.12 54.18 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.333 0.3 OUTLIER 48.71 24.75 0.85 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.049 2.54 . . . . 0.0 115.295 -169.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.13 118.44 49.65 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.24 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.96 132.52 52.71 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.448 2.765 . . . . 0.0 113.91 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp 72.19 144.59 0.07 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 128.822 2.849 . . . . 0.0 111.864 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.9 t -143.32 -61.5 0.41 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.662 1.585 . . . . 0.0 111.151 -169.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.484 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -62.72 -26.89 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.69 -5.95 33.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.446 1.098 . . . . 0.0 112.301 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -128.67 11.85 6.26 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.47 1.908 . . . . 0.0 112.328 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 7.1 tt -57.8 143.62 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.756 1.622 . . . . 0.0 114.697 -171.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.66 86.22 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.207 2.203 . . . . 0.0 109.15 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -72.02 125.92 28.45 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.014 . . . . 0.0 111.412 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm . . . . . 0 CA--C 1.54 0.558 0 C-N-CA 126.309 1.844 . . . . 0.0 109.196 -175.725 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.51 0 CA-C-O 121.479 0.657 . . . . 0.0 112.066 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 2.2 m -59.7 137.55 58.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -168.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -70.38 -25.0 63.05 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.088 0.471 . . . . 0.0 112.174 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.41 -51.58 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.037 1.735 . . . . 0.0 111.584 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 p -123.33 -18.7 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 80.19 11.31 84.5 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.68 167.45 13.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.112 2.565 . . . . 0.0 113.157 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.0 t -83.45 107.91 11.5 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.76 127.61 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.484 2.123 . . . . 0.0 113.624 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -71.1 -39.47 72.07 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.096 1.358 . . . . 0.0 111.065 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -124.7 86.83 55.42 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.792 1.237 . . . . 0.0 109.969 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.18 127.33 25.6 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.009 3.139 . . . . 0.0 110.712 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.5 t -140.01 142.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.415 1.886 . . . . 0.0 109.858 -170.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.56 157.4 46.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.801 1.641 . . . . 0.0 110.923 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -132.03 128.32 21.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.959 1.704 . . . . 0.0 108.221 169.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.68 -12.59 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.502 3.468 . . . . 0.0 116.714 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -83.79 -58.11 2.93 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.106 1.363 . . . . 0.0 110.567 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -27.16 68.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.035 1.734 . . . . 0.0 114.705 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 46.35 45.74 13.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 126.344 1.858 . . . . 0.0 113.959 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 4' ' ' ALA . 14.8 t -136.71 174.5 10.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.145 2.578 . . . . 0.0 109.401 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.52 116.75 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -111.47 168.18 9.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 111.472 173.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.97 131.11 41.09 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.778 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -46.88 -45.48 20.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.807 1.643 . . . . 0.0 109.739 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -59.29 -37.87 78.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -40.12 33.86 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.008 0.523 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.5 tp -63.11 -45.68 90.9 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -55.6 -42.62 75.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.484 1.514 . . . . 0.0 111.798 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -59.15 -53.07 62.49 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.293 -0.879 . . . . 0.0 111.408 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -67.37 -34.26 76.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.913 1.285 . . . . 0.0 112.427 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.02 -17.35 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.264 1.025 . . . . 0.0 112.845 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.61 -21.03 24.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.963 1.305 . . . . 0.0 111.426 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -57.64 3.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.348 1.859 . . . . 0.0 111.451 175.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.3 p -133.27 -21.53 2.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.143 1.377 . . . . 0.0 112.45 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.84 -12.45 57.18 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.248 0.927 . . . . 0.0 113.387 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.24 156.44 34.23 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.492 1.646 . . . . 0.0 113.267 -170.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.42 134.96 57.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 167.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.87 -5.21 12.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.993 2.462 . . . . 0.0 115.377 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.9 mt -121.55 -48.08 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.904 1.282 . . . . 0.0 111.506 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.9 p -88.75 -12.34 42.44 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.356 0.3 OUTLIER 47.42 25.17 0.57 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.053 2.541 . . . . 0.0 115.149 -169.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.72 129.96 90.77 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.495 -0.764 . . . . 0.0 110.243 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 134.47 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.958 2.438 . . . . 0.0 112.541 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.267 41.0 mt 71.79 133.92 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.695 3.198 . . . . 0.0 113.371 -175.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.12 -45.03 0.71 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.88 2.072 . . . . 0.0 111.424 -169.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.484 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.1 tp -58.33 -35.12 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.476 1.911 . . . . 0.0 114.469 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.18 -8.21 36.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.499 1.519 . . . . 0.0 111.912 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.71 7.21 5.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.442 1.497 . . . . 0.0 113.1 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.3 145.36 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.895 1.331 . . . . 0.0 114.492 -169.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.25 96.53 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.168 2.587 . . . . 0.0 108.548 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.37 117.57 27.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.976 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp . . . . . 0 CA--C 1.546 0.813 0 C-N-CA 125.377 1.471 . . . . 0.0 109.463 172.806 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 N--CA 1.47 0.558 0 CA-C-O 121.652 0.739 . . . . 0.0 111.378 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.5 t -64.89 141.3 58.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.98 1.371 . . . . 0.0 113.482 -168.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.64 -18.51 31.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.47 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.68 -52.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.328 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -140.19 -6.62 1.22 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.31 74.81 Favored Glycine 0 N--CA 1.474 1.205 0 O-C-N 120.842 -1.161 . . . . 0.0 115.263 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.07 142.67 41.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.822 2.449 . . . . 0.0 110.969 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.17 108.41 2.47 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.73 109.99 0.5 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.816 2.344 . . . . 0.0 114.367 -169.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -60.5 -48.83 80.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.556 1.142 . . . . 0.0 110.781 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -119.21 88.59 37.75 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 126.231 1.812 . . . . 0.0 109.235 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 127.65 23.74 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.029 3.153 . . . . 0.0 111.588 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.55 144.32 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 126.163 1.785 . . . . 0.0 110.104 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -133.37 149.74 51.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.401 1.88 . . . . 0.0 110.555 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 t -132.67 117.64 15.33 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.91 -12.82 5.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.327 3.351 . . . . 0.0 116.693 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -47.19 60.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.764 1.225 . . . . 0.0 112.086 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -96.77 -19.76 18.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.867 1.267 . . . . 0.0 112.592 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 64.3 -3.94 0.46 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 128.941 2.896 . . . . 0.0 116.031 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 p -72.83 168.13 19.51 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.792 2.037 . . . . 0.0 113.037 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 mm -115.11 115.96 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.32 171.98 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.05 1.74 . . . . 0.0 111.514 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.12 138.27 43.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.88 -46.41 51.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.672 1.589 . . . . 0.0 109.559 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.77 -40.83 69.01 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.487 -0.758 . . . . 0.0 111.483 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.49 -44.1 95.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.428 0.558 . . . . 0.0 109.575 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.77 -39.26 70.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.479 0.712 . . . . 0.0 111.442 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.36 -45.65 83.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.662 -0.649 . . . . 0.0 111.904 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -69.63 -37.83 76.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.312 1.045 . . . . 0.0 112.241 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.413 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.5 p -79.63 -18.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.251 1.02 . . . . 0.0 112.688 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -79.2 -30.25 43.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.9 2.08 . . . . 0.0 110.269 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -55.26 6.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.109 1.764 . . . . 0.0 111.675 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.7 p -134.24 -21.18 1.84 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.162 1.385 . . . . 0.0 112.175 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 84.71 -10.63 61.7 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.998 0.808 . . . . 0.0 113.193 -170.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.16 155.4 35.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.467 1.634 . . . . 0.0 113.257 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -78.11 136.69 61.38 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -55.79 -17.37 18.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.82 3.013 . . . . 0.0 118.584 -169.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.8 mt -126.71 -46.29 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 120.253 1.388 . . . . 0.0 111.819 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -81.42 -13.35 58.35 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.309 0.5 OUTLIER 44.66 30.29 0.5 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.927 2.491 . . . . 0.0 114.633 -170.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.23 135.64 89.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.769 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.14 135.83 28.05 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.661 2.241 . . . . 0.0 112.246 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp 70.1 147.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 0.0 111.673 -172.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 t -146.38 -48.47 0.2 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.503 1.921 . . . . 0.0 110.621 -169.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.413 ' H ' HG21 ' A' ' 32' ' ' VAL . 9.3 tp -56.89 -31.39 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 127.279 2.231 . . . . 0.0 114.986 174.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.2 -6.89 25.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.93 1.292 . . . . 0.0 112.129 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.29 8.87 4.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.627 1.571 . . . . 0.0 112.813 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 tt -60.31 137.1 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.806 1.289 . . . . 0.0 113.106 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.93 97.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 127.379 2.272 . . . . 0.0 108.575 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -76.24 124.06 26.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.915 -1.116 . . . . 0.0 109.778 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 124.697 1.199 . . . . 0.0 109.908 -174.052 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.471 0.588 0 CA-C-O 121.036 0.446 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.53 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 1.8 m -48.94 125.42 10.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -167.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.21 62.1 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.98 -57.58 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.947 2.099 . . . . 0.0 111.056 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -126.78 -11.3 6.08 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.53 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 75.14 14.27 82.0 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.587 1.085 . . . . 0.0 114.519 171.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -71.84 163.77 27.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.929 2.892 . . . . 0.0 111.516 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.8 110.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.0 126.68 12.73 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.013 1.809 . . . . 0.0 112.224 -169.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -78.46 -33.61 48.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.263 1.425 . . . . 0.0 111.84 170.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -129.93 83.89 62.4 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.688 1.595 . . . . 0.0 109.72 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.13 132.95 52.27 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.582 2.855 . . . . 0.0 111.223 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.35 148.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 126.077 1.751 . . . . 0.0 109.611 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.16 154.61 51.57 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.608 1.563 . . . . 0.0 109.505 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -126.89 119.59 22.53 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 108.403 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -56.33 -8.06 2.39 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.55 3.5 . . . . 0.0 117.326 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -40.07 62.27 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.223 1.409 . . . . 0.0 111.057 177.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.9 p -98.94 -30.43 12.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.204 1.802 . . . . 0.0 113.777 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 55.4 13.4 0.91 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.486 2.315 . . . . 0.0 114.89 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.1 p -77.66 169.47 18.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.91 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 mm -104.94 143.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -143.14 166.39 24.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.496 1.918 . . . . 0.0 110.576 168.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -74.82 128.34 35.33 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.028 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -45.27 -48.14 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.32 1.848 . . . . 0.0 109.756 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 76.0 p -68.86 -24.74 64.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -41.71 50.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.641 1.109 . . . . 0.0 110.784 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.1 tp -64.4 -44.94 89.69 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -54.9 -41.57 71.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.732 1.613 . . . . 0.0 111.864 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -61.1 -51.05 70.75 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.604 -0.685 . . . . 0.0 112.088 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.11 -35.72 80.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.166 0.984 . . . . 0.0 112.075 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -83.83 -15.52 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.858 1.263 . . . . 0.0 113.156 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -95.61 -13.17 24.58 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.149 -0.969 . . . . 0.0 111.606 168.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -57.57 3.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.143 1.777 . . . . 0.0 111.364 169.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.6 p -133.39 -21.83 2.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.905 1.282 . . . . 0.0 112.515 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -11.03 63.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.114 0.864 . . . . 0.0 113.316 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -64.35 156.11 30.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.724 1.762 . . . . 0.0 114.092 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.89 130.55 72.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.856 1.263 . . . . 0.0 108.573 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.76 -8.29 2.92 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.222 3.281 . . . . 0.0 118.647 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.88 -44.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.111 1.365 . . . . 0.0 112.282 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.6 p -98.33 -7.56 28.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.16 0.984 . . . . 0.0 112.754 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.305 0.5 OUTLIER 45.44 29.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.812 2.845 . . . . 0.0 115.686 -175.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -71.47 139.19 83.87 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.042 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.06 136.91 33.37 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.538 2.159 . . . . 0.0 112.62 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.3 mp 73.96 147.15 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.106 2.962 . . . . 0.0 112.065 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -145.89 -57.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.798 1.639 . . . . 0.0 110.596 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.1 tt -62.85 -26.87 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -70.01 -6.45 33.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.416 1.086 . . . . 0.0 112.181 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.75 9.57 6.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.364 1.866 . . . . 0.0 112.337 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.471 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 10.5 tt -59.8 150.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.032 1.733 . . . . 0.0 114.906 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.4 t -123.99 95.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 128.209 2.603 . . . . 0.0 108.321 169.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -86.37 119.48 26.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.539 0.533 0 C-N-CA 124.827 1.251 . . . . 0.0 108.401 174.081 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.2 mt . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 120.946 0.403 . . . . 0.0 111.579 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.3 m -55.32 134.38 50.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.47 -16.11 61.8 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.86 -58.73 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.73 0.812 . . . . 0.0 110.742 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -124.77 -10.53 7.26 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.76 16.29 79.37 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 119.024 0.829 . . . . 0.0 113.261 174.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -66.92 160.91 25.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.897 2.479 . . . . 0.0 110.613 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.0 112.98 16.45 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.49 106.2 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.756 2.304 . . . . 0.0 112.306 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -57.71 -45.87 85.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.659 1.584 . . . . 0.0 111.287 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.402 ' HD2' ' HE3' ' A' ' 25' ' ' LYS . 8.1 mtm180 -122.98 92.43 49.18 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.166 1.386 . . . . 0.0 109.949 170.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.64 123.99 13.35 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.617 2.878 . . . . 0.0 111.383 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.21 151.36 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.255 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tt -134.51 149.03 50.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.71 1.604 . . . . 0.0 110.794 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 t -113.39 131.74 22.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.698 1.199 . . . . 0.0 108.118 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.58 -5.48 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.439 2.093 . . . . 0.0 114.289 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -55.0 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.175 1.39 . . . . 0.0 111.042 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.8 p -79.75 -35.93 38.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.378 1.471 . . . . 0.0 112.694 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 59.86 11.25 2.46 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.906 2.882 . . . . 0.0 114.307 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.5 p -77.03 175.98 9.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 128.281 2.632 . . . . 0.0 111.793 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.13 132.61 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 108.449 171.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -129.38 173.63 10.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.074 1.749 . . . . 0.0 110.243 168.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 151.8 41.87 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.368 172.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE3' ' HD2' ' A' ' 12' ' ' ARG . 17.1 ttpp -56.91 -52.08 66.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.569 1.077 . . . . 0.0 108.679 171.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -76.19 -24.24 54.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.6 mt -72.27 -44.32 62.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.864 0.756 . . . . 0.0 111.465 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 tp -63.81 -45.14 91.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -53.85 -38.54 64.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.238 1.415 . . . . 0.0 111.693 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -62.16 -51.61 67.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.479 -0.763 . . . . 0.0 111.885 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -67.26 -37.28 83.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.457 1.103 . . . . 0.0 112.377 -173.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.467 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.9 p -81.57 -20.0 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.504 1.122 . . . . 0.0 112.398 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -81.59 -25.39 35.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.764 1.626 . . . . 0.0 111.077 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -56.0 5.58 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.261 1.824 . . . . 0.0 111.307 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.6 p -135.25 -21.4 1.6 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.885 1.274 . . . . 0.0 112.458 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -14.57 35.65 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.743 1.163 . . . . 0.0 113.857 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -67.22 151.47 47.48 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.026 1.413 . . . . 0.0 111.629 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -68.53 140.06 92.07 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.103 -0.998 . . . . 0.0 110.108 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -57.2 -14.39 15.13 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.095 3.197 . . . . 0.0 117.565 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.15 -50.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.88 1.272 . . . . 0.0 112.141 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 p -86.06 -11.23 53.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.63 0.772 . . . . 0.0 112.548 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.296 0.5 OUTLIER 45.07 30.53 0.61 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.077 2.551 . . . . 0.0 115.191 -171.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -70.76 132.22 87.18 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.431 -0.793 . . . . 0.0 109.653 172.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.02 137.18 36.93 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.729 2.286 . . . . 0.0 112.221 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 mp 69.25 139.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 128.191 2.597 . . . . 0.0 112.291 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 t -139.01 -55.12 0.6 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.556 1.542 . . . . 0.0 111.235 -169.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.467 ' H ' HG21 ' A' ' 32' ' ' VAL . 9.3 tp -59.84 -30.38 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.645 1.978 . . . . 0.0 115.104 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -71.54 -4.06 24.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.645 1.178 . . . . 0.0 112.363 171.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -127.94 9.81 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.643 1.577 . . . . 0.0 112.427 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 7.6 tp -58.87 144.08 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 114.947 -169.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.94 103.12 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.793 2.437 . . . . 0.0 109.741 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.56 123.69 33.3 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.153 . . . . 0.0 112.405 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp . . . . . 0 CA--C 1.546 0.811 0 C-N-CA 125.858 1.663 . . . . 0.0 108.92 172.975 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 pp . . . . . 0 N--CA 1.468 0.453 0 CA-C-O 121.014 0.435 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -59.33 139.1 57.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -168.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.42 -17.44 60.79 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -82.47 -59.21 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.498 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -124.82 -3.39 7.71 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.15 13.92 83.14 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 119.156 0.889 . . . . 0.0 114.812 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -78.59 163.87 25.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.296 2.638 . . . . 0.0 111.358 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.59 111.73 15.82 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.72 118.59 5.67 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.424 2.083 . . . . 0.0 112.844 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -61.28 -35.95 78.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.383 1.473 . . . . 0.0 111.604 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -129.76 91.26 40.8 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.21 1.404 . . . . 0.0 110.65 171.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.12 127.13 22.13 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.016 3.144 . . . . 0.0 112.136 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.18 143.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 126.664 1.986 . . . . 0.0 110.005 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tt -131.4 158.05 41.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.66 1.584 . . . . 0.0 110.504 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.5 t -129.69 130.0 23.17 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.756 1.623 . . . . 0.0 108.36 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.11 -16.22 12.11 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.812 3.008 . . . . 0.0 116.318 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -82.37 -47.13 12.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.153 1.381 . . . . 0.0 111.693 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.6 p -79.04 -35.75 42.16 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.014 1.326 . . . . 0.0 113.084 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.292 15.2 ptm180 50.37 11.6 0.08 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.409 3.084 . . . . 0.0 115.358 -169.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.1 p -75.51 173.73 10.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.159 2.584 . . . . 0.0 111.054 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.27 116.14 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.155 -0.965 . . . . 0.0 108.559 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -114.27 175.01 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.627 1.971 . . . . 0.0 111.25 172.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 15.1 tt0 -75.39 149.16 38.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.055 174.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -54.79 -49.71 70.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -71.32 -32.66 68.86 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.417 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 9.3 mt -71.5 -44.31 64.92 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.142 0.577 . . . . 0.0 111.524 174.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.11 -44.0 93.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HA ' HG12 ' A' ' 32' ' ' VAL . 47.7 tt0 -54.7 -39.88 68.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.57 1.548 . . . . 0.0 111.357 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -61.71 -51.38 68.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.212 0.605 . . . . 0.0 111.573 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -67.46 -35.78 79.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.028 0.918 . . . . 0.0 112.114 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.3 p -83.97 -15.28 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.955 1.302 . . . . 0.0 113.185 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -96.13 -12.63 24.47 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 121.072 -1.018 . . . . 0.0 111.486 168.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -57.65 3.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.996 1.718 . . . . 0.0 111.291 169.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -132.5 -22.34 2.19 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.025 1.33 . . . . 0.0 112.538 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.39 -11.26 63.95 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.218 0.913 . . . . 0.0 113.151 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.79 155.42 30.4 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.552 1.676 . . . . 0.0 113.862 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.33 130.96 57.34 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -66.57 -4.28 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.042 3.161 . . . . 0.0 116.243 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.82 -41.44 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.207 1.403 . . . . 0.0 111.776 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -105.03 -9.24 17.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.054 1.342 . . . . 0.0 113.662 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.373 0.0 OUTLIER 50.02 22.4 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.732 2.813 . . . . 0.0 115.635 -169.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.58 132.15 94.95 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.456 -0.777 . . . . 0.0 110.503 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 130.54 18.57 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.759 2.306 . . . . 0.0 112.398 -172.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.26 38.8 mt 71.8 139.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 129.092 2.957 . . . . 0.0 113.378 -173.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 t -137.36 -51.58 0.65 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.302 2.241 . . . . 0.0 110.59 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.3 tp -55.47 -34.66 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 127.801 2.44 . . . . 0.0 115.193 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -66.03 -9.56 31.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.393 1.477 . . . . 0.0 112.066 172.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -133.2 10.28 4.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.714 1.606 . . . . 0.0 112.941 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.44 147.35 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.6 t -121.84 91.95 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 128.011 2.524 . . . . 0.0 108.531 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -77.03 126.92 31.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.06 -1.025 . . . . 0.0 110.693 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.2 mt . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 125.328 1.451 . . . . 0.0 109.696 -177.613 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.7 mt . . . . . 0 N--CA 1.467 0.424 0 CA-C-O 121.292 0.568 . . . . 0.0 111.352 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -56.12 138.13 50.25 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -168.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -68.72 -23.86 64.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 174.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.13 -46.94 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.681 1.192 . . . . 0.0 112.12 -169.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 t -123.66 -17.81 6.3 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.22 13.86 82.87 Favored Glycine 0 N--CA 1.47 0.953 0 O-C-N 121.277 -0.889 . . . . 0.0 114.642 174.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -72.2 162.96 28.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.841 2.857 . . . . 0.0 111.285 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -76.54 106.73 3.62 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 168.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -61.04 119.15 6.16 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.293 1.995 . . . . 0.0 114.247 -168.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.2 mmt-85 -71.19 -34.84 71.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.309 1.044 . . . . 0.0 111.867 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -122.89 83.95 50.05 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.16 1.384 . . . . 0.0 110.382 169.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.3 121.61 9.88 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.132 3.221 . . . . 0.0 111.744 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.83 142.15 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 127.144 2.178 . . . . 0.0 110.876 -169.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -133.03 157.59 44.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.424 2.289 . . . . 0.0 110.075 -173.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 p -131.92 149.26 72.84 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.563 1.145 . . . . 0.0 110.681 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.61 -7.31 20.95 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.239 2.626 . . . . 0.0 113.921 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -56.06 3.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.703 1.201 . . . . 0.0 110.428 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 98.9 p -66.38 -37.21 84.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.964 1.306 . . . . 0.0 113.63 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 55.61 4.5 0.11 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 127.665 2.386 . . . . 0.0 116.272 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 4' ' ' ALA . 8.0 t -86.68 179.59 6.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.362 2.665 . . . . 0.0 111.68 170.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.46 116.51 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.23 172.11 7.11 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.312 1.845 . . . . 0.0 111.94 170.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -83.33 136.17 34.46 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.817 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.5 -43.85 45.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.305 1.842 . . . . 0.0 110.444 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 t -61.04 -39.62 90.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.883 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.69 -42.2 64.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.319 1.048 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.38 -44.57 94.35 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.68 -43.77 69.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.973 0.909 . . . . 0.0 110.72 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -59.13 -55.46 34.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.19 -0.319 . . . . 0.0 111.851 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -65.45 -33.42 75.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.226 1.012 . . . . 0.0 112.331 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.515 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.4 p -86.62 -13.46 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 113.348 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -99.55 -10.95 21.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.774 1.23 . . . . 0.0 111.618 168.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.59 -56.3 4.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.968 2.107 . . . . 0.0 110.897 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.2 p -134.57 -23.2 1.64 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.972 1.309 . . . . 0.0 112.727 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.72 -12.55 63.15 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.677 1.132 . . . . 0.0 113.086 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -63.72 156.51 26.83 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.145 1.473 . . . . 0.0 113.984 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -82.08 130.58 59.6 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 167.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.38 -4.78 10.02 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.004 3.136 . . . . 0.0 117.321 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.0 mt -116.33 -49.36 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.568 1.147 . . . . 0.0 110.912 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.9 p -91.31 -12.87 33.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.398 1.079 . . . . 0.0 113.796 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.381 0.0 OUTLIER 50.67 23.83 1.49 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.334 2.654 . . . . 0.0 115.193 -169.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -68.34 137.2 91.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.57 140.18 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.337 2.025 . . . . 0.0 112.742 -172.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 mt 66.33 128.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 128.954 2.901 . . . . 0.0 114.704 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -129.24 -45.4 1.24 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.032 1.733 . . . . 0.0 111.544 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.515 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.1 tp -58.97 -35.2 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.982 2.113 . . . . 0.0 114.507 172.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.61 -8.88 38.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.304 1.442 . . . . 0.0 111.84 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.39 8.69 6.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.627 1.571 . . . . 0.0 112.99 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.93 137.4 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.726 1.251 . . . . 0.0 114.236 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -119.66 91.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.045 2.138 . . . . 0.0 108.82 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -76.19 115.93 16.39 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.027 -1.046 . . . . 0.0 110.074 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.476 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.07 -177.35 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.7 mt . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 121.458 0.647 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 0.5 OUTLIER -56.88 135.67 55.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -168.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.97 64.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.995 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.91 -49.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.473 1.509 . . . . 0.0 112.164 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -126.23 -23.33 3.88 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.483 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.51 18.83 78.77 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.138 0.875 . . . . 0.0 113.394 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -65.93 155.2 37.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.661 2.784 . . . . 0.0 111.452 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.54 109.16 2.47 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.079 0.952 . . . . 0.0 109.481 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.05 120.36 8.18 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.944 2.429 . . . . 0.0 113.708 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -81.72 -49.08 10.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.506 1.922 . . . . 0.0 110.294 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -128.82 85.86 59.06 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 126.57 1.948 . . . . 0.0 109.545 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.32 138.31 83.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.655 2.903 . . . . 0.0 111.411 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -145.88 154.15 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 125.369 1.467 . . . . 0.0 109.969 -170.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -136.49 155.4 50.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.413 1.485 . . . . 0.0 110.173 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 t -125.15 136.55 28.3 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 125.647 1.579 . . . . 0.0 108.116 169.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.48 -10.48 27.92 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.766 2.311 . . . . 0.0 113.796 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.85 -67.69 0.62 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.859 2.064 . . . . 0.0 111.48 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.8 m -64.37 -37.0 85.98 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.365 1.066 . . . . 0.0 112.826 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 63.6 -1.53 0.59 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.845 2.458 . . . . 0.0 115.107 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.5 p -77.64 177.12 8.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.585 2.354 . . . . 0.0 111.939 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 mm -106.61 141.62 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -136.71 167.86 20.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.763 1.625 . . . . 0.0 110.27 168.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -78.35 130.51 36.25 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -43.08 40.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.696 1.998 . . . . 0.0 110.468 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 t -60.21 -43.14 96.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.78 -40.26 41.38 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 110.961 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.76 -48.66 79.69 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -58.26 -42.18 85.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.833 0.288 . . . . 0.0 111.062 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -58.43 -49.55 76.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.175 0.512 . . . . 0.0 111.926 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -64.23 -35.19 80.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.696 1.198 . . . . 0.0 111.879 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.506 HG21 ' CB ' ' A' ' 46' ' ' SER . 43.5 t -94.0 -13.55 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 112.093 -172.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -91.39 -12.71 34.03 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 119.813 -1.805 . . . . 0.0 110.391 167.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.89 -65.71 0.91 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.95 2.1 . . . . 0.0 110.995 169.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.7 p -126.6 -15.12 5.62 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.069 1.348 . . . . 0.0 113.632 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.36 -18.02 25.93 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.923 0.773 . . . . 0.0 113.822 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -68.24 149.09 49.92 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.266 1.533 . . . . 0.0 112.772 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.5 142.48 94.34 Favored Pre-proline 0 CA--C 1.549 0.939 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 169.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.75 -5.57 17.12 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.254 2.636 . . . . 0.0 114.841 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mm -118.55 -52.45 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.716 1.206 . . . . 0.0 110.566 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -89.96 -13.47 36.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.328 0.4 OUTLIER 45.84 31.07 0.97 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.208 2.203 . . . . 0.0 114.462 -169.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -75.29 135.68 72.68 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.041 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.07 140.74 42.23 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.175 2.583 . . . . 0.0 113.049 -170.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 mt 65.1 149.14 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.365 3.066 . . . . 0.0 114.192 -172.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.506 ' CB ' HG21 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -142.86 -54.18 0.4 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.301 1.84 . . . . 0.0 111.85 -173.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.414 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 10.1 tp -61.37 -30.87 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.646 1.978 . . . . 0.0 114.82 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.86 -9.37 44.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.309 1.444 . . . . 0.0 112.0 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -130.61 12.88 5.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.853 1.661 . . . . 0.0 112.483 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.6 tp -57.44 141.39 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.492 1.517 . . . . 0.0 114.118 -172.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.86 92.61 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.958 2.103 . . . . 0.0 109.792 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' HG23 ' A' ' 14' ' ' VAL . 1.5 mp0 -78.3 126.14 30.36 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.853 -1.154 . . . . 0.0 112.257 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.7 mm . . . . . 0 CA--C 1.541 0.619 0 C-N-CA 125.441 1.496 . . . . 0.0 108.783 -177.064 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.47 0.527 0 CA-C-O 121.167 0.508 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.471 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 3.0 m -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -168.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.51 -17.11 62.36 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.69 -49.97 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.269 1.428 . . . . 0.0 111.522 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.7 p -116.28 -24.47 7.93 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 82.11 12.39 80.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 115.406 0.922 . . . . 0.0 115.406 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.96 166.59 17.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.424 2.29 . . . . 0.0 112.198 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.75 107.42 7.35 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.72 114.9 1.53 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.469 2.779 . . . . 0.0 117.33 -168.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -62.55 -44.93 95.11 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.158 1.383 . . . . 0.0 110.492 169.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm-85 -126.67 94.77 39.35 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.161 1.784 . . . . 0.0 109.678 169.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.72 125.92 17.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.066 3.178 . . . . 0.0 111.036 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.34 142.71 28.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 126.302 1.841 . . . . 0.0 110.366 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tt -131.63 157.75 42.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.523 1.529 . . . . 0.0 110.889 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -134.51 125.9 17.9 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.634 1.574 . . . . 0.0 108.609 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -53.72 -11.65 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 125.172 3.914 . . . . 0.0 117.309 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.71 -55.46 5.84 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.805 1.242 . . . . 0.0 111.178 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 m -79.8 -37.34 35.44 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.505 1.522 . . . . 0.0 112.366 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm-85 56.23 7.97 0.37 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 128.114 2.566 . . . . 0.0 115.429 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.1 p -74.26 174.22 9.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.65 2.38 . . . . 0.0 110.395 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.38 118.1 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -112.76 171.14 7.71 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.428 1.891 . . . . 0.0 111.406 173.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -80.01 134.62 36.24 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.3 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -45.67 -46.64 14.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.742 2.017 . . . . 0.0 110.249 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -63.66 -33.35 75.43 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.966 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.38 -45.22 40.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.288 1.035 . . . . 0.0 110.73 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -63.33 -45.04 93.15 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -56.19 -42.77 77.66 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.867 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -59.25 -51.64 69.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.409 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.49 -34.29 76.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.147 1.379 . . . . 0.0 112.239 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.2 p -83.1 -18.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.252 1.021 . . . . 0.0 112.872 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -85.77 -22.74 27.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.089 1.355 . . . . 0.0 111.363 168.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.42 4.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.558 1.943 . . . . 0.0 111.59 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.2 p -133.38 -21.38 2.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.029 1.332 . . . . 0.0 112.451 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.14 58.84 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.231 0.92 . . . . 0.0 113.341 -171.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.44 156.06 30.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.389 1.595 . . . . 0.0 113.709 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.74 131.36 54.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.53 -4.89 10.4 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.862 3.041 . . . . 0.0 117.15 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.85 -53.2 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.736 1.214 . . . . 0.0 110.709 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.3 p -88.64 -12.07 43.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.517 1.127 . . . . 0.0 113.89 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 52.58 21.27 1.76 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.313 2.645 . . . . 0.0 115.12 -169.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.69 122.17 75.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.673 0.789 . . . . 0.0 111.048 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.9 130.26 39.68 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.469 2.779 . . . . 0.0 114.145 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.265 34.8 mt 72.0 132.69 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.272 3.029 . . . . 0.0 113.265 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.7 t -132.95 -46.71 0.86 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.126 2.171 . . . . 0.0 111.135 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 10.2 tp -56.57 -33.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.85 2.06 . . . . 0.0 114.354 171.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.13 -7.54 24.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.621 1.568 . . . . 0.0 112.077 171.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -130.83 6.65 4.69 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.3 tt -60.05 138.98 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 122.723 1.249 . . . . 0.0 113.696 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.97 88.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.112 2.165 . . . . 0.0 108.235 169.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.25 140.12 44.78 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.871 -1.143 . . . . 0.0 111.598 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 CA--C 1.546 0.817 0 C-N-CA 125.637 1.575 . . . . 0.0 108.935 169.879 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.47 0.529 0 CA-C-O 121.434 0.635 . . . . 0.0 112.202 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.6 m -58.8 145.44 40.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -168.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -68.02 -37.09 81.0 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.121 0.962 . . . . 0.0 111.335 173.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -80.15 -53.39 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.595 1.958 . . . . 0.0 112.771 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.0 m -123.23 -8.74 8.16 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.84 16.2 78.13 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 118.891 0.769 . . . . 0.0 114.543 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -76.18 164.53 26.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.581 2.753 . . . . 0.0 111.428 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.71 106.83 5.35 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 168.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.6 129.21 19.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.183 1.922 . . . . 0.0 113.594 -169.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -45.08 94.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.711 1.604 . . . . 0.0 110.159 169.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -122.83 91.05 49.92 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.587 1.555 . . . . 0.0 110.643 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.1 124.94 17.07 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.795 2.997 . . . . 0.0 111.451 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.16 145.46 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 127.25 2.22 . . . . 0.0 110.395 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.5 tp -131.94 153.77 49.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.68 1.992 . . . . 0.0 110.812 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 t -136.76 125.58 15.22 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.046 . . . . 0.0 106.205 168.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -67.81 -6.58 17.25 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.985 2.456 . . . . 0.0 114.169 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -61.38 1.92 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.748 1.619 . . . . 0.0 110.78 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 m -81.98 -10.41 59.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.268 15.2 ptp180 43.63 41.71 3.68 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.773 2.829 . . . . 0.0 117.041 169.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.402 HG21 ' HB2' ' A' ' 4' ' ' ALA . 14.8 t -133.98 172.35 12.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.239 2.216 . . . . 0.0 110.224 170.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.56 114.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.57 170.93 7.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.557 2.343 . . . . 0.0 110.638 176.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 12.2 tt0 -73.48 149.49 42.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.765 175.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -53.44 -44.14 68.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -62.2 -41.02 97.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.802 1.241 . . . . 0.0 112.894 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 8.0 mt -71.38 -45.87 61.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.139 0.576 . . . . 0.0 110.316 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -64.17 -43.69 94.38 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.86 -42.5 72.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.848 1.259 . . . . 0.0 111.453 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -59.9 -52.62 64.66 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.106 -0.371 . . . . 0.0 111.588 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.09 -34.46 77.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.169 0.985 . . . . 0.0 112.15 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -84.44 -14.27 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.333 1.053 . . . . 0.0 113.235 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.18 -11.27 22.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.408 1.083 . . . . 0.0 111.843 168.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -56.09 5.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.764 2.025 . . . . 0.0 110.841 169.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.2 p -135.19 -22.73 1.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.745 1.218 . . . . 0.0 112.726 -176.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.09 -11.28 65.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.483 1.039 . . . . 0.0 113.025 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -63.83 157.35 24.8 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.309 1.554 . . . . 0.0 113.518 -174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -80.94 135.87 51.3 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.511 1.124 . . . . 0.0 108.037 167.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.64 -8.23 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 N-CA-C 118.905 2.617 . . . . 0.0 118.905 -168.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.74 -44.78 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 121.09 1.768 . . . . 0.0 111.564 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -84.19 -13.12 53.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 44.89 30.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.677 2.391 . . . . 0.0 114.766 -170.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.61 134.37 88.49 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.641 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.11 135.56 27.52 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.512 2.142 . . . . 0.0 112.296 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 mp 70.72 144.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.97 2.508 . . . . 0.0 111.861 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -145.09 -52.4 0.28 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.723 2.009 . . . . 0.0 110.646 -169.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.426 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.0 tp -57.62 -32.87 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.553 2.341 . . . . 0.0 115.628 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -67.82 -8.26 34.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.394 1.078 . . . . 0.0 112.086 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.13 11.22 4.61 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.291 1.836 . . . . 0.0 112.532 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 tt -59.39 142.01 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.842 1.306 . . . . 0.0 113.475 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.33 97.84 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 127.839 2.456 . . . . 0.0 109.023 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.92 112.25 9.87 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.74 -1.225 . . . . 0.0 110.452 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.9 mm . . . . . 0 N--CA 1.476 0.828 0 C-N-CA 125.571 1.548 . . . . 0.0 111.227 -177.629 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.8 pt? . . . . . 0 N--CA 1.469 0.498 0 CA-C-O 121.343 0.592 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.497 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 2.7 m -58.9 136.01 57.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -168.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.58 -21.46 64.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -94.74 -49.7 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.879 1.671 . . . . 0.0 111.923 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -126.84 -16.95 5.05 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.497 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.72 13.61 83.37 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.926 -1.109 . . . . 0.0 114.72 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -69.41 164.08 23.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.885 2.874 . . . . 0.0 112.088 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -82.4 110.19 20.21 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.64 138.33 37.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.155 1.903 . . . . 0.0 113.823 -169.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -84.59 -41.3 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.433 2.293 . . . . 0.0 109.894 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -121.68 86.17 44.83 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.994 1.718 . . . . 0.0 108.832 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.02 124.75 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.886 3.057 . . . . 0.0 109.685 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.03 142.89 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 125.84 1.656 . . . . 0.0 110.494 -169.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -133.12 154.45 50.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.421 1.488 . . . . 0.0 110.568 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 t -131.9 128.73 21.66 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 127.049 2.139 . . . . 0.0 106.054 168.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.39 -7.57 18.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.35 2.7 . . . . 0.0 115.004 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -74.61 -63.34 1.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.288 1.035 . . . . 0.0 110.921 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -64.08 -36.46 84.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.86 1.264 . . . . 0.0 111.814 170.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.353 11.1 ptp180 47.92 17.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 129.741 3.216 . . . . 0.0 116.092 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.3 p -77.99 174.44 11.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.312 2.645 . . . . 0.0 109.82 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 116.51 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -114.14 169.01 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.787 2.035 . . . . 0.0 111.644 174.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.83 131.28 39.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -47.92 -45.51 30.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.948 1.699 . . . . 0.0 110.047 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 m -59.97 -35.18 74.44 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.46 -39.88 31.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.255 0.622 . . . . 0.0 111.089 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -62.69 -46.11 89.65 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -56.2 -40.39 73.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.551 1.54 . . . . 0.0 112.023 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -60.91 -52.52 64.68 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.513 -0.742 . . . . 0.0 111.83 170.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -67.37 -34.7 77.84 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.204 1.002 . . . . 0.0 111.849 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.507 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.9 p -82.84 -18.36 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.631 1.172 . . . . 0.0 113.033 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -91.38 -15.4 29.04 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 121.07 -1.019 . . . . 0.0 111.636 168.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.87 -56.41 4.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.388 1.875 . . . . 0.0 111.702 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -132.93 -21.84 2.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.086 1.354 . . . . 0.0 112.395 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.11 -12.13 55.24 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.27 0.938 . . . . 0.0 113.575 -171.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -66.58 156.07 36.06 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.589 1.694 . . . . 0.0 113.927 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.95 135.09 59.24 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 166.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.89 -4.05 11.64 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.211 2.607 . . . . 0.0 115.018 -170.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.28 -50.65 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 110.714 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -87.25 -13.01 44.98 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.384 0.0 OUTLIER 49.68 21.33 0.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.338 2.655 . . . . 0.0 115.138 -168.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -68.32 129.13 93.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.234 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.87 135.72 33.39 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.833 2.356 . . . . 0.0 112.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.27 39.1 mt 70.86 141.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 129.405 3.082 . . . . 0.0 113.082 -171.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -140.99 -53.86 0.48 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 110.58 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.507 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -61.76 -24.75 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -16.54 62.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.466 1.906 . . . . 0.0 111.674 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.12 10.27 8.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.675 1.99 . . . . 0.0 112.161 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.471 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 11.3 tt -58.48 139.89 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 122.955 1.359 . . . . 0.0 114.404 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -120.75 91.78 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.834 2.454 . . . . 0.0 108.406 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -75.55 121.6 22.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.979 -1.076 . . . . 0.0 110.356 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt . . . . . 0 CA--C 1.545 0.767 0 C-N-CA 126.09 1.756 . . . . 0.0 108.559 173.275 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 N--CA 1.469 0.501 0 CA-C-O 121.193 0.521 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 3.2 m -59.08 138.69 57.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -168.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.59 61.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.824 -0.547 . . . . 0.0 112.422 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.65 -51.35 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.804 1.242 . . . . 0.0 111.455 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -124.27 -10.51 7.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.0 11.88 84.43 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 119.018 0.826 . . . . 0.0 114.947 170.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -72.62 161.08 31.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.605 2.762 . . . . 0.0 111.176 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.1 t -76.33 106.68 3.49 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 168.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.51 118.25 5.11 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.608 2.205 . . . . 0.0 114.385 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.02 -47.06 84.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.865 1.266 . . . . 0.0 111.343 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -129.62 90.25 44.3 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.233 1.413 . . . . 0.0 109.339 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.83 149.53 86.59 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.185 2.59 . . . . 0.0 113.38 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.44 155.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 110.46 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.98 154.07 48.24 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.653 1.181 . . . . 0.0 110.608 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -117.36 134.11 23.14 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 125.658 1.583 . . . . 0.0 108.986 169.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.09 -4.7 14.77 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.359 2.706 . . . . 0.0 113.762 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -86.72 -48.84 7.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 110.535 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.4 p -97.62 -24.16 15.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 114.861 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.12 4.08 1.13 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 129.164 2.986 . . . . 0.0 116.685 170.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -71.8 174.43 6.89 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.992 1.717 . . . . 0.0 110.248 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.9 mt -119.34 116.1 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -112.57 165.71 12.0 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.53 1.532 . . . . 0.0 111.25 174.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -75.17 134.6 41.19 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -52.83 -41.53 64.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.872 1.669 . . . . 0.0 109.845 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -61.61 -37.15 82.89 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.3 -43.13 52.7 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.564 0.746 . . . . 0.0 110.648 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.27 -45.58 83.94 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 119.221 -0.418 . . . . 0.0 109.922 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.9 -41.86 68.08 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.182 0.993 . . . . 0.0 111.793 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.51 -52.92 63.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.986 0.514 . . . . 0.0 111.761 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.24 -36.02 80.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.35 1.06 . . . . 0.0 112.076 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.469 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.4 p -84.94 -18.72 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.282 1.033 . . . . 0.0 112.884 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -91.04 -14.8 30.67 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.988 -1.07 . . . . 0.0 111.576 168.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -60.11 2.39 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.641 1.576 . . . . 0.0 110.555 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.9 p -137.4 -16.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.695 1.198 . . . . 0.0 113.104 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 83.6 -15.63 34.97 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.768 1.175 . . . . 0.0 114.007 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -67.33 149.03 50.88 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.928 1.364 . . . . 0.0 111.52 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.99 143.49 91.76 Favored Pre-proline 0 CA--C 1.548 0.904 0 O-C-N 120.936 -1.102 . . . . 0.0 108.791 168.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -4.66 14.13 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.304 2.669 . . . . 0.0 114.684 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.8 -52.34 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.453 1.501 . . . . 0.0 110.851 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -85.38 -15.06 44.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.391 0.0 OUTLIER 49.17 22.4 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.055 2.542 . . . . 0.0 114.609 -168.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -73.89 130.79 82.55 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.099 -1.001 . . . . 0.0 109.696 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.79 141.15 48.49 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.426 2.751 . . . . 0.0 113.705 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.3 mt 65.89 132.43 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 129.928 3.291 . . . . 0.0 113.756 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -131.96 -48.0 0.94 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.262 1.825 . . . . 0.0 111.456 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.469 ' H ' HG21 ' A' ' 32' ' ' VAL . 10.3 tp -60.13 -32.79 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.05 1.74 . . . . 0.0 114.405 173.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.06 -7.73 38.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.248 1.419 . . . . 0.0 112.162 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -126.96 7.58 6.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.015 1.726 . . . . 0.0 112.531 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.406 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 6.1 tp -58.39 142.0 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.43 89.66 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 107.567 169.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -75.16 141.43 43.66 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.026 -1.046 . . . . 0.0 112.5 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.2 mm . . . . . 0 N--CA 1.471 0.614 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 -175.143 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 N--CA 1.468 0.433 0 CA-C-O 120.785 0.326 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.4 m -57.34 130.07 44.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.37 62.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.56 -56.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.962 0.905 . . . . 0.0 110.984 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 -13.78 8.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 80.31 9.57 86.4 Favored Glycine 0 N--CA 1.47 0.915 0 O-C-N 121.486 -0.759 . . . . 0.0 114.994 170.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -71.05 162.75 28.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.47 2.708 . . . . 0.0 111.745 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.59 107.43 5.23 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.722 1.209 . . . . 0.0 107.812 168.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.91 116.28 3.01 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.965 2.443 . . . . 0.0 114.972 -169.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -75.36 -36.39 60.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.997 0.919 . . . . 0.0 111.477 169.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -121.47 81.51 39.06 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 125.725 1.61 . . . . 0.0 109.723 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.1 126.27 19.8 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.257 3.305 . . . . 0.0 111.27 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 50' ' ' ILE . 9.0 p -141.91 153.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.483 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -131.11 150.44 52.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.047 2.139 . . . . 0.0 109.677 -171.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.3 t -125.63 125.22 24.99 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.911 1.684 . . . . 0.0 107.738 169.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.46 -7.68 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.82 3.68 . . . . 0.0 116.613 173.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.39 -67.19 0.85 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.336 1.854 . . . . 0.0 111.127 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.2 m -70.14 -31.65 69.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.383 1.073 . . . . 0.0 113.396 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 62.22 7.31 2.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.216 2.606 . . . . 0.0 115.715 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.5 p -75.94 174.0 10.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.172 2.589 . . . . 0.0 111.755 170.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.4 mt -121.05 117.05 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 120.98 -1.075 . . . . 0.0 108.468 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -117.08 175.55 5.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.473 1.909 . . . . 0.0 112.219 178.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.22 130.7 36.32 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.308 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -53.37 -41.01 65.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.673 1.589 . . . . 0.0 110.64 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -57.5 -44.04 84.69 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.053 0.846 . . . . 0.0 112.748 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . 0.311 1.0 OUTLIER -94.45 -25.14 17.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.934 0.894 . . . . 0.0 113.291 -173.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.36 -52.52 57.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 167.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.25 -39.76 79.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.124 0.57 . . . . 0.0 111.351 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -56.84 -52.57 64.57 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.304 0.502 . . . . 0.0 112.239 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -64.92 -29.54 70.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.125 1.77 . . . . 0.0 112.336 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.481 HG21 ' CB ' ' A' ' 46' ' ' SER . 42.1 t -93.31 -5.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 125.904 1.682 . . . . 0.0 112.047 -177.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -98.76 -17.57 18.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.152 -1.593 . . . . 0.0 110.606 167.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -63.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.904 2.482 . . . . 0.0 111.327 170.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.6 p -126.56 -21.88 4.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.962 1.305 . . . . 0.0 113.104 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.06 -18.59 26.57 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 123.656 0.646 . . . . 0.0 114.1 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.08 145.72 54.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.795 1.297 . . . . 0.0 111.685 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 149.49 90.49 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.19 -0.944 . . . . 0.0 111.131 169.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.92 -17.66 60.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.858 2.372 . . . . 0.0 115.988 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.0 mm -125.62 -48.3 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.068 0.947 . . . . 0.0 110.978 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.8 p -82.43 -14.81 54.51 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.359 0.0 OUTLIER 51.7 19.78 0.98 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.033 2.533 . . . . 0.0 114.535 -169.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.61 124.6 88.81 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.914 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.44 133.59 43.5 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.737 2.958 . . . . 0.0 114.533 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 mt 66.0 143.16 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.143 2.977 . . . . 0.0 114.323 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.481 ' CB ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -136.15 -41.14 0.66 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.284 1.833 . . . . 0.0 111.823 -174.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.21 -33.71 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.656 1.583 . . . . 0.0 113.965 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.5 -5.45 28.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.253 1.421 . . . . 0.0 112.146 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.52 8.15 6.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 14' ' ' VAL . 4.5 tp -58.87 126.79 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.088 1.755 . . . . 0.0 114.959 -169.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -120.63 85.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.4 1.88 . . . . 0.0 110.221 171.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -80.01 118.57 21.86 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.954 -1.092 . . . . 0.0 112.073 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.2 mt . . . . . 0 CA--C 1.538 0.503 0 C-N-CA 126.612 1.965 . . . . 0.0 109.085 -175.036 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.1 mt . . . . . 0 N--CA 1.467 0.391 0 CA-C-O 121.572 0.701 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.0 t -63.52 139.07 58.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.058 1.409 . . . . 0.0 113.698 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.84 -15.56 47.78 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.072 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -76.91 -56.67 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.915 174.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m -134.54 -6.03 2.54 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.94 7.43 70.65 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.91 1.232 . . . . 0.0 114.109 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -56.29 137.98 51.35 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.301 2.64 . . . . 0.0 111.11 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.31 108.85 3.18 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.908 1.283 . . . . 0.0 107.663 169.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.74 128.02 28.6 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.586 2.191 . . . . 0.0 114.872 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -75.25 -46.05 36.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 108.782 169.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -124.32 91.16 49.93 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 127.212 2.205 . . . . 0.0 108.162 172.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.64 130.72 38.48 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.839 3.026 . . . . 0.0 111.4 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.9 144.02 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.971 1.708 . . . . 0.0 110.218 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.2 tp -131.65 154.32 49.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.5 1.92 . . . . 0.0 110.248 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 t -135.03 135.03 22.2 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.867 2.067 . . . . 0.0 107.703 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.87 -8.4 23.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -80.89 -64.19 1.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.978 1.711 . . . . 0.0 111.649 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -67.84 -32.73 73.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.883 0.873 . . . . 0.0 112.43 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 -2.0 0.51 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.351 2.66 . . . . 0.0 115.191 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.5 p -73.5 169.1 17.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.777 2.431 . . . . 0.0 112.617 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -112.76 116.55 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.7 168.96 9.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.588 1.555 . . . . 0.0 111.613 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.3 131.91 42.47 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.135 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -46.86 53.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.597 1.559 . . . . 0.0 110.283 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 t -62.18 -40.05 94.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -39.74 53.62 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.137 -0.977 . . . . 0.0 111.666 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.6 tp -60.64 -45.22 94.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.643 0.656 . . . . 0.0 109.302 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.424 ' HA ' HG12 ' A' ' 32' ' ' VAL . 39.0 tt0 -55.72 -38.82 70.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.013 0.925 . . . . 0.0 111.544 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.37 -49.57 73.34 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.768 -0.582 . . . . 0.0 111.827 173.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -67.95 -35.26 78.09 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.052 0.929 . . . . 0.0 112.221 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 29' ' ' GLU . 1.6 p -82.84 -15.95 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.369 1.068 . . . . 0.0 112.984 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.19 -14.05 25.99 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.166 -0.959 . . . . 0.0 111.519 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.88 -57.63 3.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.874 1.67 . . . . 0.0 111.373 170.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.9 -22.12 1.86 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.847 1.259 . . . . 0.0 112.539 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.11 60.14 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.226 0.917 . . . . 0.0 113.459 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.99 155.01 37.86 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.24 1.52 . . . . 0.0 113.449 -172.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.07 141.24 74.33 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 166.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.73 -7.47 18.33 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.159 2.573 . . . . 0.0 115.432 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.0 mt -126.8 -46.94 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.636 1.107 . . . . 0.0 111.879 -175.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.0 p -83.69 -12.78 55.42 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.343 0.3 OUTLIER 48.44 23.5 0.6 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.008 2.523 . . . . 0.0 115.083 -169.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.94 118.04 44.99 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.25 1.02 . . . . 0.0 110.644 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.39 132.65 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.474 2.782 . . . . 0.0 113.843 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.72 137.71 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.518 3.127 . . . . 0.0 112.864 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.69 -44.91 0.48 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.315 1.846 . . . . 0.0 111.164 -171.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 10.6 tp -58.89 -31.2 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 126.837 2.055 . . . . 0.0 115.568 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -14.74 62.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.369 1.868 . . . . 0.0 112.071 170.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -124.6 13.08 8.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.82 2.048 . . . . 0.0 112.035 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 6.7 tp -56.32 125.01 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.575 1.55 . . . . 0.0 112.947 -175.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.98 92.33 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.421 1.489 . . . . 0.0 109.26 170.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -78.63 123.11 26.77 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.055 -1.028 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.9 mm . . . . . 0 CA--C 1.537 0.465 0 C-N-CA 125.636 1.575 . . . . 0.0 109.655 -179.898 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.675 0.75 . . . . 0.0 111.369 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.19 146.11 51.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -169.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.21 68.57 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.98 -48.22 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 110.968 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -135.3 -11.5 2.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.22 12.07 79.64 Favored Glycine 0 N--CA 1.469 0.881 0 O-C-N 121.228 -0.92 . . . . 0.0 113.961 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -51.2 136.22 24.62 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 128.341 2.656 . . . . 0.0 111.509 171.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -66.42 110.2 4.46 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 168.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.85 105.16 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.996 2.464 . . . . 0.0 115.846 -169.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -59.33 -41.2 88.56 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.309 1.843 . . . . 0.0 111.109 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -132.69 94.8 20.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.054 1.741 . . . . 0.0 108.678 169.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 135.3 62.3 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.662 2.908 . . . . 0.0 112.153 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.31 146.05 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.408 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.53 152.75 49.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.533 1.133 . . . . 0.0 110.611 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 t -120.37 133.3 23.98 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 125.744 1.618 . . . . 0.0 109.646 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.71 -19.62 25.05 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.313 2.675 . . . . 0.0 114.395 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -93.87 -58.96 2.1 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.921 1.689 . . . . 0.0 111.93 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.0 m -78.53 -16.59 57.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 58.32 -16.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 129.887 3.275 . . . . 0.0 118.627 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 t -74.48 173.39 10.41 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.363 1.465 . . . . 0.0 110.924 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 mm -106.79 118.91 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.258 1.423 . . . . 0.0 108.736 175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.26 170.61 7.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 111.38 173.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 139.81 43.35 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.41 -45.68 62.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 109.393 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m -66.72 -42.04 86.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.907 0.883 . . . . 0.0 113.201 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.31 -40.36 64.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.565 0.746 . . . . 0.0 111.534 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.8 tp -61.35 -49.23 77.8 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -55.61 -41.78 73.97 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.017 0.527 . . . . 0.0 110.681 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.16 -53.65 55.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.034 0.534 . . . . 0.0 111.695 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -61.75 -35.18 77.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.349 1.071 . . . . 0.0 111.849 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.473 HG11 ' H ' ' A' ' 47' ' ' ILE . 41.7 t -93.75 -6.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 124.444 1.097 . . . . 0.0 112.258 -173.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -100.49 -10.59 20.93 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.937 -1.727 . . . . 0.0 110.81 167.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.108 2.563 . . . . 0.0 110.019 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -128.37 -21.77 3.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.38 1.472 . . . . 0.0 113.229 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.11 24.18 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.725 0.679 . . . . 0.0 113.758 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.74 147.72 52.93 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.588 1.194 . . . . 0.0 111.534 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.71 147.27 89.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.95 -1.094 . . . . 0.0 110.374 169.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.52 -10.75 27.32 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.909 2.406 . . . . 0.0 114.457 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.59 -46.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.312 0.96 . . . . 0.0 111.609 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.8 p -85.84 -10.4 55.46 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.327 0.3 OUTLIER 48.06 24.96 0.71 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.772 2.429 . . . . 0.0 115.671 -170.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.47 119.34 59.04 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.138 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.77 128.03 26.88 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.742 2.961 . . . . 0.0 114.334 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt 65.37 141.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.885 2.874 . . . . 0.0 114.664 -172.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.464 ' CB ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -136.29 -54.54 0.75 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.723 1.609 . . . . 0.0 112.614 -173.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.473 ' H ' HG11 ' A' ' 32' ' ' VAL . 7.8 tp -61.62 -32.04 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.808 1.643 . . . . 0.0 114.066 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -68.87 -7.09 31.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 112.078 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -133.31 12.67 4.19 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.8 1.64 . . . . 0.0 112.122 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 9.7 tp -59.22 150.1 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.623 1.969 . . . . 0.0 115.305 -171.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.53 87.54 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.224 1.81 . . . . 0.0 108.385 169.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -75.8 137.44 40.52 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.921 -1.112 . . . . 0.0 111.596 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 125.49 1.516 . . . . 0.0 109.962 178.879 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 121.389 0.614 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.8 t -66.77 144.05 56.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.619 1.199 . . . . 0.0 113.915 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.12 -15.35 38.7 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.389 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -77.56 -53.62 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.122 0.569 . . . . 0.0 110.008 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 m -136.72 -5.84 1.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.71 6.91 82.36 Favored Glycine 0 N--CA 1.473 1.103 0 CA-C-N 120.069 1.304 . . . . 0.0 115.493 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.55 147.14 46.48 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.69 2.396 . . . . 0.0 110.819 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.57 108.78 3.2 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.1 115.11 3.29 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.459 2.106 . . . . 0.0 112.717 -169.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -63.74 -34.99 79.12 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.612 1.165 . . . . 0.0 111.708 170.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.8 mtm-85 -123.63 87.09 52.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.323 1.849 . . . . 0.0 109.501 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.57 128.69 22.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.888 3.058 . . . . 0.0 111.736 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 152.09 20.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.245 1.418 . . . . 0.0 110.503 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -139.24 155.53 47.71 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.977 1.311 . . . . 0.0 110.407 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 p -123.81 146.96 52.19 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 109.029 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.22 -10.23 28.43 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 121.917 1.744 . . . . 0.0 113.183 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -59.51 2.75 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.081 1.753 . . . . 0.0 111.366 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.2 m -79.59 -32.51 41.96 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 112.072 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 59.94 1.72 0.34 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.467 2.307 . . . . 0.0 115.437 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 p -73.07 173.46 9.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.117 2.567 . . . . 0.0 111.679 170.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.33 116.22 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.84 173.44 6.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 126.287 1.835 . . . . 0.0 110.452 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.12 143.54 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.111 -0.993 . . . . 0.0 109.554 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.59 -46.18 66.81 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.13 1.372 . . . . 0.0 108.815 171.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -67.81 -42.79 80.99 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.6 -40.79 66.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.151 0.887 . . . . 0.0 111.439 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.92 -47.56 84.38 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -56.05 -42.99 77.44 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.695 0.398 . . . . 0.0 110.552 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -57.85 -52.13 66.75 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.688 0.795 . . . . 0.0 111.491 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.46 -36.21 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.025 1.33 . . . . 0.0 111.967 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 46' ' ' SER . 43.1 t -91.78 -6.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.016 1.326 . . . . 0.0 112.232 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -101.96 -10.77 19.48 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 119.994 -1.691 . . . . 0.0 110.567 167.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -61.6 1.9 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.034 2.134 . . . . 0.0 110.226 169.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.4 p -130.41 -16.75 3.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.983 1.313 . . . . 0.0 113.58 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.22 -19.64 30.14 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-O 119.507 -0.607 . . . . 0.0 113.656 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.56 148.83 51.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.827 1.314 . . . . 0.0 113.216 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.76 140.82 84.15 Favored Pre-proline 0 CA--C 1.549 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 110.83 169.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -60.42 -12.22 19.69 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.883 3.055 . . . . 0.0 117.594 -170.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mt -129.87 -42.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.38 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -86.87 -16.66 35.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.709 0.804 . . . . 0.0 112.26 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.317 0.5 OUTLIER 43.01 32.25 0.4 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.066 2.546 . . . . 0.0 114.798 -169.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -81.59 145.67 55.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 118.925 -0.559 . . . . 0.0 110.113 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.61 142.89 36.97 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.712 2.275 . . . . 0.0 114.042 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.2 mt 65.44 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 130.152 3.381 . . . . 0.0 115.019 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.514 ' HB3' HG21 ' A' ' 32' ' ' VAL . 3.1 t -129.63 -52.12 1.16 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.217 1.807 . . . . 0.0 112.037 -172.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.445 ' H ' HG11 ' A' ' 32' ' ' VAL . 8.8 tp -60.33 -31.57 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.039 1.736 . . . . 0.0 114.298 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -69.38 -8.47 46.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.187 1.395 . . . . 0.0 112.147 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -127.62 11.46 6.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.192 1.797 . . . . 0.0 112.328 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.5 tp -58.78 145.35 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.781 1.632 . . . . 0.0 115.276 -169.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.53 91.87 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.541 2.336 . . . . 0.0 108.477 169.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -77.15 112.36 13.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.956 -1.09 . . . . 0.0 111.361 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.0 mm . . . . . 0 CA--C 1.547 0.839 0 C-N-CA 125.197 1.399 . . . . 0.0 111.728 -177.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 121.514 0.673 . . . . 0.0 111.979 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 3.0 m -60.65 138.6 58.05 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.91 -14.83 61.55 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.49 -53.13 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.908 1.283 . . . . 0.0 111.727 -170.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 m -118.69 -14.3 9.56 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.85 16.11 81.05 Favored Glycine 0 N--CA 1.467 0.719 0 O-C-N 121.79 -0.569 . . . . 0.0 114.022 169.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -91.42 174.04 7.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.409 1.884 . . . . 0.0 113.577 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.33 114.35 28.87 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 125.55 10.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.177 1.918 . . . . 0.0 113.825 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -57.64 -50.72 72.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 111.257 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.48 100.72 14.92 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.812 1.645 . . . . 0.0 110.101 170.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.87 131.78 39.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.664 2.909 . . . . 0.0 111.678 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.16 145.9 23.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 127.894 2.478 . . . . 0.0 110.321 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tt -134.19 159.4 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.248 1.819 . . . . 0.0 110.041 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 p -128.88 152.41 79.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 110.932 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.91 -5.01 16.22 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.241 2.627 . . . . 0.0 113.564 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -70.87 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.21 1.404 . . . . 0.0 110.551 174.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -75.17 -29.66 60.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 113.056 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 56.11 5.54 0.18 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.951 2.1 . . . . 0.0 115.278 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.6 p -70.59 171.6 10.01 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.584 2.353 . . . . 0.0 111.183 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.56 115.96 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -113.78 171.91 7.3 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.09 2.156 . . . . 0.0 111.467 173.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -81.29 137.72 35.77 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -42.98 -49.92 5.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 128.289 2.636 . . . . 0.0 110.363 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.95 71.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.801 -171.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -76.31 -45.0 34.36 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.8 0.84 . . . . 0.0 110.348 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.28 -48.72 74.6 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.94 -45.06 78.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.718 0.407 . . . . 0.0 110.837 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -59.11 -50.69 73.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.282 0.492 . . . . 0.0 111.824 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.38 -34.35 77.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.149 0.976 . . . . 0.0 111.513 -174.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' A' ' 46' ' ' SER . 48.2 t -95.55 -9.89 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.874 1.27 . . . . 0.0 112.314 -173.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -94.44 -13.27 26.38 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 119.909 -1.745 . . . . 0.0 110.441 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.77 -66.64 0.84 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.136 2.574 . . . . 0.0 111.466 169.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.4 p -119.76 -20.31 7.68 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.387 1.475 . . . . 0.0 113.024 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.53 -20.57 13.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.087 0.851 . . . . 0.0 113.896 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.0 148.66 50.73 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.059 1.43 . . . . 0.0 112.423 -170.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.71 144.69 88.74 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.08 -1.013 . . . . 0.0 109.649 168.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.95 -6.84 18.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.678 2.918 . . . . 0.0 116.142 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mt -127.37 -49.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.605 1.162 . . . . 0.0 111.485 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.5 p -83.58 -14.6 51.72 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.339 0.2 OUTLIER 49.52 23.72 0.98 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.528 2.331 . . . . 0.0 114.981 -169.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.28 133.63 91.34 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.3 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.17 135.3 34.09 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.874 2.383 . . . . 0.0 112.715 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.0 mt 67.82 144.34 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.363 3.065 . . . . 0.0 113.998 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.562 ' HB3' HG21 ' A' ' 32' ' ' VAL . 3.8 t -141.04 -49.52 0.42 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.949 2.099 . . . . 0.0 112.364 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.498 ' H ' HG11 ' A' ' 32' ' ' VAL . 44.5 mm -58.65 -33.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.834 2.054 . . . . 0.0 113.808 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.3 -8.78 19.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.75 1.22 . . . . 0.0 112.419 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -132.48 9.17 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.431 1.893 . . . . 0.0 113.183 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.25 139.4 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.831 1.252 . . . . 0.0 114.16 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.14 92.43 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.26 2.224 . . . . 0.0 109.0 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -72.71 130.58 40.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.787 -1.196 . . . . 0.0 110.88 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mm . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 124.66 1.184 . . . . 0.0 109.04 179.792 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 tp . . . . . 0 N--CA 1.468 0.437 0 N-CA-C 111.048 0.018 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.8 t -69.25 147.8 50.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.726 1.25 . . . . 0.0 112.629 -170.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.91 -23.12 25.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.79 . . . . 0.0 112.531 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.16 -45.19 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.951 0.9 . . . . 0.0 111.163 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 t -126.21 -40.14 2.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.687 0.795 . . . . 0.0 112.701 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.34 20.03 36.71 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 121.702 0.612 . . . . 0.0 113.95 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -78.25 168.34 20.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.012 1.325 . . . . 0.0 110.982 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.29 112.83 17.41 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 133.82 20.98 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.649 2.233 . . . . 0.0 112.484 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.12 -34.58 73.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.949 1.3 . . . . 0.0 111.824 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -124.23 83.35 56.62 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.657 1.583 . . . . 0.0 111.067 173.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.54 125.56 18.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.734 2.956 . . . . 0.0 112.273 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 145.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.943 2.097 . . . . 0.0 110.507 -173.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.81 156.3 42.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.15 1.78 . . . . 0.0 109.841 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -127.11 143.54 47.37 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.919 1.288 . . . . 0.0 108.251 169.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.18 0.82 5.39 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.605 2.87 . . . . 0.0 113.866 -172.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -92.69 -67.85 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.202 1.801 . . . . 0.0 109.878 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -56.44 -41.64 76.79 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 59.25 5.67 0.62 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.258 2.223 . . . . 0.0 114.378 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.9 p -77.35 177.02 8.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.761 2.424 . . . . 0.0 111.579 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -122.68 114.54 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.49 171.22 7.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.436 1.894 . . . . 0.0 111.233 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.8 144.19 49.25 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.818 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -56.76 -44.37 81.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 109.707 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -68.18 -36.51 79.72 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.56 -38.76 65.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 0.0 112.022 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -44.48 96.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.948 0.795 . . . . 0.0 109.24 171.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -54.62 -41.23 69.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.5 0.72 . . . . 0.0 110.917 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -58.98 -53.43 58.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.465 0.706 . . . . 0.0 111.398 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.62 -36.65 81.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.366 1.079 . . . . 0.0 112.348 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.471 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.66 -10.86 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.772 1.229 . . . . 0.0 112.999 -175.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -102.1 -10.46 19.65 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.95 -1.094 . . . . 0.0 111.462 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -55.54 5.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.125 1.77 . . . . 0.0 110.691 169.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.4 p -133.98 -22.87 1.8 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.787 1.235 . . . . 0.0 112.426 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.6 -12.89 59.96 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.144 0.878 . . . . 0.0 113.081 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.32 154.88 40.29 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.586 1.693 . . . . 0.0 113.621 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.39 135.09 90.93 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.24 -5.31 12.21 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 121.871 1.714 . . . . 0.0 113.633 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mm -123.12 -45.38 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.197 1.362 . . . . 0.0 111.485 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 p -99.78 -4.93 29.51 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.546 0.739 . . . . 0.0 112.934 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.362 0.0 OUTLIER 45.1 23.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.483 3.113 . . . . 0.0 116.596 -172.041 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -69.82 137.16 87.66 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.58 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.84 130.87 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.933 2.422 . . . . 0.0 112.069 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.253 35.3 mt 70.45 146.29 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.375 3.07 . . . . 0.0 113.411 -170.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 t -143.7 -56.77 0.39 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.342 1.857 . . . . 0.0 110.69 -170.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.471 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.0 tt -59.69 -25.49 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 126.497 1.919 . . . . 0.0 116.041 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.78 -9.35 43.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.001 1.32 . . . . 0.0 112.157 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -126.66 9.21 7.03 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.058 . . . . 0.0 112.626 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.7 tt -58.3 147.11 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.097 1.759 . . . . 0.0 115.403 -172.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.7 97.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 128.635 2.774 . . . . 0.0 109.775 171.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.95 132.1 36.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.356 -1.465 . . . . 0.0 112.309 174.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.596 1.158 . . . . 0.0 110.605 179.746 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.468 0.437 0 CA-C-O 121.052 0.453 . . . . 0.0 110.72 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.7 t -68.34 140.23 55.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 123.074 1.416 . . . . 0.0 113.329 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.18 -20.05 42.02 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.69 -53.32 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.556 0.742 . . . . 0.0 110.871 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -132.24 -16.8 2.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.51 6.65 60.94 Favored Glycine 0 N--CA 1.468 0.797 0 O-C-N 121.295 -0.878 . . . . 0.0 114.822 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -69.08 161.1 29.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.46 1.504 . . . . 0.0 112.583 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.3 119.24 72.56 Favored Pre-proline 0 N--CA 1.473 0.684 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 169.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.83 125.2 9.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.13 1.887 . . . . 0.0 112.191 -171.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -64.6 -41.65 96.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.074 1.349 . . . . 0.0 110.452 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -124.72 92.76 47.3 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 0.0 109.393 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.37 127.78 24.03 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.547 2.832 . . . . 0.0 111.444 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -139.86 148.72 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.46 1.504 . . . . 0.0 110.682 -176.399 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.35 155.52 50.1 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.6 1.56 . . . . 0.0 111.689 -175.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 t -127.88 133.42 25.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 C-N-CA 126.64 1.976 . . . . 0.0 107.409 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.5 -10.0 27.25 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.041 2.494 . . . . 0.0 114.409 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -75.9 -63.64 1.26 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.013 1.725 . . . . 0.0 111.578 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.6 m -66.32 -36.05 81.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.008 0.923 . . . . 0.0 112.167 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 61.05 3.61 0.71 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.534 2.733 . . . . 0.0 114.912 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 p -75.23 174.88 8.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.932 2.493 . . . . 0.0 111.947 171.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.47 117.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.39 168.04 9.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.056 1.742 . . . . 0.0 111.109 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.446 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 5.5 tp10 -67.7 135.09 52.21 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.051 169.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -57.99 -43.51 86.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.952 0.796 . . . . 0.0 109.919 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 m -62.21 -41.91 98.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.467 1.107 . . . . 0.0 113.824 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -75.93 -38.25 57.85 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.129 0.877 . . . . 0.0 111.988 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 tp -60.3 -45.86 91.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 170.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 32' ' ' VAL . 34.4 tt0 -54.87 -37.98 66.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -62.16 -52.08 65.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.631 -0.668 . . . . 0.0 111.708 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.61 -35.62 79.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.114 0.959 . . . . 0.0 112.248 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 29' ' ' GLU . 2.9 p -82.87 -15.46 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.837 1.255 . . . . 0.0 113.027 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -94.88 -13.48 25.42 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.714 -1.241 . . . . 0.0 111.543 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -57.21 4.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.439 170.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -133.18 -22.18 2.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.9 1.28 . . . . 0.0 112.609 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.32 -11.38 58.44 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.191 0.9 . . . . 0.0 113.656 -171.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -65.65 153.62 41.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.154 1.477 . . . . 0.0 113.164 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.8 86.08 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -67.63 -7.27 18.87 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.075 2.517 . . . . 0.0 115.414 -171.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mt -127.38 -47.21 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.441 1.096 . . . . 0.0 111.795 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.2 p -83.96 -12.64 55.03 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.342 0.3 OUTLIER 48.22 24.54 0.69 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.994 2.517 . . . . 0.0 115.237 -169.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.48 119.25 61.2 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.12 0.968 . . . . 0.0 110.589 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.03 133.55 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.598 2.865 . . . . 0.0 114.054 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.7 mp 71.04 141.41 0.05 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.318 3.047 . . . . 0.0 112.845 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.57 -45.84 0.41 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.386 1.874 . . . . 0.0 111.392 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.424 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.2 mm -61.7 -31.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 114.654 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -12.53 53.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.259 1.824 . . . . 0.0 112.445 170.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -124.38 8.33 8.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.974 1.71 . . . . 0.0 112.719 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.424 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.4 tp -58.56 132.55 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.133 1.373 . . . . 0.0 113.878 -172.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.97 94.44 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.069 2.147 . . . . 0.0 109.115 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 14' ' ' VAL . 2.6 mt-10 -74.97 134.71 41.44 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.578 -1.326 . . . . 0.0 110.845 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 123.575 0.75 . . . . 0.0 110.277 179.059 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.8 mt . . . . . 0 N--CA 1.47 0.535 0 CA-C-O 121.514 0.673 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 13.5 t -60.87 137.63 58.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.973 1.368 . . . . 0.0 112.652 -169.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.58 -16.97 40.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.172 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.3 mt -82.77 -47.66 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.476 1.51 . . . . 0.0 110.538 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 p -128.9 -30.18 2.27 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.3 61.18 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 114.764 0.665 . . . . 0.0 114.764 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -53.5 137.38 36.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.458 1.903 . . . . 0.0 110.689 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.77 105.73 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.3 117.16 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.892 2.395 . . . . 0.0 113.663 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -74.36 -42.35 59.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.706 1.602 . . . . 0.0 110.519 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -126.42 90.1 50.69 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.063 2.145 . . . . 0.0 107.682 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -62.69 129.1 25.21 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.704 2.936 . . . . 0.0 111.857 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.02 153.74 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.452 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.44 156.87 47.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.406 1.882 . . . . 0.0 110.08 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -123.17 127.8 25.52 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.501 1.52 . . . . 0.0 108.34 168.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.69 -12.0 2.69 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.816 3.678 . . . . 0.0 117.217 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -62.54 1.66 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.927 1.291 . . . . 0.0 110.964 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 m -69.29 -38.12 78.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.704 1.602 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 57.47 10.88 1.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.938 2.495 . . . . 0.0 114.985 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.2 p -75.14 170.87 15.17 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.135 2.574 . . . . 0.0 111.057 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.21 116.51 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.431 ' CE1' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -113.76 168.96 9.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.409 1.884 . . . . 0.0 111.194 175.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -67.87 137.12 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.492 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -51.66 -46.12 63.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.728 1.211 . . . . 0.0 109.661 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -59.88 -42.07 92.95 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.05 0.843 . . . . 0.0 112.562 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -44.7 67.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.431 HD22 ' CE1' ' A' ' 23' ' ' PHE . 54.0 tp -65.71 -38.85 90.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.546 176.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.49 -40.32 90.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.502 0.721 . . . . 0.0 111.587 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.53 -50.17 73.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.077 0.951 . . . . 0.0 111.582 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -67.06 -37.36 83.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.128 0.966 . . . . 0.0 111.317 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.07 -18.48 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -89.86 -15.68 31.69 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.015 -1.053 . . . . 0.0 112.011 168.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -58.08 3.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.866 1.666 . . . . 0.0 110.978 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.9 p -137.59 -16.87 1.32 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 112.635 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.45 57.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.273 0.939 . . . . 0.0 113.524 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -63.12 153.91 32.73 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.23 1.515 . . . . 0.0 113.48 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.29 129.26 75.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.528 1.131 . . . . 0.0 108.209 167.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.0 -13.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.793 3.662 . . . . 0.0 119.718 -169.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.29 -41.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.141 1.337 . . . . 0.0 112.358 -171.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -92.21 -10.69 37.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.947 0.899 . . . . 0.0 112.576 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.311 0.5 OUTLIER 44.2 31.15 0.52 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.749 2.82 . . . . 0.0 115.355 -171.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.87 134.32 94.04 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.672 172.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.04 133.24 28.37 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.651 2.234 . . . . 0.0 111.628 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 mp 73.86 144.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 128.458 2.703 . . . . 0.0 112.488 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -147.5 -40.42 0.18 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.779 2.431 . . . . 0.0 110.24 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 tp -58.91 -36.18 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.361 1.864 . . . . 0.0 114.677 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -67.6 -7.68 28.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.121 1.368 . . . . 0.0 112.123 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.41 4.73 5.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.183 1.393 . . . . 0.0 113.318 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 tt -66.64 137.8 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 122.313 1.054 . . . . 0.0 113.675 -169.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.2 96.95 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.839 2.056 . . . . 0.0 111.23 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -72.59 123.63 23.6 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.55 -1.344 . . . . 0.0 110.462 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.2 mm . . . . . 0 N--CA 1.474 0.738 0 C-N-CA 125.323 1.449 . . . . 0.0 110.707 -174.913 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.4 mmm . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -119.15 152.67 36.15 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 126.093 1.757 . . . . 0.0 112.033 171.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 11.8 t -65.19 138.88 58.54 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.741 1.258 . . . . 0.0 113.409 -168.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.46 -19.72 49.13 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.841 -1.072 . . . . 0.0 112.116 178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -74.6 -58.23 5.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.095 175.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 22.3 m -135.95 -5.58 2.15 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 116.128 1.899 . . . . 0.0 116.128 -178.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 86.48 7.35 79.36 Favored Glycine 0 N--CA 1.472 1.059 0 CA-C-N 119.961 1.255 . . . . 0.0 115.444 172.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -62.4 141.67 58.23 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 128.018 2.527 . . . . 0.0 111.783 175.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.04 114.63 19.1 Favored Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 169.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.64 145.66 37.49 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 121.956 1.771 . . . . 0.0 114.038 -169.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.4 ptt180 -91.89 -31.39 15.7 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 126.772 2.029 . . . . 0.0 110.136 168.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -126.42 83.25 64.71 Favored Pre-proline 0 N--CA 1.472 0.649 0 C-N-CA 126.29 1.836 . . . . 0.0 109.482 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -57.99 127.48 25.19 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 124.036 3.157 . . . . 0.0 110.637 175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.3 t -141.63 143.56 27.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 C-N-CA 126.413 1.885 . . . . 0.0 110.842 -169.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -125.29 157.4 36.73 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 125.979 1.712 . . . . 0.0 110.296 177.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 30.4 t -127.51 133.35 24.99 Favored Pre-proline 0 N--CA 1.471 0.613 0 C-N-CA 125.699 1.599 . . . . 0.0 108.619 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -55.05 -13.61 6.88 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.931 3.088 . . . . 0.0 117.058 -172.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -95.88 -56.99 2.48 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 119.142 0.883 . . . . 0.0 111.619 -175.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 46.7 p -63.78 -37.95 89.28 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 126.252 1.821 . . . . 0.0 114.264 172.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 51.2 mtp85 58.62 1.14 0.17 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 128.965 2.906 . . . . 0.0 116.923 176.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.9 t -69.52 177.38 2.95 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 126.556 1.942 . . . . 0.0 110.04 168.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.7 mm -116.45 115.81 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 169.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -112.67 169.21 9.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.041 1.336 . . . . 0.0 112.282 172.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -74.25 131.02 40.82 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.389 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -52.42 -42.65 64.28 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.684 1.593 . . . . 0.0 110.622 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.9 m -63.55 -40.42 96.95 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -75.83 -35.18 60.06 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 121.443 -0.786 . . . . 0.0 111.336 -179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 25.1 tp -63.17 -44.79 94.47 Favored 'General case' 0 C--O 1.223 -0.341 0 CA-C-O 119.091 -0.481 . . . . 0.0 109.714 170.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.405 ' HA ' HG12 ' A' ' 32' ' ' VAL . 41.2 tt0 -54.94 -38.93 68.32 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.646 0.778 . . . . 0.0 111.401 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -60.69 -53.32 58.86 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.122 0.487 . . . . 0.0 112.112 171.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -67.18 -34.78 78.25 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.984 0.897 . . . . 0.0 112.328 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.1 p -83.07 -17.36 11.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 124.739 1.215 . . . . 0.0 112.795 -175.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -92.81 -14.65 27.5 Favored 'General case' 0 N--CA 1.48 1.048 0 O-C-N 120.854 -1.154 . . . . 0.0 111.405 168.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.05 -56.96 4.3 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.995 1.718 . . . . 0.0 111.677 170.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -133.67 -21.61 1.95 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 124.938 1.295 . . . . 0.0 112.505 -176.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 83.85 -11.9 55.11 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.086 0.85 . . . . 0.0 113.658 -172.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -67.17 154.51 41.08 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 119.222 1.511 . . . . 0.0 113.317 -170.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.63 133.94 79.45 Favored Pre-proline 0 CA--C 1.55 0.96 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -55.11 -14.08 7.92 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.157 3.238 . . . . 0.0 118.002 -174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 68.6 mt -122.97 -48.84 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.712 1.142 . . . . 0.0 111.548 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 22.3 p -85.84 -11.12 54.18 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.333 0.3 OUTLIER 48.71 24.75 0.85 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 128.049 2.54 . . . . 0.0 115.295 -169.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -65.13 118.44 49.65 Favored Pre-proline 0 CA--C 1.541 0.626 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.24 176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -54.96 132.52 52.71 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 123.448 2.765 . . . . 0.0 113.91 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.1 mp 72.19 144.59 0.07 Allowed 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 128.822 2.849 . . . . 0.0 111.864 -174.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.9 t -143.32 -61.5 0.41 Allowed 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.662 1.585 . . . . 0.0 111.151 -169.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.484 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -62.72 -26.89 41.85 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -70.69 -5.95 33.57 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.446 1.098 . . . . 0.0 112.301 170.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -128.67 11.85 6.26 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.47 1.908 . . . . 0.0 112.328 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.47 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 7.1 tt -57.8 143.62 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.756 1.622 . . . . 0.0 114.697 -171.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.8 t -120.66 86.22 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 127.207 2.203 . . . . 0.0 109.15 170.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -72.02 125.92 28.45 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.078 -1.014 . . . . 0.0 111.412 173.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 29.6 mm -82.25 78.45 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 126.309 1.844 . . . . 0.0 109.196 -175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.8 m -61.9 151.76 78.78 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 125.158 1.383 . . . . 0.0 112.543 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -72.9 -11.23 25.51 Favored 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 123.307 2.671 . . . . 0.0 114.315 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.471 0.579 0 C-N-CA 126.734 2.013 . . . . 0.0 112.859 -177.774 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.8 tpp . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.15 145.56 29.2 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.828 1.651 . . . . 0.0 112.066 174.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 2.2 m -59.7 137.55 58.01 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 115.998 1.851 . . . . 0.0 115.998 -168.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -70.38 -25.0 63.05 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-O 121.088 0.471 . . . . 0.0 112.174 174.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.41 -51.58 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 126.037 1.735 . . . . 0.0 111.584 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 28.8 p -123.33 -18.7 6.17 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.337 1.606 . . . . 0.0 115.337 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 80.19 11.31 84.5 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -67.68 167.45 13.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.112 2.565 . . . . 0.0 113.157 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.0 t -83.45 107.91 11.5 Favored Pre-proline 0 N--CA 1.478 0.935 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -71.76 127.61 13.25 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 122.484 2.123 . . . . 0.0 113.624 -169.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -71.1 -39.47 72.07 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.096 1.358 . . . . 0.0 111.065 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 94.6 mtt-85 -124.7 86.83 55.42 Favored Pre-proline 0 N--CA 1.471 0.604 0 C-N-CA 124.792 1.237 . . . . 0.0 109.969 170.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.18 127.33 25.6 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 124.009 3.139 . . . . 0.0 110.712 175.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.5 t -140.01 142.31 32.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 C-N-CA 126.415 1.886 . . . . 0.0 109.858 -170.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.6 tt -134.56 157.4 46.65 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.801 1.641 . . . . 0.0 110.923 -174.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -132.03 128.32 21.4 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.959 1.704 . . . . 0.0 108.221 169.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -55.68 -12.59 6.74 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.502 3.468 . . . . 0.0 116.714 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -83.79 -58.11 2.93 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.106 1.363 . . . . 0.0 110.567 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 58.2 m -64.98 -27.16 68.64 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.035 1.734 . . . . 0.0 114.705 177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 46.35 45.74 13.45 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 126.344 1.858 . . . . 0.0 113.959 178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.403 HG21 ' HB2' ' A' ' 4' ' ' ALA . 14.8 t -136.71 174.5 10.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.145 2.578 . . . . 0.0 109.401 177.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.5 mt -120.52 116.75 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 171.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -111.47 168.18 9.74 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 126.288 1.835 . . . . 0.0 111.472 173.609 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -73.97 131.11 41.09 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.476 -1.238 . . . . 0.0 107.778 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -46.88 -45.48 20.45 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 125.807 1.643 . . . . 0.0 109.739 179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.7 m -59.29 -37.87 78.77 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -175.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.8 -40.12 33.86 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.008 0.523 . . . . 0.0 110.936 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.5 tp -63.11 -45.68 90.9 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -55.6 -42.62 75.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.484 1.514 . . . . 0.0 111.798 176.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -59.15 -53.07 62.49 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.293 -0.879 . . . . 0.0 111.408 172.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -67.37 -34.26 76.92 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.913 1.285 . . . . 0.0 112.427 -173.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.484 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.02 -17.35 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 124.264 1.025 . . . . 0.0 112.845 -176.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -88.61 -21.03 24.22 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.963 1.305 . . . . 0.0 111.426 168.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.69 -57.64 3.96 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.348 1.859 . . . . 0.0 111.451 175.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.3 p -133.27 -21.53 2.05 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.143 1.377 . . . . 0.0 112.45 -176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.84 -12.45 57.18 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.248 0.927 . . . . 0.0 113.387 -171.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -66.24 156.44 34.23 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 119.492 1.646 . . . . 0.0 113.267 -170.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.42 134.96 57.64 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 167.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.87 -5.21 12.8 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 122.993 2.462 . . . . 0.0 115.377 -169.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 30.9 mt -121.55 -48.08 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 124.904 1.282 . . . . 0.0 111.506 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 40.9 p -88.75 -12.34 42.44 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.356 0.3 OUTLIER 47.42 25.17 0.57 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.053 2.541 . . . . 0.0 115.149 -169.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -69.72 129.96 90.77 Favored Pre-proline 0 CA--C 1.542 0.648 0 CA-C-O 118.495 -0.764 . . . . 0.0 110.243 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -69.4 134.47 28.82 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 122.958 2.438 . . . . 0.0 112.541 -172.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.267 41.0 mt 71.79 133.92 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 129.695 3.198 . . . . 0.0 113.371 -175.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -135.12 -45.03 0.71 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.88 2.072 . . . . 0.0 111.424 -169.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.484 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.1 tp -58.33 -35.12 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 C-N-CA 126.476 1.911 . . . . 0.0 114.469 172.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -68.18 -8.21 36.75 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.499 1.519 . . . . 0.0 111.912 172.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.71 7.21 5.67 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.442 1.497 . . . . 0.0 113.1 -177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.6 tt -63.3 145.36 13.73 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.895 1.331 . . . . 0.0 114.492 -169.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 60.9 t -121.25 96.53 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 128.168 2.587 . . . . 0.0 108.548 169.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -88.37 117.57 27.38 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.1 -1.0 . . . . 0.0 110.976 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.5 mp -83.05 154.28 3.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 C-N-CA 125.377 1.471 . . . . 0.0 109.463 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.3 149.64 82.35 Favored Pre-proline 0 N--CA 1.479 0.979 0 O-C-N 121.051 -1.03 . . . . 0.0 112.921 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.43 -11.39 24.56 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.494 2.796 . . . . 0.0 114.046 177.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 126.849 2.06 . . . . 0.0 113.089 -176.788 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.5 mmm . . . . . 0 CA--C 1.542 0.653 0 N-CA-C 113.62 0.97 . . . . 0.0 113.62 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 92.0 mt -101.65 150.92 22.61 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.187 1.395 . . . . 0.0 111.378 171.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 12.5 t -64.89 141.3 58.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 122.98 1.371 . . . . 0.0 113.482 -168.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.64 -18.51 31.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.665 -1.152 . . . . 0.0 112.47 178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -73.68 -52.75 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 CA-C-O 118.982 -0.532 . . . . 0.0 110.328 172.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 t -140.19 -6.62 1.22 Allowed 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 116.028 1.862 . . . . 0.0 116.028 -176.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.68 5.31 74.81 Favored Glycine 0 N--CA 1.474 1.205 0 O-C-N 120.842 -1.161 . . . . 0.0 115.263 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -57.07 142.67 41.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 127.822 2.449 . . . . 0.0 110.969 173.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.3 t -67.17 108.41 2.47 Favored Pre-proline 0 N--CA 1.477 0.889 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 169.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -55.73 109.99 0.5 Allowed 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 122.816 2.344 . . . . 0.0 114.367 -169.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 70.9 mtm180 -60.5 -48.83 80.03 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.556 1.142 . . . . 0.0 110.781 169.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -119.21 88.59 37.75 Favored Pre-proline 0 N--CA 1.471 0.617 0 C-N-CA 126.231 1.812 . . . . 0.0 109.235 172.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -60.25 127.65 23.74 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.029 3.153 . . . . 0.0 111.588 -176.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -140.55 144.32 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 126.163 1.785 . . . . 0.0 110.104 -171.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -133.37 149.74 51.85 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.401 1.88 . . . . 0.0 110.555 -171.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.4 t -132.67 117.64 15.33 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 168.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -54.91 -12.82 5.28 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 124.327 3.351 . . . . 0.0 116.693 -177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.89 -47.19 60.57 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.764 1.225 . . . . 0.0 112.086 178.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 75.1 m -96.77 -19.76 18.7 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.867 1.267 . . . . 0.0 112.592 174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 48.2 tpt85 64.3 -3.94 0.46 Allowed 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 128.941 2.896 . . . . 0.0 116.031 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.8 p -72.83 168.13 19.51 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 126.792 2.037 . . . . 0.0 113.037 175.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.3 mm -115.11 115.96 51.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -115.32 171.98 7.36 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 126.05 1.74 . . . . 0.0 111.514 177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -74.12 138.27 43.78 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 172.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.88 -46.41 51.66 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 125.672 1.589 . . . . 0.0 109.559 174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 11.7 t -64.4 -42.49 96.07 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.77 -40.83 69.01 Favored 'General case' 0 CA--C 1.537 0.461 0 O-C-N 121.487 -0.758 . . . . 0.0 111.483 -178.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.9 tp -63.49 -44.1 95.36 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.428 0.558 . . . . 0.0 109.575 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -55.77 -39.26 70.97 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.479 0.712 . . . . 0.0 111.442 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.36 -45.65 83.32 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.662 -0.649 . . . . 0.0 111.904 175.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -69.63 -37.83 76.95 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.312 1.045 . . . . 0.0 112.241 -176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.413 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.5 p -79.63 -18.32 12.73 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 124.251 1.02 . . . . 0.0 112.688 -179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -79.2 -30.25 43.28 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 126.9 2.08 . . . . 0.0 110.269 168.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.62 -55.26 6.52 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 126.109 1.764 . . . . 0.0 111.675 -178.107 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 69.7 p -134.24 -21.18 1.84 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.162 1.385 . . . . 0.0 112.175 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 84.71 -10.63 61.7 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 123.998 0.808 . . . . 0.0 113.193 -170.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.16 155.4 35.05 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 119.467 1.634 . . . . 0.0 113.257 -171.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -78.11 136.69 61.38 Favored Pre-proline 0 CA--C 1.55 0.943 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -55.79 -17.37 18.06 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 123.82 3.013 . . . . 0.0 118.584 -169.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 37.8 mt -126.71 -46.29 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 120.253 1.388 . . . . 0.0 111.819 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 p -81.42 -13.35 58.35 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.309 0.5 OUTLIER 44.66 30.29 0.5 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.927 2.491 . . . . 0.0 114.633 -170.744 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.23 135.64 89.07 Favored Pre-proline 0 CA--C 1.544 0.742 0 CA-C-O 118.799 -0.619 . . . . 0.0 109.769 173.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.14 135.83 28.05 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.661 2.241 . . . . 0.0 112.246 -171.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp 70.1 147.7 0.07 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 127.881 2.472 . . . . 0.0 111.673 -172.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.5 t -146.38 -48.47 0.2 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 126.503 1.921 . . . . 0.0 110.621 -169.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.413 ' H ' HG21 ' A' ' 32' ' ' VAL . 9.3 tp -56.89 -31.39 35.97 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 127.279 2.231 . . . . 0.0 114.986 174.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.3 mm-40 -68.2 -6.89 25.89 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.93 1.292 . . . . 0.0 112.129 172.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -132.29 8.87 4.35 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.627 1.571 . . . . 0.0 112.813 -178.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.0 tt -60.31 137.1 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-O 122.806 1.289 . . . . 0.0 113.106 -175.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.5 t -119.93 97.66 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 C-N-CA 127.379 2.272 . . . . 0.0 108.575 169.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -76.24 124.06 26.87 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 120.915 -1.116 . . . . 0.0 109.778 174.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 36.8 mm -82.2 90.56 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.697 1.199 . . . . 0.0 109.908 -174.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 79.2 t -62.22 117.58 31.47 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 125.187 1.395 . . . . 0.0 110.103 175.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -75.7 -16.06 18.91 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 123.079 2.519 . . . . 0.0 114.295 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 126.737 2.015 . . . . 0.0 113.878 -177.769 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.9 ttm . . . . . 0 CA--C 1.54 0.592 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.4 mt -112.76 163.22 14.85 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.535 1.534 . . . . 0.0 111.497 171.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.53 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 1.8 m -48.94 125.42 10.37 Favored 'General case' 0 N--CA 1.445 -0.675 0 N-CA-C 116.284 1.957 . . . . 0.0 116.284 -167.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -70.08 -13.21 62.1 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 177.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.6 mt -89.98 -57.58 4.15 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.947 2.099 . . . . 0.0 111.056 178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 16.9 m -126.78 -11.3 6.08 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -176.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.53 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 75.14 14.27 82.0 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.587 1.085 . . . . 0.0 114.519 171.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -71.84 163.77 27.22 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 128.929 2.892 . . . . 0.0 111.516 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.2 p -75.8 110.14 9.99 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 169.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -71.0 126.68 12.73 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.013 1.809 . . . . 0.0 112.224 -169.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 32.0 ptt180 -78.46 -33.61 48.22 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.263 1.425 . . . . 0.0 111.84 170.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 96.8 mtt-85 -129.93 83.89 62.4 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 125.688 1.595 . . . . 0.0 109.72 170.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -58.13 132.95 52.27 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 123.582 2.855 . . . . 0.0 111.223 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -143.35 148.23 19.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 126.077 1.751 . . . . 0.0 109.611 -169.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.6 tt -135.16 154.61 51.57 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.608 1.563 . . . . 0.0 109.505 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 46.7 m -126.89 119.59 22.53 Favored Pre-proline 0 N--CA 1.469 0.508 0 C-N-CA 124.81 1.244 . . . . 0.0 108.403 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -56.33 -8.06 2.39 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 124.55 3.5 . . . . 0.0 117.326 -174.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.4 -40.07 62.27 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.223 1.409 . . . . 0.0 111.057 177.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.9 p -98.94 -30.43 12.37 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.204 1.802 . . . . 0.0 113.777 173.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 66.8 mtt85 55.4 13.4 0.91 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.486 2.315 . . . . 0.0 114.89 -170.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.1 p -77.66 169.47 18.23 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 125.73 1.612 . . . . 0.0 111.91 170.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 mm -104.94 143.68 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 170.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -143.14 166.39 24.81 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.496 1.918 . . . . 0.0 110.576 168.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -74.82 128.34 35.33 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 114.597 -1.183 . . . . 0.0 108.028 172.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -45.27 -48.14 12.89 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 126.32 1.848 . . . . 0.0 109.756 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 76.0 p -68.86 -24.74 64.38 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -173.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.01 -41.71 50.2 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 119.641 1.109 . . . . 0.0 110.784 172.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.1 tp -64.4 -44.94 89.69 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -54.9 -41.57 71.1 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.732 1.613 . . . . 0.0 111.864 176.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -61.1 -51.05 70.75 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.604 -0.685 . . . . 0.0 112.088 172.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -67.11 -35.72 80.37 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 122.166 0.984 . . . . 0.0 112.075 -175.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -83.83 -15.52 11.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.858 1.263 . . . . 0.0 113.156 -176.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 11.8 ptmm? -95.61 -13.17 24.58 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 121.149 -0.969 . . . . 0.0 111.606 168.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.8 -57.57 3.83 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 126.143 1.777 . . . . 0.0 111.364 169.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 71.6 p -133.39 -21.83 2.0 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.905 1.282 . . . . 0.0 112.515 -175.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.75 -11.03 63.01 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 124.114 0.864 . . . . 0.0 113.316 -171.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -64.35 156.11 30.2 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 119.724 1.762 . . . . 0.0 114.092 -170.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -77.89 130.55 72.74 Favored Pre-proline 0 CA--C 1.549 0.933 0 C-N-CA 124.856 1.263 . . . . 0.0 108.573 168.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -56.76 -8.29 2.92 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 124.222 3.281 . . . . 0.0 118.647 -171.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.1 mt -127.88 -44.35 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.111 1.365 . . . . 0.0 112.282 -169.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.6 p -98.33 -7.56 28.71 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.16 0.984 . . . . 0.0 112.754 178.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.305 0.5 OUTLIER 45.44 29.3 0.58 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 128.812 2.845 . . . . 0.0 115.686 -175.116 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -71.47 139.19 83.87 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-O 118.74 -0.648 . . . . 0.0 110.042 172.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.06 136.91 33.37 Favored 'Trans proline' 0 CA--C 1.536 0.596 0 C-N-CA 122.538 2.159 . . . . 0.0 112.62 -172.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.3 mp 73.96 147.15 0.09 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 129.106 2.962 . . . . 0.0 112.065 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 1.6 t -145.89 -57.79 0.31 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.798 1.639 . . . . 0.0 110.596 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.1 tt -62.85 -26.87 41.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 116.329 1.974 . . . . 0.0 116.329 -177.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -70.01 -6.45 33.49 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.416 1.086 . . . . 0.0 112.181 170.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -127.75 9.57 6.46 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 126.364 1.866 . . . . 0.0 112.337 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.471 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 10.5 tt -59.8 150.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 126.032 1.733 . . . . 0.0 114.906 -174.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 69.4 t -123.99 95.78 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 C-N-CA 128.209 2.603 . . . . 0.0 108.321 169.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -86.37 119.48 26.69 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 121.11 -0.994 . . . . 0.0 110.867 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.1 mp -83.42 97.27 4.51 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 C-N-CA 124.827 1.251 . . . . 0.0 108.401 174.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 14.2 p -53.56 121.09 25.09 Favored Pre-proline 0 N--CA 1.476 0.874 0 C-N-CA 124.153 0.981 . . . . 0.0 111.733 -178.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.78 -15.38 24.02 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.942 2.428 . . . . 0.0 114.336 -171.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.4 m . . . . . 0 N--CA 1.473 0.683 0 C-N-CA 126.347 1.859 . . . . 0.0 112.387 179.774 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 ptm . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.2 mt -102.19 153.68 19.73 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.461 1.505 . . . . 0.0 111.579 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.495 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.3 m -55.32 134.38 50.05 Favored 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 115.737 1.755 . . . . 0.0 115.737 -168.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.47 -16.11 61.8 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 173.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.1 mp -82.86 -58.73 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 C-N-CA 123.73 0.812 . . . . 0.0 110.742 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 m -124.77 -10.53 7.26 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.76 16.29 79.37 Favored Glycine 0 N--CA 1.47 0.956 0 CA-C-N 119.024 0.829 . . . . 0.0 113.261 174.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 56.9 tptt -66.92 160.91 25.26 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 127.897 2.479 . . . . 0.0 110.613 176.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 67.8 t -72.0 112.98 16.45 Favored Pre-proline 0 N--CA 1.473 0.707 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 168.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.49 106.2 0.48 Allowed 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 122.756 2.304 . . . . 0.0 112.306 -169.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 54.2 mtm180 -57.71 -45.87 85.13 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 125.659 1.584 . . . . 0.0 111.287 174.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.402 ' HD2' ' HE3' ' A' ' 25' ' ' LYS . 8.1 mtm180 -122.98 92.43 49.18 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 125.166 1.386 . . . . 0.0 109.949 170.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.64 123.99 13.35 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.617 2.878 . . . . 0.0 111.383 -176.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -138.21 151.36 24.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 114.163 -1.38 . . . . 0.0 110.255 -176.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.8 tt -134.51 149.03 50.65 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.71 1.604 . . . . 0.0 110.794 -173.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.0 t -113.39 131.74 22.8 Favored Pre-proline 0 N--CA 1.468 0.445 0 C-N-CA 124.698 1.199 . . . . 0.0 108.118 168.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -67.58 -5.48 14.27 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.439 2.093 . . . . 0.0 114.289 -177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -55.0 5.13 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.175 1.39 . . . . 0.0 111.042 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 90.8 p -79.75 -35.93 38.03 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.378 1.471 . . . . 0.0 112.694 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 38.9 mtp85 59.86 11.25 2.46 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 128.906 2.882 . . . . 0.0 114.307 -175.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 53.5 p -77.03 175.98 9.09 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 128.281 2.632 . . . . 0.0 111.793 169.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.6 mm -115.13 132.61 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 124.065 0.946 . . . . 0.0 108.449 171.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -129.38 173.63 10.36 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 126.074 1.749 . . . . 0.0 110.243 168.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -72.81 151.8 41.87 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 119.801 -0.759 . . . . 0.0 109.368 172.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE3' ' HD2' ' A' ' 12' ' ' ARG . 17.1 ttpp -56.91 -52.08 66.57 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 119.569 1.077 . . . . 0.0 108.679 171.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 68.4 m -76.19 -24.24 54.7 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -169.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 11.6 mt -72.27 -44.32 62.99 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 118.864 0.756 . . . . 0.0 111.465 171.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 19.6 tp -63.81 -45.14 91.0 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 175.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -53.85 -38.54 64.78 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.238 1.415 . . . . 0.0 111.693 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -62.16 -51.61 67.14 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.479 -0.763 . . . . 0.0 111.885 171.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -67.26 -37.28 83.23 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.457 1.103 . . . . 0.0 112.377 -173.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.467 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.9 p -81.57 -20.0 10.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 C-N-CA 124.504 1.122 . . . . 0.0 112.398 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.0 tttp -81.59 -25.39 35.8 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.764 1.626 . . . . 0.0 111.077 169.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.59 -56.0 5.58 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.261 1.824 . . . . 0.0 111.307 177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 68.6 p -135.25 -21.4 1.6 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.885 1.274 . . . . 0.0 112.458 -174.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.69 -14.57 35.65 Favored Glycine 0 CA--C 1.525 0.671 0 C-N-CA 124.743 1.163 . . . . 0.0 113.857 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -67.22 151.47 47.48 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.026 1.413 . . . . 0.0 111.629 -173.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -68.53 140.06 92.07 Favored Pre-proline 0 CA--C 1.549 0.932 0 O-C-N 121.103 -0.998 . . . . 0.0 110.108 169.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -57.2 -14.39 15.13 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.095 3.197 . . . . 0.0 117.565 -174.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.4 mt -129.15 -50.16 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.88 1.272 . . . . 0.0 112.141 -169.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.6 p -86.06 -11.23 53.34 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.63 0.772 . . . . 0.0 112.548 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.296 0.5 OUTLIER 45.07 30.53 0.61 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.077 2.551 . . . . 0.0 115.191 -171.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -70.76 132.22 87.18 Favored Pre-proline 0 CA--C 1.545 0.779 0 O-C-N 121.431 -0.793 . . . . 0.0 109.653 172.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.02 137.18 36.93 Favored 'Trans proline' 0 CA--C 1.537 0.673 0 C-N-CA 122.729 2.286 . . . . 0.0 112.221 -172.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.4 mp 69.25 139.87 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 128.191 2.597 . . . . 0.0 112.291 -173.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.2 t -139.01 -55.12 0.6 Allowed 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.556 1.542 . . . . 0.0 111.235 -169.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.467 ' H ' HG21 ' A' ' 32' ' ' VAL . 9.3 tp -59.84 -30.38 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 C-N-CA 126.645 1.978 . . . . 0.0 115.104 177.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.3 mm-40 -71.54 -4.06 24.77 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.645 1.178 . . . . 0.0 112.363 171.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -127.94 9.81 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.643 1.577 . . . . 0.0 112.427 177.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.428 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 7.6 tp -58.87 144.08 12.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 125.863 1.665 . . . . 0.0 114.947 -169.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.6 t -121.94 103.12 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 127.793 2.437 . . . . 0.0 109.741 169.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -88.56 123.69 33.3 Favored 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.856 -1.153 . . . . 0.0 112.405 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.9 mp -86.45 151.1 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 125.858 1.663 . . . . 0.0 108.92 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 m -59.04 132.74 87.27 Favored Pre-proline 0 N--CA 1.477 0.913 0 O-C-N 120.862 -1.149 . . . . 0.0 112.515 177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -77.97 -13.17 15.92 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.233 2.622 . . . . 0.0 114.079 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.7 m . . . . . 0 N--CA 1.477 0.888 0 C-N-CA 127.567 2.347 . . . . 0.0 114.199 179.682 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.9 pp -132.23 142.97 49.61 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 125.923 1.689 . . . . 0.0 110.853 170.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -59.33 139.1 57.33 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -168.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.42 -17.44 60.79 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.627 0.602 . . . . 0.0 112.627 171.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -82.47 -59.21 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 C-N-CA 123.783 0.833 . . . . 0.0 110.498 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.7 m -124.82 -3.39 7.71 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 77.15 13.92 83.14 Favored Glycine 0 N--CA 1.472 1.077 0 CA-C-N 119.156 0.889 . . . . 0.0 114.812 170.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -78.59 163.87 25.14 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 128.296 2.638 . . . . 0.0 111.358 -178.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.59 111.73 15.82 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 168.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.72 118.59 5.67 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.424 2.083 . . . . 0.0 112.844 -169.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 59.7 ttm-85 -61.28 -35.95 78.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.383 1.473 . . . . 0.0 111.604 170.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 86.1 mmt-85 -129.76 91.26 40.8 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.21 1.404 . . . . 0.0 110.65 171.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.12 127.13 22.13 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 124.016 3.144 . . . . 0.0 112.136 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.9 t -141.18 143.36 28.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 C-N-CA 126.664 1.986 . . . . 0.0 110.005 -173.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.9 tt -131.4 158.05 41.8 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.66 1.584 . . . . 0.0 110.504 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.5 t -129.69 130.0 23.17 Favored Pre-proline 0 CA--C 1.538 0.504 0 C-N-CA 125.756 1.623 . . . . 0.0 108.36 169.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -55.11 -16.22 12.11 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.812 3.008 . . . . 0.0 116.318 -176.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -82.37 -47.13 12.68 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.153 1.381 . . . . 0.0 111.693 -178.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 82.6 p -79.04 -35.75 42.16 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.014 1.326 . . . . 0.0 113.084 174.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.292 15.2 ptm180 50.37 11.6 0.08 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 129.409 3.084 . . . . 0.0 115.358 -169.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 60.1 p -75.51 173.73 10.6 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 128.159 2.584 . . . . 0.0 111.054 169.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -122.27 116.14 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 O-C-N 121.155 -0.965 . . . . 0.0 108.559 171.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -114.27 175.01 5.66 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 126.627 1.971 . . . . 0.0 111.25 172.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 15.1 tt0 -75.39 149.16 38.69 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.055 174.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 19.9 ttpp -54.79 -49.71 70.26 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.7 m -71.32 -32.66 68.86 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 -172.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.417 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 9.3 mt -71.5 -44.31 64.92 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.142 0.577 . . . . 0.0 111.524 174.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.11 -44.0 93.61 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.407 ' HA ' HG12 ' A' ' 32' ' ' VAL . 47.7 tt0 -54.7 -39.88 68.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.57 1.548 . . . . 0.0 111.357 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.4 tt0 -61.71 -51.38 68.63 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.212 0.605 . . . . 0.0 111.573 172.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -67.46 -35.78 79.86 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 122.028 0.918 . . . . 0.0 112.114 -174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.3 p -83.97 -15.28 11.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 124.955 1.302 . . . . 0.0 113.185 -176.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.4 ptmt -96.13 -12.63 24.47 Favored 'General case' 0 N--CA 1.481 1.075 0 O-C-N 121.072 -1.018 . . . . 0.0 111.486 168.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.02 -57.65 3.77 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.996 1.718 . . . . 0.0 111.291 169.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -132.5 -22.34 2.19 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.025 1.33 . . . . 0.0 112.538 -175.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.39 -11.26 63.95 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 124.218 0.913 . . . . 0.0 113.151 -171.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -63.79 155.42 30.4 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 119.552 1.676 . . . . 0.0 113.862 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -82.33 130.96 57.34 Favored Pre-proline 0 CA--C 1.548 0.88 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 167.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -66.57 -4.28 10.63 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 124.042 3.161 . . . . 0.0 116.243 -169.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 46.5 mm -115.82 -41.44 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.207 1.403 . . . . 0.0 111.776 -176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -105.03 -9.24 17.98 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.054 1.342 . . . . 0.0 113.662 -177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.373 0.0 OUTLIER 50.02 22.4 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 128.732 2.813 . . . . 0.0 115.635 -169.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -65.58 132.15 94.95 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.456 -0.777 . . . . 0.0 110.503 176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -70.51 130.54 18.57 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.759 2.306 . . . . 0.0 112.398 -172.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.26 38.8 mt 71.8 139.1 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 129.092 2.957 . . . . 0.0 113.378 -173.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 5.6 t -137.36 -51.58 0.65 Allowed 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.302 2.241 . . . . 0.0 110.59 -169.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.3 tp -55.47 -34.66 35.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 127.801 2.44 . . . . 0.0 115.193 174.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -66.03 -9.56 31.71 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.393 1.477 . . . . 0.0 112.066 172.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -133.2 10.28 4.14 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.714 1.606 . . . . 0.0 112.941 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 12.7 tt -59.44 147.35 8.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 -174.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 58.6 t -121.84 91.95 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 128.011 2.524 . . . . 0.0 108.531 169.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -77.03 126.92 31.77 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 121.06 -1.025 . . . . 0.0 110.693 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 76.2 mt -98.65 148.03 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 C-N-CA 125.328 1.451 . . . . 0.0 109.696 -177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 46.4 t -60.49 117.9 29.03 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.185 1.394 . . . . 0.0 110.343 177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -57.64 -24.67 63.76 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 123.581 2.854 . . . . 0.0 116.428 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.473 0.698 0 C-N-CA 126.123 1.769 . . . . 0.0 112.498 179.655 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.542 0.669 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 71.7 mt -99.83 148.81 24.03 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.169 1.388 . . . . 0.0 111.352 -175.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.7 m -56.12 138.13 50.25 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 116.525 2.046 . . . . 0.0 116.525 -168.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.427 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -68.72 -23.86 64.4 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 174.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.0 mt -94.13 -46.94 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 124.681 1.192 . . . . 0.0 112.12 -169.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.9 t -123.66 -17.81 6.3 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.22 13.86 82.87 Favored Glycine 0 N--CA 1.47 0.953 0 O-C-N 121.277 -0.889 . . . . 0.0 114.642 174.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -72.2 162.96 28.73 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.841 2.857 . . . . 0.0 111.285 179.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -76.54 106.73 3.62 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 168.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -61.04 119.15 6.16 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.293 1.995 . . . . 0.0 114.247 -168.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 61.2 mmt-85 -71.19 -34.84 71.25 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.309 1.044 . . . . 0.0 111.867 170.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -122.89 83.95 50.05 Favored Pre-proline 0 N--CA 1.478 0.928 0 C-N-CA 125.16 1.384 . . . . 0.0 110.382 169.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -61.3 121.61 9.88 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 124.132 3.221 . . . . 0.0 111.744 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.83 142.15 32.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 127.144 2.178 . . . . 0.0 110.876 -169.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 tp -133.03 157.59 44.85 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 127.424 2.289 . . . . 0.0 110.075 -173.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.1 p -131.92 149.26 72.84 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 124.563 1.145 . . . . 0.0 110.681 169.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -71.61 -7.31 20.95 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.239 2.626 . . . . 0.0 113.921 -178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.82 -56.06 3.23 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.703 1.201 . . . . 0.0 110.428 172.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 98.9 p -66.38 -37.21 84.75 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.964 1.306 . . . . 0.0 113.63 -176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 70.2 mtm180 55.61 4.5 0.11 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 127.665 2.386 . . . . 0.0 116.272 -177.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 4' ' ' ALA . 8.0 t -86.68 179.59 6.76 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 128.362 2.665 . . . . 0.0 111.68 170.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -121.46 116.51 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.433 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.23 172.11 7.11 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 126.312 1.845 . . . . 0.0 111.94 170.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -83.33 136.17 34.46 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.817 173.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -49.5 -43.85 45.75 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.305 1.842 . . . . 0.0 110.444 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 t -61.04 -39.62 90.5 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.612 -0.722 . . . . 0.0 112.883 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 9.7 mt -72.69 -42.2 64.48 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.319 1.048 . . . . 0.0 110.804 179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.38 -44.57 94.35 Favored 'General case' 0 C--O 1.223 -0.342 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -53.68 -43.77 69.18 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.973 0.909 . . . . 0.0 110.72 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.6 tp60 -59.13 -55.46 34.72 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 122.19 -0.319 . . . . 0.0 111.851 174.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -65.45 -33.42 75.91 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.226 1.012 . . . . 0.0 112.331 -173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.515 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.4 p -86.62 -13.46 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 124.957 1.303 . . . . 0.0 113.348 -175.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 45.8 pttt -99.55 -10.95 21.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.774 1.23 . . . . 0.0 111.618 168.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.59 -56.3 4.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.968 2.107 . . . . 0.0 110.897 169.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.2 p -134.57 -23.2 1.64 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.972 1.309 . . . . 0.0 112.727 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.72 -12.55 63.15 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.677 1.132 . . . . 0.0 113.086 -171.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -63.72 156.51 26.83 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 119.145 1.473 . . . . 0.0 113.984 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -82.08 130.58 59.6 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 167.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -65.38 -4.78 10.02 Favored 'Trans proline' 0 CA--C 1.543 0.936 0 C-N-CA 124.004 3.136 . . . . 0.0 117.321 -168.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 74.0 mt -116.33 -49.36 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.568 1.147 . . . . 0.0 110.912 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.9 p -91.31 -12.87 33.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.398 1.079 . . . . 0.0 113.796 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.381 0.0 OUTLIER 50.67 23.83 1.49 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.334 2.654 . . . . 0.0 115.193 -169.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -68.34 137.2 91.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.508 0.723 . . . . 0.0 110.219 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.57 140.18 39.04 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.337 2.025 . . . . 0.0 112.742 -172.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.4 mt 66.33 128.27 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 128.954 2.901 . . . . 0.0 114.704 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -129.24 -45.4 1.24 Allowed 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 126.032 1.733 . . . . 0.0 111.544 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.515 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.1 tp -58.97 -35.2 55.48 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 126.982 2.113 . . . . 0.0 114.507 172.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -67.61 -8.88 38.08 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.304 1.442 . . . . 0.0 111.84 170.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -128.39 8.69 6.0 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.627 1.571 . . . . 0.0 112.99 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.2 tt -59.93 137.4 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.726 1.251 . . . . 0.0 114.236 -169.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.3 t -119.66 91.14 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 127.045 2.138 . . . . 0.0 108.82 169.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -76.19 115.93 16.39 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 121.027 -1.046 . . . . 0.0 110.074 173.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.5 mt -80.44 -25.88 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 C-N-CA 125.033 1.333 . . . . 0.0 111.07 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.0 t -23.56 98.57 0.06 OUTLIER Pre-proline 0 N--CA 1.481 1.105 0 C-N-CA 130.44 3.496 . . . . 0.0 114.34 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -59.05 -24.01 71.52 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 124.057 3.172 . . . . 0.0 115.936 -178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.471 0.59 0 C-N-CA 126.122 1.769 . . . . 0.0 112.878 -175.951 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.6 mmm . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.7 mt -101.8 154.11 19.21 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.379 1.471 . . . . 0.0 111.564 172.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.483 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 0.5 OUTLIER -56.88 135.67 55.81 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -168.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.29 -23.97 64.8 Favored 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.995 174.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.91 -49.06 14.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 125.473 1.509 . . . . 0.0 112.164 -169.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.4 t -126.23 -23.33 3.88 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.483 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.51 18.83 78.77 Favored Glycine 0 N--CA 1.469 0.853 0 C-N-CA 124.138 0.875 . . . . 0.0 113.394 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -65.93 155.2 37.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 128.661 2.784 . . . . 0.0 111.452 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.54 109.16 2.47 Favored Pre-proline 0 N--CA 1.476 0.868 0 C-N-CA 124.079 0.952 . . . . 0.0 109.481 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.05 120.36 8.18 Favored 'Trans proline' 0 CA--C 1.54 0.798 0 C-N-CA 122.944 2.429 . . . . 0.0 113.708 -171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -81.72 -49.08 10.86 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 126.506 1.922 . . . . 0.0 110.294 169.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -128.82 85.86 59.06 Favored Pre-proline 0 N--CA 1.471 0.601 0 C-N-CA 126.57 1.948 . . . . 0.0 109.545 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -59.32 138.31 83.78 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.655 2.903 . . . . 0.0 111.411 177.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -145.88 154.15 13.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 125.369 1.467 . . . . 0.0 109.969 -170.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.2 tt -136.49 155.4 50.03 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.413 1.485 . . . . 0.0 110.173 -177.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 40.4 t -125.15 136.55 28.3 Favored Pre-proline 0 N--CA 1.469 0.48 0 C-N-CA 125.647 1.579 . . . . 0.0 108.116 169.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.48 -10.48 27.92 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.766 2.311 . . . . 0.0 113.796 -178.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -74.85 -67.69 0.62 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 126.859 2.064 . . . . 0.0 111.48 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.8 m -64.37 -37.0 85.98 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.365 1.066 . . . . 0.0 112.826 174.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 9.0 tpp85 63.6 -1.53 0.59 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 127.845 2.458 . . . . 0.0 115.107 -171.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.5 p -77.64 177.12 8.35 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.585 2.354 . . . . 0.0 111.939 173.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 mm -106.61 141.62 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 170.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -136.71 167.86 20.62 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.763 1.625 . . . . 0.0 110.27 168.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -78.35 130.51 36.25 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 174.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.06 -43.08 40.54 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.696 1.998 . . . . 0.0 110.468 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 t -60.21 -43.14 96.21 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.78 -40.26 41.38 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 121.49 -0.756 . . . . 0.0 110.961 -175.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 23.1 tp -61.76 -48.66 79.69 Favored 'General case' 0 C--O 1.226 -0.182 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -58.26 -42.18 85.91 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 117.833 0.288 . . . . 0.0 111.062 179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -58.43 -49.55 76.9 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.175 0.512 . . . . 0.0 111.926 175.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -64.23 -35.19 80.01 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.696 1.198 . . . . 0.0 111.879 -177.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.506 HG21 ' CB ' ' A' ' 46' ' ' SER . 43.5 t -94.0 -13.55 8.41 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 124.775 1.23 . . . . 0.0 112.093 -172.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -91.39 -12.71 34.03 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 119.813 -1.805 . . . . 0.0 110.391 167.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.89 -65.71 0.91 Allowed 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.95 2.1 . . . . 0.0 110.995 169.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 29.7 p -126.6 -15.12 5.62 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.069 1.348 . . . . 0.0 113.632 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.36 -18.02 25.93 Favored Glycine 0 CA--C 1.524 0.598 0 C-N-CA 123.923 0.773 . . . . 0.0 113.822 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -68.24 149.09 49.92 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 119.266 1.533 . . . . 0.0 112.772 -170.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.5 142.48 94.34 Favored Pre-proline 0 CA--C 1.549 0.939 0 O-C-N 121.364 -0.835 . . . . 0.0 110.281 169.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.75 -5.57 17.12 Favored 'Trans proline' 0 CA--C 1.545 1.047 0 C-N-CA 123.254 2.636 . . . . 0.0 114.841 -173.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.4 mm -118.55 -52.45 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.061 0 C-N-CA 124.716 1.206 . . . . 0.0 110.566 -176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.7 p -89.96 -13.47 36.1 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 113.347 0.869 . . . . 0.0 113.347 -177.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.328 0.4 OUTLIER 45.84 31.07 0.97 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.208 2.203 . . . . 0.0 114.462 -169.035 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -75.29 135.68 72.68 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 118.796 -0.621 . . . . 0.0 110.041 169.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.07 140.74 42.23 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.175 2.583 . . . . 0.0 113.049 -170.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.1 mt 65.1 149.14 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 129.365 3.066 . . . . 0.0 114.192 -172.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.506 ' CB ' HG21 ' A' ' 32' ' ' VAL . 1.0 OUTLIER -142.86 -54.18 0.4 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.301 1.84 . . . . 0.0 111.85 -173.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.414 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 10.1 tp -61.37 -30.87 48.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.646 1.978 . . . . 0.0 114.82 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -67.86 -9.37 44.16 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.309 1.444 . . . . 0.0 112.0 171.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -130.61 12.88 5.41 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.853 1.661 . . . . 0.0 112.483 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.414 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.6 tp -57.44 141.39 14.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 C-N-CA 125.492 1.517 . . . . 0.0 114.118 -172.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 25.6 t -122.86 92.61 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 C-N-CA 126.958 2.103 . . . . 0.0 109.792 171.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.418 ' HA ' HG23 ' A' ' 14' ' ' VAL . 1.5 mp0 -78.3 126.14 30.36 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 120.853 -1.154 . . . . 0.0 112.257 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.7 mm -96.6 57.72 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 125.441 1.496 . . . . 0.0 108.783 -177.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 37.3 t -52.82 112.46 3.52 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 126.564 1.946 . . . . 0.0 112.079 -169.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -55.98 -29.91 75.72 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 123.839 3.026 . . . . 0.0 115.77 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 16.4 m . . . . . 0 N--CA 1.473 0.685 0 C-N-CA 126.0 1.72 . . . . 0.0 112.639 -178.66 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ttt . . . . . 0 CA--C 1.546 0.822 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 4.0 pp -102.26 149.33 24.43 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.632 1.573 . . . . 0.0 111.446 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.471 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 3.0 m -59.47 136.43 57.97 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 115.783 1.772 . . . . 0.0 115.783 -168.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.51 -17.11 62.36 Favored 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 175.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.7 mt -98.69 -49.97 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 125.269 1.428 . . . . 0.0 111.522 -171.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 31.7 p -116.28 -24.47 7.93 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 177.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.471 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 82.11 12.39 80.99 Favored Glycine 0 CA--C 1.528 0.891 0 N-CA-C 115.406 0.922 . . . . 0.0 115.406 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -68.96 166.59 17.62 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 127.424 2.29 . . . . 0.0 112.198 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.75 107.42 7.35 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 168.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.72 114.9 1.53 Allowed 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.469 2.779 . . . . 0.0 117.33 -168.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.9 ttp180 -62.55 -44.93 95.11 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.158 1.383 . . . . 0.0 110.492 169.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 16.3 mmm-85 -126.67 94.77 39.35 Favored Pre-proline 0 N--CA 1.473 0.696 0 C-N-CA 126.161 1.784 . . . . 0.0 109.678 169.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -61.72 125.92 17.79 Favored 'Trans proline' 0 C--N 1.35 0.614 0 C-N-CA 124.066 3.178 . . . . 0.0 111.036 178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.4 t -141.34 142.71 28.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 126.302 1.841 . . . . 0.0 110.366 -171.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 tt -131.63 157.75 42.85 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.523 1.529 . . . . 0.0 110.889 -177.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.6 t -134.51 125.9 17.9 Favored Pre-proline 0 CA--C 1.539 0.551 0 C-N-CA 125.634 1.574 . . . . 0.0 108.609 169.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -53.72 -11.65 2.45 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 125.172 3.914 . . . . 0.0 117.309 -178.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.71 -55.46 5.84 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.805 1.242 . . . . 0.0 111.178 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 38.6 m -79.8 -37.34 35.44 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 125.505 1.522 . . . . 0.0 112.366 178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.1 mtm-85 56.23 7.97 0.37 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 128.114 2.566 . . . . 0.0 115.429 -171.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.1 p -74.26 174.22 9.09 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 127.65 2.38 . . . . 0.0 110.395 169.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.2 mt -121.38 118.1 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 171.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -112.76 171.14 7.71 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 126.428 1.891 . . . . 0.0 111.406 173.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -80.01 134.62 36.24 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.3 172.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -45.67 -46.64 14.84 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.742 2.017 . . . . 0.0 110.249 179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.0 m -63.66 -33.35 75.43 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.041 -0.981 . . . . 0.0 112.966 -172.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 5.2 mt -75.38 -45.22 40.45 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.288 1.035 . . . . 0.0 110.73 177.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -63.33 -45.04 93.15 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -56.19 -42.77 77.66 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.71 1.604 . . . . 0.0 111.867 175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 -59.25 -51.64 69.09 Favored 'General case' 0 CA--C 1.539 0.544 0 O-C-N 121.188 -0.945 . . . . 0.0 111.409 172.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -67.49 -34.29 76.85 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.147 1.379 . . . . 0.0 112.239 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.501 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.2 p -83.1 -18.64 10.37 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 C-N-CA 124.252 1.021 . . . . 0.0 112.872 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -85.77 -22.74 27.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.089 1.355 . . . . 0.0 111.363 168.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.44 -57.42 4.02 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 126.558 1.943 . . . . 0.0 111.59 176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 74.2 p -133.38 -21.38 2.04 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.029 1.332 . . . . 0.0 112.451 -176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.13 -12.14 58.84 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.231 0.92 . . . . 0.0 113.341 -171.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.44 156.06 30.68 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 119.389 1.595 . . . . 0.0 113.709 -170.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -82.74 131.36 54.89 Favored Pre-proline 0 CA--C 1.548 0.884 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 167.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -65.53 -4.89 10.4 Favored 'Trans proline' 0 CA--C 1.544 1.001 0 C-N-CA 123.862 3.041 . . . . 0.0 117.15 -168.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 48.6 mm -112.85 -53.2 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.736 1.214 . . . . 0.0 110.709 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 55.3 p -88.64 -12.07 43.58 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.517 1.127 . . . . 0.0 113.89 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.38 0.0 OUTLIER 52.58 21.27 1.76 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 128.313 2.645 . . . . 0.0 115.12 -169.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -63.69 122.17 75.0 Favored Pre-proline 0 CA--C 1.545 0.754 0 C-N-CA 123.673 0.789 . . . . 0.0 111.048 177.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -54.9 130.26 39.68 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.469 2.779 . . . . 0.0 114.145 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.265 34.8 mt 72.0 132.69 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 129.272 3.029 . . . . 0.0 113.265 -178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 6.7 t -132.95 -46.71 0.86 Allowed 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 127.126 2.171 . . . . 0.0 111.135 -169.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.501 ' H ' HG21 ' A' ' 32' ' ' VAL . 10.2 tp -56.57 -33.78 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 126.85 2.06 . . . . 0.0 114.354 171.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -67.13 -7.54 24.14 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.621 1.568 . . . . 0.0 112.077 171.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -130.83 6.65 4.69 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.285 1.434 . . . . 0.0 113.461 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.3 tt -60.05 138.98 20.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 122.723 1.249 . . . . 0.0 113.696 -171.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 61.2 t -120.97 88.73 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.112 2.165 . . . . 0.0 108.235 169.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -74.25 140.12 44.78 Favored 'General case' 0 CA--C 1.54 0.596 0 O-C-N 120.871 -1.143 . . . . 0.0 111.598 174.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mp -101.2 153.41 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 125.637 1.575 . . . . 0.0 108.935 169.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.97 153.55 79.84 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 125.512 1.525 . . . . 0.0 111.804 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -53.97 -34.37 76.5 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.842 3.028 . . . . 0.0 115.596 -178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 64.9 p . . . . . 0 C--O 1.239 0.545 0 C-N-CA 125.212 1.405 . . . . 0.0 111.801 175.202 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 tpt . . . . . 0 CA--C 1.546 0.793 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.457 ' H ' HD23 ' A' ' 2' ' ' LEU . 1.8 pt? -100.34 143.53 30.42 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.329 1.452 . . . . 0.0 112.202 177.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.441 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.6 m -58.8 145.44 40.66 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 116.814 2.153 . . . . 0.0 116.814 -168.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.402 ' HB2' HG21 ' A' ' 21' ' ' THR . . . -68.02 -37.09 81.0 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 122.121 0.962 . . . . 0.0 111.335 173.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 84.1 mt -80.15 -53.39 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.595 1.958 . . . . 0.0 112.771 -168.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 25.0 m -123.23 -8.74 8.16 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 72.84 16.2 78.13 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-N 118.891 0.769 . . . . 0.0 114.543 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -76.18 164.53 26.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.581 2.753 . . . . 0.0 111.428 -177.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 66.0 t -79.71 106.83 5.35 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 168.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -67.6 129.21 19.53 Favored 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 122.183 1.922 . . . . 0.0 113.594 -169.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.93 -45.08 94.18 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.711 1.604 . . . . 0.0 110.159 169.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 67.3 mtp85 -122.83 91.05 49.92 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.587 1.555 . . . . 0.0 110.643 170.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -58.1 124.94 17.07 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.795 2.997 . . . . 0.0 111.451 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.16 145.46 28.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 127.25 2.22 . . . . 0.0 110.395 -172.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.5 tp -131.94 153.77 49.95 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.68 1.992 . . . . 0.0 110.812 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 11.4 t -136.76 125.58 15.22 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 126.816 2.046 . . . . 0.0 106.205 168.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -67.81 -6.58 17.25 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.985 2.456 . . . . 0.0 114.169 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.26 -61.38 1.92 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.748 1.619 . . . . 0.0 110.78 176.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.1 m -81.98 -10.41 59.26 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 176.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.268 15.2 ptp180 43.63 41.71 3.68 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 128.773 2.829 . . . . 0.0 117.041 169.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.402 HG21 ' HB2' ' A' ' 4' ' ' ALA . 14.8 t -133.98 172.35 12.94 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.239 2.216 . . . . 0.0 110.224 170.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.56 114.23 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -112.57 170.93 7.83 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 127.557 2.343 . . . . 0.0 110.638 176.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 12.2 tt0 -73.48 149.49 42.28 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 117.922 -1.511 . . . . 0.0 109.765 175.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -53.44 -44.14 68.61 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.116 0.966 . . . . 0.0 109.046 169.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.0 m -62.2 -41.02 97.98 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.802 1.241 . . . . 0.0 112.894 -178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 8.0 mt -71.38 -45.87 61.76 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.139 0.576 . . . . 0.0 110.316 -179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -64.17 -43.69 94.38 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -54.86 -42.5 72.12 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.848 1.259 . . . . 0.0 111.453 176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -59.9 -52.62 64.66 Favored 'General case' 0 N--CA 1.467 0.376 0 O-C-N 122.106 -0.371 . . . . 0.0 111.588 173.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -67.09 -34.46 77.69 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-O 122.169 0.985 . . . . 0.0 112.15 -173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.426 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.0 p -84.44 -14.27 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 124.333 1.053 . . . . 0.0 113.235 -176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.8 pttp -98.18 -11.27 22.93 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.408 1.083 . . . . 0.0 111.843 168.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.86 -56.09 5.01 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.764 2.025 . . . . 0.0 110.841 169.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 67.2 p -135.19 -22.73 1.54 Allowed 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.745 1.218 . . . . 0.0 112.726 -176.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.09 -11.28 65.54 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 124.483 1.039 . . . . 0.0 113.025 -170.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -63.83 157.35 24.8 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.309 1.554 . . . . 0.0 113.518 -174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -80.94 135.87 51.3 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.511 1.124 . . . . 0.0 108.037 167.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -64.64 -8.23 16.85 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 N-CA-C 118.905 2.617 . . . . 0.0 118.905 -168.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 59.9 mt -124.74 -44.78 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 121.09 1.768 . . . . 0.0 111.564 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 p -84.19 -13.12 53.59 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.315 0.4 OUTLIER 44.89 30.64 0.58 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.677 2.391 . . . . 0.0 114.766 -170.392 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -69.61 134.37 88.49 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.641 173.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.11 135.56 27.52 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.512 2.142 . . . . 0.0 112.296 -172.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.7 mp 70.72 144.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 127.97 2.508 . . . . 0.0 111.861 -172.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.9 t -145.09 -52.4 0.28 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.723 2.009 . . . . 0.0 110.646 -169.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.426 ' H ' HG21 ' A' ' 32' ' ' VAL . 11.0 tp -57.62 -32.87 43.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 C-N-CA 127.553 2.341 . . . . 0.0 115.628 178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -67.82 -8.26 34.66 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.394 1.078 . . . . 0.0 112.086 171.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -132.13 11.22 4.61 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.291 1.836 . . . . 0.0 112.532 -177.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.8 tt -59.39 142.01 15.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 CA-C-O 122.842 1.306 . . . . 0.0 113.475 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -122.33 97.84 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 127.839 2.456 . . . . 0.0 109.023 169.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -73.92 112.25 9.87 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 120.74 -1.225 . . . . 0.0 110.452 174.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 47.9 mm -80.64 -29.6 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 125.571 1.548 . . . . 0.0 111.227 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 11.9 p -54.4 133.98 62.13 Favored Pre-proline 0 CA--C 1.548 0.866 0 C-N-CA 125.234 1.414 . . . . 0.0 111.459 171.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -70.38 -16.76 35.0 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.866 2.377 . . . . 0.0 114.27 -177.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 4.6 t . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 127.166 2.186 . . . . 0.0 114.025 173.38 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.6 ptm . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.426 ' H ' HD23 ' A' ' 2' ' ' LEU . 1.8 pt? -124.88 153.53 42.48 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.727 2.011 . . . . 0.0 112.482 179.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.497 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 2.7 m -58.9 136.01 57.73 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -168.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.58 -21.46 64.52 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.45 0.537 . . . . 0.0 112.45 176.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -94.74 -49.7 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 C-N-CA 125.879 1.671 . . . . 0.0 111.923 -170.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.3 t -126.84 -16.95 5.05 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.497 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.72 13.61 83.37 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 120.926 -1.109 . . . . 0.0 114.72 175.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -69.41 164.08 23.79 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 128.885 2.874 . . . . 0.0 112.088 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 p -82.4 110.19 20.21 Favored Pre-proline 0 N--CA 1.475 0.791 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.64 138.33 37.94 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 122.155 1.903 . . . . 0.0 113.823 -169.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.3 mpt_? -84.59 -41.3 16.55 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.433 2.293 . . . . 0.0 109.894 169.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 6.7 mmt180 -121.68 86.17 44.83 Favored Pre-proline 0 N--CA 1.474 0.744 0 C-N-CA 125.994 1.718 . . . . 0.0 108.832 169.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -58.02 124.75 16.67 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 123.886 3.057 . . . . 0.0 109.685 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.6 t -138.03 142.89 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 125.84 1.656 . . . . 0.0 110.494 -169.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -133.12 154.45 50.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.421 1.488 . . . . 0.0 110.568 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 16.5 t -131.9 128.73 21.66 Favored Pre-proline 0 N--CA 1.469 0.507 0 C-N-CA 127.049 2.139 . . . . 0.0 106.054 168.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -66.39 -7.57 18.03 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.35 2.7 . . . . 0.0 115.004 -169.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -74.61 -63.34 1.27 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.288 1.035 . . . . 0.0 110.921 174.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 m -64.08 -36.46 84.08 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.86 1.264 . . . . 0.0 111.814 170.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . 0.353 11.1 ptp180 47.92 17.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 129.741 3.216 . . . . 0.0 116.092 -172.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 44.3 p -77.99 174.44 11.09 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 128.312 2.645 . . . . 0.0 109.82 168.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mp -121.16 116.51 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 170.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.434 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -114.14 169.01 9.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 126.787 2.035 . . . . 0.0 111.644 174.907 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -75.83 131.28 39.63 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 173.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -47.92 -45.51 30.9 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.948 1.699 . . . . 0.0 110.047 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 16.9 m -59.97 -35.18 74.44 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -79.46 -39.88 31.16 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.255 0.622 . . . . 0.0 111.089 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.0 tp -62.69 -46.11 89.65 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -56.2 -40.39 73.93 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 125.551 1.54 . . . . 0.0 112.023 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -60.91 -52.52 64.68 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 121.513 -0.742 . . . . 0.0 111.83 170.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -67.37 -34.7 77.84 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.204 1.002 . . . . 0.0 111.849 -173.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.507 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.9 p -82.84 -18.36 10.67 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.697 0 C-N-CA 124.631 1.172 . . . . 0.0 113.033 -176.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.9 pttp -91.38 -15.4 29.04 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 121.07 -1.019 . . . . 0.0 111.636 168.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.87 -56.41 4.7 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.388 1.875 . . . . 0.0 111.702 172.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.8 p -132.93 -21.84 2.11 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.086 1.354 . . . . 0.0 112.395 -176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.11 -12.13 55.24 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.27 0.938 . . . . 0.0 113.575 -171.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -66.58 156.07 36.06 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 119.589 1.694 . . . . 0.0 113.927 -169.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.95 135.09 59.24 Favored Pre-proline 0 CA--C 1.546 0.808 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 166.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.89 -4.05 11.64 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 123.211 2.607 . . . . 0.0 115.018 -170.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 50.3 mm -118.28 -50.65 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 124.92 1.288 . . . . 0.0 110.714 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 44.7 p -87.25 -13.01 44.98 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.384 0.0 OUTLIER 49.68 21.33 0.63 Allowed 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 128.338 2.655 . . . . 0.0 115.138 -168.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -68.32 129.13 93.0 Favored Pre-proline 0 CA--C 1.542 0.664 0 CA-C-O 118.449 -0.786 . . . . 0.0 110.234 176.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.87 135.72 33.39 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.833 2.356 . . . . 0.0 112.655 -172.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.27 39.1 mt 70.86 141.43 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 129.405 3.082 . . . . 0.0 113.082 -171.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.4 t -140.99 -53.86 0.48 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.889 1.676 . . . . 0.0 110.58 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.507 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.2 tt -61.76 -24.75 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.32 -16.54 62.38 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.466 1.906 . . . . 0.0 111.674 169.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -124.12 10.27 8.74 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 126.675 1.99 . . . . 0.0 112.161 -176.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.471 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 11.3 tt -58.48 139.89 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 122.955 1.359 . . . . 0.0 114.404 -174.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 47.8 t -120.75 91.78 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 127.834 2.454 . . . . 0.0 108.406 169.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -75.55 121.6 22.63 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 120.979 -1.076 . . . . 0.0 110.356 170.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.9 mt -82.79 155.5 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.09 1.756 . . . . 0.0 108.559 173.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.1 m -57.34 134.39 81.44 Favored Pre-proline 0 N--CA 1.478 0.931 0 O-C-N 121.126 -0.984 . . . . 0.0 112.198 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.03 -14.45 18.98 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.211 2.608 . . . . 0.0 114.024 -177.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.471 0.608 0 C-N-CA 125.917 1.687 . . . . 0.0 112.153 177.742 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 CA--C 1.544 0.725 0 N-CA-C 113.567 0.951 . . . . 0.0 113.567 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.35 146.53 27.91 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.41 1.484 . . . . 0.0 111.095 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 3.2 m -59.08 138.69 57.45 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 115.23 1.567 . . . . 0.0 115.23 -168.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.28 -19.59 61.65 Favored 'General case' 0 CA--C 1.545 0.753 0 O-C-N 121.824 -0.547 . . . . 0.0 112.422 174.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 96.5 mt -91.65 -51.35 11.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 C-N-CA 124.804 1.242 . . . . 0.0 111.455 -170.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.1 m -124.27 -10.51 7.52 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.414 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.0 11.88 84.43 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-N 119.018 0.826 . . . . 0.0 114.947 170.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -72.62 161.08 31.23 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 128.605 2.762 . . . . 0.0 111.176 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.1 t -76.33 106.68 3.49 Favored Pre-proline 0 N--CA 1.477 0.903 0 N-CA-C 105.082 -2.192 . . . . 0.0 105.082 168.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -60.51 118.25 5.11 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.608 2.205 . . . . 0.0 114.385 -168.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.6 tpp180 -63.02 -47.06 84.7 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.865 1.266 . . . . 0.0 111.343 173.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 21.1 tpt85 -129.62 90.25 44.3 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 125.233 1.413 . . . . 0.0 109.339 173.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -65.83 149.53 86.59 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.185 2.59 . . . . 0.0 113.38 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -150.44 155.71 7.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 126.389 1.876 . . . . 0.0 110.46 -179.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.4 tt -138.98 154.07 48.24 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.653 1.181 . . . . 0.0 110.608 -178.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 32.5 t -117.36 134.11 23.14 Favored Pre-proline 0 N--CA 1.467 0.419 0 C-N-CA 125.658 1.583 . . . . 0.0 108.986 169.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -70.09 -4.7 14.77 Favored 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 123.359 2.706 . . . . 0.0 113.762 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.0 mtpt -86.72 -48.84 7.92 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.292 1.837 . . . . 0.0 110.535 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 83.4 p -97.62 -24.16 15.65 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.151 1.78 . . . . 0.0 114.861 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 62.12 4.08 1.13 Allowed 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 129.164 2.986 . . . . 0.0 116.685 170.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.2 t -71.8 174.43 6.89 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.992 1.717 . . . . 0.0 110.248 168.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.9 mt -119.34 116.1 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 N-CA-C 106.888 -1.523 . . . . 0.0 106.888 169.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -112.57 165.71 12.0 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 125.53 1.532 . . . . 0.0 111.25 174.05 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -75.17 134.6 41.19 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -52.83 -41.53 64.3 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.872 1.669 . . . . 0.0 109.845 -176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.6 m -61.61 -37.15 82.89 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.3 -43.13 52.7 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.564 0.746 . . . . 0.0 110.648 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.9 tp -65.27 -45.58 83.94 Favored 'General case' 0 C--O 1.223 -0.324 0 CA-C-O 119.221 -0.418 . . . . 0.0 109.922 178.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.9 -41.86 68.08 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.182 0.993 . . . . 0.0 111.793 176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -60.51 -52.92 63.16 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 122.986 0.514 . . . . 0.0 111.761 173.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -67.24 -36.02 80.76 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.35 1.06 . . . . 0.0 112.076 -173.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.469 HG21 ' H ' ' A' ' 47' ' ' ILE . 2.4 p -84.94 -18.72 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.282 1.033 . . . . 0.0 112.884 -174.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -91.04 -14.8 30.67 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.988 -1.07 . . . . 0.0 111.576 168.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.61 -60.11 2.39 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.641 1.576 . . . . 0.0 110.555 169.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 78.9 p -137.4 -16.69 1.36 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.695 1.198 . . . . 0.0 113.104 -173.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.407 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . 83.6 -15.63 34.97 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.768 1.175 . . . . 0.0 114.007 179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -67.33 149.03 50.88 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 118.928 1.364 . . . . 0.0 111.52 -172.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -69.99 143.49 91.76 Favored Pre-proline 0 CA--C 1.548 0.904 0 O-C-N 120.936 -1.102 . . . . 0.0 108.791 168.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.24 -4.66 14.13 Favored 'Trans proline' 0 CA--C 1.545 1.035 0 C-N-CA 123.304 2.669 . . . . 0.0 114.684 -173.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.8 mt -124.8 -52.34 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.453 1.501 . . . . 0.0 110.851 -172.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 77.7 p -85.38 -15.06 44.42 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.391 0.0 OUTLIER 49.17 22.4 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 128.055 2.542 . . . . 0.0 114.609 -168.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -73.89 130.79 82.55 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 121.099 -1.001 . . . . 0.0 109.696 175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.79 141.15 48.49 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.426 2.751 . . . . 0.0 113.705 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.3 mt 65.89 132.43 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 129.928 3.291 . . . . 0.0 113.756 -176.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 2.1 t -131.96 -48.0 0.94 Allowed 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 126.262 1.825 . . . . 0.0 111.456 -169.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.469 ' H ' HG21 ' A' ' 32' ' ' VAL . 10.3 tp -60.13 -32.79 51.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 126.05 1.74 . . . . 0.0 114.405 173.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -69.06 -7.73 38.48 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.248 1.419 . . . . 0.0 112.162 170.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -126.96 7.58 6.67 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.015 1.726 . . . . 0.0 112.531 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.406 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 6.1 tp -58.39 142.0 14.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 115.433 1.642 . . . . 0.0 115.433 -169.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 59.6 t -122.43 89.66 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 127.344 2.258 . . . . 0.0 107.567 169.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -75.16 141.43 43.66 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.026 -1.046 . . . . 0.0 112.5 -178.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 35.2 mm -105.38 142.44 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 C-N-CA 125.142 1.377 . . . . 0.0 110.007 -175.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 17.8 t -66.49 124.42 88.2 Favored Pre-proline 0 N--CA 1.476 0.862 0 C-N-CA 124.114 0.966 . . . . 0.0 110.168 179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -75.63 -10.06 20.09 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.36 2.707 . . . . 0.0 115.454 -171.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 N--CA 1.474 0.751 0 C-N-CA 125.335 1.454 . . . . 0.0 112.918 -178.539 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.8 mpt? . . . . . 0 CA--C 1.541 0.628 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -131.98 142.36 49.57 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 126.301 1.84 . . . . 0.0 110.309 169.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 2.4 m -57.34 130.07 44.59 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -167.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -71.29 -17.37 62.47 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.56 -56.38 5.41 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 C-N-CA 123.962 0.905 . . . . 0.0 110.984 177.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 -13.78 8.47 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 115.267 1.58 . . . . 0.0 115.267 -171.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.402 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 80.31 9.57 86.4 Favored Glycine 0 N--CA 1.47 0.915 0 O-C-N 121.486 -0.759 . . . . 0.0 114.994 170.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.6 tttp -71.05 162.75 28.9 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 128.47 2.708 . . . . 0.0 111.745 178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -77.59 107.43 5.23 Favored Pre-proline 0 N--CA 1.474 0.762 0 C-N-CA 124.722 1.209 . . . . 0.0 107.812 168.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -54.91 116.28 3.01 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.965 2.443 . . . . 0.0 114.972 -169.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 33.3 mmt180 -75.36 -36.39 60.97 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.997 0.919 . . . . 0.0 111.477 169.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 63.6 mtp180 -121.47 81.51 39.06 Favored Pre-proline 0 N--CA 1.476 0.825 0 C-N-CA 125.725 1.61 . . . . 0.0 109.723 169.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.1 126.27 19.8 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 124.257 3.305 . . . . 0.0 111.27 -178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.461 HG21 HD11 ' A' ' 50' ' ' ILE . 9.0 p -141.91 153.18 18.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 114.46 -1.246 . . . . 0.0 111.483 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.3 tp -131.11 150.44 52.15 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.047 2.139 . . . . 0.0 109.677 -171.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 45.3 t -125.63 125.22 24.99 Favored Pre-proline 0 C--O 1.235 0.326 0 C-N-CA 125.911 1.684 . . . . 0.0 107.738 169.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -52.46 -7.68 0.32 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.82 3.68 . . . . 0.0 116.613 173.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -88.39 -67.19 0.85 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 126.336 1.854 . . . . 0.0 111.127 -178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.2 m -70.14 -31.65 69.27 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.383 1.073 . . . . 0.0 113.396 173.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 62.22 7.31 2.17 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 128.216 2.606 . . . . 0.0 115.715 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 76.5 p -75.94 174.0 10.5 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 128.172 2.589 . . . . 0.0 111.755 170.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 68.4 mt -121.05 117.05 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 O-C-N 120.98 -1.075 . . . . 0.0 108.468 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.2 OUTLIER -117.08 175.55 5.54 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 126.473 1.909 . . . . 0.0 112.219 178.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -90.22 130.7 36.32 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.308 177.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 tptm -53.37 -41.01 65.42 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.673 1.589 . . . . 0.0 110.64 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.3 m -57.5 -44.04 84.69 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 124.053 0.846 . . . . 0.0 112.748 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . 0.311 1.0 OUTLIER -94.45 -25.14 17.02 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.934 0.894 . . . . 0.0 113.291 -173.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.5 tp -64.36 -52.52 57.92 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 167.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -58.25 -39.76 79.99 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.124 0.57 . . . . 0.0 111.351 -177.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -56.84 -52.57 64.57 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 118.304 0.502 . . . . 0.0 112.239 171.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -64.92 -29.54 70.49 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.125 1.77 . . . . 0.0 112.336 -177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.481 HG21 ' CB ' ' A' ' 46' ' ' SER . 42.1 t -93.31 -5.48 10.64 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.031 0 C-N-CA 125.904 1.682 . . . . 0.0 112.047 -177.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -98.76 -17.57 18.44 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.152 -1.593 . . . . 0.0 110.606 167.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.41 -63.14 1.17 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.904 2.482 . . . . 0.0 111.327 170.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 55.6 p -126.56 -21.88 4.05 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.962 1.305 . . . . 0.0 113.104 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 85.06 -18.59 26.57 Favored Glycine 0 C--N 1.339 0.742 0 C-N-CA 123.656 0.646 . . . . 0.0 114.1 -173.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -68.08 145.72 54.15 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 118.795 1.297 . . . . 0.0 111.685 -170.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.04 149.49 90.49 Favored Pre-proline 0 CA--C 1.548 0.891 0 O-C-N 121.19 -0.944 . . . . 0.0 111.131 169.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -63.92 -17.66 60.73 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.858 2.372 . . . . 0.0 115.988 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 36.0 mm -125.62 -48.3 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.068 0.947 . . . . 0.0 110.978 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.8 p -82.43 -14.81 54.51 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.359 0.0 OUTLIER 51.7 19.78 0.98 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 128.033 2.533 . . . . 0.0 114.535 -169.515 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -66.61 124.6 88.81 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-O 118.317 -0.849 . . . . 0.0 110.914 178.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -51.44 133.59 43.5 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.737 2.958 . . . . 0.0 114.533 -179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 33.3 mt 66.0 143.16 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 129.143 2.977 . . . . 0.0 114.323 -178.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.481 ' CB ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -136.15 -41.14 0.66 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.284 1.833 . . . . 0.0 111.823 -174.212 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.21 -33.71 51.52 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.656 1.583 . . . . 0.0 113.965 171.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -70.5 -5.45 28.9 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.253 1.421 . . . . 0.0 112.146 170.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -127.52 8.15 6.42 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.46 1.504 . . . . 0.0 112.708 -179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.461 HD11 HG21 ' A' ' 14' ' ' VAL . 4.5 tp -58.87 126.79 17.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 126.088 1.755 . . . . 0.0 114.959 -169.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.9 t -120.63 85.33 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 126.4 1.88 . . . . 0.0 110.221 171.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -80.01 118.57 21.86 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.954 -1.092 . . . . 0.0 112.073 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.2 mt -82.45 127.17 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 126.612 1.965 . . . . 0.0 109.085 -175.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 98.6 t -60.99 116.23 17.8 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 124.427 1.091 . . . . 0.0 110.457 176.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -76.81 -18.61 14.85 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 122.866 2.377 . . . . 0.0 113.884 -175.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.3 m . . . . . 0 N--CA 1.471 0.618 0 C-N-CA 126.087 1.755 . . . . 0.0 113.01 -178.472 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 CA--C 1.541 0.616 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.1 mt -119.13 148.43 43.08 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 126.146 1.778 . . . . 0.0 110.451 170.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 26.0 t -63.52 139.07 58.73 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 123.058 1.409 . . . . 0.0 113.698 -168.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -83.84 -15.56 47.78 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 114.559 -1.201 . . . . 0.0 112.072 177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -76.91 -56.67 7.46 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.915 174.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 20.7 m -134.54 -6.03 2.54 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.94 7.43 70.65 Favored Glycine 0 N--CA 1.472 1.072 0 CA-C-N 119.91 1.232 . . . . 0.0 114.109 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.9 tptt -56.29 137.98 51.35 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 128.301 2.64 . . . . 0.0 111.11 175.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.6 t -68.31 108.85 3.18 Favored Pre-proline 0 N--CA 1.475 0.796 0 C-N-CA 124.908 1.283 . . . . 0.0 107.663 169.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -55.74 128.02 28.6 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.586 2.191 . . . . 0.0 114.872 -170.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -75.25 -46.05 36.19 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.87 1.268 . . . . 0.0 108.782 169.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -124.32 91.16 49.93 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 127.212 2.205 . . . . 0.0 108.162 172.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -58.64 130.72 38.48 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 123.839 3.026 . . . . 0.0 111.4 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.0 t -140.9 144.02 27.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 C-N-CA 125.971 1.708 . . . . 0.0 110.218 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 23.2 tp -131.65 154.32 49.06 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.5 1.92 . . . . 0.0 110.248 -171.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.7 t -135.03 135.03 22.2 Favored Pre-proline 0 CA--C 1.537 0.446 0 C-N-CA 126.867 2.067 . . . . 0.0 107.703 169.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -68.87 -8.4 23.38 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.985 2.456 . . . . 0.0 114.259 -175.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -80.89 -64.19 1.24 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 125.978 1.711 . . . . 0.0 111.649 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.7 m -67.84 -32.73 73.46 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.883 0.873 . . . . 0.0 112.43 173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 63.38 -2.0 0.51 Allowed 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 128.351 2.66 . . . . 0.0 115.191 -175.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 67.5 p -73.5 169.1 17.91 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 127.777 2.431 . . . . 0.0 112.617 174.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 29.4 mm -112.76 116.55 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.7 168.96 9.34 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 125.588 1.555 . . . . 0.0 111.613 174.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -73.3 131.91 42.47 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.135 170.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -50.03 -46.86 53.39 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 125.597 1.559 . . . . 0.0 110.283 177.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.4 t -62.18 -40.05 94.75 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -177.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.26 -39.74 53.62 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.137 -0.977 . . . . 0.0 111.666 -179.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 22.6 tp -60.64 -45.22 94.89 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 118.643 0.656 . . . . 0.0 109.302 171.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.424 ' HA ' HG12 ' A' ' 32' ' ' VAL . 39.0 tt0 -55.72 -38.82 70.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.013 0.925 . . . . 0.0 111.544 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -63.37 -49.57 73.34 Favored 'General case' 0 CA--C 1.538 0.503 0 O-C-N 121.768 -0.582 . . . . 0.0 111.827 173.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -67.95 -35.26 78.09 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 122.052 0.929 . . . . 0.0 112.221 -176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 29' ' ' GLU . 1.6 p -82.84 -15.95 11.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.369 1.068 . . . . 0.0 112.984 -176.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 12.3 ptmm? -94.19 -14.05 25.99 Favored 'General case' 0 N--CA 1.481 1.083 0 O-C-N 121.166 -0.959 . . . . 0.0 111.519 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.88 -57.63 3.84 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.874 1.67 . . . . 0.0 111.373 170.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 70.9 p -133.9 -22.12 1.86 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.847 1.259 . . . . 0.0 112.539 -175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.66 -11.11 60.14 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.226 0.917 . . . . 0.0 113.459 -171.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -65.99 155.01 37.86 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 119.24 1.52 . . . . 0.0 113.449 -172.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.07 141.24 74.33 Favored Pre-proline 0 CA--C 1.546 0.825 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 166.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -66.73 -7.47 18.33 Favored 'Trans proline' 0 CA--C 1.544 1.007 0 C-N-CA 123.159 2.573 . . . . 0.0 115.432 -170.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.0 mt -126.8 -46.94 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 119.636 1.107 . . . . 0.0 111.879 -175.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.0 p -83.69 -12.78 55.42 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.343 0.3 OUTLIER 48.44 23.5 0.6 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 128.008 2.523 . . . . 0.0 115.083 -169.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -64.94 118.04 44.99 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.25 1.02 . . . . 0.0 110.644 175.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_exo -54.39 132.65 52.09 Favored 'Trans proline' 0 CA--C 1.537 0.674 0 C-N-CA 123.474 2.782 . . . . 0.0 113.843 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.5 mp 73.72 137.71 0.05 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 129.518 3.127 . . . . 0.0 112.864 -178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.69 -44.91 0.48 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.315 1.846 . . . . 0.0 111.164 -171.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 10.6 tp -58.89 -31.2 44.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 126.837 2.055 . . . . 0.0 115.568 173.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.45 -14.74 62.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.369 1.868 . . . . 0.0 112.071 170.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -124.6 13.08 8.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.82 2.048 . . . . 0.0 112.035 -178.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.401 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 6.7 tp -56.32 125.01 11.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 125.575 1.55 . . . . 0.0 112.947 -175.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.6 t -117.98 92.33 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 125.421 1.489 . . . . 0.0 109.26 170.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -78.63 123.11 26.77 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 121.055 -1.028 . . . . 0.0 110.8 176.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.9 mm -83.95 128.03 39.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 125.636 1.575 . . . . 0.0 109.655 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.7 t -67.7 115.83 31.53 Favored Pre-proline 0 N--CA 1.474 0.752 0 C-N-CA 124.045 0.938 . . . . 0.0 109.541 171.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.68 -18.13 19.84 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.791 2.327 . . . . 0.0 114.096 -174.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.6 m . . . . . 0 N--CA 1.473 0.702 0 C-N-CA 125.892 1.677 . . . . 0.0 113.018 -179.222 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.6 ttp . . . . . 0 CA--C 1.543 0.703 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.8 mt -101.65 148.64 25.01 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.552 1.541 . . . . 0.0 111.369 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.1 t -62.19 146.11 51.65 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -169.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.41 -36.21 68.57 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.725 176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -73.98 -48.22 39.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 124.447 1.099 . . . . 0.0 110.968 -169.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.1 t -135.3 -11.5 2.17 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.339 1.237 . . . . 0.0 114.339 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.22 12.07 79.64 Favored Glycine 0 N--CA 1.469 0.881 0 O-C-N 121.228 -0.92 . . . . 0.0 113.961 -178.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -51.2 136.22 24.62 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 128.341 2.656 . . . . 0.0 111.509 171.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.3 t -66.42 110.2 4.46 Favored Pre-proline 0 N--CA 1.476 0.849 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 168.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -54.85 105.16 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.996 2.464 . . . . 0.0 115.846 -169.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -59.33 -41.2 88.56 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 126.309 1.843 . . . . 0.0 111.109 169.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 89.4 mmt-85 -132.69 94.8 20.97 Favored Pre-proline 0 N--CA 1.473 0.703 0 C-N-CA 126.054 1.741 . . . . 0.0 108.678 169.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.9 135.3 62.3 Favored 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 123.662 2.908 . . . . 0.0 112.153 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -144.31 146.05 20.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 114.185 -1.37 . . . . 0.0 110.408 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.0 tp -130.53 152.75 49.57 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.533 1.133 . . . . 0.0 110.611 -172.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 19.4 t -120.37 133.3 23.98 Favored Pre-proline 0 C--O 1.237 0.443 0 C-N-CA 125.744 1.618 . . . . 0.0 109.646 169.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.71 -19.62 25.05 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.313 2.675 . . . . 0.0 114.395 169.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 16.7 mtmt -93.87 -58.96 2.1 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.921 1.689 . . . . 0.0 111.93 -175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.0 m -78.53 -16.59 57.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.1 mtm180 58.32 -16.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 129.887 3.275 . . . . 0.0 118.627 170.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 15.0 t -74.48 173.39 10.41 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.363 1.465 . . . . 0.0 110.924 169.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.3 mm -106.79 118.91 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 125.258 1.423 . . . . 0.0 108.736 175.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -109.26 170.61 7.94 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.652 1.181 . . . . 0.0 111.38 173.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.9 139.81 43.35 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 169.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -51.41 -45.68 62.63 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.78 1.232 . . . . 0.0 109.393 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.9 m -66.72 -42.04 86.99 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 123.907 0.883 . . . . 0.0 113.201 -175.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.1 mt -73.31 -40.36 64.56 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.565 0.746 . . . . 0.0 111.534 -177.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 29.8 tp -61.35 -49.23 77.8 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 173.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -55.61 -41.78 73.97 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.017 0.527 . . . . 0.0 110.681 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.16 -53.65 55.87 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 123.034 0.534 . . . . 0.0 111.695 174.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.8 t80 -61.75 -35.18 77.36 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 122.349 1.071 . . . . 0.0 111.849 -176.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.473 HG11 ' H ' ' A' ' 47' ' ' ILE . 41.7 t -93.75 -6.78 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.01 0 C-N-CA 124.444 1.097 . . . . 0.0 112.258 -173.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.5 pttt -100.49 -10.59 20.93 Favored 'General case' 0 N--CA 1.481 1.114 0 O-C-N 119.937 -1.727 . . . . 0.0 110.81 167.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.24 -62.31 1.7 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 128.108 2.563 . . . . 0.0 110.019 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 75.8 p -128.37 -21.77 3.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 125.38 1.472 . . . . 0.0 113.229 -176.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.03 -22.11 24.18 Favored Glycine 0 C--N 1.338 0.673 0 C-N-CA 123.725 0.679 . . . . 0.0 113.758 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -65.74 147.72 52.93 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.588 1.194 . . . . 0.0 111.534 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.71 147.27 89.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 O-C-N 120.95 -1.094 . . . . 0.0 110.374 169.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.52 -10.75 27.32 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.909 2.406 . . . . 0.0 114.457 -173.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 25.1 mt -128.59 -46.15 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.312 0.96 . . . . 0.0 111.609 -177.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.8 p -85.84 -10.4 55.46 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.327 0.3 OUTLIER 48.06 24.96 0.71 Allowed 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.772 2.429 . . . . 0.0 115.671 -170.227 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -65.47 119.34 59.04 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.111 -0.947 . . . . 0.0 111.138 176.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -52.77 128.03 26.88 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.742 2.961 . . . . 0.0 114.334 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 64.2 mt 65.37 141.38 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 128.885 2.874 . . . . 0.0 114.664 -172.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.464 ' CB ' HG21 ' A' ' 32' ' ' VAL . 0.4 OUTLIER -136.29 -54.54 0.75 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.723 1.609 . . . . 0.0 112.614 -173.503 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.473 ' H ' HG11 ' A' ' 32' ' ' VAL . 7.8 tp -61.62 -32.04 52.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 125.808 1.643 . . . . 0.0 114.066 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -68.87 -7.09 31.37 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.73 1.612 . . . . 0.0 112.078 171.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -133.31 12.67 4.19 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.8 1.64 . . . . 0.0 112.122 -177.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.415 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 9.7 tp -59.22 150.1 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 126.623 1.969 . . . . 0.0 115.305 -171.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.7 t -120.53 87.54 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 126.224 1.81 . . . . 0.0 108.385 169.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -75.8 137.44 40.52 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.921 -1.112 . . . . 0.0 111.596 -179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.0 mt -115.09 146.08 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 125.49 1.516 . . . . 0.0 109.962 178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.0 m -70.06 143.19 91.17 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 120.901 -1.124 . . . . 0.0 112.473 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -75.62 -16.25 18.97 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.021 2.481 . . . . 0.0 113.945 178.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 32.4 t . . . . . 0 N--CA 1.473 0.723 0 C-N-CA 125.982 1.713 . . . . 0.0 112.122 178.403 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 CA--C 1.541 0.613 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.5 mt -111.4 147.31 35.5 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 125.62 1.568 . . . . 0.0 111.074 170.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 27.8 t -66.77 144.05 56.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 122.619 1.199 . . . . 0.0 113.915 -168.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.12 -15.35 38.7 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.389 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -77.56 -53.62 14.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 123.122 0.569 . . . . 0.0 110.008 175.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.6 m -136.72 -5.84 1.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.71 6.91 82.36 Favored Glycine 0 N--CA 1.473 1.103 0 CA-C-N 120.069 1.304 . . . . 0.0 115.493 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -61.55 147.14 46.48 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 127.69 2.396 . . . . 0.0 110.819 174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.5 t -68.57 108.78 3.2 Favored Pre-proline 0 N--CA 1.475 0.822 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 169.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -66.1 115.11 3.29 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.459 2.106 . . . . 0.0 112.717 -169.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 96.1 mtt-85 -63.74 -34.99 79.12 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.612 1.165 . . . . 0.0 111.708 170.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 41.8 mtm-85 -123.63 87.09 52.52 Favored Pre-proline 0 N--CA 1.473 0.717 0 C-N-CA 126.323 1.849 . . . . 0.0 109.501 173.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.57 128.69 22.97 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 123.888 3.058 . . . . 0.0 111.736 -176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -141.09 152.09 20.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 125.245 1.418 . . . . 0.0 110.503 -175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 tt -139.24 155.53 47.71 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.977 1.311 . . . . 0.0 110.407 -175.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.2 p -123.81 146.96 52.19 Favored Pre-proline 0 N--CA 1.47 0.535 0 C-N-CA 124.163 0.985 . . . . 0.0 109.029 168.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -69.22 -10.23 28.43 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 121.917 1.744 . . . . 0.0 113.183 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -78.47 -59.51 2.75 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 126.081 1.753 . . . . 0.0 111.366 178.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 66.2 m -79.59 -32.51 41.96 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.358 1.063 . . . . 0.0 112.072 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.5 tpp85 59.94 1.72 0.34 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 127.467 2.307 . . . . 0.0 115.437 -173.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 66.0 p -73.07 173.46 9.32 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 128.117 2.567 . . . . 0.0 111.679 170.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.7 mp -117.33 116.22 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 171.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.84 173.44 6.35 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 126.287 1.835 . . . . 0.0 110.452 173.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.12 143.54 39.1 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.111 -0.993 . . . . 0.0 109.554 173.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -52.59 -46.18 66.81 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 125.13 1.372 . . . . 0.0 108.815 171.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.3 m -67.81 -42.79 80.99 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 -177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 mt -72.6 -40.79 66.25 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.151 0.887 . . . . 0.0 111.439 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.3 tp -61.92 -47.56 84.38 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.9 tt0 -56.05 -42.99 77.44 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 122.695 0.398 . . . . 0.0 110.552 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -57.85 -52.13 66.75 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.688 0.795 . . . . 0.0 111.491 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -65.46 -36.21 83.2 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 125.025 1.33 . . . . 0.0 111.967 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 46' ' ' SER . 43.1 t -91.78 -6.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.917 0 C-N-CA 125.016 1.326 . . . . 0.0 112.232 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -101.96 -10.77 19.48 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 119.994 -1.691 . . . . 0.0 110.567 167.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.42 -61.6 1.9 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.034 2.134 . . . . 0.0 110.226 169.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 32.4 p -130.41 -16.75 3.44 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.983 1.313 . . . . 0.0 113.58 -177.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 87.22 -19.64 30.14 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-O 119.507 -0.607 . . . . 0.0 113.656 -179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -66.56 148.83 51.35 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 118.827 1.314 . . . . 0.0 113.216 -170.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -71.76 140.82 84.15 Favored Pre-proline 0 CA--C 1.549 0.918 0 O-C-N 120.976 -1.077 . . . . 0.0 110.83 169.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -60.42 -12.22 19.69 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.883 3.055 . . . . 0.0 117.594 -170.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 mt -129.87 -42.7 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.338 1.055 . . . . 0.0 112.38 -169.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 p -86.87 -16.66 35.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.709 0.804 . . . . 0.0 112.26 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.317 0.5 OUTLIER 43.01 32.25 0.4 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 128.066 2.546 . . . . 0.0 114.798 -169.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -81.59 145.67 55.25 Favored Pre-proline 0 CA--C 1.546 0.822 0 CA-C-O 118.925 -0.559 . . . . 0.0 110.113 169.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -72.61 142.89 36.97 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.712 2.275 . . . . 0.0 114.042 -169.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.2 mt 65.44 132.3 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 130.152 3.381 . . . . 0.0 115.019 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.514 ' HB3' HG21 ' A' ' 32' ' ' VAL . 3.1 t -129.63 -52.12 1.16 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.217 1.807 . . . . 0.0 112.037 -172.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.445 ' H ' HG11 ' A' ' 32' ' ' VAL . 8.8 tp -60.33 -31.57 48.79 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 126.039 1.736 . . . . 0.0 114.298 176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -69.38 -8.47 46.76 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.187 1.395 . . . . 0.0 112.147 170.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -127.62 11.46 6.76 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.192 1.797 . . . . 0.0 112.328 -178.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.412 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.5 tp -58.78 145.35 10.57 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 125.781 1.632 . . . . 0.0 115.276 -169.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 38.2 t -121.53 91.87 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 127.541 2.336 . . . . 0.0 108.477 169.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -77.15 112.36 13.74 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 120.956 -1.09 . . . . 0.0 111.361 -176.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 38.0 mm -82.21 -15.15 12.11 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 C-N-CA 125.197 1.399 . . . . 0.0 111.728 -177.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 19.9 t -40.66 110.69 0.71 Allowed Pre-proline 0 N--CA 1.481 1.124 0 C-N-CA 128.252 2.621 . . . . 0.0 112.484 178.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_endo -75.26 -14.91 20.45 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.024 2.483 . . . . 0.0 114.594 -171.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 30.4 t . . . . . 0 C--O 1.241 0.643 0 C-N-CA 125.435 1.494 . . . . 0.0 112.266 178.489 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.6 mtm . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 113.486 0.921 . . . . 0.0 113.486 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.447 ' H ' HD23 ' A' ' 2' ' ' LEU . 1.9 pt? -99.48 146.91 25.84 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.365 1.466 . . . . 0.0 111.979 176.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.487 ' HB2' ' H ' ' A' ' 7' ' ' GLY . 3.0 m -60.65 138.6 58.05 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -168.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.91 -14.83 61.55 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 175.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 97.5 mt -100.49 -53.13 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.908 1.283 . . . . 0.0 111.727 -170.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.6 m -118.69 -14.3 9.56 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 177.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.487 ' H ' ' HB2' ' A' ' 3' ' ' CYS . . . 76.85 16.11 81.05 Favored Glycine 0 N--CA 1.467 0.719 0 O-C-N 121.79 -0.569 . . . . 0.0 114.022 169.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.9 ptmm? -91.42 174.04 7.59 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 126.409 1.884 . . . . 0.0 113.577 -169.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.4 p -72.33 114.35 28.87 Favored Pre-proline 0 N--CA 1.475 0.778 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 168.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -73.51 125.55 10.2 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.177 1.918 . . . . 0.0 113.825 -169.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 65.9 mtt85 -57.64 -50.72 72.21 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 126.052 1.741 . . . . 0.0 111.257 169.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 37.2 mtp-105 -132.48 100.72 14.92 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 125.812 1.645 . . . . 0.0 110.101 170.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -60.87 131.78 39.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.664 2.909 . . . . 0.0 111.678 177.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 2.5 t -142.16 145.9 23.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 C-N-CA 127.894 2.478 . . . . 0.0 110.321 -169.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 tt -134.19 159.4 41.03 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.248 1.819 . . . . 0.0 110.041 -175.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.5 p -128.88 152.41 79.02 Favored Pre-proline 0 N--CA 1.469 0.511 0 C-N-CA 124.106 0.963 . . . . 0.0 110.932 169.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.91 -5.01 16.22 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.241 2.627 . . . . 0.0 113.564 -177.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -82.2 -70.87 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.21 1.404 . . . . 0.0 110.551 174.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.2 m -75.17 -29.66 60.49 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.817 1.247 . . . . 0.0 113.056 -171.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 12.3 mmt85 56.11 5.54 0.18 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 126.951 2.1 . . . . 0.0 115.278 -171.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 38.6 p -70.59 171.6 10.01 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 127.584 2.353 . . . . 0.0 111.183 169.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.5 mt -120.56 115.96 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 3' ' ' CYS . 0.1 OUTLIER -113.78 171.91 7.3 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 127.09 2.156 . . . . 0.0 111.467 173.936 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -81.29 137.72 35.77 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.069 175.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -42.98 -49.92 5.94 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 128.289 2.636 . . . . 0.0 110.363 177.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.2 m -68.19 -31.95 71.84 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.623 -1.171 . . . . 0.0 112.801 -171.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 8.9 mt -76.31 -45.0 34.36 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.8 0.84 . . . . 0.0 110.348 179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 20.9 tp -64.28 -48.72 74.6 Favored 'General case' 0 N--CA 1.462 0.15 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 179.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -55.94 -45.06 78.91 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.718 0.407 . . . . 0.0 110.837 177.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -59.11 -50.69 73.1 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.282 0.492 . . . . 0.0 111.824 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 49.3 t80 -64.38 -34.35 77.97 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.149 0.976 . . . . 0.0 111.513 -174.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.562 HG21 ' HB3' ' A' ' 46' ' ' SER . 48.2 t -95.55 -9.89 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 124.874 1.27 . . . . 0.0 112.314 -173.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.3 ptmt -94.44 -13.27 26.38 Favored 'General case' 0 N--CA 1.482 1.161 0 O-C-N 119.909 -1.745 . . . . 0.0 110.441 167.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.77 -66.64 0.84 Allowed 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 128.136 2.574 . . . . 0.0 111.466 169.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 51.4 p -119.76 -20.31 7.68 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.387 1.475 . . . . 0.0 113.024 -176.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.53 -20.57 13.75 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.087 0.851 . . . . 0.0 113.896 -175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.0 148.66 50.73 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 119.059 1.43 . . . . 0.0 112.423 -170.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -71.71 144.69 88.74 Favored Pre-proline 0 CA--C 1.547 0.858 0 O-C-N 121.08 -1.013 . . . . 0.0 109.649 168.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.95 -6.84 18.03 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 123.678 2.918 . . . . 0.0 116.142 -169.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mt -127.37 -49.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.605 1.162 . . . . 0.0 111.485 -173.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 75.5 p -83.58 -14.6 51.72 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.339 0.2 OUTLIER 49.52 23.72 0.98 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.528 2.331 . . . . 0.0 114.981 -169.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -68.28 133.63 91.34 Favored Pre-proline 0 N--CA 1.472 0.638 0 CA-C-O 118.636 -0.697 . . . . 0.0 110.3 175.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.17 135.3 34.09 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.874 2.383 . . . . 0.0 112.715 -173.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 40.0 mt 67.82 144.34 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 129.363 3.065 . . . . 0.0 113.998 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.562 ' HB3' HG21 ' A' ' 32' ' ' VAL . 3.8 t -141.04 -49.52 0.42 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 126.949 2.099 . . . . 0.0 112.364 -174.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.498 ' H ' HG11 ' A' ' 32' ' ' VAL . 44.5 mm -58.65 -33.04 47.67 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 126.834 2.054 . . . . 0.0 113.808 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -65.3 -8.78 19.64 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.75 1.22 . . . . 0.0 112.419 170.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -132.48 9.17 4.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.431 1.893 . . . . 0.0 113.183 -176.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.6 tt -57.25 139.4 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 C-N-CA 124.831 1.252 . . . . 0.0 114.16 -172.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.2 t -119.14 92.43 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 127.26 2.224 . . . . 0.0 109.0 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -72.71 130.58 40.84 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 120.787 -1.196 . . . . 0.0 110.88 175.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 28.9 mm -83.49 76.64 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 C-N-CA 124.66 1.184 . . . . 0.0 109.04 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 22.2 m -63.28 151.03 87.99 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 124.86 1.264 . . . . 0.0 112.706 -178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.73 -10.11 19.96 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.428 2.752 . . . . 0.0 114.063 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 20.9 m . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 126.558 1.943 . . . . 0.0 113.433 -176.858 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.6 tpt . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 20.0 tp -100.09 116.75 32.84 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.284 1.434 . . . . 0.0 111.048 -176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 13.8 t -69.25 147.8 50.7 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-O 122.726 1.25 . . . . 0.0 112.629 -170.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.91 -23.12 25.3 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.674 0.79 . . . . 0.0 112.531 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -83.16 -45.19 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 C-N-CA 123.951 0.9 . . . . 0.0 111.163 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 17.3 t -126.21 -40.14 2.01 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.687 0.795 . . . . 0.0 112.701 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.34 20.03 36.71 Favored Glycine 0 C--N 1.337 0.624 0 CA-C-O 121.702 0.612 . . . . 0.0 113.95 179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 53.2 pttt -78.25 168.34 20.0 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.012 1.325 . . . . 0.0 110.982 171.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.5 t -73.29 112.83 17.41 Favored Pre-proline 0 N--CA 1.477 0.892 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 169.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.7 133.82 20.98 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.649 2.233 . . . . 0.0 112.484 -171.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.2 mmm180 -70.12 -34.58 73.27 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.949 1.3 . . . . 0.0 111.824 169.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -124.23 83.35 56.62 Favored Pre-proline 0 N--CA 1.475 0.786 0 C-N-CA 125.657 1.583 . . . . 0.0 111.067 173.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.54 125.56 18.22 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.734 2.956 . . . . 0.0 112.273 179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -139.25 145.45 27.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 126.943 2.097 . . . . 0.0 110.507 -173.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.0 tt -127.81 156.3 42.72 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.15 1.78 . . . . 0.0 109.841 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 61.6 m -127.11 143.54 47.37 Favored Pre-proline 0 CA--C 1.537 0.444 0 C-N-CA 124.919 1.288 . . . . 0.0 108.251 169.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.18 0.82 5.39 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.605 2.87 . . . . 0.0 113.866 -172.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -92.69 -67.85 0.83 Allowed 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 126.202 1.801 . . . . 0.0 109.878 178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 73.2 p -56.44 -41.64 76.79 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 115.303 1.594 . . . . 0.0 115.303 171.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 59.25 5.67 0.62 Allowed 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.258 2.223 . . . . 0.0 114.378 -169.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.9 p -77.35 177.02 8.29 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.761 2.424 . . . . 0.0 111.579 171.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.6 mt -122.68 114.54 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 O-C-N 121.214 -0.929 . . . . 0.0 108.943 170.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.49 171.22 7.59 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 126.436 1.894 . . . . 0.0 111.233 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -71.8 144.19 49.25 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 119.319 -0.952 . . . . 0.0 109.818 169.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -56.76 -44.37 81.69 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.978 0.911 . . . . 0.0 109.707 171.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.9 m -68.18 -36.51 79.72 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.5 mt -73.56 -38.76 65.09 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 119.106 0.866 . . . . 0.0 112.022 176.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.6 tp -61.66 -44.48 96.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.948 0.795 . . . . 0.0 109.24 171.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -54.62 -41.23 69.76 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.5 0.72 . . . . 0.0 110.917 178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -58.98 -53.43 58.44 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.465 0.706 . . . . 0.0 111.398 174.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.62 -36.65 81.2 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.366 1.079 . . . . 0.0 112.348 -174.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.471 HG21 ' H ' ' A' ' 47' ' ' ILE . 1.8 p -83.66 -10.86 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.78 0 C-N-CA 124.772 1.229 . . . . 0.0 112.999 -175.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -102.1 -10.46 19.65 Favored 'General case' 0 N--CA 1.481 1.089 0 O-C-N 120.95 -1.094 . . . . 0.0 111.462 168.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -55.54 5.5 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 126.125 1.77 . . . . 0.0 110.691 169.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 80.4 p -133.98 -22.87 1.8 Allowed 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.787 1.235 . . . . 0.0 112.426 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 86.6 -12.89 59.96 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 124.144 0.878 . . . . 0.0 113.081 -171.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -67.32 154.88 40.29 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.586 1.693 . . . . 0.0 113.621 -169.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -68.39 135.09 90.93 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 167.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.24 -5.31 12.21 Favored 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 121.871 1.714 . . . . 0.0 113.633 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 49.0 mm -123.12 -45.38 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 120.197 1.362 . . . . 0.0 111.485 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.6 p -99.78 -4.93 29.51 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.546 0.739 . . . . 0.0 112.934 -176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.362 0.0 OUTLIER 45.1 23.86 0.11 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 129.483 3.113 . . . . 0.0 116.596 -172.041 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -69.82 137.16 87.66 Favored Pre-proline 0 N--CA 1.475 0.805 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.58 175.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.84 130.87 24.16 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.933 2.422 . . . . 0.0 112.069 -176.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . 0.253 35.3 mt 70.45 146.29 0.06 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 129.375 3.07 . . . . 0.0 113.411 -170.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 4.4 t -143.7 -56.77 0.39 Allowed 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 126.342 1.857 . . . . 0.0 110.69 -170.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.471 ' H ' HG21 ' A' ' 32' ' ' VAL . 3.0 tt -59.69 -25.49 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.442 0 C-N-CA 126.497 1.919 . . . . 0.0 116.041 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -67.78 -9.35 43.43 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.001 1.32 . . . . 0.0 112.157 169.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -126.66 9.21 7.03 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.844 2.058 . . . . 0.0 112.626 -178.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.467 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.7 tt -58.3 147.11 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 C-N-CA 126.097 1.759 . . . . 0.0 115.403 -172.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.7 97.68 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 128.635 2.774 . . . . 0.0 109.775 171.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -78.95 132.1 36.58 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 120.356 -1.465 . . . . 0.0 112.309 174.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.1 mp -79.54 -35.67 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 124.596 1.158 . . . . 0.0 110.605 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.6 t -60.56 119.27 42.07 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 125.31 1.444 . . . . 0.0 111.617 -177.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -74.5 -12.83 22.68 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.391 2.727 . . . . 0.0 114.369 -175.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.477 0.878 0 C-N-CA 127.354 2.261 . . . . 0.0 113.83 179.362 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mmt . . . . . 0 CA--C 1.544 0.733 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.24 147.64 51.1 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.865 2.066 . . . . 0.0 110.72 170.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 34.7 t -68.34 140.23 55.9 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 123.074 1.416 . . . . 0.0 113.329 -168.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.18 -20.05 42.02 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.234 -0.894 . . . . 0.0 111.998 177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -78.69 -53.32 13.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.556 0.742 . . . . 0.0 110.871 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.5 t -132.24 -16.8 2.74 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.51 6.65 60.94 Favored Glycine 0 N--CA 1.468 0.797 0 O-C-N 121.295 -0.878 . . . . 0.0 114.822 171.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 9.5 ptmm? -69.08 161.1 29.76 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.46 1.504 . . . . 0.0 112.583 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.3 119.24 72.56 Favored Pre-proline 0 N--CA 1.473 0.684 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 169.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -74.83 125.2 9.26 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.13 1.887 . . . . 0.0 112.191 -171.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 mtp-105 -64.6 -41.65 96.09 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.074 1.349 . . . . 0.0 110.452 169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 15.5 ttm-85 -124.72 92.76 47.3 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 126.522 1.929 . . . . 0.0 109.393 172.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.37 127.78 24.03 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.547 2.832 . . . . 0.0 111.444 176.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 52' ' ' GLU . 0.4 OUTLIER -139.86 148.72 22.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 125.46 1.504 . . . . 0.0 110.682 -176.399 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 tt -134.35 155.52 50.1 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.6 1.56 . . . . 0.0 111.689 -175.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 41.3 t -127.88 133.42 25.1 Favored Pre-proline 0 N--CA 1.468 0.426 0 C-N-CA 126.64 1.976 . . . . 0.0 107.409 169.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.5 -10.0 27.25 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.041 2.494 . . . . 0.0 114.409 -173.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -75.9 -63.64 1.26 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.013 1.725 . . . . 0.0 111.578 175.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.6 m -66.32 -36.05 81.93 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.008 0.923 . . . . 0.0 112.167 172.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 61.05 3.61 0.71 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 128.534 2.733 . . . . 0.0 114.912 -175.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.5 p -75.23 174.88 8.89 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 127.932 2.493 . . . . 0.0 111.947 171.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.3 mt -120.47 117.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 173.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -112.39 168.04 9.95 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 126.056 1.742 . . . . 0.0 111.109 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.446 ' HB3' ' HG ' ' A' ' 27' ' ' LEU . 5.5 tp10 -67.7 135.09 52.21 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.051 169.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -57.99 -43.51 86.61 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 118.952 0.796 . . . . 0.0 109.919 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 12.4 m -62.21 -41.91 98.81 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.467 1.107 . . . . 0.0 113.824 178.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.446 ' HG ' ' HB3' ' A' ' 24' ' ' GLU . 0.6 OUTLIER -75.93 -38.25 57.85 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.129 0.877 . . . . 0.0 111.988 -179.535 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 21.7 tp -60.3 -45.86 91.9 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 170.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 32' ' ' VAL . 34.4 tt0 -54.87 -37.98 66.93 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.0 0.92 . . . . 0.0 112.006 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -62.16 -52.08 65.26 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.631 -0.668 . . . . 0.0 111.708 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.2 t80 -67.61 -35.62 79.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 122.114 0.959 . . . . 0.0 112.248 -175.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 29' ' ' GLU . 2.9 p -82.87 -15.46 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 124.837 1.255 . . . . 0.0 113.027 -176.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -94.88 -13.48 25.42 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 120.714 -1.241 . . . . 0.0 111.543 168.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.21 -57.21 4.1 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.439 170.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 82.2 p -133.18 -22.18 2.02 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.9 1.28 . . . . 0.0 112.609 -176.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 84.32 -11.38 58.44 Favored Glycine 0 CA--C 1.528 0.872 0 C-N-CA 124.191 0.9 . . . . 0.0 113.656 -171.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -65.65 153.62 41.12 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.154 1.477 . . . . 0.0 113.164 -172.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.39 141.8 86.08 Favored Pre-proline 0 CA--C 1.547 0.845 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 167.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -67.63 -7.27 18.87 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.075 2.517 . . . . 0.0 115.414 -171.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.8 mt -127.38 -47.21 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.441 1.096 . . . . 0.0 111.795 -175.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.2 p -83.96 -12.64 55.03 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.342 0.3 OUTLIER 48.22 24.54 0.69 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 127.994 2.517 . . . . 0.0 115.237 -169.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -66.48 119.25 61.2 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.12 0.968 . . . . 0.0 110.589 175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -54.03 133.55 55.63 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.598 2.865 . . . . 0.0 114.054 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.7 mp 71.04 141.41 0.05 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 129.318 3.047 . . . . 0.0 112.845 -177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -140.57 -45.84 0.41 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 126.386 1.874 . . . . 0.0 111.392 -169.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.424 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 13.2 mm -61.7 -31.72 51.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.332 1.453 . . . . 0.0 114.654 175.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.42 -12.53 53.27 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 126.259 1.824 . . . . 0.0 112.445 170.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 -124.38 8.33 8.42 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.974 1.71 . . . . 0.0 112.719 -179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.424 ' HB ' ' HA ' ' A' ' 47' ' ' ILE . 8.4 tp -58.56 132.55 23.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.133 1.373 . . . . 0.0 113.878 -172.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 48.9 t -120.97 94.44 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 127.069 2.147 . . . . 0.0 109.115 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.401 ' HA ' HG23 ' A' ' 14' ' ' VAL . 2.6 mt-10 -74.97 134.71 41.44 Favored 'General case' 0 N--CA 1.473 0.694 0 O-C-N 120.578 -1.326 . . . . 0.0 110.845 172.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 mp -78.02 -33.88 18.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 123.575 0.75 . . . . 0.0 110.277 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 32.7 m -64.02 149.56 93.48 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.115 0.966 . . . . 0.0 112.516 176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -74.08 -27.52 11.81 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.829 2.352 . . . . 0.0 112.881 173.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.7 p . . . . . 0 C--O 1.24 0.564 0 C-N-CA 126.578 1.951 . . . . 0.0 111.322 176.259 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.5 ttm . . . . . 0 CA--C 1.542 0.673 0 CA-C-O 120.675 0.274 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 90.8 mt -120.36 156.18 31.87 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.777 1.631 . . . . 0.0 112.432 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 23' ' ' PHE . 13.5 t -60.87 137.63 58.2 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-O 122.973 1.368 . . . . 0.0 112.652 -169.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.58 -16.97 40.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 114.313 -1.312 . . . . 0.0 112.172 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 90.3 mt -82.77 -47.66 18.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 C-N-CA 125.476 1.51 . . . . 0.0 110.538 176.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 73.1 p -128.9 -30.18 2.27 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.03 7.3 61.18 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 114.764 0.665 . . . . 0.0 114.764 -169.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -53.5 137.38 36.37 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.458 1.903 . . . . 0.0 110.689 172.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.77 105.73 1.13 Allowed Pre-proline 0 N--CA 1.477 0.9 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 169.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.3 117.16 3.62 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.892 2.395 . . . . 0.0 113.663 -169.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.3 mmt-85 -74.36 -42.35 59.51 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.706 1.602 . . . . 0.0 110.519 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 13.9 tpp85 -126.42 90.1 50.69 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 127.063 2.145 . . . . 0.0 107.682 169.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -62.69 129.1 25.21 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.704 2.936 . . . . 0.0 111.857 -177.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -135.02 153.74 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.311 1.444 . . . . 0.0 111.452 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 6.5 tt -137.44 156.87 47.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.406 1.882 . . . . 0.0 110.08 -176.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.0 t -123.17 127.8 25.52 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 125.501 1.52 . . . . 0.0 108.34 168.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -53.69 -12.0 2.69 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 124.816 3.678 . . . . 0.0 117.217 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.54 -62.54 1.66 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.927 1.291 . . . . 0.0 110.964 174.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 m -69.29 -38.12 78.17 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 125.704 1.602 . . . . 0.0 112.355 179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 57.47 10.88 1.05 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 127.938 2.495 . . . . 0.0 114.985 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.2 p -75.14 170.87 15.17 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.135 2.574 . . . . 0.0 111.057 169.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -122.21 116.51 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 173.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.431 ' CE1' HD22 ' A' ' 28' ' ' LEU . 0.1 OUTLIER -113.76 168.96 9.34 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 126.409 1.884 . . . . 0.0 111.194 175.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -67.87 137.12 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.492 172.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -51.66 -46.12 63.64 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.728 1.211 . . . . 0.0 109.661 175.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 14.5 m -59.88 -42.07 92.95 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.05 0.843 . . . . 0.0 112.562 -177.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.4 -44.7 67.45 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.185 1.394 . . . . 0.0 112.665 178.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.431 HD22 ' CE1' ' A' ' 23' ' ' PHE . 54.0 tp -65.71 -38.85 90.33 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 119.238 -0.985 . . . . 0.0 109.546 176.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.49 -40.32 90.89 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.502 0.721 . . . . 0.0 111.587 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -61.53 -50.17 73.75 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.077 0.951 . . . . 0.0 111.582 172.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -67.06 -37.36 83.91 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 122.128 0.966 . . . . 0.0 111.317 -173.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 p -83.07 -18.48 10.47 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -175.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -89.86 -15.68 31.69 Favored 'General case' 0 N--CA 1.479 0.995 0 O-C-N 121.015 -1.053 . . . . 0.0 112.011 168.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -74.1 -58.08 3.53 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.866 1.666 . . . . 0.0 110.978 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 73.9 p -137.59 -16.87 1.32 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.802 1.241 . . . . 0.0 112.635 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 82.99 -10.45 57.84 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 124.273 0.939 . . . . 0.0 113.524 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 31.8 m120 -63.12 153.91 32.73 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 119.23 1.515 . . . . 0.0 113.48 -171.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -78.29 129.26 75.64 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 124.528 1.131 . . . . 0.0 108.209 167.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.0 -13.68 2.99 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 124.793 3.662 . . . . 0.0 119.718 -169.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 13.6 mt -128.29 -41.02 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-N 120.141 1.337 . . . . 0.0 112.358 -171.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.1 p -92.21 -10.69 37.72 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.947 0.899 . . . . 0.0 112.576 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . 0.311 0.5 OUTLIER 44.2 31.15 0.52 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 128.749 2.82 . . . . 0.0 115.355 -171.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -66.87 134.32 94.04 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-O 118.415 -0.802 . . . . 0.0 109.672 172.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -68.04 133.24 28.37 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 122.651 2.234 . . . . 0.0 111.628 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.0 mp 73.86 144.14 0.07 Allowed 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 128.458 2.703 . . . . 0.0 112.488 -173.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.2 t -147.5 -40.42 0.18 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 127.779 2.431 . . . . 0.0 110.24 -170.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 8.6 tp -58.91 -36.18 60.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 126.361 1.864 . . . . 0.0 114.677 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -67.6 -7.68 28.33 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.121 1.368 . . . . 0.0 112.123 172.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -128.41 4.73 5.68 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.183 1.393 . . . . 0.0 113.318 -177.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 7.9 tt -66.64 137.8 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 CA-C-O 122.313 1.054 . . . . 0.0 113.675 -169.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.5 t -124.2 96.95 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 126.839 2.056 . . . . 0.0 111.23 178.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -72.59 123.63 23.6 Favored 'General case' 0 N--CA 1.478 0.928 0 O-C-N 120.55 -1.344 . . . . 0.0 110.462 169.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 51.2 mm -78.53 -35.86 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 125.323 1.449 . . . . 0.0 110.707 -174.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.3 t -131.18 97.14 20.36 Favored Pre-proline 0 N--CA 1.472 0.661 0 C-N-CA 125.802 1.641 . . . . 0.0 107.37 170.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -76.02 -6.38 17.3 Favored 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.592 2.861 . . . . 0.0 114.524 -174.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 21.0 m . . . . . 0 N--CA 1.473 0.722 0 C-N-CA 126.931 2.092 . . . . 0.0 114.36 -176.028 . . . . . . . . 0 0 . 1 stop_ save_